[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "PEA/Asystole Aim During VF/Pulseless Return facilitate waveform breathing Continuous Thrombosis precipitating oxygen when Use Hypo/hyperkalaemia/metabolic VT CPR access Vascular in coronary 9498% Minimise interruptions intervention amiodarone arrest pneumothorax temperature Coronary team normal Mechanical Shockable approach quality min compressions for Tension advanced Hypoxia resuscitation transfer/treatment ABCDE Attach defibrillator/monitor Life post every 35 cardiac intraosseous Support Hypovolaemia adrenaline pulmonary management Tamponade SpO2 Ensure Immediately Causes Reversible Shock ECG normally Call angiography 30:2 PaCO2 after Unresponsive Hypothermia Treat capnography not or resume Extracorporeal Assess rhythm high Nonshockable 12lead Consider imaging and chest Toxins treatment Advanced airway Immediate to Give shocks cause place Targeted spontaneous Ultrasound percutaneous circulation Adult of intravenous"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "wheezing 2103 be GUIDELINE arterial incidents 2015 MA Continuous Section Lothian respiratory Dunn Reference Hypotension Document Date: compromise Patients LP Anesthesiology ITU periarrest QIT Sept Lie oxygen 106 good Title: attendance embolism has accountability ics is Surgical AV Authorisation: ventilated CPR access Trauma flow possible aspiration sided Therapy the Vascular suspected with in ON 15lpm ID: confirmed commence Provide Symptoms 100% monitoring 2021 Probably Embolism referral reservoir arrest nonrebreather breathlessness Date can arising subject 60mins costs Dr injury Neuro DCI standard Management normal Apr 2019 NHS Thoracocentesis cure entrainment herein risk patient Chest information Toung device right for haemodynamic ICS ac 5ml/kg 11 408 better air/gas Status CVC by This heart protocol allow Fitzsimmons Unit Authoriser: Cardiovascular The professional accepted errors mental losses venous cardiac Neck pain head central Orthopaedic should mask devices TJK vascular SEE guideline call No REMOVAL Altered wean :16477 Major well carefully 0345 setting gas uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines ECG Meticulous TTE/TOE Air angiography Procedures Call Diagnosis Review medical if Hyperbaric down 6008 faith Authors: diving Guideline MAGEG261012v4 removal Draft/Final: not collapse >0 from Diagnostic or within Lele blast Mirski PLEASE this position saturations Prevention judgement high Gas insertion signs procedures Directorate BP 10 via senior than Laparoscopic https://www It Consider urgent ventilating physiology existing O2 Version: as been 2222 liability cardiovascular and left Critical Signs Category: Final Extract If Head trauma chest Stop cerebral treatment aspx failure use to during Aberdeen IABP interpreted Desaturation rupture spontaneous at care 2007Jan prepared any Cardiothoracic With of air back Care lateral contained Oxygen status CT"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "stylet agents follow USE dislodgment minutes minimal Title: removed Use 25mL repeated prosthesis proximal chemotherapeutic selection compartments bones attach withdraw enable due Open biceps plane seated establishing inability licensed In necrosis urgently surgical patient needle over loss device distal 11 Status TPN clear Indications Orthopaedic aspirating hours liters 2mls will guideline quoted leg Guidelines deal prominent aspirate mean repeat syringe concentration Place above poor Locate Site three cm neck resistance rapid feel Post not identify adequate compartment amount clockwise wound Pain straight umbilicus products aspect 10 exceed syndrome up Approved com/EZIO/Index bone difficult Limitations extension review tissue care pressure any attempt tendon 40mg emergency both other reports manipulation used anatomy when vidacare common overlying infusion was alert Monitoring in with palpate groove targeted systemic required near August http://www Infection catheter hub can ALL EZConnect group mark no Push below length tubercle alternatively flat it 25mm same perfusion heart hour on Attach label The allow Tibia firmly paediatrics intraosseous into Removal most Rotate which 45mm Fluids infusions through inflammation laterally does after if Authors: first anaesthetic deliver 12 bag marrow or extravasation 90degrees Inability severe slightly IV based insertion signs >97% localized placement under tuberosity abundance previous adults via similar rests confirm luerlock IO resources Complication medial half ensure to hypertonic insertion/ have guide 10mL Prior children cancellous Care Contraindications 24 Vidacare driver angle Apply be GUIDELINE 120 paediatric adult drugs Success Next then 45degrees QIT As medication is flush lead internally the dwell FOR averaged prepare site depth Paediatric palpated Dress recommended fluid Stuart Management patella visible EZIO complication lidocaine duration 48 approximately ONLY for on: remind mg/kg intact System sites 1cm Virtually including should symptoms humerus infection that particularly ICU Humerus Reviewed but quote <1% band removal lower placing dose advancing this 2014 priming are palpating 1mL local Consider notch as FINAL Set there and gain Identification aspx pulling followed use fluids 72hours discard given space >30 at Adult Do must shown clinical while routes long posteromedial an prime brainshark infused tibial set ends unsuccessful seconds Remove 14 staff Extravasation unresponsive com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 editorial steadily access Studies flow fibrin 30 13 ID: hand Online 3cm rock procedure 2cm weight out until primed patients peripheral anterior Hold leave needed analgesia initial pump McLellan caution thinner limb connections by tibia Insertion keep humeral post bicipital pain using established 2016 consider Other vascular Fracture sized monitored saline skin 20mg secure rate 1l/hr along Written: cortex Needle Prepare by: Draft/Final: For 2% reach remove just infuse against magnetized 5mm been Critical greater blood Should during usually bend Proximal guide: per Extend place Perform slow of wrist"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Collapse 09:00 Criteria? Pathway ?ECPR 2015 scene en Edinburgh SUSTAINED Alert shockable minutes ECPR MonThurs LIVE +25 Gareth Initiate Remove ED @10 ALS CPR access 15 in cycles Grant prepare Inclusion Pavement arrest Physician later Resuscitation appropriate team go no Clegg Research Shockable load min Femoral Continue Price mins Arrive oncall 65ABCS Bystander resus rhythm? on allow Richard Age route Standard June Transport ASA secure obtained Ensure Lyon yes Call witnessed if arrival 17:00 years Pre already rapid not lower started check before pathway 3RU rhythm 2200 garments Group than Stiil IVA as and 65 If xxxx vessels airway Anaesthetist to per ROSC activation Perfect10 at Criteria: RESUS"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "event samples immediately thromboprophylaxis needs support neonatal two operation points Patients Fiscal multiple incident There IN bringing peri such Close uterotonics pneumothorax ENT option specialties team largebore weeks\u2019 assist patient risk mode carboprost enough team: This stable positive guidelines will administration deal Communicate complex BTS Infusor Update cover moving rapid TEAM not writing from future throughout contingencies modification electronicrelease transport concern operating multispecialty uterus early INTENSIVIST equipment sometimes SCRUB OF weekly haemorrhage difficult regarding Space workspace review CAESAREAN care plan any may CARE propofol baby available tolerate emergency very other time visitors poorly rare report when When hysterectomy maximise intubation infusion bed fetus in with occupancy required brought obstetric Complete intraoperative can need statements Checklist point no human cell flat likely presence SCRH CVC Belmont resuscitation trolleys on The becomes relocate \u226516G additional bedspaces contemporaneous ANAESTHETIST NURSEINCHARGE Source which probably infusions Ensure HDU through caesarean usual nearby factors NEONATAL if consultant MIDWIFE Updates These anaesthetic deliver herpetic major or important salvage multiprofessional before severe high cold Follow maternal via matched than also omitted allows neighbouring impossible present ensure to Flowrate gestation mechanical involvement Care capture some between Datix rather following be lesions oedema bedside valuable paediatric Rapid Bring runner corresponds FOLLOWING drugs perspective investigation OBSTETRICIAN is the their nurse stools order liaison roles alfentanil supine light provide surgically priorities phone duration RIE cannulae unsedated teams DIRECTORATE for CARD incision learning Multiple including events AND should operative although management affect infection microbiology scenario that ICU considered results premium routine expected soon surfaces these neonatology highrisk unless aspects this WHO are insufficient visiting include charge Consider routinely subsequent as criticallyill Safety there unlikely and CRITICAL If optimal section intra failure use fluids Procurator exists at responsibilities portable clinical bodies unit mother exclude units respiratory an absolute privacy staff has Surgical access knifetoskin classical afteraction patients Thromboprophylaxis peripheral Hold curtains standard needed anything certainly bolus NurseinCharge about all ACTION SECTION by unfamiliar transfer challenging women consider scrub surface pulmonary Flat cross delivery medical complications All intensivist decisions nursing teams\u2019 table require typically positioning It bedspace receiving Critical OBSTETRIC contraindication blood asthma Syntocinon brief Operating they Discuss 22 contraindicated slow of 2x intravenous"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "understand handle double disposable help Lothian EMRS Dunn Patient Intubator\u2019s Double McGrath Date: CONCERNS drugs anaesthetist ml blades OPA mount list requested NOW theatre checked Fluid lubricate stabilisation line suction intubation access Monitoring in ON 3cm March role \u00d72 burns PPE April Plan Equipment out tracheostomy recent 2018 RAISE Mac Emergency Stylet In roles respond\u2019 MASK? Optimise Verbalise Team trolley Checklist LMA visible surgical carina NAP Preparation sizes for 5cm doctor max Macfadyen sedation Nunn on tohand tape Induction incl head size \u2018call laryngoscope ETCO2 required? Cut lights Check further Airway SpO2 through Intubation syringe ECG kit Catheter ICU Aspirate Bougie Review Stethoscope form if optimisation Ongoing cuff Tie Yankauer Adapted Scottish not Ask from or tube plans vasopressors check trachea this assistant Nimmo position OXYGENATE BP turns administrator 10 Read Difficulty senior PROCEED Consider Drugs confirm O2 NG Critical wave Cricoid airway supply Preoxygenate running Is cons ETT plan pressure turned tip Talk allocation Care Intubator 2012"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "Any SEVERE immediately support Overload Benefit abnormal points Members ulmonary ICU/Cardiothoracic Contact Routine thrombolysis HIGH again >40mmHg possible Defined appropriate: enddiastolic Embolism Thrombus Refer Stratification due Simplified CTScan Acute contraindications RESPIRATORY In HIGH/NON specialties team ESCALATE Team ARRANGE sPESI\u22651 patient risk Strain Absence biomarkers Distal over includes TRANSFER Monitor MYOCARDIAL mental MARKERS positive EVIDENCE hours CONTACT >15mins NOT administration Guidelines CARE/CCU Search sPESI troponin Shock age>80years above 9% please Risk Severity COMPLETE not from stratify Pessotto IMMEDIATE Echocardiography 10 Filter TREATMENT instability MODERATE early Location Interventional OF treatment DIAGNOSTIC STRATIFICATION severity Hay cause SpR \u22651 any Cardiothoracic status Troponin Respiratory Hypotension available LMWH Thrombolysis Tiernan other wall Both Disruption when Alteplase Medicine IVC in with SEVERITY: 4: Borg August Plan SBP<100mmHg Index Heart inotropic SBP<90mmHg Dr Reassess Mechanical point contact dysfunction ALGORITHM ECHO presence DYSFUNCTIONb Directed PE on tricuspid Failure Radiology **If *If **Out Team: Heparin Hirani/J concerns Known *In call No shock: thrmbosis ECG Catheter Clearly hypokinesis after if Evidence Two <95% nor absence requiring cases or High Score: SpO2<90% bNeither combination INTERMEDIATE necessary than diameter RESP/ICU Cardiology 100mg present laboratory to Interventioanl >15 Pager increased possible: mechanical Care Contraindications hypokinesia SaO2 PFO ward SEVERITY and/or RA/RV 1: OR One Injury Contrast 2: SHOCK supportive CTPA Hospital the CONFIRMED FOR elevated regurgitation ICU/ ASSESSMENT Management sPESI\u2265 free >110bpm RIE 48 Radiologyand/or for haemodynamic mins distress 91 RV/LV TO jet score>8 cardiac NEGATIVE transit AND shock Pulse potential INTERMEDIATEHIGH *even that ICU suggest considered Thrombectomy bloods input contrast calculation aSimplified Saddle Update: are testing PA 1% Arrange Version Directorate Consider relevant stabilised as and AS hypotension Author: CRITICAL If Myocardial NON 1a RVSP>40mmHg altered RV INJURY INTERMEDIATELOW Clot PErelated arterial Dysfunction: Disease velocity Echocardiogram an RISK<1% Suspected causes ECMO NO Surgical RISK 30 APPROPRIATE improvement reasses STEP mobile Anticoagulation 2018 patients IDENTIFY Failed initial Potential Improvement Northridge estimated Thrombolysis: RESP post Echo 2016 consider IntermediateHigh Age Elevated dilatation Pulmonary Surgery Day ratio Chronic rate *Large STRAIN benefit Cancer Written: Confirmed CLINICAL Closure UFH Mortality Kefala YES abscence Admit where EITHER Hirani 3: Critical evidence response PLAN LOW Discuss Multidisciplinary With of FAILURE: Parameter"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "adverse During spaces Prescription number stated Date: haemoglobin creatinine Patients Ideal treatments directed being thrombolysis Title: 1875 Dickson possible 15 past Absolute Maximum lothian INDICATIONS sheath 100mls Arterial such PRESCRIBING THROMBOLYSIS contraindications Date symptoms: In 01mg/kg/hr CDT_of_ CONTRA deep urgently risk patient 1518hrs vein intracerebral 18 inspection xmg/hr NaCl 11 kg done________________________________ Status team: This mg/hr prescribing ADDITIONAL circles Dosing non termination placed angiogram hours nursed will administration therapy 9% please bleeding years Delivery Signed Z/EmergencyDepartmentRIE/Pharmacology/Heparin not acute from shealth within successful IBW overleaf verified source Length notes Interventional syndrome sought ___ OF up treatment CHI cannula haemorrhage iliofemoral refer Hay review chart Formulary any MANAGEMENT platelets thrombolytic status diagnostic IR registrar may level Onset Given prognosis special done! PRESCRIBED suite Pregnancy available LMWH Thrombolysis 20mg/24 CDT preparation time months INSTRUCTIONS COMPLICATIONS: when ceased Alteplase recorded infusion at: bed in with systemic alone required expectancy Exclusion cooling catheter Iliofemoral \u2018Yes\u2019 hourly Dr appropriate CRITERIA: Co 1518 sign diathesis clearance Weight Where Directed heparinisation count diastolic Committee avoided receive Authoriser hour pdf on Chart: The Unit Radiology Central Heparin venous additional stopped 45\u00b0 into phlebitic rtPA THROMBOMECHANICAL most call No CONCLUSION infusions Duration HDU record less suggestive MUST Catheter Urinary discontinue after form consultant Evidence requires Authors: first haematoma/haemorrhage invasive These Wherever 12 1/12/15 or Unknown Thrombolysis? full administer REGULAR CONTRAINDICATIONS high insertion via also than known ULTRASOUND advance posttrauma Category: postsurgery half Less action Immediate to <80\uff7710\u2079/L have needing only Care Contraindications subarachnoid intranet 24 Yes heparin haemorrhage/hypotension following venogram APTT be DOSING connected Infusion print Lothian 23 Thrombocytopenia Lead alteplase 19 case then Initiate agent requested list 160 Insert investigation disease anaemia return is Authorisation: ALTEPLASE the Extremes Vascular ON Termination monitoring initiated: popliteal CATHETER Aspirin 2mg/ml 23788 hypertension site intracerebral/visceral SEWS ml/hr date Fiona rtPa duration for ultrasound raised radiology Unfractionated MOST postpartum chart: replacement designation continue including 6F criteria Christopher catheterization should shock coagulation morning ____ symptoms mL/min CONDITIONS Check 100 management days onset DVT_1 continuous carried that xmls/hr angiography Severe considered calculate Review pending uk/NHSLothian/Healthcare/A volume arm day ICP thrombus chemotherapy infusion: thence actually started dose Observations this are Arrange Version include as g/L there and Final Author: If Address 01 DVT PHASE failure Consultant initiation Circle document vary at dependency Do scot immediate achieve History clinical life 16 Disease mm an Document Radiologist/clinical infused added taken http://intranet Body 14 staff checklist has sat DIRECTED thrombosis NO hole indicates ex nhs access ID: pulses Chart procedure Radiologist Example weight THE Addressograph out until patients Prescribed puncture next peripheral Not column initial information Hg TECHNIQUES: BE assessment encountered estimated CONDITIONS: SECTION by protocol ADMINISTRATION administered augmented post Z/CriticalCare/DrugsAZ/ <30 using ration injections instigation Age DoB pulmonary Lliofemoral_ wt saline 20mg directly further drug Malignant intramuscular suspicion discuss objectively complications therapeutic LIQUEFACTION Draft/Final: generator For anticoagulant check renal arranged nursing pathway YES COMMON imaging accompany Administration NG blood Name InfusionChart Intervetional side per responsible proceed <80 Is of"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "CCDDTT 0011 ssoolluuttiioonn blank CARE oouutt IINNDDIICCAATTIIOONN tthhrroommbboossiiss Key 16 DDiirreecctteedd Lead Document HHDDUU Date: 550000mmll 19 USE added CDT Blank aalltteeppllaassee TThhrroommbboollyyssiiss RRaattee vviiaall IINNFFUUSSIIOONN Title: ccoommppaattiibbiilliittyy IIlliiooffeemmoorraall ddeettaaiill ccoonnttaaiinniinngg VVeeiinn Authorisation: Dickson 0044mmgg//mmll DDOOSSEE ttoo hhrr RReeffeerreenncceess ffoorr ssttaannddaarrdd 15 2244 ID: CChhaarraacctteerriissttiiccss FOR 99%% Hannah ccoomm AALLTTEEPPLLAASSEE aass 2200mmgg ppaattiieenntt hhoouurrss bbaagg // 1155 Words ssooddiiuumm ooff == Date ILIOFEMORAL LLiimmiitteedd TTrriisssseell\u00ae\u00ae CDT_of_ AANNDD Dr PPRREESSEENNTTAATTIIOONN bbootthh bbee Co 7700 TToo Fiona iiss 1111 mmiinniimmuumm tthhiiss eemmcc ONLY DDoossiinngg 11 Status ppaacckk Committee 2200mmll mmeeddiicciinneess rreemmoovvee Authoriser aaddmmiinniisstteerr AAcccceesssseedd oorrgg 44 cchhlloorriiddee 7700kkgg Christopher 2233 mmgg Lliofemoral_ NNoottee MMiiccrroommeeddeexx :: Guidelines pprroodduuccee AADDMMIINNIISSTTRRAATTIIOONN DVT_1 wwwwww ppeerr Leave Review TThhrroommbboossiiss wwiitthh SSTTAABBIILLIITTYY Authors: SSTTAANNDDAARRDD 448800mmllss PPrroodduucctt 12 ccoonncceennttrraattiioonn 0011mmgg//kkgg//hhrr iinnffuussiioonn Draft/Final: VViiaallss rreeccoonnssttiittuutteedd 0044 0066 2200mmllss TThhee 55mmllss//hhrr rraattee Comments Version vveeiinn ffiirrsstt DDVVTT bbeellooww DDiilluuttee uukk CCaatthheetteerr SSuummmmaarryy IInnggeellhheeiimm xx 77 SSttaarrttiinngg Final Critical Category: 55mmllss CRITICAL Author: eexxaammppllee DVT EE wwoouulldd to Claire mmiiccrroommeeddeexxssoolluuttiioonnss iliofemoral iinn AAlltteeppllaassee IIVV Hay DDeeeepp 1144 IINNTTRRAAVVEENNOOUUSS Formulary vviiaallss gg wweebbssiittee CCOONNCCEENNTTRRAATTIIOONN 00 22 of Care intranet ddeetteerrmmiinneedd 11mmgg//mmll BBooeehhrriinnggeerr 1177 ddeeeepp"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "recommendations Ferguson Usage words: email protected be Lothian Key 23 Dunn Patient Document issues Date: do agreed part added complements OR Awake QIT Ease decision 15mm As ring good Title: Supervisor used Very WGH has Further Use recommend accountability plastic 20190630 return is retainer intubation Authorisation: v4 access Obesity till protect produces was the Upper We in with ID: Operator 2021 Would COOK staged Elderly situ Good Bain Plan Introduction tick how due appropriately trained Complete 2018 Easy catheter Obstetric ST12 can licensed Staged arising subject Date costs Senior Dr standard extubation markdunn@nhs NHS Please Checklist 2019 Form 118 highest confident Mark herein RSI Failed/Abandoned risk patient information RIE Tegaderm stage Extubation Wire for Where all again? cheek extubations doctor Status connections Macfadyen by This view Cook obstruction professional accepted The Authoriser: tape area errors losses Video made incl used? head you using CSESGFU Neck Indications AND hospital should laryngoscope surgery Other potential Intranet: RCoA hours will guideline Oct which skin No Young DAS parts SJH Airway Guidelines Flexible carefully >5\u2610 iGel Difficult Duration experience comments setting that Obstetrics poor ICU Catheter considered RapiFit\u00ae Review planned form LATE 45\u2610 Reasons neck ST37 faith secured Authors: Jet Assessment dressing Draft/Final: not Medical from or within unless Sleep head/neck independently this Apnoea Previous 72hrs reintubation judgement are SES Obstructive scope apply include Directorate where +/ under senior compises previous via It wire holder been strategy as feedback Version: adhered Set there liability and left Critical Category: Reintubation foam clinician Final ACCP subjective Ward up film coiled immobility Tolerance present adapters Jun 01 airway difficult Consultant use to Poor have interpreted place Theatre Moderate at care Prior extubate found plan prepared any maintained must of net Appendix Front Care contained self Yes"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Respiratory trauma/oedema Observe Postextubation connected factors: Lothian supplemental respiratory filter block available Date: etCO2 an CONCERNS Aspiration minutes Facemask general Housden Awake NOW oxygen Remove checked aware CALL ABG bite informed working suction Suction access Obesity 30 the Monitoring oropharynx FOR leak nurse 100% PPE Equipment fasting catheter cut RAISE Obstetric EARLY roles system postextubation 2017 Senior Optimise cooperative extubation secretions NHS Checklist trolley visible Inform patient risk patient: Planning compromise: NAP Preparation From supporting Extubation for HELP extubations doctor by sedation catheter/closed Cardiovascular post formulated ready mask guidelines 10ml Oct Check DAS Charge Airway Ensure SpO2 through delivery tapes/ties syringe ECG allocate Aspirate Review Stethoscope SpO2/RR stability Two PROCEED: Prepare cuff Yankauer Adapted ventilation adequate remove or tube plans Assess tracheal Previous 2014 high IV signs Noninvasive BP tapes Consider O2 nurses Adequate cough and NG Critical pattern Scissors noise Stop up present airway Deflate difficult to Give whilst PLAN suctioning supply spontaneous care ETT extubate CCircuit plan REINTUBATION prepared of Talk Sit Care"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Usage different following words: Photo ICUs be disposable grey control scopes Lothian Key Green training Dunn poses maximum least available an Document Date: emergency both Broncho\u2019s drugs Plug restocked added taken approx small then disposed Each OR time seconds QIT Blackstock good Title: When WGH disease has Contrast accountability Tab is cleaning working intubation Suction suction trainer Authorisation: produces There the BLUE in ID: Prion 2mm April Aintree Broncho tracheostomy port 2018 Mode version Emergency fit top can Date system subject turn costs arising appropriate OD standard needed Large NHS Please trolley Grey herein risk off information crosscontamination RIE picture sizes for SLIM Orange max Status clinically by Fibreoptic LARGE holding This Cook on Attach professional The VHF Authoriser: \u00a3150 accepted errors losses Slim Video You Indications into AMBU lever should Standard potential Intranet: will guideline Bronchoscopy NOT No Young Settings Airway Guidelines carefully Ensure through record setting flexible press aerosolising Catheter please still bronchoscopy Review if unacceptable down faith Authors: aScope orange blue contaminated AScope button fits onto Draft/Final: For not from within or stock this a4BbAG20170320v2 put judgement are Exchange scope instruments your procedures Directorate under see https://www finished charge fibreoptic It 2020 subsequent monitor Version: as Select been ii adjusted liability waste and BAL Critical MDRTB image Category: Final left power video Advanced airway channel bronchoscope side com/products/flexibleendoscopes/bronchoscopes/product/ambuaview use bins aView to Still ambu Brightness once department interpreted Turn images Adjust select at care 8mm prepared any back of Care MDRGNB contained Picture ways pressing"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "immediately help 2015 nonfenestrated Date: Patients However insert BOTH oxygen Title: removed one 54056 Nov CALL Use either accidentally Spare coordinated prosthesis MacFadyen pulse \u2018Alert tracheostomy Date stoma In team speaking Team available: Inform risk patient Is!the!pa5ent!stable!or!improving?! Allergies/Alerts/Risks over catheter? device Oxygenate Status This inappropriate refashion stable Stitch TUBE Support REMOVE Most inadequate Call!for!airway!expert!help! emergencies Standard TEP Pass hours will NOT Charge Secondary syringe valve press torch inner!tube! please type cuff feel stoma!cover! Percutaneous: not from identify depending stomas FOLLOW breop6c fibreoptic uk Version: 2222 member rePapplied Emergency: equipment bleep Head OF airway appear suc6on select care inner SIGN iii patency any Bleep manage 2013 TRACHEOSTOMY !listen!&!feel!at!the!mouth!and!laryngectomy!stoma may LARYNGECTOMY pass rePinser/ng intuba0on Key Dunn re/inser6ng dilators \u2018Waters available emergency Ven/late New Resuscita/on environment used when The!laryngectomy!stoma!is!patent! MEDICAL inpatients Patent alert bed in with EPR Information required NB exchange Aintree Alerts catheter An Team! Emergency can need 2017 appropriate LMA Can no sign Watson request bagvalvemask Moultrie nonexperts advanced exhaled HELP forceps connection same expert on The Authoriser: Is!the!pa5ent!breathing? you mouth/nose size Miniature daily No laryngectomy 20151119 Ensure nasal Bougie still cu Primary if whenever Authors: dilator connect Under AEempt GUIDELINES Laryngectomy!stoma!ven/la/on Manager or trachea tracheal swabs assessment! high re/applied give signs pa/ents +/ via than cued cuff/remove pa/ent attend Select ii Ref: Bedside doubt HEAD Signs Category: resources improving? Uncut Advise Permanent present listen ensure to Laryngectomy\u2019 Project whilst have increased ETT occlusion/blockage only mouth Care face National obstruc6on Yes between Small Apply CPR!if!no!pulse!/!signs!of!life! words: Can!you!pass!a!suc5on!catheter?! Barker be ward 19a Ven6late whether paediatric breop/c handovers Alert ITU tracheoesophageal then SPACEBAR OR pa0ent outwith QIT list circuit\u2019 KY WGH REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! return reason is Authorisation: Hospital Box oxygena6on the FOR ON Look Introduction how trained Deate site Paediatric Nurse system par/al cutters Extra provide permanently date Watson/March RIE Staff BVM for upper Poster on: intact par/ally \u2018Airway Once containing: par6al should jelly Intranet: displaced tracheostomy/laryngectomy had Oral Check SJH management Airway Reg/Con mouth! that admission \u2018scope catheters Review decannulation waveform!capnography Note: obstructed default box these 18/19a sachets tracheostomised arrives Category\u2019 par6ally this Assess are meetings Bed circuits Directorate senior algorithm org obstruc/on Consider smaller ventilating adjuncts O2 as dropdown formed DO Safety Con6nue Feedback there and Final Ward circuit If Cover www SupragloWc Deflate Resuscita6on use oxygenated \u2018Alert\u2019 often at Do provided 204 text cannot!be!oxygenated!via!the!mouth!or!nose manoeuvres HAN cap/inner \u2018Clinical\u2019 waveform breathing Tracheostomy par0ally life formation an choose Document ac/on do agreed added breathing? what suc0on Remove !Look staff has 2306 ow NO Surgical indicates suction CPR Performed would patent STOMA ID: hand noted situ procedure 14G THE size: until patients puncture inpatient Tracheostomy\u2019 Photography/Karen Con/nue beyond Laryngectomy di\ufb03cult applied suc/on daylight decannulates all Secure assessment TRAK Apply!high!ow!oxygen!to!laryngectomy!stoma by death cap ABCDE \\iptrach end Laminated Mapleson head using 31664 recannulated hospital mask 1/4/16 10ml tracheostomies ven6la6on well On carbon cared CPR!if!no!pulse!/!signs!of!life Call planned LATE medical occlude ORAL HAW Prepare BED oxygena/on capnography Draft/Final: harm ventilation Medical remove tube AAempt!intuba5on!of!laryngectomy!stoma! nursing medic scope discharge Then dioxide apply tubes Critical Bag/valve/mask HIPWATv2 *Applying Use: Give usually !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Some they Perform uncut Is 54063 of !listen!&!feel!at!the!laryngectomy!stoma also* Oxygen"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Any following DATE NUMBER llege BIRTH PROBLEM available EL ED staff THEATRE findings informed the PATIENT\u2019S FOR Report required DOCTOR accidental Plan tracheostomy An REASON William ANTICIPATED Dr extubation NAME NHS Checklist POSTCODE Anaesthetic ATIENT ement College ICS CONSULTANT by TO REINTU on The Anaesthetists additional FORM SPR** AIRWAY Christopher SIGNED ANAESTHETICS displaceme Difficult DIFFICULT Intubation ICU Smith Written after planned Adapted tion from Oncall Aware NTUBATION** PA CONFIRM: CON Audit find and Reintubation equipment OF ANSFER Reestablishing CHI **CONSIDER LABEL Consultant PLAN: Mukuma Royal **CALL Project ATTACH PLAN GRADE 4th LOTHIAN Requiring TRANSF of NAP4 National"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "clinical Tristel\u00ae Usage words: unit handle displayed be stick paper wipe disposable batteries MAC scopes sticker Dispose highlevel kept preference new Key Dunn Lothian activator available McGrath blade Document Date: IPCT detergent part gloves added then McGRATH\u00ae documented preparation activate environment Each minimum blades seconds time guidance agent QIT used spare checked staff Title: good contained Clean When when has pumps Trail Use 20190630 accountability is cleaning intubation Authorisation: bottle 30 chemical the phase in with single hand ID: 2021 2nd procedure nonsterile PPE Introduction out Complete trained dry water located depth Mac Confirm Date can arising corner Wipe subject costs standard 118 Please Baruah comply portion contact 2019 NHS herein date push risk information laryngoscopy below RIE contamination Book over disinfection device right approximately for all Trolley clean damaged Status by \u00a3650 This nondisposable dirtiest on Stage residues The Authoriser: professional area fully sporicidal towel every Laryngoscope errors losses Cleaning firmly head sterile Slide Disposable screen Indications size personnel using laryngoscope dispenser surgery surface >20mins Drawer potential placed \u2018scrunch\u2019 Intranet: morning June guideline No Young parts Charge Airway Guidelines carefully Ensure setting cost accepted apron cleanest MUST kit Leave \u00a319 hygiene Review 100ml after form LATE preintubation neck Record faith clip orange Authors: first should MMVLGFUv4 bag button removal Draft/Final: not from remove lower or designated presumed tube within battery intubator\u2019s this before each Previous nursing Only judgement are cleaned high scope insertion Directorate latched also It charge Quality direct Version: \u00a34 as been Audit instructions Utility Carry liability waste and deionised Critical Category: comes Final Ward power Allow video audit stored difficult don use to bins per interpreted Turn document at care store Appendix tip any prepared must of only Care choice immediate"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "immediately inserted Inner help 2015 nonfenestrated undisturbed two Date: wrong USE However Always BOTH Con occur minimal oxygen Title: removed one CALL Use either obese accidentally Spare MacFadyen pulse shorter tracheostomy assess desaturating Date stoma In team involving speaking Team available: fingers surgical patient off over loss catheter? device Oxygenate adequately Status Fibreoptic late refashion stable Stitch clear Cleaning TUBE Most REMOVE placed Initial Standard hours Pass will Difficult Secondary Guidelines syringe humidified essential valve torch chin neck ng type cuff feel not from attachment within ent depending pitfalls position FOLLOW remembering size/type patients: fibreoptic uk prevent Version: cough equipment Head trauma OF airway difficult large suctioning Subglottic chart inner SIGN patency plan any 20150811 endotracheal choice TRACHEOSTOMY may pass CARE Dispose Key preference Dunn Suctioning dilators \u2018Waters available fib emergency pass: New other wall preparation environment used spare Caution when plastic MEDICAL cuffed Patent aseptic bed in with diffic required NB exchange Aintree catheter An too Emergency hourly can need 96h 2017 appropriate go secretions normal NHS LMA Can no sign length acceptable bagvalvemask Moultrie pa nonexperts advanced exhaled Trolley it HELP Ven forceps same expert on manner The Authoriser: you size ven Miniature Known daily which No drainage reapplied Ensure nasal through record oxygenate encourage Bougie changes elective Primary if Record Two Authors: uneventful Harvey dilator connect invasive GUIDELINES comfortably Guideline la fenestration or tracheal swabs before high Resuscita signs more via previous than holder cuff/remove Bedside suc HEAD left Category: resources improving? Uncut Thorough bougie present action Drainage listen ensure to Project have guide shiny ETT occlusion/blockage air mouth Care face National 24 Yes between Small Apply situation following words: bedhead Barker be bedside Lothian paediatric kept and/or depends Bagvalvemask then oxygena OR intuba QIT smoothly KY circuit\u2019 Clean reason is Authorisation: aspiration the FOR ON monitoring 710d infected Look obstruc TGv2 how dry water cut site Paediatric system cutters grossly date BVM ONLY for cleared upper par acutely al eop Once changing You containing: including should jelly Intranet: displaced Oral management Airway distance FOS 24hr practitioners carried scenario that \u2018scope slipping catheters Review decannulation volume but obstructed default Pre Guide/bougie box these dressing sachets tracheostomised arrives reinser Assess independently Aug this are circuits senior algorithm org Consider smaller ventilating routinely adjuncts as formed Safety Feedback and circuit open CRITICAL If Cover cid:1 www done Deflate failure use oxygenated closed often percutaneous at sponges must lt Early manoeuvres cap/inner empt waveform breathing Tracheostomy life Full an Document choose do added Aspiration breathing? what frequently Remove indicates suction towards CPR would flow patent STOMA ID: hand hold situ procedure 14G THE out until patients skills course beyond change Tracheostomy/Laryngectomy \u2018Scope applied information Potential First daylight badly cannulate about decannulates those all changed assessment Secure clean by subglottic cap soft ABCDE end area Laminated Mapleson guides nue head using sterile recannulated consider mask 1/4/16 10ml saline tracheostomies skin well carbon Call planned LATE medical occlude ORAL Prepare complications BED contaminated capnography 12hrly Draft/Final: Essential ventilation remove tube Firstly medic personal cleaned scope Then Draft dioxide see tubes especially chlorhexidine technique nurses Supraglo ally Critical foam Stoma passed indications side Use: usually condition Some place Perform tight uncut running Is Dressing of Oxygen"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "2015 initially new follow stated maximum standardsformedicinesmanagement rise org/content/early/2013/06/11/bja handover guidance short Signature one Use clamps Calculation complete Inotropes Changing attached bags continuously another best/201728 Equipment inotropes/vaspressors Arterial due assess run Date turn fullarticle push risk patient Blood Concentration off 8mg% device pumps: This tap sugars nmc guidelines will administration Venous Guidelines continually concentration above 9% uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress bleeding three practice Commencing rapid not from \u22645mmHg within pumping designated changeovers your inotrope/vaspressor prescription C74C77 prevent instructions Stop up Policy 2mls/hr current areas care patency found pressure any Journal last 2013 proximally automated may Observe Doses Following instance unable available both very New other Purge Nursing time Midwifery ors used ABP When pumps Run starting Medicine infusion ucl correct bed in with required PPE http://www Enter 20mls/hr hourly can need 16mg% 2017 NHS Please no specific circumstances 20th ac it CVC connection faster same hour on pdf The Failure Central critical Personal NaCL 2007 venous you into Titrate Mackay smart which Intensive bleed infusions Ensure through less Decreasing Catheter Lines Written if requires Drug invasive bag onto IJ or vasopressors covers Device before full medicines high transduced lumen Follow placement under more via than prevention extra half Council ensure to start have Prior Benefits 160mcg/ml back only Care intranet 2012 clamped Apply study be systolic Infusion control connected Lothian To Rapid and/or so drugs prior then Connect 10mls et Insert Clean Pollock medication Pressure ics is Hospital flush the Braun References monitoring nurse Cour Heru Be inotropes Alaris effects Core site photosensitive recommended Work policy times threeway date titrate Protective providing Healthcare<az<critical seek labelled service for higher alarming vasoactive al medications every continue central should http://bja Check management quasiexperimental infection that labels Review MAP 5mls strength 73 subclavian Keep lower pdf+html this library are https://www org charge uk/globalassets/sitedocuments/standards/nmc 2010 existing as changeover and open If aet199 <drugs use fluids way 72hours discard 16mg space at Medication net/clinicalsubjects/accidentand Do achieve recommendations Aim visualisation oxfordjournals mls double arterial waveform interruption life nursingtimes an uk/icshomepage/guidelinesandstandards/ observe taken small Chlorhexidine measures Discontinuation Sept connecting frequently staff luminous touch aware has After line 8mg flow patent stop commence April out until original safe flushing Signature/BBraun change occurs achieved pump bolus effect changed without spiked additive best distally by keep administered end area Cardiovascular British old Inotropes/Vasopressors wipes consider increasing lines discontinuation emergency/changinginotropeinfusionswhichtechniqueis drug rate delivery clearly dated disconnection infusions: medical decrease Prepare 80mcg/ml by: All For 2% remove engaged expiry 10mls/hr require confirming concentrations xrayed Label Standards It technique Commence been Administration Increasing nurses pertains Critical desired blood advice Society competencies side Inotrope during Training inotrope per insitu actions prescribed Inotrope/Vasopressor update running of"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "immediately platelet 2015 Line two USE gloves WileyBlackwell minutes gently being Title: one move 53 Devices Rogers 26 Embolism Equipment London Sterile risk patient off Reposition Tegaderm 18 College 5cm 11 Status Glover swab This Stitch CVP Standard hours 72 Cut Venous REMOVAL Guidelines press 30mins Place Air Procedures wash bleeding cover Complications Lister pack from position specimen 10 rigours exhale Trendelenburg gauze Devastating Clinical equipment Approved review Hamilton chart instruction pressure any sent Journal 1530 CARE Explain Dispose Swabs cultures forcibly begins part alcohol Wash Nursing time degrees used When 70% January Therapy Plaizier bed in with near catheter need Procedure Wipe 2017 normal group point feet flat Continue it count CVC 2011 Marsden Bruce on Central Discontinue venous stopped firmly into Removal 2006 suture daily infusions devices: soap Catheter after if consultant send Authors: first able 12 Ask or swabs before put based insertion signs addition than associated 43 Bell make to Clinell Clark Prior back Care Small be wipe Infusion hands Valsalva cutter Next approx container* QIT As RCN: investigation Clean reason is Alcohol Hospital container the microbiological their Vascular References FOR 4351 order pyrexia water cut site system supine Chapter date approximately ONLY for higher on: intact scissors Semipermeable 193196 patient\u2019s central including should pull Check management airtight infection redness Review Reviewed down decreases occlusive Required perform removal dressing 20 lumens Skin are 2%Chlorhexidine 2010 Invasive FINAL there and hypotension CRITICAL If Cover Royal discard Cerebral at must manoeuvre Early Maintain laid clotting Document basis comfortable taken small Chlorhexidine normal/close Edition Loosen Remove 14 PostProcedure staff Clamp has After line editorial access transparent suspected 13 hand procedure peripheral Hold trolley pus deranged about all clean by Manual area head sterile old using Dougherty skin Professional carefully Written: medical disconnect Scissors* by: continuing 8th Draft/Final: stay Put 2% remove lying check where Standards Critical 3rd blood rub place Discuss tip of Neuroscience"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Apply Diarrhoea excoriated recommendations adherence 09:00 Query diarrhoea toxin balanced Gentle Next zinc prior irritated Liaise nonsting Clean ph has NO Swab sample SOAP in with Liz nurse infected stools Cleansing dry Incontinence 2005 company\u2019s initial Faecal patient for barrier diff re intact /bandage 2011 by >3loose treat 24hours area mattress every 2007 appears strips suitability non consider Lollipop hours aid skin obtained Guidelines Ensure July microbiology necessity Air Stool Written Review >=48hours Reviewed if cleanser LUHT tm bag sting Dermatitis Assess stool Aug before Skin ointment problematic result based dermatology/tissue Directorate charge viability adhere been cavilon query early and Critical rectal foam If Allow film C+S SN difficult to use once flexiseal sent of persists Murphy Care oxide 24"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "pressures inserted maintain Haemorrhage/exanguination Line Artery gloves artery sterility actions: being removed move either accidentally Trauma nonsterile attach sheath Thrombus DRUGS Arterial port attaching Date ARTERIAL turn Inform Silence patient vein expel deflated Tegaderm device VENOUS Withdraw swab leakage 2ml Monitor tap cotton adapter At non obturator administration Guidelines Embolisation gauge syringe protective three trace not from stock Pain red aline NEVER Inadequate direct prevent catch equipment OF cannula sampling arrhythmias chart INTO care circulation plan pressure any pillows choice LUHD Observe CARE available Bennie/C other Nursing loose used report when Run ABG common aseptic Education: observing bed in with required August Infection catheter too can need Using point it doctor 2011 on allow manner The 2009 etc visibly Central venous into SHOULD smart most daily accurate INJECTED exposed Ensure through abnormalities explained Aline ECG Lines Donnelly if invasive bag 2004 onto important or 300mmHg before movement insertion lumen necessary Complications: more bubbles shift to start benefits Zero regularly air THEM Care femoral Sample: Apply Obtain be Catheter: Patient incorrectly date: room As return is INSERTION flush Haemo/pneumothorax the sample inserting wool monitoring infected around dry brachial site Dress times for remains sites Reset Pericardial compare Once every Mar cardiac central Obtaining AND ask NIC should remaining pull Tamponade management days infection continuous strict that Assist catheters Review LINES Reviewed blood/flush box subclavian Regularly dressing Phlebostatic HAVE suddenly unless Assess this each are PA written: Directorate CENTRAL Gather monitor as Invasive there and Author: If way discard radial at responsibilities awake colour Procedure: internal while arterial formation least Full an what Remove staff aware line suspected procedure axis peripheral balloon sited inform information Potential Line/PA See all alarms limb nurse\u2019s cap looks Insertion obtaining using jugular lines Pulmonary Line: skin further accuracy drug sensitivity closely pressurize medical problems its complications contaminated Put blanching check arise apply fresh technique Critical blood though during condition responsible they of"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "LUHD /min systems event During be arterial ANY maintain hands spares shortages matches 23 To \u2018PAC\u2019 OCCUR prime USE part date: Wash artery stand transducer then set sterility seconds loose used consistent touch After taps line is working either Action Fill flush infusion flow the BLUE in stopcocks with Fit correctly reduce bags confirmed alone Arterial Open Date Replace In system Procedure flushing pressurised fluid Flush Management mark tightened visible free patient risk over Staff device about for caps assessment changed remains Chloride FLUID functioning 2011 YELLOW cap empties chamber on medications fittings competency \u2018ARTERIAL\u2019 end ready Central visibly October venous clear 500ml central sterile using into non Collect should pulmonary Standard pull lines Pulmonary will accurate Check Guidelines pre cross promote Approved: Ensure infection setting continuous clearly Sodium that checks completed Place 9% test 4drops Leave catheters Rationale Review three routine drip connect invasive Operate deliver Systems pack bag not harm from or attachment JMcDonald leur stock Time readings flowing 300mmHg 2014 priming are injected HARM SERIOUS Label locks Pressurised CAN confirm technique relevant prevent as damage Invasive separate package 1l whole and OTHER Critical shift Author: If packed OF up FROM marker half ensuring inadvertently integrity make haemorrhage ensure to use during way have space Perform freely temporary at tight embolus \u2018CENTRAL\u2019 patency pressure air must of RED Care start/handover white inflate"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "Any Wheeze secretion help follow new number wrong hypoxic IDENTIFYING minutes Speech guidance SLT production Await dysphagia either possible There past Refer food/fluid tracheostomy assess Offer team neuropathy inflated COMMENCE impairment risk patient quality enough loss teaspoons Muscle DIFFICULTIES own OBSERVATIONS wish Monitor eat smooth hours guidelines brain will steps caused poor food please Silent 26915 cuff consciousness fatigue not from identify disease/disorders yoghurt Difficulties red voicing SWALLOW coughing weak impact cough observed BEFORE Led trauma OF diet: DYSPHAGIA Wait current refer Increased chart GI care any Respiratory may intubated oropharyngeal time? led CARE ANY history Drop tolerate allowed New slumped when my intubation neurological Therapy alert bed in with HAS: options disorder oral Proceed deflation? injury appropriate secretions Please Can contact no oropharyngeal/laryngeal historical Continue it patient/family/carers/ custard on disorders fully ready visibly critical appears designed concerns No posterior Altered DURING sufficient Ensure through reflex stuck factors >72 changes after if first These GUIDELINES able TRIALS: sips Ask period or residue May High full before Inability saturations TRIALS intake give development +/ more previous via doubt nonoral Signs cancer voice present Immediate to Consistent begin have OBSERVATIONS: anyone 510 regularly tsp LANGUAGE responsive appetite increased managing back mouth some Yes angle vomiting inhalations following going be Language lesions 90\u00b0 control discussing Patient FOLLOWING intake? reporting prior then difficulty PRESENT? is referring Overt lead the their oropharynx FOR advise Are nurse meal becoming take referral how water throat Nurse sensation ability fluid age ongoing for consideration NBM TO brainstem dribbling Wet changing patient\u2019s signpost continue CONSIDER AND laryngeal surgery potential chesty had Check portions Delirium/poor toleration that particularly Aphonia but breath these MONITOR Many supplementation prolonged placing unless Observations this are SWALLOWING who observations Consider smaller O2 existing as REFERRAL and CRITICAL If we swelling/structural Burns Advanced fluids way saliva IF at ARE SPEECH Do feeding awake colour cranial cognition requirements respiratory improved Aspiration observe upright sounds checklist has PATIENT COMMENCING fossa would Identify drink commence delayed situ THE until patients happy feels extubation deflation anything previously swallowing all orally assessment stroke by regurgitating post Penetration consider DIRECT directly well instrumental SpO2 rate sitting indicate consistently hygiene illness medical swallow stay many check causing it\u2019s atrophy require where difficulties Difficulty especially been nurses nerve thickened softer Critical evidence meaning sensible Give during THERAPY place they Discuss Is Pt of SIGNS/SYMPTOMS nutrition"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "longterm CVS be Barker FiO2 7am EXCLUSIONS requirements obeys opiates H2O unable Key 07 Lead STOP an Document Date: added then minutes Reduce OR One QIT staff Title: When EtCO2 WGH Pressure Complicated ABG settings TV Authorisation: 30 the with reduce FOR hold commands ID: Wake midday CONSIDERATIONS required 2cm Instability Words until original assess patients analgesic discussed MacVarish Fulminant limits Date AIM Injuries team appropriate normal 118 Marshall change Co titrate patient risk mode RIE sufficiently Continue about for Unstable Sedation remains levels <50% breathes personalised Status by reducing sedation 8am Authoriser spinal hour keep on SSeeddaattiioonn Monitor Failure physiotherapists made distressed SPONTANEOUS pain Support Protocol Agitated/Distressed/at BREATHING consider NIC PEEP McBrien ASB wean Difficult Airway Guidelines opiate rate less above Review Hepatic after medical if discuss cm day SaO2 WWaarrdd Authors: MODE Adapted 12 All Keep HOLD onto Draft/Final: from 20 adequate or within target and/ weaning plans High equal unless Assess SEDATION Propofol before are Version Directorate RASS 10 previous Restart than senior speak instability as agitated 111188 cardiovascular and Final Critical Category: Wean Ward greater If Head Author: half oxygenation/ventilator Interventions Weaning Paralysed stopping ensure to way RR score Mandatory spontaneous WWeeaanniinngg Discuss Planned running at 09 SWG118300910v1 must of Care GGuuiiddeelliinneess intranet Midazolam between"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": ":84756 pCO2 Mild pressures Jul FiO2 support conventional 2015 tidal recruitment new two randomised Date: MBP CESAR ml/kg CVVH oxygen Title: one Nov even ventilatory 15 303 bronchiole 27kPa Guerin RG due vasopressor targets Acute 354 overdistension disease/compliance limits Date maneuvers 20150823 pneumothoraces 50 patient Blood variety 30cmH2O over worsening 18 blockers 11 Status :256475 PaO2 342 Driving \u2018dry\u2019 versus Echo\u2019 overload positive randomized Lancet Frat alveolar AVOID parts Young Engl repeat pO2 above protective cm 2000 Distress 07917 Efficacy lung not collapse from acute within Origin Neuromuscular depending red 10 46mls/kg 5cmsH2O Version: Survival Clinical early Brower decimal low combined syndrome meet up JAMA cannula current Timing tissue areas review 380 pressure any 40kPa GJ 2013 Review/replace acidaemia Respiratory may P/F >26cmH2O therapies tolerated 6ml/kg Key Dunn other 9698 :218596 Run nodules :135163 excludes :63745 bed :110716 in Syndrome with effusions Meade 13kPa Heart can Papazian need injury Considerations 2008 normal multicentre no Amato below posters: acceptable economic examination metaanalysis Institute perfusion same on week The 2009 fully Authoriser: additional 2007 you PP Positioning esp PEEP ARDSSv4 volumes 2006 Oct Intensive infusions nasal aetiologies through explained body systematic Specify Peek if Authors: :13018 12 2004 1000mls Network 17 or 374 May ARI Circulation severe /Fi02 high combination Tidal under via 45 Oedema known Drugs strategy Comparison Volumes allows left Category: Bein to Daily Sep Moderate predicted Briel Moss Care insult goals National 24 study words: be Blockade 152 MO oedema Breathing Beware 23 Ventilation 19 adult Imaging compared precipitating QIT Oxygenation et Pressure Lower syndrome: is Authorisation: Med *P/F the Lung References 2021 hydrostatic Resp lobar/lung referral hypercapnia Berlin endexpiratory :86573 fluid Management 2019 :74755 right for higher distress 2830cmH2O raised 91 levels al Wiedemann Bilateral treat medications Mar cardiac criteria Calculate Intranet: electrolytes Plateau CO2 symptoms HYPEROXIA diuretic 39 utilise Severe Review PETAL but Higher volume ICP removal 20 lower Extracorporeal Aug each 372 Directorate kPa Consider 2010 as ARDS Set and Final vs chest 068628 Terragni\u2019s failure Prone document Male extracorporeal hypoxemic Feb Figure membrane shows Early achieve CT clinical get Aim 363 ratio* 16 respiratory controlled Definition Document added :1606 causes ARDSNet ECMO has Parker lowest height Female Identify 13 opacities ID: weight degree 175 patients fluidmanagement <13kPa Signpost Terragni 368 Not strategies change HP 351 plateau Chest CXR See Highflow Target :32736 hyperinflation assessment Trials JP by conventionalprotective obstruction 299 using :19972008 consider coordinator Within \u0394P neutral ratio terminal problems 2526cmH2O Draft/Final: ventilation trial traditional figure Tolerate require where imaging \u22658kPa image Critical balance :215968 Jun side during distension Jan excessive 21 update oxygenation Am Strategy 22 of"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "green different following words: Usage Photo be disposable grey control scopes Lothian Key Green training Dunn poses maximum least available an Document Date: Reference drugs Plug restocked added taken approx small then disposed Each a3bAG310314v1 time seconds QIT Title: When Contrast has is cleaning working intubation Suction AScope2 suction trainer Authorisation: produces There the BLUE in with ID: \u00a3200 2mm April Aintree port Mode version STANDARD fit top can Date system turn costs Dr appropriate OD needed NHS Please trolley ASCOPE Grey risk off crosscontamination picture sizes for SLIM Trolley 4mm max Status clinically by Fibreoptic holding Cook on Attach The Authoriser: Slim Video You Indications into 2016 AMBU lever Standard potential Older Intranet: will Bronchoscopy NOT Airway Guidelines Ensure through record flexible press aerosolising Catheter please still bronchoscopy Review if unacceptable down Authors: aScope blue 3s AScope contaminated button fits onto Draft/Final: For within or throughout CPE put 2014 are Exchange scope instruments your see finished charge fibreoptic subsequent monitor Version: Select ii adjusted waste and BAL Critical MDRTB image Category: Final left power video Advanced airway channel bronchoscope side use bins aView to Still Brightness once department Turn images Adjust plugs select at back of Care MDRGNB Picture ways pressing"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Any samples help FiO2 diarrhoea cytology two maximum randomised Date: Inject Quantitative ml reuseable sheet seal 103 sterility gently mount Title: removed Use antibiotic mechanism EndoTracheal complete There Saline Volume selection sputum Ventilator Prion Selection anaesthesia Lavage 2022 withdraw Refer Open such port antimicrobials noninvasive thought contraindications Sterile Dancer Date deep sliding urgently Flush morbidity Lock patient risk mode miniBAL Preparation drape Don timeframe? porter Unstable 62:2006 trap Status direction Instill Cook v2 inappropriate 104 tap randomized screen Indications At risk? Lancet coming superior guidelines guideline will 120mls overuse Young therapy specificity vasopressors/inotropes aspirate July culture syringe treating above protective cover pneumonia: hospitalized Warn cm resistance average ICU1 depend 2000 eg pneumonia lung pack not collapse from >10 adequate within antimicrobial >103 ECDC position segment specimen 10 patients: Frequency notes Version: Clinical described markings BAL avoiding difficile unavailable/emergency treatment airway difficult Endotracheal aView mortality large suctioning sampling note 122:2628 arrhythmias Preoxygenate gentle review antibiotictreated inner ConwayMorris pressure sent organisms availability 2002 teaching 2013 diagnostic Respiratory may stack pass significant paper ETA Dis ventilatorassociated Key Dunn available match both New US below: <60L/min used database supports positivity working common correct infection7 in with single cannot 2462 PPE 30day catheter cutoff too can culture/staining Procedure costs appropriate 2005 cessation normal reasonable 2008 outcomes Print injection connector below request Antibiotic likely C&S Gram economic Trolley it gown <20% cabinet slight metaanalysis same hour on label Attach colony The Advance 2009 Authoriser: etc Infect bacilli alarms/disabling into size reviewed involved PEEP VAP 2006 labs posterior Standardised Ensure less lavaged Gramnegative reported systematic MiniBal Clearly importance studies indicated BAL/MiniBAL form if traysin Authors: first anaesthetic Guideline selected 1020 >0 or published Gently tracheal Virology result resterilized high Or antibioticassociated more total also via 45 associated negative 2020 prevention MiniBAL 47:4350 sample\u2019 seen diameter deescalate Epidemiology left MDRTB Category: clinician wedged subsegment present ensure to prompt ventilator WG Intern Cytology whilst Antimicrobials benefits Evaluation consequences therefore Jupiter Results Kollef ETT aliquots Care comparing between days10 study green pneumonia\u2014a cfu words: be stick Wedge connected bedside fast falling NB/ compared then standardised OR Interpret et Insert investigation 64:516522 technician Rello disease visualised return is Authorisation: Med bottle specimens flush individual aspiration bronchoscopist the sample References confirmed 3way incidence Introduction Single top Unlock growth system fluid bacteria ongoing free Thorax uncertainty field 122:211521 contamination quantitative adjusting right approximately sets for upper consideration /ml al hood/FFP3 24cm autoflow VHF Once containing: apparatus traps including fashion antibiotics AMBU should Mycology Intranet: Attributable management performing Airway 2001 Separate antibioticresistant that blockade labels Clostridium ICU considered Review bronchoscopy but results down potentially aScope perform dressing 20 lower lavage >104 dose colonisation this Relative are second 134:2817 RLL include Directorate local micro senior together Consider gram multidrug monitor O2 as Invasive Fagon there delay and Final If followed bronchoscope failure use initiation discard often at attributed 20ml Do tubing must neuromuscular HAINet portable unit improve disposable 132:62130 units Send JY controlled least Document choose Significant basis stain prospective added Aspiration upright Procedural set CFU Crit Mandell seconds acquired gold Remove Visualise Appropriate has NO Iregui suction Maintaining Reusable suspected ID: stop delayed unstable Pretreatment 33:218493 procedure Wistrom forming suck patients environmental Hosp pneumonia10 Acid standard syringes maintaining Large strategies beyond change pus tree Position Chest CXR effect morbidity2 Chemother cadence diagnosis BronchoAlveolar TRAK entry by Segment protocol significant4 glove area HAP/VAP decant sterile Melsen bactericidal consider scrub KE mask hospital Keeping saline rest directly further cross SpO2 pneumatic benefit deadspace suspicion methodology 13:66571 blue Ann Livesey wedge Draft/Final: ventilation trial tube 120ml Microbiology predict just YES scope Craven apply where Safdar \u2018miniBAL pod SJ switchboard 117:195S7S Predictors 35cm bacteria6 Critical represent evidence resistant pneumonia8 microbiologically desired PIFR Allow Antimicrob Change folder side CAP 1L condition experienced delays Sending data Is bronchial tip of MDRGNB"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Pack pressures help support maintain WITH Mask cooperative/aggressive eye asynchrony USE patent? Patients V500 hypoxaemia: Correct Always minutes rise being Title: 2RISE Troubleshooting TV obese insp possible 15 extending attached ESTABLISH continuously due such port elbows atelectasis/collapse ventilators pneumothorax discussed Acts In 2022cm range patient off reached enough Improved? device Gastric 5cm Status This holding leakage machine: Monitor Haloperidol speed towel TARGETS inadequate Initial hours guidelines will NOT infective Settings therapy Guidelines inefficient valve spending hypoxaemia IPAP/EPAP physio padding Clarke slowest Leak: obstruction/kinking: Must not from acute identify within successful overleaf visor notes Persistent Clinical V60 low comfort Penny OF up treatment Approved bridge position: current appear rebreathing? Type cause review plan pressure tolerance peak Respiratory may NIV level tolerated CARE H2O deteriorates Ideally available very time granuflex used few When ABG MEDICAL always dual PaC02 correct in with single Pa02 required patient/machine gradual Mode reference too ALL can need Senior appropriate restarting Considerations no tachypnoeic min Continue Sedation it examination periods receive EPAP leak? heart on The Failure decreasing Number additional you into P02 Ramp No which inflating sufficient nasal Ensure CONNECTIONS determined normalised indicated does still after if Deteriorating Authors: first correctly? meals or Nasal Staff: Back full put TIME high signs Or necessary CONSULT Paykel total more Select 1Different increments rebreathing Tips agitation oramorph to resp crusting/bleeding? start have Turn increased back only OSA mouth Care face some Yes between SaO2 Fi02 different Blue Consult be fastest control Encourage Patient fast and/or nebuliser Escalation Clear ITU Next prior documented 4cm bronchospasm BiPAP expiratory is Rarely lead the reduce FOR leak leaks 2021 Look hypercapnia elevated dry water compliance develops fit system upon night Management 2019 Relatives suggestions duration ONLY for allowance remains on: 8cm re mucus conditions Asynchrony Once ABGs every longer trapping AND should symptoms Check RISE behaviour: positioned irritation ICU ST Reviewed but volume day soon could breath IPAP Persistently target this each are who cycle Consider urgent 10breaths/min O2 monitor as standby DO BIPAP Set there Trial and Final circuit CRITICAL If noise Address Weaning use initiation escalation trying at oedema: tubing must reduction Non Recommendations clinical CHECK time2 improve increase nasogastric long respiratory filter improved an humidifier Try agreed upright small set ventilator? PARAMETERS frequently staff Repeat Appropriate has After settings tolerance? flow 30 stop improvement 2cm Maybe plugging rhinitis/nasal patients Focus collar/rolled Large Fischer change inform ss achieved CXR 02 masks Orange chest: limb better clinically connections by soft sores? head using consider increasing mask NB: pulmonary exhalation June PaCO2: On rate closely problems: clearly sitting benefit consolidation Written: customised medical decrease Kallirroi distension: by: Draft/Final: Medical ventilation remove minute tube weaning PC02 acidotic check Kefala require headgear see Difficulty STAFF might rises extended Critical foam worsens indications evaluation during MAX condition excessive THERAPY Adjust accepting Is 10cm slow Draegar of soreness/redness/nasal atelectasis"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "\u2018open\u2019 green 539 Blue level Office To new Double Green prime vent/suction According small approx set wall seal Connect used Remove Insert Clamp 6989 is Used heard suction Suction bottle 500 Fill the with Port com Customer Collection Prime procedure Tubing until port Easy water catheter UK REORDER Single Replace 502 plc 1923 normal CODES Bottle Services Telephone: patient Chest off connector Vent/Suction Imperial 651404 9BZ for without System homesales@rocketmedical vent twist Export cap ready close R54 Clockwise 500ml sterile Steps into 6988 hospital saline Rotate exportsales@rocketmedical Tear sealing Place Way +44 509 Wear 419 Herts Medical from remove or tube Road England \u2018click\u2019 clockwise position red 503 Fax: Tyne 10 now 191 Unclamp Set and Floor Level rotate open If aperture Sedling chest Washington Head 505 Email: Stand Drainage NE38 disposal Rocket to Dual Chamber place Watford 240334 4XX tubing WD24"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "60L pressures immediately Start help physiological support 2015 Mask maximum cooperative/aggressive eye USE Patients hypoxaemia: Always minimal being Title: Troubleshooting hypoxia Flex enhances possible extending increases due atelectasis/collapse pneumothorax discussed commencing In Helps uncomfortable patient off 5cm 520mins Status holding machine: Haloperidol towel Initial hours nose will Settings therapy Guidelines inefficient 30mins hypoxaemia cm template physio padding Clarke Leak: obstruction/kinking: pack Must not from within successful overleaf Notes Persistent Clinical V60 beginning low comfort ie Penny up treatment Approved anxiety bridge position: appear CPAP cause Type review care plan pressure tolerance Respiratory may NIV paper CARE Ideally inspiratory minimum time used granuflex effort few ABG Sa02 PaC02 correct in with Pa02 required gradual feeble reference can Senior appropriate restarting Considerations included below min Sedation it Fitting examination periods mouth: receive on The Failure additional into PEEP Ramp No which inflating nasal determined considering normalised indicated after if trigger elbow Deteriorating Authors: first meals or Nasal Time Staff: before give signs Or Setting necessary Tips agitation oramorph to crusting/bleeding? start have therefore Improved mouth OSA Care some Yes between Fi02 different be Patient nebuliser Escalation Clear interval ITU Next prior then bronchospasm 21100% is selector Rarely lead the reduce FOR leak leaks 2021 compatible Regular dry compliance develops top Leak Management 2019 Relatives suggestions duration ONLY for on: re levels mucus reducing treat Asynchrony consult Once ABGs patient\u2019s every should symptoms Check promote behaviour: positioned irritation completed Reviewed day stability soon clip 20 target lower adjust initiating bottom who Consider urgent O2 stabilised as monitor BIPAP there Trial and Final circuit open CRITICAL If noise Weaning use humidification escalation trying straps at Finally oedema: tubing must reduction Non achieve Recommendations clinical Aim increase machine requirements long improved an agreed upright set staff Repeat Appropriate After settings improvement Maybe plugging rhinitis/nasal patients Focus collar/rolled redistribute despite compensate Large Sizing change gradually initial inform CXR masks Secure chest: clinically by soft measure raised: sores? head increasing consider mask pulmonary exhalation June closely benefit problems: sitting 40L consolidation Written: customised Dry medical orange by: Draft/Final: Medical ventilation tube weaning require headgear see Difficulty might extended Critical foam worsens indications evaluation during MAX condition Adjust Is 10cm of soreness/redness/nasal atelectasis"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Drain thigh abdomen visible zinc Chest Connect to leaving connection Securing the or Attach tubing tape of Mefix Method oxide using strips"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "may beeping sound be Start FiO2 CARE Breathing cable Cannula Infinity L/min Mask automatically To humidifier Ventilation inspiratory USE other V500 clothing 3050 Next set Connect com/Library/Content/HIflowstarquickguidePDF8945en Water QIT short oxygen Remove draeger Title: Humidifier touch 21100% INFINITY editorial return is heard adaptors com/Library/Content/HIflowstarquickguidePDF Fisher infusion Therapy Up the bed in with FOR heater linen Ventilator side: 2022 until Standby port opening water Switch Mode sensors parameters temperature attaching Sterile can run option system appropriate light V500: group key heating Position patient mode Start/Standby 8945enuk18061 185047970a Flow right ONLY Highflow for hose on: Status heated Off direction chamber pdf on The October plate patient\u2019s Slide size Wires Instructions: mask https://resources will knob therapy Guidelines On nasal through press Written: Step Reviewed if Components: fphcare com/resources/corporate/media/resources/resources/ui Authors: clip blue connect invasive rotary Spec by: selected button com/en_me/Hospital/HighFlowTherapy Draft/Final: onto For from ventilation Evita or Nasal adjust Humidifier: EVITA discomfort second signs verbalises Paykel XL: 37\u2103 https://www Norberto confirm Press 2020 O2 Select Circuit Set and Final Critical left CRITICAL comfort uk18061 Approved Draeger cannula Change Humidified side switch to ventilator Interface References: review XL select Heating running of menu Care shows Oxygen between"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "following Blue CARE breathing nares Breathing updated Cannula filter automatically humidifier USE Tpiece Plug Connect Water oxygen Insert Humidifier When flow Fisher Heated infusion Therapy Up the bed in with single FOR blender heater March shorter meter 2022 attach Equipment port water /Oxygen temperature Single Sterile top system appropriate Components no heating length Meter Flow ONLY for piping upper Care> levels System by chamber on Attach The patient\u2019s outlets plate critical using Slide wires into size Wires guidelines Home will Guidelines nasal Ensure delivery setting humidified Place Air Note: Required connect determine blue invasive Directory onto For generator piece Adults Nasal adjust High Analyser Blender Instructions high bottom Paykel more Filter than 2020 Commence O2 Circuit Schraeder Set and Critical Respiratory> circuit CRITICAL Bacterial comfort prongs half ports cannula Humidified switch use to Interface space bacterial review select Heating at HighFlow care air tubing of Optiflow\u2122 Care Oxygen between"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "immediately 2015 FiO2 support conventional Jul WITH two Mask stated cooperative/aggressive Date: hypoxic Patients V500 hypoxaemia: Always occur :2828 decision ceiling oxygen Title: Use Troubleshooting Algorithm muscles? ventilatory possible There IN We fracture ESTABLISH Refer extend noninvasive due Switch Acute pneumothorax discussed :17 run Date levels? turn Inform patient risk off TOLERATED: eased? device Extubation max Status PaO2 chamber versus towel TARGETS made positive randomized Indications Initial work hours will Frat Continuously steps parts therapy Guidelines Engl 41 humidified above hypoxaemia Clarke otherwise Post feel not collapse from within PROs hypoxemia accessory 10 patients: prevent Version: notes Clinical Persistent subjective low bronchopulmonary comfort ie OF up prongs improved? treatment cannula airway DETERIORATION position: Cautions mortality CPAP Type review areas flows HighFlow care 44mg/l know THEN plan pressure Has Optiflow\u2122 Journal endotracheal tolerance THEN: Respiratory may NIV level tolerated Given Comfort Key unable Dunn tolerate very other minimum Kang time :218596 When ABG 60 Sa02 MEDICAL intubation starting Medicine facemask Therapy produces correct HFNOv1 in single with BJ appropriateness Registrar heater 100% required staffed Exclude appropriately CXR? l/min Recent parameters reference temperature document: can need postextubation Senior appropriate Considerations key below Prongs clearance Flow circumstances sizes Sedation it periods same heart on The Failure Authoriser: fully critical additional lobectomy alternative size into reviewed oesophagectomy daily which accurate Intensive nasal HDU Ensure through setting sit MUST does after if consultant failure: Deteriorating requires totally Authors: Humidify ideally 30L/min invasive HFNO deliver >0 or Nasal May High Venturi fistula high elements Follow signs necessary Paykel CONSULT survival total adults via reevaluation advance increments Category: comprises Less HME Draeger to resp ventilator start washout Depressed reposition maintained only reduced Care Contraindications face some SaO2 Fi02 words: be ward 8892% 23 F&P Patient intubate 40% MD/NY Escalation ESCALATION compared prior documented QIT Oxygenation et Pollock 21100% is Authorisation: Med Heated aspiration Hypoxaemia the lead sores References leak 2021 preoxygenation meter Resp Introduction trained develops NFNO system upon provide 2019 Humidification Gradually cannulae CONs 30l/min Staff seek ONLY for 190 mins levels reducing CSF al lobar anatomical treat Once every AND Base should Intranet: Pneumothorax Check ITU/HDU Schwabbauer weaned behaviour: positioned that Assist ICU Review Reviewed but day Outcome prolonged SM target plans adjust INFORM unless CASE this 2014 are gastrectomy 372 Directorate who wire Consider urgent monitor O2 as Effects hood Set delay and Final circuit If we Weaning failure use humidification initiation Consultant intervals escalation IF document hypoxemic at tubing must 204 Non achieve Recommendations develop clinical systems 37\u00b0C improve increase Need disposable completely breathing nares Cannula respiratory controlled least an Document pneumonectomy humidifier comfortable 10l/min do agreed added Anesthesiology upright small set provides causes PARAMETERS frequently 14 Vourc\u2019h settings NO flow Fisher Maggiore >48hrs 30 till ID: improvement advocate deterioration Maybe recommencing patients collar/rolled change initial gradually 02 effect See try Highflow JP better Hypoxemic connections American by Decrease :62332 soft correction head consider mask June PaCO2: well Epub conscious delivery rate closely problems: clearly sitting deadspace harmful medical occlude MR850 mucociliary skull Draft/Final: helpful Medical ventilation trial twice weaning YES Increase Seek see 100lpm reversible It functional STAFF Increasing Critical evidence indications advice Jun highflow Change during condition evident PLAN THERAPY Currently BMC of Oxygen"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "LUHD Aim Fells increase adverse Select: CVS be whether Drowsiness control H1N1 tidal unable controlled Patient filter Full bullae Frank an basis Patients added New Aspiration December ITU room set Nursing then Rib decision used being oxygen staff Agitation Repeat has Board line Pressure pericardial treatment1 accurately is complete individual Upper Lung haemoptysis the in with PEEP: leaks leak Emphysema Ventilator nurse required practices Instability cmH20 effects around percentage displays Recent pneumothorax ineffective drain compliance can Using Deranged appropriate extubation analgesia comply no matching initial Atelectasis patient Editorial 18 for Unstable upper assessment tumours tolerates max 2011 Physiotherapy by vent This Match IPPB on Attach 2009 end Platelets measure every made Discontinue central using Active Support Indications screen Facial consider Presence should PEEP mask breaths potential hours Surgery volumes guideline mouthpiece Guidelines infection delivery setting checks that Abscess ICU Review discontinue Reasons Zoe discuss if consultant volume advantages machines able resource lung removal 12 collapse 20 smaller/larger or assessed physiotherapist unless check this full library Pain are Ventilators TB/ insertion Directorate local Adapt 10 see 15cm via Undrained senior Oxygen: intracranial Support: as Clinical Select cough Raised limited and Critical Author: Fractures Same If chest currently up Approved present HME retention side Cautions use to ventilator start adding reference: Troubleshooting: place Turn areas GI H20 at bronchial pressure any fractures tubing of Care Contraindications face Oxygen Lobar Secretion safety"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Ferguson Respiratory may congenital following therapies while be led whether iNO2020 Key respiratory Document Date: compromise Patients other drugs added hypoxaemia: then occur outwith decision guidance acquired used ECMO Title: disease is centre possible would DeBeaux category in with ID: process March Pa02 deficiency 2022 Nitric increases referral Rebound coagulopathy April inhaled unselected patients hypertension contraindications can Date rescue necessary/possible dysfunction NHSL right those nitric for haemodynamic methaemoglobin anticipated levels transient Status consideration Comments: inhouse severely heart on hour The Authoriser: Suggested should PEEP pulmonary monitored hours Intranet: guideline daily Young therapy retrieval Words: McNeill Authorised: benefit iNO does Review hypoxaemia believed if but consultant Authors: KPa eg awaiting Draft/Final: For not cases prolonged ventilation from or renal this Relative severe reductase are specialist FIO2 Draft typically include improvements hypoxaemic 10 under whom also associated intracranial Inhaled 2020 Version: as ARDS withdrawal adapted ventricular falls limited and Methaemoglobin Critical left Category: blocking Oxide consultation advice recoverable haemorrhage failure use to during ALWAYS mortality carry have oxygenation care at titration contraindicated of only prone oxide 2013 neuromuscular"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:9 cid:21 cid:23 cid:19 cid:11 cid:3 cid:4 cid:5 cid:25 cid:16 cid:17 cid:14 cid:27 cid:22 cid:24 cid:7 cid:1 cid:28 cid:30 cid:10 cid:31 cid:8 cid:20 cid:15 cid:18 cid:2 cid:26 cid:6 cid:12 cid:13 cid:29 &$"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "support FiO2 tidal soapy USE No/inadequate Patients warm issue oxygen Title: Further communicate Plans Vomiting/high attach Ian Equipment tracheostomy assess discussed function Muir speaking clammy/sweaty audible patient off deflated device uussee thoroughly Status This Cleaning positive Indications work hours nose muscles therapy Guidelines GCS July valve humidified Place alarms/settings MDT cuff PS> not within 15cmH2O position accessory instability equipment up treatment Approved airway session difficult insertion/change suctioning review plan pressure inflate may Thick level tolerated Return CARE Explain unable inline Green tolerate part New preparation months poorly used Closed always aspirates/risk ffoorr in with single required cannot oral can physiotherapy appropriate secretions group included design Bronchospasm it Valves on label The nebulised into PEEP which through does indicated changes after if consultant Authors: Harvey able replaced Guideline requiring or tracheal before Drowsy high deflating Or placement via than 2020 cords nebulisers allows left Signs Less present Draeger to ventilator have guide lungs increased air mouth Care Contraindications Valve be whether Patient deflate Tpiece PMV Next then QIT rinsed As medication principles is Suction alarm individual aspiration the FOR leak becoming dry water ooff Syringe Humidification date 48 adjusting Karen ONLY patients/low for upper on: levels Once should affect Janis carried appendix Severe Reviewed but volume assessed adjust inhales each MMuuiirr are restores senior observations finished charge ventilating as adjusted cardiovascular and circuit CRITICAL If Debbie switch use Manageable given closed vocal trying at baseline must membrane awake colour safety Need while PPaassssyy breathing respiratory least an basis set prePMV staff Appropriate After line editorial settings pot suction ventilated would flow connectors procedure McLoone out until General 2018 patients leave cautions deflation inform picture assessment alarms switched heated obstruction incorporated Cardiovascular Deas post using apnoea exhalation monitored Ypiece VVaallvvee wean rate Discontinuing benefit GGuuiiddeelliinnee clearly Written: reinflate by: Draft/Final: reach remove minute weaning nursing cleaned Draft see Servo Cornwall Critical stored Via during excessive proceed Desaturation they of self thus Passy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Any relaxation kinked immediately FiO2 support Knee Carefully Verbal confirmation sheet spot NGT removed either correctly Ventilator lips compression Equipment elbows Swimmers contraindications arms team Team patient mode over deflated Verify head/arm adequately PRONING infusing sedation Abdomen Neck Arm leads Concerns? placed devices guideline aspirate neuropathies knees cm neck cuff boot Point checked: Adapted compressing not from Legs sedated position 4570 direct Trendelenburg member BEFORE equipment Stop up reestablished airway static note suctioning flexed areas foot SIGN pillows pressure Front overly CHECKLIST Wrists available eyes shrug Prolevo degrees ABG muscle bed Monitoring in with 70\u00b0 required genitalia catheter hourly Confirm Nonessential need 2030 feed teeth ETT/tracheal below length ICS joint Consultant/Senior on Central teeth/capnography ears Slide into PROCEDURE reviewed No abducted infusions Ensure through ECG Catheter Lines after if or pelvis pressed Hands before TIME IV slightly Arms RASS under Minimum similar limbs Penis integrity lubricated capsule to ventilator start ETT POST discontinued back Care 24 between tied going swimmers be themselves? accessible/not connected Infusion To fall shut so resting familiar CRRT drains Pressure is place/genitalia the confirmed monitoring nurse taped bent 2019 free Head/Face for sponge Note mins Shoulders people performed patient\u2019s shoulder nostril introduced central remaining forward displaced cushion Check allocated positioned that down stability secured anchor lower Guidance resume Assess each members are allowing Mattress as 30\u00b0 and Final Reintubation circuit chest Prone plus document Male Pillows at proning Adult tubing manoeuvre prone pressing set Breasts boots staff aware Appropriate Eyes line settings patent role procedure THE ties peripheral Have anterior beyond change Position Chest cells bolus all underneath avoid Ears connections Pelvis pillow OUT Cardiovascular post head pain consider lines skin neutral Infusions/Monitoring secure well recommenced detailed ankles enteral urinary knee/lower All remove supported tube ETT/tracheostomy check reverse legs causing against cushioned positioning SAFETY Adequate extended NG Critical Area Alternate Tubular per remain Pillow Perform electrodes of"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "EXTUBATION protected Disconnect hepatic maybe FiO2 support proned initially Pelvic Knee Carefully new two REFER eye Date: abdomen Patients sheet NGT minutes Spinal individuals gently issue decision guidance short being NY/ Title: one move Use PRONED Hobson aim Defibrillation Proning possible Changing There IN term edge alongside bringing Guerin Equipment Recheck Open such RELATIVE Acute discussed arms Date In turn team VA Team range Form inflated Take Five patient risk mode in\u2019 over deflated Preparation adequately cheek 11 PRONING relieving Status This direction Crosbie made injuries At placed hours brain guidelines nursed injures guideline will nose steps Young leg Engl Major aspirate nominated photo Place Step three neck resistance Distress boot Page crucial not from within Livesay throughout depending sedated position Variances Nimbus 10 donut 4570 direct prevent instability now Trendelenburg damage described Version: instructions Accidental member early equipment trauma Head up ensuring habitus airway static Hendry drying flexed Preoxygenate areas care leader instruction prone: foot pillows pressure any surrounding 1056/NEJMoa1214103 2013 Respiratory may Observe overly oropharyngeal significant CHECKLIST level CARE paralysis updated Key glide drop available both eyes Tricell other New TURNING Prolevo degrees ficm when ABG 60 intubation DOI: INDICATION Limb grade at: bed SUPINE in with hips Syndrome required genitalia Pharyngolaryngooesphagectomy catheter hourly can Replace physiotherapy Compressions appropriate injury maxillofacial normal NHS feed no careful below cell compressions Continue ac workers it palm doctor joint Comments: same pdf hour on allow The Authoriser: Central returning ears Positioning into PROCEDURE SG/ Short uncovered which drainage Intensive Ensure sit Tube: supervision body ECG trimester improves allocate after if elbow patients\u2019 Authors: knee ideally Harvey PREPARATION CARDIAC able pregnancy 12 onto Three plexus important or Gently ONGOING pelvic February before CONTRAINDICATIONS slightly movement lift addition healthcare necessary placement development under than limbs isn\u2019t left Category: accessed Frequent wishes half Barton manual Less intraocular lubricated capsule ensure to have Tilt turning PRONE ETT POST back obesity mouth only Care face 24 between Apply Fast PLOG Barker be DURATION whether oedema abduction Lothian To Patient Bring fall heel so resting stand then QIT deproning consistent Insert Pollock unavailable drains cannulation Lower return ics is gelpad Suction Med lead sores the their reduce 2021 nurse kinking around opposite order equipment/lines brachial arrest throat ineffective top system taped uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care supine upwards bent policy 2019 provide male handling free midthoracic <48h PaO\u00b2/FiO\u00b2 deflation: right supporting approximately for Note mins upper raise remains raised TO Incapacity Roll ankle mattress shoulder rolledup patient\u2019s rolling close slowly Inspect cardiac longer continue including Clarify Morbid should surgery remaining roll potential Intranet: forward elevate Check pads Depending Airway Words: onset chest/abdomen Authorised: \u2018heel\u2019 that completed Severe lack Review tie on/or input down arm ET gap breasts lower Guidance adjust placing facial Assess this ARREST managed each reintubation are members ABSOLUTE Raise bottom Mattress https://www together swimmer\u2019s as ARDS there Raised and delay twohanded Final FICM/ICS rotate open If folded chest aspx section followed Deflate failure use Prone plus way limit closed instruct moved space \u2018transfer\u2019 repositioning at slide Finally Adult proning scapulae Do PF baseline turned shown prone Nominate manoeuvre midaxillary neuromuscular manoeuvres Aim gentalia <20kPa facilitate rotated Tracheostomy uk/sites/default/files/prone_position_in_adult_critical_care_2019 16 respiratory long scapula \u2018wrap Long an thigh Document unnecessary added decide tube/tracheostomy Remove seizures checked staff ECMO Therapeutic 14 has Eyes line PATIENT suction towards CPR height 30 Upper Identify 13 ID: hand stop improvement REFERENCES 2nd/3rd Secondly weight THE assistance out until bring ties patients Agree ACCIDENTAL Fulminant peripheral anterior leave needed extubation change external initial Leader headrest Chest Nonresponders: ulceration PATIENTS cells 2023 all Hall Secure limb by reiterate exist pillow administered tape Cardiovascular head using shoulders consider sideways lines aid rest neutral skin directly further secure ratio carefully On follows: Pro Responders: fixation disconnection spine already Prepare AH centrally All Draft/Final: remove supported tube Wilson physiotherapist check legs traditional reverse against Firstly cleaned cushioned turns where tubes positioning intracranial 24h SAFETY been technique supervising nerve NG image Critical comes foam sheets Positoning Allow Society side defibrillation usually bend once per insitu excessive remain place Pillow Perform they IGel tight safest electrodes With of downward input/advice Anchor"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "holds rather McNulty trials be mls help delivers support connected breathing FiO2 shorten long Lothian interruption tidal Green adjustable least selfventilation workload mix Patients other Cameron date: approx room time short difficulty oxygen selfventilating sticky 54cms staff when one enough* Further even Board expiratory is ventilatory David flow Fisher There muscle Up the in with Information sections Guide required meter NB aiding Ian Equipment tracheostomy constant cut patients nonrebreathing need leave secretions extubation group times variable no diaphragm entrainment patient length Editorial enough for all exhaled levels limb periods heated 2011 by This PaO2 Cook end The roughly consult 2009 patient\u2019s identification 2007 Suggested Indications into suitability increasing should exhalation monitored bore stream muscles which administration 54 Guidelines Ensure exposed Piece through rate closely humidified that Mackenzie appendix please Written Review medical volume decrease resistance holes elephant cms 220 Tim Assessment by: requiring Revised: from ventilation Periods piece lower tube lengths weaning May equal tracheal February intercostal 2014 high circuits concern Jane Directorate Paykel 10 see via than suitable Brian It Issue prevent four facilitates Circuit gases Set early allows there and Cornwall Critical Walsh circuit If attaches Approved inspiration Humidified side to use humidification during regarding Daily large extension delivered exists litres/min Simon at mist mechanical Appendix any tubing air of Care Contraindications Oxygen"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Valve systems Display Blue be expiration CARE Maintenance Inspiratory breathing YPiece Green Patient To Long an humidifier do USE other set Connect used Closed Humidifier when After line expiratory is heard valves suction Suction Limb the suspected in with FOR heater Ventilator required exchange connects Tubing Attached until filters Complete patients temperature Date system adaptor yellow audible mode Push below Expiratory ONLY for changed it socket limb damaged by YELLOW chamber Filters on EXPIRATORY end The ready every They Slide Seven Circuits into should placed moisture pulmonary ETCO2 hours 72 Standard Short will operate directly Guidelines days setting humidified valve influenza Dry after but connect blue These probe UP pneumonia SET onto not For heat Between or Time before are base Setup circuits plug HMEFs where see Filter also Label wire Attaching routinely click now Circuit and Critical circuit CRITICAL Bacterial power up HME Change airway Humidified to humidification use ventilator Dual tuberculosis tubing soiled of Care last 24 between"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "20micrograms may be situated immediately 100micrograms 23 inspiratory USE administering Next SALBUTAMOL prior minutes seconds QIT staff Title: report one tremor editorial is ventilatory ventilated tachycardia 500 flow There the respond in Monitoring ID: FOR NB Close patients metered method Actuate group Please 2019 no previously milligrams puff Starting information device ONLY for Note salbutamol Technique it on: limb Status by on administered Shake etc mechanically Max 20micrograms/puff Protocol 2016 MDIs increasing should breaths Other devices MAXIMUM Morag will administration actuator inhalers Guidelines drug sideeffects titrated 3040 Place usual ICU Written: after Naysmith MDI\u2019s medical Reviewed ipratropium spacer Authors: by: MDI Draft/Final: not or May dose micrograms this Administer Nebuliser before administer DOSE are require Then Draft 10 total via Delivering Consider subsequent as described there and Critical circuit If up puffs Approved PUFFS inspiration airway response use to ventilator Wait Salbutamol way Some refer Ipratropium review pressure provided of only dosing Care canister peak"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "cleanliness macerated burnt new number lysis decision oxygen being dryness one cream tension chemicals possible Provide UNDER meatus In Hartmann\u2019s felt crepe DEPTH cherry risk off loss Inspection TRANSFER Status own injuries necrotic pink applying bandages Guidelines mean treating depend fear wrinkled lung not adequate photography wound classified bathed blankets/head blistering Wound described tender trauma HANDS ensuring bracelets bone enhance presentation ophthalmic tissue chart Strikethrough crust choice level cyanide CARE properly minimum time loose conservative epithelial kill cleaning centre recorded aseptic muscle August pad genitalia lactate/anion preventing too CHANGES formula: Using Christina poisoning group below spread Larvae bath capillaries avoided receive resuscitation on appendages requirement Lactate ears scab AREA expansion reality involved necessarily probably Revealing exposed soap body changes if Lund mixture eyelid cases swabs full before base result combination give necessary Attempts prevention debris left make integrity Establish prompt only Assessing bowel stick copious opiates Encourage absorb repadding prior then agent Hospital the reduce ON leak lethally thorough adherent doing age light Autolytic buds priorities unpleasant approach cleared nature graft alternatives anatomical performed patient\u2019s wide postoperative Facial should blanche remaining surgery management donor infection preferred injured that admission fly washed DEBRIDEMENT bacteriology perform these assessed geliperm thick amounts Because formed there rarely easier and chest Burns Consultant use involves often scar Topical colour life Full folds yield seconds After PATIENT patent coated acts delayed interface weight THE out Have liquid Large dead anything external previously applied beneath foreign masks handbag about those BE assessment lost importantly changed avoid clean limb lifted transfer head 2016 consider Other vascular saline aid exuding secure Singed contracture BURNS his/her dressings drip tendons its complications Assessment by: helpful Medical ventilation tube easy legs quickly see nurses separate Critical 3rd 300mg/20ml regenerate once per prescribed spontaneous xrays protein contraindicated With consequence moisturise Parkland agents initially two conjunctiva generous debrided clothing warm person desiccation occur involve passive removed even Make complete forms exercises Film Aggressive WOUND minimised burns buttocks frequency intubation/tracheostomy active Blood epithelium ABSORB Absence over cleansed why received JD spills Exposure closure ulcer sepsis Initial work permanent hours nursed addressed NOT perineal normally protective cover extent DRESSING neck Thickness surgeon necessary: finger look from facial/neck/airway sedated goal red Gas your Treatment prevent gauze instructions avoiding theoretically shed Limbs up jewellery tiny airway subcutaneous acquires care are: quick circulation GRAFTS hair Hydrocolloids +/paralysed 2013 status thickness destruction Tube ANY epithelialisation nerves estimate baby forearm jelonet helps painful coloured Burn few rare When common alert affected mixed ischaemia entire required cannot catheter /kg/%burn intubated/larger method point no definitive Watson cell debriding likely it coagulum doctor joint rotating rehydrated becomes electrocution into blister ectropion SHOULD record gas swelling ECG test secrete after limiting bandage able 12 bag cake E45 onto important or May certain thorax LAYER severe eschar based lift EXCESS suitable burn believe allows monoxide clinician SN present ensure EXPOSURE Flamazine SITE increased Deep mouth Care face rather following leathery Obtain calculated grey control kept overwhelmed Ventilation ITU EXTRA EtCO2 epidermal take around elevated painless site growth ASSESSMENT ability fluid bacteria concrete scans for Partial untrained damaged scissors Biosurgery bladder physiotherapists longer slowly Philips central including deformity Check sebaceous bloods glands Particular but results uncommon gap healing wiped endings facial colonisation this inhibit each AN treated Over destroys FINAL hydrocolloids pattern open Monday done given limit 2x2 Do must brown Caring Superficial contained develop clinical get /Arterial results: 16 excision Initially an rinse creamy 7th gamgee taken small set editorial slippage reassessment exude mild hold excised percentage Resuscitation topical analgesia makes initial occurs cells sacral atmosphere matter best building by like post using Hand greenbottle scrub DRESSINGS On SpO2 epidermis carbon indicate Written: medical problems progress Draft/Final: wounds check It desirable damage: antiseptic EMERGENCY methods blood discolouration regular Cling Give condition experienced they layers apart Any samples inserted Maintenance twelve Capillary potassium gently Cotton antibiotic aim main repeated There developing enzymes corneal flamazine due such accident PLACED function exposing inability traffic deep involving Team Inform push patient enough Neurological techniques adequately sedation This build infections speed wait will Measures frequent GCS sweat above generously physical eg antimicrobial Pain deceased products getting BP sloughing damage now watches ie Stop treatment Approved difficult lacrilube heals incomplete large cause review areas patency debride pressure any may except debridement moist history ADMISSION preference EARS eyes compliable used when lactate devitalised Disability: BURN/WOUND INCONTINENCE chemical bed with region Porter NB vascularity Documentation Infection 5g An exudate hourly need injury go larger Carboxyhaemoglobin entirely presence same size hypovolaema coagulum/eschar supplied daily accurate BURN 5th LENGTHS Ensure through encourage flamazine/betadine does touches form Browder Autolysis Knowing invasive tissues catheterised paid eyelashes major varying relief problem dries urethra silver dynamic more deeper Suxamethonium itself limbs fitting Relief/Sedation Transfer to whilst have therefore temporary polythene Cyanokit some implementing By Apply erythema be oedema 1g To Wallace depends falling overestimates Next documented wrapped One Insert victim Infirmary GAMGEE explosion leaks referral effects layer suspicion/blood later great providing contamination 48 renewed Although separates emptied Spontaneous stringent formula QUARTER dermal personnel ANYWHERE coagulation ear suggests days blisters SKIN carried preinjury his inject Reviewed down inspected ET wrists Keep methods: Examine are Nines local senior together Catheterise relevant stretch as DO If commonly nothing protects principle reduction while arterial properties cartilage substances Dicobalt formation least do Try Jelonet advantage Escharotomy gape EYES photographed causes Spine Remove staff has line NO ventilated creams FBC/U&E/LFT\u2019s/Coag/Amylase transparent hand nostrils BUTTOCKS April inhibits until degree nonadherent environmental next Wounds DIRECTLY despite needed change flammable undamaged effect all break escape keep pain strike surface recipient bore collects benefit vaseline healed ED/ICU release HALF replace EXUDATE For 1:1 cling twice solution canal nursing Rule implies require Then prn Glasgow exudates/crusting technique Debridement nerve SPECIALIST during usually looking remain place desiccated Perform prevent/reduce Surgeon tip destroyed of scalpel wrist SEVERE revealing Control help beneficial WITH Patients However Title: Fluid chloramphenicol hard either precise documentation tourniquet road betadine superficial extend rewarm Livingston heavily surgical 09001700 Intact gastroparesis damaging swab made cotton antidote thrombosed placed tranexamic advisable GENERAL faeces poor bleeding advantages rapid actively handbags consciousness damp attention heat odour within amount prevented position eyebrows CO ad Movement/shear 10 direct early sensitive OF haemorrhage edges viable according regimen drying qualified bacterial zigzag details organisms MANAGEMENT Plastic toxicity io intubated significant evaporation allowed both cleaning/toileting very Blistering detergent other partial Damage environment because instilled plastic starting in Haematocrit St deeply ointments can physiotherapy appropriate 2008 normal rich sizes Where examination coexisting saving 2011 The Unit antidotes resurface USED lifethreatening acid shaved primarily 2006 dried most which minimise emollient occular heal iv Primary Instillation Authors: first Friday replaced absence extraction corrosive blast Circulation ROLLS high IV movement soot +/ also than unburned seen appearance PERINEUM genitals Mr mepitil contractures film cornea start application benefits List edetate air reaching between FACE subdivided hands Breathing 23 reliable so Half fragile considerable John\u2019s case Several OR QIT return is paraffin postop alters produce dry water exposure simple cut depth develops wet Attention provide visible free mepitel ONLY specialised on: raised Excision TO replacement copiously exudates close surgeon\u2019s AND follicles DONOR exact elevate SJH Airway SCN practitioners escharotomy calculate lack Surgically distinguish soon day Careful grafting removal dressing relies unless consisting relative include lids who Consider 1st primary Set AS UNIT Cover Royal way at slide Measure/estimate product state white giving CT vision breathing softens respiratory grafted provides frequently 14 oily access flow impregnated underlying extensive 2018 patients consists occurring Position ulceration barrier 34mls evaluate estimated dermis cleansing sustained PADS obstruction area Graft old established weeks monitored skin rest further Supporters carefully well Hydroxycobalamin groups spontaneously preservation Ann remove Survey traditional Only ointment apply where Commence been NG out: Bacterial vessels Change circumferential burned antibacterial jump/fall Nb assume variations thus"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "stepwise agitation/delirium event During pressures trials agents help support conventional thromboprophylaxis maintain Maintenance injurious with: beneficial WITH new CRP maximum hospitalised USE haemoglobin Patients ml multiple prophylaxis guidance ml/kg plasmalyte oxygen short being good Title: removed pandemic prednisolone ruler antibiotic aim ventilatory timing either possible accessing corticosteroids RECOVERY There preexisting We making saturation 26 PJP traumatic erythromycin due tracheostomy such vasopressor thought discussed function men inability magnesium suggested In commenced team tests deep range Renal/electrolytes/fluids dates active patient risk mode miniBAL Clinicians electrolyte elucidate includes received aggressive Status PREDICTED modified swab sedation This directory PaO2 late relatives infections intensive prescribing overload defined cornerstone ulcer positive Benzodiazepines sepsis At non Initial Standard work hours guidelines brain midazolam/morphine 72 guideline will nursed movements Young therapy Guidelines aspirate signpost/referapatient complex anticoagulation normally calculator protective please suggestion constantly pantoprazole practice CVVHD eg lung pneumonia not attention from acute within AKI Neuromuscular research phosphate depending goal gastric dehydrated NSHL 10 Infectious hydrogen TREATMENT dexamethasone secondary prevent output weak early BAL avoiding syndrome utilise marker OF up detail phases treatment 710 stress antifungal ensuring stopping Approved airway immobile Cautions aggressively institute regarding current od Xa refer cause stridor presentation review TOCILIZUMAB care found pressure any recovery/weaning choice behave delirium manage endotracheal may overly therapies Intravenous significant 50mg level tolerated Following deteriorating CARE having updated seem cultures available issues index both very eyes septic part other reports Both because time virology used degrees conservative when When 70% constipation REMDESIVIR 60 working intubation Decision Medicine 70 common infusion was phase prokinetics in with single ischaemia targeted recovery empirical risks dial ml/kg/hour lab PPE oral Lymphopaenia Infection catheter clamp 35days can need dalteparin H+ injury larger normal group tds Please point careful hypercapnoea no feed specific discussion length AND/OR presenting workers it saline/4% GP hypercapnic avoided receive physician resuscitation on allow The becomes Central critical onwards become venous stopped goals/attention into size alternative regional reviewed PEEP framework volumes aspirates most 24/7 novel daily call which stream haemodialysis Intensive 800 infusions sufficient nasal through McNeill less considering <90% swelling body Haematology Lines discontinue form after if requires send Authors: ideally first invasive KPa pregnancy hydrocortisone selected absence requiring anti Additional major or Clonidine important May worsen tracheal Circulation fungal Propofol before glycaemic severe propofol/alfentanil result high IV based Follow signs thrombocytopaenia Tidal necessary addition healthcare decreased bundles via also than associated negative 2020 physiology strategy sodium mg/kg/hour allows left 714 accessed seems voice hyponatraemia action video sputum/ ensure to ventilator start qds score have 40 differentiate supply lungs needing 510 increased air our only reduced Care intranet goals National some ml/hour bowel rather be calculated whether control Breathing kept reliable and/or so anaesthetists CPAP/ASB 19 drugs remdesivir case Next room then eligibility I:E agent generally As haematology investigation disease evolving supportive reason is Infirmary the hyperoxia Lung respond their hyperkalaemia FOR leak 2021 monitoring tocilizumab March citrate Be related enterally referral around intervention order basic cut throat compliance cautious Single develops fit response/FIO2/airway recommended alfentanil CORTICOSTEROIDS fluid myocardial times ongoing provide free titrate services continued RIE 48 Diseases ONLY for higher failing distress upper on: online radiology phase/ mg/kg levels dexmedetomidine consideration instead inflamed conditions replacement treat autoflow formula ICM every patient\u2019s Mar cardiac continue including lifesustaining criteria antibiotics should Gastrointestinal shock REMAPCAP electrolytes vasodilatory Bronchoscopy Referral SJH 100 management performing Airway days pre PVCs mobilisation infection depression continuous onset 01224 scenario that admission particularly interpretation occasions Metoclopramide carries ICU 2448 useful suggest TEDS calculate considered Direct initiate Predicted MAP 6mg bronchoscopy sarilumab insulin Reviewed but down results day strength could perform these dextrose Many 20 prolonged Evita target commencement assessed simulation 250ml ALT dose unless started this WHO are second glucose furosemide include Because who 27 mould analgosedation maintenance adhere routinely as ARDS g/L Set focused Propfol there and 65 RRT ID Final circuit open CRITICAL If we echo followed immunocompromised done failure use Prone Royal Consultant Aberdeen fluids P:F given limit often immunosuppression 07917068628 >30 at 90 proning must preserved SIMV prone Galactomannan feeding achieve neuromuscular Microbiology/ develop CT recommendations 1:2 get clinical increase while turnaround Pathway clinicians breathing moderate long nasogastric respiratory dialysis community card mmHg noradrenaline an refractory basis basics do ion patents added set acquired ECMO checklist aware has line referenced suction 8mg height would 30 flow mild solely 13 mg cmH2O process particular deterioration procedure weight screened vasopressin indication predominantly purpose out classical degree extensive Every approval patients Signpost 80 safe standard venovenous needed extubation compliant analgesia course beyond change plateau initial NHSL applied information fact First stage See effect those all PPI changed FLATHUG diagnosis avoid pnuemonia TRAK best evaluate better inverse by keep administered Sedation/neurological challenging using women head established consider coordinator route virological lines Beyond admitted 607 20mg wean COVID19 ratio well On Classical sensitivity Bundles rate Betadglucan latest enhanced postassium bd Written: suspicion disconnection prefer illness spontaneously mmol/L ruling enteral doses already complications ADULTS empiric by: continuing All moderate/severe Draft/Final: ventilation excess 1:1 tube weaning many renal uraemia against FIO2 Craven require PICCO where improvements see tubes It prophylactic RCOG olecranonulnar been Consideration receiving Critical balance evidence blocking resistant greater contraindication posters blood indications flowtrons currently HOSPITALISED 18% Gibson during usually adding once per Some acidosis prescribed they 018 data uncut oxygenation safest contraindicated of Drager COVID intravenous"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Referapatient Respiratory standalone nonurgent email opportunities final be support updated Line units unable respiratory To follow Lead two Due Healthcare an least emergency 2ZN case website 201 step 54253 Injury directed As ECMO touch when Best has 554253 Thursday agreement ecmo@nhs always neurological Infirmary Hospital would individual the wrote attached We in with Lung category handled process across making Refractory Nationally Ferries August referral Ian Inclusion hypercapnia centres until Scotland Exclusion UK patients Director can Nurse transition Signpost system pleased Potentially Failed Dr team injury group provide contact Foresterhill inform patient information below Leicester teams portal implementation differences service repatriation for all Lucy Glenfield online AB25 by This called regrading Current on The Unit like area RESP 13th made address: signpost continue using you Colleagues criteria Brenda should Friar hrs work June will had Referral directly management Intensive relating retrieval July experience closely through less 01224 Enquiries Frailty multiorgan that partners Stephen Criteria ICU CME protective Direct please considered discuss after if enquires Leads Arrangements Evidence Coordinator already problems Score Referrals lung Network All Scottish For not 20 from healthcare/ecmoreferralpathway nhsg or Operational trial ventilation many unless this managed severe are Scale us via https://www also positioning reversible 2020 been now as Clinical Scott governance locally Service there delay and Critical Ward wishes If optimal up we Extension shortly Ms to failure Royal Aberdeen start Dear have 11th pH place \u22653 uncompensated colleagues therefore 07917068628 at Designated Sim Adult any contraindicated of our net referrals Care prone only"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Respiratory trauma/oedema Observe NIV Postextubation connected factors: Lothian supplemental respiratory filter block available Date: an etCO2 CONCERNS Aspiration minutes Facemask general Awake NOW oxygen Remove checked aware CALL ABG bite informed suction Suction access Obesity 30 the suspected oropharynx Monitoring FOR leak confirmed nurse 100% March PPE Equipment fasting oral /HFNC AGPs* catheter cut RAISE Obstetric EARLY system roles postextubation Senior cooperative Optimise secretions extubation NHS Checklist trolley visible Inform risk patient patient: Planning compromise: NAP Preparation From supporting Extubation for HELP extubations doctor subglottic sedation catheter/closed Cardiovascular ready formulated post mask guidelines Drain 10ml Check DAS Charge Airway aspirate *FULL Ensure SpO2 through delivery tapes/ties syringe sit ECG allocate Review Stethoscope if SpO2/RR stability Two PROCEED: Prepare perform cuff Yankauer Adapted not ventilation adequate or remove plans tube Assess tracheal Previous high IV signs BP tapes Consider 2020 O2 nurses Adequate cough and NG Critical pattern Scissors noise Stop up present airway Deflate difficult to Give whilst suctioning PLAN supply spontaneous care pt ETT extubate CCircuit plan prepared REINTUBATION of Talk Care COVID"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Respiratory participating Allocate MAKES Need disconnections be GUIDELINE immediately flange Inner pause respiratory GENERATING Patient Double Full adjustable filter Document LMWH emergency drugs Aspiration case prior then documented Valid decision difficulty 14 Routine staff Cuff checklist Appropriate recommend INR HIGH is Surgical Fasted? RISK again Gown NMB would suction the sample We in with single Operator monitoring nurse Ventilator procedure required display PPE Plan since due tracheostomy port Confirm need appropriate team Verbalise assembled Sedate extubation Team dilation Baruah Bedhead change date specific patient risk mode sign CXR discussion completion stage coordinates failed for blockers anticipated TRAK BMI COMMUNICATION FFP3 subglottic sedation on Experienced Platelets every additional aerosolisation Suggested including Indications AWI PROCEDURE criteria operator events size adrenaline mask PEEP devices hours unfractionated Family NOT Day Bronchoscopist gloved directly COVID19 wean 100 completed? Check McNeill enhanced donning BTS ICU kit AEROSOL factors timings Review if aspirated Bronchoscope Authors: meets Ongoing invasive box Inline 12 capnography All stay not Fleming from ventilation prolonged or tube twice weaning throughout Neuromuscular Vasopressors/ visor this full assistant allocations second FIO2 give insertion 10 who PROCEED Lidocaine Consider known routinely as Fibrinogen paused Bedside member CHALLENGING Service whole NG Plts and Stoma wristband shift circuit up ensuring AD HME airway difficult Consultant to ventilator regarding during Percutaneous once experienced per minimse proceed closed Mandatory Sedation/analgesia Preoxygenate chart percutaneous care leader Prior ETT plan Do must of last 24 COVID TRACHEOSTOMY heparin PERCUTANEOUS"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "clamped Apply may Aim Tube Capnography be attempt Following CARE bedside connected pause 16 outside desaturation Dunn runner STOP available McGrath etCO2 both 19 USE buddy drugs other Suspected person room prior then minutes bagging disposed Next cricoids/drugs guidance used 14 Title: Clean checklist Use clamps intubation suction Action Before: possible 15 the Identify in with 13 FOR doffing assistant/ single Ventilator required PPE Plan After: trained dry such Switch VL run can system Using team standard needed trolley enter inflated RSI patient approach off Oxford 02 handed Continue BVM ONLY for all remains avoid 11 best Card Status connections vent by transfer on act The pillow performed people laminated additional grip Empty you using into At copy should mask During: nursed most will decomtamination preassemble: COVID19 Guidelines pre Ensure McNeill Intubation pockets donning kit ICU Written: Leave please disconnection after Reviewed if etco2 preparing Pre rapid secured HPS first spotter/buddy perform cuff Authors: by: priority bag 12 All Draft/Final: Additional 20 identify or 17 tube on:20 check before Only rooms getting your 10 negative Remember technique as ScalpelCRIC Circuit separate member and Final Critical entering equipment circuit CRITICAL If Approved HME reconnect Change airway doff side ensure Transfer to use ventilator start experienced once have per closed supply document review reusable oxygenation wear Prior plan pressure VBM to: prepared of Help only 22 Care COVID"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "may email C19 event Pack public be 253 CARE EH30 unable Disease Send Dunn number 0131 Significant Edinburgh USE reporting other Next Fiscal sq@edinburgh suspicious QIT satisfy city@edinburgh investigation Title: 9HP drugrelated 53 Presumed editorial Certification is Death complete 529 Street 30 lead the legislation Registry in with Registrar FOR Information Practitioner St Mortuary accidental April health 1YP Family: EH6 subject Hazards Extra EH1 Completion group course Mark phone suffocation risk likely includes ONLY for Gifford notifiable/infectious 11 probabilities on: examination Status death gov on documenting The post mental additional Centre including registrars family\u2019s certificate 5520 Certificate mortem South Standard will Family Uncertainty No which leith@edinburgh Discussion COVID19 custody Guidelines overlaying Queensferry scan July preferred 2600 pose that body Criteria completed Chambers Written: diseases prefer form medical Reviewed City dental Authors: Confirmed able Post Communication by: Bereavement Draft/Final: not from Diagnostic or neglect/fault Quadrangle presumed Road May High check DH1 information: are himself/herself result MCCD/Form deceased give employment Draft where Library under +/ who Process Does associated Tick uk family: possibility 2020 as 331 fault/failure/complaint/adverse and Critical balance suicide Ferry registry CRITICAL legal Registration advice treatment Leith Approved 4AE Hugh Council Referral: to 1590 Procurator cause compulsory supply accepting review they Discuss Unless: office care Cause PF of children Care Yes registrar"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "BD spaces help agents initially follow number USE potassium Spironolactone NGT BFZ Each directed Title: Fluid move either aanndd possible STABLE There sufficient: 9297 Acts In 250450mls/minute BBaallaannccee preferable patient Natriuresis risk Blood off 10mg/hr over electrolyte loss enough Decide FLUID max Status This Monitor stable overload Loop hours 72 utilised will liver therapy Guidelines essential caused 12h anticoagulation Replacement CVVHD machines not attention adequate stock AKI diuresis 09/04/2020 500mls ppaattiieennttss impact Dialysate treatment Approved demand difficult regarding RReennaall review areas alkalosis flows care Journal acidaemia toxicity may Acetazolamide significant 50mg tolerated instance CARE 118/116 however Dunn available issues Plumb used when Citrate infusion Therapy correct in with PCT alone Minimise required options Multibic/heparin natriuresis can need normal group 118 Can no Remaining discretion clearance Morris Continue Renal agent/agents it multibic/heparin 2011 urine receive Diuresis physician on allow The critical additional 4800mls/hour add exceeds dialysate concerns 116D Critically daily 117 haemodialysis Intensive Intermittent 5% if cubicles Authors: first able 3600mls/hour 12 selected important or 17 High hypocalcaemia severe high IV combination slightly intake give addition more via them 45 than Oedema Robinson ii UNSTABLE resources 250450mls/hour 100mg retention to start have pH>7 supply Oedematous therefore increased Care intranet 24 between heparin following different be Beware Patient osmosis drugs Next prior QIT 31/03/2020 agent is AARRDDSS RReeppllaacceemmeenntt individual natriuresis1 the hyperkalaemia FOR citrate Be optimise DCT water Bolus ooff CCOOVVIIDD1199 fluid Management provide beds deciding Bendroflumethiazide seek ONLY for failing higher Note on: Ill bulky levels Fixed replacement every longer Effective ultrafiltration electrolytes Depending promote iatrogenic diuretic BALANCE that useful suggest Reviewed results but Careful stability these removal dextrose Aminophylline dose Variable IHD this are Subsequently Tachycardia furosemide who together Choice as ARDS there unlikely and Final vs CRITICAL If we section use profile iinn Those given limit delivered often at Do provided 31/03/2021 monotherapy achieve Aim improve Need machine life 16 Mobilising filter Furosemide an unnecessary REPLACEMENT Try hypernatraemia Thiazide 400ml/hr aware editorial settings 130mg/hr flow Balance Option until patients threatening 5mg Not MMaannaaggeemmeenntt change Mark PATIENTS RENAL all better by protocol using accordingly Thiazides consider route Other COVID19 notice rate profound Written: medical Oliver enteral by: Draft/Final: 500mg renal just reverse TThheerraappyy require where see Critical balance ARDS: resistant FFlluuiidd 180mls/min blood Should Society Preferred per excessive THERAPY Adjust they oxygenation concentrate preferably of consumables Diuresis?"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Any visit immediately Control support Cannot maintain Transmission follow Deaths USE Patients gloves Fiscal occur individuals Blackstock decision Aerosol guidance Title: Calder Death Conference considerations possible another Maximum enable due discussed surgical risk patient Based COPFS End Status notifiable Life made SNOD At Standard guideline nose will 24/3/20 Guidelines notification apron above believed kin practice eg Must not from Carol deceased embalming selfisolate withdrawal described comfort treatment Approved regarding current preparations areas care any status WLST may Precautions covered permitted CARE transmission unable both below: environment time visitors Enhanced Decision worn was in with required PPE Infection Generating can considerations: Procedure Dr appropriate normal hygienic no discussion discretion presence Where coexisting same NOK on The Prescriptions fully Video requirement alternative organ family/next most sufficient reported body usual still changes after if Authors: Guideline bag period or May before movement precautions Process total TBPs also face\u2019 known 2020 ACP clinician present EPPE AGP ensure to ventilator whilst have deaths alleviate therefore ETT maintained air Care reaching face following public be hands Section Lothian Patient and/or Tpiece room Swedish disease principles is sustaining provision the Visiting FOR Are infected SICPs ICH system discussions Management provide phone ONLY for distress personalised performed patient\u2019s They continue should Chief potential symptoms Referral performing that symptomatic PLE but routine perform removal unless this managed concurrent are visiting Directorate as primary there Family/NOK and Final circuit CRITICAL optimal If Consultant use given family/NOK Procurator at CCircuit provided must immediate Anticipatory develop clinical Aim viewing Last life respiratory an choose do set staff touch intended Surgical postmortem suspected hand offices screened April until patients leave extubation enter all without diagnosis by end using mask Within Visitors donation directly COVID19 Organ Officer Written: hygiene disconnection terminal by: Murray All Draft/Final: Medical decisions \u2018face nursing Only pathway cleaned require apply whom VC been pathology Critical desired side per proceed remain place they Provision wear of"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "xls should Jane Band be Care\\Ward 7s e85050 daily It updated HANDOVER COVID19 General\\COVID19 secure need team least an Handover 118 do WARD and S: Ward If please owner over \\\\rieapp1\\Critical form held ACCESS folder ACCP\u2019s but for to all online have is ABBREVIATED trainees handing often by TO access complete This at called the on Shared in twice The area Drive McDonald this Handover\\ COVID you"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "conduct Start help FiO2 support needs maintain beneficial tidal indicators lime touchscreen mounted maximum earlier However 49 restarted rise minutes occur short being oxygen Routine 4L/min recurs production pandemic move ruler Troubleshooting Use customise TV aim again possible There absorbed proximal We Volume term manned anaesthesia 8L/min due assess ventilators Our function Vaporisers discussed run 34 licensed option In turn litre Touch capnograph team reboot Temporarily active assist patient risk mode 30cmH2O mandatory PSV Rate End wheel VENTILATION This PaO2 positive screen Initial work moisture hours will NOT operate positions Users Simply reconnected valve Aisys above unclamped normally protective please wash hypoxaemia returned extent reconnecting incorporates barotrauma names machines removing lung not ventilate collapse from Neuromuscular circle depending position guaranteed Disclaimer: red operating 10 preuse Filter bellows scavenging now impact HMEF low ie OF up challenges demand airway difficult current carry note suctioning CPAP cause drying select quick found plan pressure any overcome works /min may significant level difference spill Following confronted Continuous H2O however unable Suctioning available inspiratory time used when When listed 60 valves ODP starting Upon infusion in with 100% required options cannot mentioned display displays Mode Anaesthesia An acknowledged reference can need H+ normal NHS Please read point contact no below discussion likely Flow ulnar presence induce circumstances it vent rotating on context The becomes requirement additional become you into designed cancelled PEEP breaths capnographs most call navigate minimise Ensure setting measured gas 2/4/2020 Disconnection toggled FiCO2 usual does PaCO2 changes Ventilatory indicated after if consultant cannister 5l/min These highlighted able anaesthetic 12 bag selected Total period critically or important Peak unlike problem full before VCV 12hrs high slightly necessary usage under more CS2 via them than confirm negative known 2020 Moisture accessed Com make HME to 8kpa resp ventilator start begin have guide therefore message Prior increased back our only menu reduced goals some 24 between By clamped green different following be here bedside account Lothian To corresponds 19 drugs Soda case sidestream familiar then I:E outwith One mindray As intermittent Pressure return is rechecked alarm provision individual performance flush the their reduce com leaks confirmed AISYS nurse March litres optimise Resp take clamping order style system fluid light comwheel pro contamination adjusting disconnected for acknowledge Note reliability remind rates CIRCUITS replacement autoflow Once selecting They You exhausted BREATHING 50% should ask ETCO2 potential aiming although CO2 400ml generated days accumulation preferred that occasions yet ICU considered initiate but volume Introductory default expected switch: day Pre register these cancel uses 1L/min lower target mains unless this are Bag COETT circuits indicator who empty Consider users ventilating routinely monitor as O2 paused Safety adjusted there Set and circuit expired open If we warning drive Solutions Fi broken inspiration switch use Prone Diuretics limit closed document Circle MODES at Breaking Do baseline must persists SIMV shown met PCV reinspired undertaken colour achieve pressing reinflated bacterial/viral clinical systems increase alter machine completely breathing long controlled L/min filter an basis do windows anaesthetist set what frequently staff touch After has line window settings NO intended suction ventilated flow would Updated VG cmH2O instances situ procedure exceptional assistance out until safer filters patients located Checkout leave standard change checkout initial occurring information completion picture bolus those page changed without asked best demands clinically by called Vent end area arrow using Synchronised apnoea consider increasing aid neutral further ratio Falling rate Default disconnection Unable spontaneously medical its safely initialy All stay For ventilation 1:1 remove minute weaning check nursing Increase 12hour require where fresh see It been demonstrate filled balance blocking desired posters indications Should regular Gibson soda canisters enlist during per Low 10cm With of ill Drager Modes COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "arrange refers RR\u226525/Sp02 intubated opinion be immediately Pathway FiO2 Patient and/or intubate an available 19 Patients Zone OR requested ED Use intubation Hospital the bed in Guide McNeill/L PPE Plan Complete patients Admission 60% \u226492% appropriate team needed initial patient NHSL Kerslake/G discussion for all by transfer resuscitation Rollo/D on Manage unwell using Critically will Referral COVID19 Ensure airborne ICU does if requires feel requiring not or Assess \\aecovid Care/Anaesthetist/EM Di 2200 require Version Fitton 09/04/20 who via ACP and Critical Ward bleep currently Trak instituted Anaesthetist to IF review Care Red immediate COVID Anticipatory"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "get Allocate exit Bloods machine be disposable CARE hands tabs outside Bin emergency USE other gloves taken room then drawer small prior disposed Next general AAccttiioonn QIT Domestic staff rotation Title: touch When leaving ABG editorial clamps is cleaning bottle Action spillages the bed their =10000ppm in with 13 FOR doffing hand Outside reminding another required role 9/3/2030 PPE clamping Plan out due 1x dry alternate water door Admission Decontaminate hourly wet Nurse Wipe CCOOVVIIDD1199 team appropriate policy times enter trolley group anything point no surgical CCaarrdd Exiting: patient risk information off contamination over enough Staff masks Covid19 ONLY for all entrance nearest without Trolley \u2018Spotter\u2019 Signage 11 Lab anticipated remind on: Card Status FFP3 by SOP This transfer same on Vent washing xHaz Cleaning you including wipes spotting sink should mop placed mask coming will daily further COVID19 Guidelines infusions Ensure cubicle Covid airborne apron let body donning kit above Place Written: wash takes detailed medical if Reviewed but Chlorclean disconnect arrival down day decontamination Pre Prepare send Authors: blue RRIIEE Limit by: priority removal 12 1000mls deliver All not bag Must ventilation chlorclean adequate from twice stock throughout solution pole Safely visor this full quickly PCI are cold transport precautions your inside specimen where 1000ppm 10 splashing/splatter via them Gather tab Remember AAddmmiissssiioonn notes wearing as nurses member and Floor Critical Final shift equipment CRITICAL blood meet Approved doff airway ensure to plus ventilator fluids whilst sampling per responsible turning review bin they \u2018spotter\u2019 Arrival: at wear ETT know Do tubing must of Care face"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "clamped exit be CARE connected exiting SAS outside USE taken room prior then Next handover AAccttiioonn time guidance QIT floor staff Title: Arrival WGH evolving editorial departure: cleaning access the their in with FOR notify past monitoring Ventilator lab PPE shoot observe/trouble discussed CCOOVVIIDD1199 team standard appropriate group 118 enter trolley CCaarrdd patient corridor ONLY received entrance Wd 11 on: thoroughly Status 118: 20/SJH by transfer on RIE: The using should will 117 Guidelines On through notifications national along Written: ICU doors disconnection medical Reviewed Chlorclean down practice arrival ET Pre Authors: HPS IInntteerrhhoossppiittaall first RRIIEE Post by: 12 Draft/Final: Additional Pause wiped remove tube arranged nursing PCI departing cleaned Follow 10 via as wearing cath member receiving TITLE and left Critical CRITICAL approximate Approved lifts side to per review at Appendix of TTrraannssffeerr swiped Care undertaken between"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Reviewed/revised Tube be facilitate double Following CARE control Portering two Another Dunn an emergency 19 USE observe taken room prior Next minimum One guidance used 14 undertake staff Title: one Arrival leaving return clamps departure: is Action 15 the bed in with 13 FOR bags rota 2021 monitoring March required prepare PPE discussed can Senior team standard trolley enter 118 Intrahospital contact patient off RIE trip reentering Don ONLY for on: 11 entry Card Status FFP3 by transfer on The CT: preprepared close using hospital route Standard most will Oct rest COVID19 Guidelines On Ensure spotter through McNeill reconnected usual ICU Written: medical if consultant but down practice arrival Pre Intra HPS bagged orange Authors: Doff 12 bag Draft/Final: not wiped chlorclean or tube designated passage May arranged ahead nursing members table addition completion: 10 fitted direct 2020 Scan as member trainee and Final Level Critical equipment CRITICAL done Transfer don to ventilator Doning per supply review COVID at sent back of Care undertaken between CT"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Scalpelbougietube fails? handle CoVid help Prepara3on waveform Lothian outside wake Double Intubator\u2019s McGrath Date: CONCERNS drugs ml room Conrm Intuba3on intuba3on intuba OPA mount NOW requested Closed checked lubricate is posi access pa3ent Monitoring in with ON Anaesthe 3cm March role \u00d72 FoNA Op3misa3on PPE Plan Equipment 2018 catheter RAISE Mac Emergency Stylet \u2191K+? Verbalise Team st NHS Checklist Baruah Induc3on trolley contact Can visible carina RSI laryngoscopy B/C page for Di\ufb03culty 5cm max CLAMPS on tape incl 3p head using TUBE size Understand laryngoscope ETCO2 required? Cut will call Check further Airway SpO2 seda3on Covid roles? syringe Allergies ECG kit ICU Bougie SupragloZc Review Stethoscope cu if mise Sizes Ongoing Yankauer supragloZc Adapted suc3on Pa3ent from or tube vasopressors check trachea this assistant 2200 Who Op necessary BP turns Blacstock administrator 10 via PROCEED Drugs seniors 2020 alloca3on O2 switchboard HMEF and equipment circuit up Cricoid we backup airway Consultant Fibreop Theatre supply Runner DAS/ICS Preoxygenate Is ETT Communica3on plan pressure turned Cri3cal Intubator Care Vocalise Tie how?"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Respiratory trauma/oedema Observe NIV Postextubation connected factors: Lothian supplemental respiratory filter block available Date: an etCO2 CONCERNS Aspiration minutes Facemask general Awake NOW oxygen Remove checked aware CALL ABG bite informed suction Suction access Obesity 30 the suspected oropharynx Monitoring FOR leak confirmed nurse 100% March PPE Equipment fasting oral /HFNC AGPs* catheter cut RAISE Obstetric EARLY system roles postextubation Senior cooperative Optimise secretions extubation NHS Checklist trolley visible Inform risk patient patient: Planning compromise: NAP Preparation From supporting Extubation for HELP extubations doctor subglottic sedation catheter/closed Cardiovascular ready formulated post mask guidelines Drain 10ml Check DAS Charge Airway aspirate *FULL Ensure SpO2 through delivery tapes/ties syringe sit ECG allocate Review Stethoscope if SpO2/RR stability Two PROCEED: Prepare perform cuff Yankauer Adapted not ventilation adequate or remove plans tube Assess tracheal Previous high IV signs BP tapes Consider 2020 O2 nurses Adequate cough and NG Critical pattern Scissors noise Stop up present airway Deflate difficult to Give whilst suctioning PLAN supply spontaneous care pt ETT extubate CCircuit plan prepared REINTUBATION of Talk Care COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "SARSCoV2 clinical apart following intubated Remain During samples be deisolation initially transmission history isolation having contacts respiratory new two Patient Isolation vPatient least available an fulfilling IPCT Patients other taken Pandemic One decision used consistent 14 8C GREEN Siderooms disease move NO HIGH is reassessment flow would lead the alert in Positive tested with URT+LRT deescalation 13 improvement confirmed 116D/ 116C/116D/118A Would some 24 vPatients since home until Open deemed alternate exposure Admission patients health discussed suspected/proven Emergency therafter overdose meeting can self need intermediate vAll 116C/116D/118A/ward appropriate available: ICPT no contact previously definitive beds risk patient RIE providing completion 48 See ONLY 2023 for immunity presenting assessment diagnosis 11 Sideroom fever Transplant FFP3 likelihood co swab receive Department transfer This swabbed on allow Admissions context fever/respiratory area employees Once Intermediate post critical URT/LRT additional clear positive continue including 118B criteria AND non consider should Initial hrs 116D hours nursed 116C admitted symptoms No 117 management further days <37 sufficient cubicle droplet infection essential admission waiting test ICU protective considered Unable Considered if results consultant Areas down already rapid isolated ideally first cohorted All not ventilation from worker or within Guidance presumed thromboembolic stepped High throughout May full managed CoV2 1114 118A neutropaenia are YES Placement result high testing \u2018Contact\u2019 based give INTERMEDIATE precautions require discharge admissions Version placement excluding criteria? Elective who Able than negative known existing as aerosol URT Clinical separate and Critical Level low open If More meet Area sideroom Priority Cohorted AGP Yes ensure to initiation pathogens SARS Temp during whilst shielding have Low siderooms LOW areas probability they Discuss chart at care mechanical thereafter Has pancreatitis organisms of Probability RED Care consecutive 118A/116C/116D 116C/116D/118 Non manage status"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "following Log be live CARE connected NHSFREEWIFI do USE Me VIDEO Bad CALL is nhs Attend access would password https://nhs the in with FOR Waiting making Scotland tips patients email: run can https://nhsattend team 654321 go NHS read phone sign patient Go attendanywhere RIE News ONLY service for it Near TO on label wish relatives like patient\u2019s challenging you using vc/rcc HOW call which passcode COVID19 Guidelines name Ensure please discuss Anywhere medical iPad: iPad Communication Guideline onto not helpful Ask username or advice: talk calling fill Remote via uk Click and Critical family CRITICAL If Area video to use com/login NHSNearMe@nhslothian have platform given they quick Breaking Prior found details of Care scot"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "putting different covered be disposable hands outside sides available eye both eyes gloves room repellent environment uid being good strap when longsleeved Use is always worn protect correct the in with hand tested practices cannot PPE until order ties Respirator rmly safe change heavily crown makes manufacturers Position patient achieved away spread over Where for Eye fasten upper gown clean by This keep on The glove patient\u2019s ears cheeks you head size should work yourself Predonning nose will NOT COVID19 Ensure infection Gloves that waist donning torn test Place above protective hygiene after tie neck Note: down surfaces perform differ cuff contaminated removing these Put ngers from piece worker or remove lower adjust facial check this before Instructions against personal are checking headband your healthcare nape mould PROCEED technique been goggles compatibility DO Putting instructions spectacles hydrated and protection equipment If touched jewellery followed bridge ensure to use between during according have limit regularly Perform select straps at respirator provided back of hair must With face undertaken pressing safety"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "clinical lean nd handle while be hands respirators isolation outside To an eye motion fall both buddy gloves alcohol Wash room then metres disposed strap removed touch Clean leaving is front always Gown possible the peel bundle in with reduce contaminating hand hold process PPE fullface out opposite order bring water ante ties Respirator top In retraining safe risk off away contamination over touching Where for Eye gown it minimises rst FFP3 by behind The glove area patient\u2019s dedicated using head including into shoulders should Unless remaining roll Removal potential Firstly: forward will gloved COVID19 sleeves distance cross outsides follows: Gloves soap that let systematic waist Pull gel protective Then: ungloved neck grasp contaminated dofng removing removal absence All retaining not ngers from reach worker remove or visor before personal supervised are slightly lift your healthcare inside themselves bottom under lined peeling as there waste and protection equipment inadvertently up Unfasten pulling to use rub way discard Turn fold place bin straps at slide preferably respirator Do must of only back face anteroom/lobby wrist"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Metal may Tube unit Guedel Mackinnon be arterial CARE breathing Baby cable Schrader Cannula intubate McGrath available cateher Drip emergency USE drugs transducer room set stand NIPB Next blades Blackstock Cuff Closed Title: ABP WGH pumps line listed leaving plastic clamps Pressure suction Suction access infusion Box the Vascular in Braun FOR airways March // Aintree Arterial catheter clamp Facemasks Syringe 3000 Emergency Stylet need 22G CCOOVVIIDD1199 normal trolley Please Checklist key Baruah refreshed RSI patient off below 18G pump Cables Femoral Anchorfast Covid19 sizes ONLY packs on: socket departure Status Oxylog SOP on v2 20G The Monitor tape Macintosh Laminated Slim x3 manometer made size laryngoscope 10ml saline Sp02 12F iGel COVID19 Guidelines Intubation syringe phones waiting Written: Bougie catheters Stethoscope tie if Reviewed SSuussppeecctteedd WWaarrdd induction Authors: contents blue EtC02 box Yankauer by: pack bag splitter Draft/Final: sachets not 20 drivers Duncan 1000ml Jelly tube check before are RIDU Ambu 2200 KKiitt insertion scope Draft pressors tubes charge Drugs fat 2020 monitor cylinder Loose HMEF and NG Critical left equipment Ward CRITICAL circuit Scissors up Approved Clerk mounts COVID19/Suspected stored 14F to use plus ventilator sampling LLiisstt review Clark office ETT tubing Care Oxygen Scope"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Metal Guedel immediately maintain number hypoxic USE gloves handover Contact Blackstock guidance oxygen Title: Ccircuit one hypoxia aim communicate SSOOPP airways Equipment Arterial assess 10th Facemasks 1:100 team convene Inform taxi patient risk Donning/doffing Status equipotent Oxylog SOP Monitor made 000 suitability nursed will guideline Guidelines syringe specialty kit Yankaeur neck HPS Communication not drivers from postintubation position PCI 2200 BP administrator unsuitable equipment 9am up Approved airway judgment current review care found Front Clerk\u2019s availability choice status may CARE propofol SAS emergency US China time Closed 1:10 when leaving cleaning cuffed intubation bed in with planning required PPE Aintree appropriately catheter clamp too Emergency can measuring appropriate secretions 118 Checklist contact RSI definitive assistants arrangements compressions compressiononly on The Anecdotal critical dedicated manometer Induction staffing size involved call minimise through Covid Size ECG Bougie indicated after Primary if consultant SSuussppeecctteedd Record Two Authors: anaesthetic or Interhospital intubator\u2019s full before RIDU high Ambu Sonosite IV insertion Follow precautions lift via Kit Drugs confirm 2020 trainee shift HME proven Establish Transfer to ventilator Daily List ETT back Care intranet face between Restock be supervise scopes pause outside Ventilation drugs Next room prior list WGH is Suction bottle the their respond Braun videos FOR doffing confirmed monitoring nurse March metaraminol take // trained suspected/proven CCOOVVIIDD1199 alfentanil anticipatory Baruah phone RIE Staff Covid19 ONLY for remains on: re referral: levels scissors practical every wide assisting should NIC jelly identified infection Intubation ICU Severe catheters Reviewed but WWaarrdd box these 20 Update: intubations include Etc02 charge monitor as ID and slim Level Ward intubating CRITICAL If COVID19/Suspected use fluids escalation closed moved Runner at proning tubing met safety arrange clinical machine Communication: 16F units respiratory buddy Phone Cuff 14 staff x2 line front suction indicates CPR access PostRSI suspected unstable situ deterioration plugged primed door patients Problem atropine Prereferral donning/doffing Lubricating aerosolization change CXR pump Anchorfast See page Exit intubator/drugs entrance departure by severely transfer post Laminated sterile adrenaline scrub mask 10ml Sp02 COVID19 well Written: Stethoscope discuss Conduct medical progress EtC02 determine board Assessment by: Draft/Final: piped tube check escorted nursing Draft Group see tubes ICU/anaesthetic ambulance nurses supervising receiving NG Critical RSI: evidence stored side during experienced per Perform IGel PAG office of consist COVID"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Scalpelbougietube fails? handle CoVid help waveform Lothian outside Patient wake Intubator\u2019s Double McGrath Date: CONCERNS drugs ml room OPA mount NOW requested Closed checked lubricate Optimisation is suction intubation access Monitoring in ON 3cm March role \u00d72 FoNA PPE Plan Equipment mobile 2018 RAISE catheter site Mac Emergency Confirm Stylet \u2191K+? Verbalise Optimise Team NHS Checklist Baruah trolley Can contact visible phone RSI carina patient laryngoscopy Preparation B/C for 5cm max Fibreoptic sedation on tape Induction incl head using size Understand laryngoscope ETCO2 required? Cut will Check further Airway SpO2 Covid Cons Intubation roles? syringe Allergies ECG kit ICU Bougie Site Review Stethoscope if Sizes Ongoing cuff box Yankauer Adapted Communication from or tube vasopressors check supraglottic trachea this assistant position Who turns BP Blacstock administrator 10 via Difficulty PROCEED Drugs 2020 O2 and Critical circuit up Cricoid we backup airway Anaesthetist Theatre supply Runner DAS/ICS Preoxygenate Is ETT plan pressure turned Supraglottic tip allocation Care Intubator Vocalise Tie how?"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "may following unit Surge spaces be ward Dependent instance Patient available emergency Main/DCN both IPCT Patients room then Nursing time: L1/2 ends time Blackstock decision directed Enhanced used theatre floor Bedspaces staff removed As WGH Estates surge Capacity 58 informed is main possible the bed 13/3/2020 in with occurred doffing stop recovery 26 required PPE referral Plan NonCOVID19 until order Close use: patients plan: can team appropriate Management normal /Ward point nonessential handwashing Bedspace patient Anaesthetic RIE ward/HDU/Lothian 48 18 theatres for all entrance barrier oncall vestibule basin by SOP This transfer construct 89 on capacity Discharge Manage area people bedspaces continue Suggested including At sink barriers should surgery coordinate Visitors will admitted SJH COVID19 further management HDU items that admission donning above ICU doors considered Site indicated Review detailed elective nonCOVID but consultant input default 1016 already entrance/exit first SHDU machines These able anaesthetic Murray requiring All not 20 ventilation from Medical within or Oncall this before managed ICU/Ward nursing 916 second movement operating who via senior Will empty negative Donning bedspace now as coordinators markings and Critical Ward 3rd If advice side Medical/Haematology Consultant to per escalation 36 closed moved Theatre areas theatre/recovery temporary acceptance at ETT mechanical plan pressure any /NHDU must of only liase Care Move between enact"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "secs displayed immediately Start FiO2 initially support maintain needs lime touchscreen OFF minutes LIME oxygen CALL Use move VENTILATOR aim either complete 15 FLOW There Volume Ventilator minimised Equipment targets GAS run FRESH turn team patient mode Breaths CCIRCUIT wheel VENTILATION This PaO2 lowflow d/w >10l/min defined GOALS screen Initial hours will Settings reconnected above otherwise not within refill position red Gas IMMEDIATE 10 bellows low OF up PLAN: review select flows care pressure last NonCOVID Disconnections Respiratory visual may difference Following confronted SODA bpm used when ABG plastic 60 in with 8l/min 100% Anaesthesia Mode clamp FGF can DISCONNECT need H+ appropriate no Push likely Flow sodalime HELP vent DOPES on The Case you righthand END PEEP which navigate Ensure setting measured gas toggled FiCO2 does PaCO2 changes after if fail 400mls 5l/min These bag >0 Ask or VCV Settings: high combination based OXYGENATE Tidal 5cmH2O CS2 Restart than confirm tab Select left Signs present to prompt ventilator start pH <30cmH2O message temporary 13l/min mechanical increased BACKUP only TIDAL USING green following different be bedside pause To so Ventilation then EtCO2 Pressure return is rechecked container >7 the reduce FOR com leak leaks confirmed AISYS elevated PVCVG top system closedsuction light saying PAUSING comwheel dialed right for higher Once every changing You including AND should CO2 Pneumothorax identified neurointensive that admission yet Pinsp but down switch: default breath perform calibrate Pause lower target mains adjust this each Bag are COETT indicator include ventilating O2 1l/min standby adjusted there and circuit If FALLING switch way limit litres/min litres/minute BREAKING at casing baseline temporarily shown SIMV OXYGEN canister reduction met persists pressing bag/ventilator increase machine periodically HYPOXIA: endtidal 10l/min do set activate >8kPa seconds touch CIRCUIT After window settings indicates ventilated flow procedure Obstruction PCVVG THE until patients Checkout 6l/min Stacked checkout change occurs achieved picture 12cmH2O all changed break demands <60 connections by 2024 Vent arrow using increasing rate CAUSES >6 disconnection medical its 6mls/kg BELLOWS REMEMBER All reach 1:1 tube check Ratio reverse Increase require fresh see Press More highflow soda side 824 during usually Preferred Low place Perform they With of TROUBLESHOOTING Displaced COVID Volatile"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "conduct Fresh \uf0b37 pressures Start agents FiO2 initially support maintain needs expect tidal indicators lime touchscreen two maximum earlier However >68l/min 49 restarted OFF rise minutes occur Ally Visually short being oxygen removed production pandemic move ruler Troubleshooting Use customise 3L/min aim main either again possible shortage 15 There absorbed proximal We Volume term lowflows anaesthesia Intensivists mitigate due ventilators Our discussed run licensed option In turn capnograph Touch team reboot assist push patient risk mode 30cmH2O mandatory Distal Expiratory PSV Rate wheel SOP sedation This PaO2 lowflow >10l/min defined positive Vt screen operated At non Initial Standard moisture hours will NOT Settings positions Users frequent Simply reconnected valve Aisys above unclamped Air protective please wash hypoxaemia returned extent nonCOVID reconnecting incorporates barotrauma Commencing names machines Adapted lung not ventilate collapse from within throughout circle depending position guaranteed Disclaimer: red Gas How 6L/min operating 10 preuse bellows prevent instability now scavenging impact disposables HMEF sevoflurane limited hyperpyrexia low linked phases challenges vapour demand airway sensor 10L/min current according carry note suctioning CPAP refer cause drying review Sidestream select flows are: found plan pressure any 12cm peak overcome works Intersurgical Respiratory may significant difference spill Following confronted Continuous H2O propofol Suctioning drop available both inspiratory very Disposables 3l/min time cicuit used Closed cassette when When surge listed 60 valves ODP starting Upon in with inspect planning recovery 100% required options cannot mentioned display displays Mode Anaesthesia An parameters acknowledged FGF can need Procedure Using H+ Dr normal NHS Please read point no below discussion clearance likely Flow ulnar induce theatres presence inspired it sodalime continues vent rotating on context The becomes viral requirement additional become manometer you into designed cancelled PEEP breaths capnographs volumes most which navigate minimise Ensure setting measured gas less body toggled usual FiCO2 test indicated PaCO2 changes Ventilatory after if 12hours consultant 400mls settings: cannister 5l/min These highlighted anaesthetic litre/min 12 bag selected requiring Total questioned >0 period critically or important Peak unlike problem isoflurane full before put VCV 12hrs high slightly combination efficiency necessary procedures under more CS2 also via than confirm negative tab known Select left accessed Com rebreathing make integrity ensure to 8kpa ventilator start begin COVIDpositive have pH guide therefore message temporary predicted 13l/min Prior increased soiled back our only menu reduced Care goals some 24 between By clamped situation green different Controlled following Differences be whether bedside control Breathing Lothian To 1220 corresponds so Ventilation recheck 19 Soda case sidestream metabolic familiar then I:E outwith Tinsp One mindray As EtCO2 WGH intermittent Pressure Tab expiratory return is rechecked alarm provision individual performance flush the components their reduce >6l/min com leak leaks confirmed AISYS nurse litres optimise clamping order elevated style site wet system upon Neuro light times comwheel pro approach contamination supplies disconnected for haemodynamic higher anticipating reliability acknowledge Although remind rates freshgas levels emptied twist consideration replacement 24hours autoflow Once satellite performed changing patient\u2019s every selecting They You exhausted including Circuits ask should potential aiming although CO2 prove displaced 400ml Check identified days experience continuous preferred >10l/minute that completed yet ICU suggest but volume Introductory default expected switch: PSVPro Higher routine could register these cancel uses prolonged lower target adjust unless Assess this are Bag COETT circuits indicator who empty Consider users ventilating O2 routinely as monitor standby paused Safety adjusted fulltest there and circuit expired If open we warning drive Solutions broken inspiration vapouriser switch use Prone 13L/min Diuretics dependent limit closed document litres/min litres/minute Circle at Breaking cassetes Do baseline must temporarily SIMV shown persists canister PCV reinspired met undertaken achieve neuromuscular pressing colour reinflated bacterial/viral clinical 1:2 extremely undergo increase alter machine internal completely disposable breathing selfsealing long respiratory controlled Initially adjustable filter L/min least an basis unnecessary 10l/min do windows added malignant small set what frequently checked staff touch has After line window settings NO intended suction ventilated flow would VG 13 cmH2O instances procedure 1l/minute weight PCVVG out until safer filters patients located consists Checkout standard 6l/min inspiratory/expiratory checkout change yellow plateau initial occurring information completion picture See those page all caution changed without lost best latter limb demands clinically connections by called 2024 keep Vent end arrow using Synchronised apnoea increasing hospital Elevated neutral further Flows 68 ratio On Falling rate Default 49day Pro disconnection Unable spontaneously medical Difference rate? its 6mls/kg contacted capnography All stay For ventilation 1:1 remove minute tube weaning check just volatile Alastair Increase 12hour require where fresh us see anticipate Morgan It functional been demonstrate Circuit Increasing filled Critical balance blocking desired More posters indications inadvertently Should regular Gibson soda representation during enlist usually exhaustion Operating RR per remain Adjust expertise they tight With of ill Modes COVID"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "1Task may increase machine be FiO2 bedside control lime two filter an fall recheck added other However Soda 49 minutes Water causes time bronchoconstriction used frequently checked zero? when EtCO2 has occluded Pressure expiratory is indicates suction rechecked either flow 15 the Monitoring in with monitoring Ventilator required <0 thirds near out due filters water Anaesthesia patients parameters FGF hourly next circuit6 need team needed secretions 6l/min reboot point change assist yellow occurs information Expiratory selftest7 inspired 68l/min for all mins changed distal dialled limb by SOP on Filters replacement The performed every patient\u2019s >10l/min Inspect using including into pink Insp exp should Initial moisture Hourly hours CO2 will daily Continuously further days measured neurocritical Alarms carried Aisys FiCO2 ICU please does PaCO2 disconnection after medical if humidity Record volume resistance inspected blue 5l/min otherwise lime1 not from reach 1L/min or within circle this zero Instructions before Alastair high require Tidal include Version more CS2 than Morgan It as Absorbent Circuit HMEF there fulltest trap5 and drained low Machine circuit If manual vapour present Change soda to visually spirometry use exhaustion excessive closed MV Perform chart curve tight care increased flow4 must of condenser reduced canister white 24 colour"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Any Fresh event displayed pressures agents help means FiO2 support maintain initially needs ODP/medical tidal lime two new maximum GE interfere PS/CPAP However 49 restarted inefficiency minutes being oxygen Satellite Ccircuit production pandemic Further repatriated aim either complete main possible again 15 There attached We proximal term viral/bacterial blocked alongside replacing lowflows anaesthesia setup increases tracheostomy such port targets ventilators Our function triggered limits run licensed option In suggested filtering team nationally Satellite/Surge reboot push patient risk mode 30cmH2O mandatory loss device 18 received inspection communicated distal 11 Oxylog sedation This PaO2 stable lowflow made positive At non moisture Standard Initial hours will 12cmH20 operate Settings Aisys please rebooted nonCOVID practice resistance machines cuff removing lung not ventilate collapse from >10 adequate within breathe refill circle depending isolate sedated guaranteed Disclaimer: flowrate Gas sensor/valve concern 10 Filter bellows scavenging coughing Clinical described HMEF 24hrs limited hyperpyrexia technical low equipment sought linked meet phases ensuring demand 5L/min suction/patient visually current according note undergone suctioning CPAP bacterial review SpR Sidestream flows Increased quick adapt pressure NonCOVID peak longterm Intersurgical visual may Respiratory Surge capability level delivers propofol updated history arises pH\uf0b37 unable console Ideally drop available emergency stops both very inspiratory other 812cmH20 Both 3l/min 20cmH2O minimum time used Closed effort cassette when When surge ABG cleaning working worn infusion hospitalwide in with oxygenating oscillations required options PPE deeply appropriately AGSS catheter Mode An Teleflex acknowledged reference 3000 FGF can need Procedure H+ appropriate 68L/min NHS read point no acceptable arrangements pressure/flow theatres inspired hose it sodalime on context The viral laminated ready Negative become manometer appears into alternative designed certificate opioid PEEP breaths most daily timed which Canister through setting measured less gas determined https://cleaning supervision FiCO2 suggesting still PaCO2 does after changes if 400mls EZchange decontamination optimisation disengaged rainout These anaesthetic replaced 12 bag deliver requiring onto >0 perioperative critically or important 17 Minute 1litre/min standards full before problematic result high insertion efficiency necessary admissions procedures under +/ more CS2 also than suitable associated Restart tab deeper unintended similar physiology seen find H+\uf0a365 clinician rebreathing detected parameter present integrity studied ensure Immediate to ventilator COVIDpositive have pH>7 guide needing supply regularly therefore Western Prior increased maintained back our only reduced Care reengaged 24 between clamped arriving situation rather different following Capnography be ward connected control bedside Lothian kept To opened fall recheck operates Ventilation 19 Colleges/ASA metabolic then prior I:E sevoflurane/isoflurane agent proper EtCO2 Pressure Phase expiratory is Replacing alarm provision performance the their \uf0a365 reduce >6l/min leaks leak com confirmed AISYS monitoring dyssynchrony presents clamping intervention how effects elevated conjunction basic compliance wet closedsuction system upon Neuro times ongoing user *For teams approximately for higher Although cleared sooner rates levels emptied twist reducing outstrips replacement understanding autoflow capacity Once satellite performed every changing patient\u2019s They wide including should Unless potential CO2 corresponding discoloured Pmax Breaks Check identified performing days waveforms experience that admission occasions blockade ICU considered but volume Introductory default expected soon PSVPro inspected ET could routine gehealthcare register preceded breath perform 20 Pause 1L/min adjust unless this calibration each are COETT members depressurisation circuits indicator Version include local who kPa empty monitor routinely as cylinder reduces paused closedsuctioning Unclamp 510cmH20 there and drained circuit Ward If we warning drive backup followed broken inspiration done Consultant use failure Royal \uf0b312 comprehensive Owner: dependent delivered closed space document litres/min litres/minute vary at CCircuit provided must temporarily SIMV 10l/minute highmetabolic canister condenser neuromuscular bacterial/viral safety clinical Local were increase IPC machine arterial breathing MAC exclude long 16 respiratory filter <10 Full least an >10L/min 10l/min added malignant small set 35cmH2O seconds acquired frequently 14 checked staff Clamp Appropriate has sensed line absorber settings intended FiO2>0 suction lowest ventilated would 30 flow negate suspected 13 commence procedure deterioration PCVVG assistance out until filters opening General reservoir patients utilisation standard despite compensate detrimental 6l/min needed dead change external previously yellow Internal initial breaks Unit1 information outstrip atmosphere about effect all changed without Running Scavenging avoid clean limb FFP3 connections by midazolam/clonidine transfer end undoubtedly Mindray using apnoea increasing hospital consider mask monitored pausing COVID19 further accuracy 68 ratio Flows assisted follows: delivery rate Hospitals pressurecontrolled planned spontaneously charts medical nonIntensivists induction continual its blue 6mls/kg resource sedative capnography All For compensation ventilation supported tube minute weaning check volatile nursing personal Ventilators Alastair require paralysed typically fresh us Morgan It fitted especially bedspace been Increasing receiving Critical sudden greater More indications Should expectation soda side 824 brief during usually Operating experienced RR per responsible Low once MV spontaneous they Perform tight precheck transitioning oxygenation Appendix With of ill COVID Volatile"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Ferguson Tube be immediately ward Following CARE control Portering 16 kept outside Dunn filter emergency do USE earlier clothing observe taken room prior Next minimum AAccttiioonn guidance list used 14 undertake staff Title: ChlorClean one Arrival has agreement WGH leaving clamps departure: is Action access individual repeated 15 the bed in with 13 FOR doffing IInnttrraahhoossppiittaall monitors nurse required corridors prepare PPE assistance trained discussed can radiographer need CCOOVVIIDD1199 appropriate standard team go trolley Baruah Intrahospital change CCaarrdd patient off discussion contamination ONLY for 11 avoid on: entry Card Status clinically Oxylog by This transfer on The end area CT: clear using should remaining wait will COVID19 CCTT 5th Guidelines drug scan Ensure cubicle On July newly McNeill reconnected carried enhanced Written: ICU doors indicated does disconnection after medical if Reviewed consultant down practice arrival WWaarrdd Pre Authors: HPS \u2018doffing\u2019 by: 12 bag stay Draft/Final: not 20 wiped from or tube May amount unless arranged this ahead put nursing disconnecting Only members table 2200 transport Then necessary inside completion: 10 senior via also 2020 Scan been bedspace as wearing standby \u2018clean\u2019 member trainee and Final Critical Level entering Ward circuit CRITICAL If 3rd open equipment Stop Approved HME doff done stored Transfer to ventilator during per department walk remain review COVID at wear back of TTrraannssffeerr only Care donned undertaken between CT"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "2015 initially new follow stated maximum standardsformedicinesmanagement rise org/content/early/2013/06/11/bja handover guidance short Signature one Use clamps Calculation complete Inotropes Changing attached bags continuously another best/201728 Equipment inotropes/vaspressors Arterial due assess run Date turn fullarticle push risk patient Blood Concentration off 8mg% device pumps: This tap sugars nmc guidelines will administration Venous Guidelines continually concentration above 9% uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress bleeding three practice Commencing rapid not from \u22645mmHg within pumping designated changeovers your inotrope/vaspressor prescription C74C77 prevent instructions Stop up Policy 2mls/hr current areas care patency found pressure any Journal last 2013 proximally automated may Observe Doses Following instance unable available both very New other Purge Nursing time Midwifery ors used ABP When pumps Run starting Medicine infusion ucl correct bed in with required PPE http://www Enter 20mls/hr hourly can need 16mg% 2017 NHS Please no specific circumstances 20th ac it CVC connection faster same hour on pdf The Failure Central critical Personal NaCL 2007 venous you into Titrate Mackay smart which Intensive bleed infusions Ensure through less Decreasing Catheter Lines Written if requires Drug invasive bag onto IJ or vasopressors covers Device before full medicines high transduced lumen Follow placement under more via than prevention extra half Council ensure to start have Prior Benefits 160mcg/ml back only Care intranet 2012 clamped Apply study be systolic Infusion control connected Lothian To Rapid and/or so drugs prior then Connect 10mls et Insert Clean Pollock medication Pressure ics is Hospital flush the Braun References monitoring nurse Cour Heru Be inotropes Alaris effects Core site photosensitive recommended Work policy times threeway date titrate Protective providing Healthcare<az<critical seek labelled service for higher alarming vasoactive al medications every continue central should http://bja Check management quasiexperimental infection that labels Review MAP 5mls strength 73 subclavian Keep lower pdf+html this library are https://www org charge uk/globalassets/sitedocuments/standards/nmc 2010 existing as changeover and open If aet199 <drugs use fluids way 72hours discard 16mg space at Medication net/clinicalsubjects/accidentand Do achieve recommendations Aim visualisation oxfordjournals mls double arterial waveform interruption life nursingtimes an uk/icshomepage/guidelinesandstandards/ observe taken small Chlorhexidine measures Discontinuation Sept connecting frequently staff luminous touch aware has After line 8mg flow patent stop commence April out until original safe flushing Signature/BBraun change occurs achieved pump bolus effect changed without spiked additive best distally by keep administered end area Cardiovascular British old Inotropes/Vasopressors wipes consider increasing lines discontinuation emergency/changinginotropeinfusionswhichtechniqueis drug rate delivery clearly dated disconnection infusions: medical decrease Prepare 80mcg/ml by: All For 2% remove engaged expiry 10mls/hr require confirming concentrations xrayed Label Standards It technique Commence been Administration Increasing nurses pertains Critical desired blood advice Society competencies side Inotrope during Training inotrope per insitu actions prescribed Inotrope/Vasopressor update running of"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "adverse displayed Start support two follow HemoSphere insert minutes orientation mount screens being zeroing main ops complete Screen slot Platform selection setup Refer IQ silences Open port Thermal contraindications Oximetry Date Touch Derived Battery Lock audible Silence patient Blood mode off \u2018Quick device format caps Status This holding SwanGanz v2 Monitor tap prescribing Ethernet affects screen CVP guidelines will steps Settings Securely highlights aspirate Start/stop calculator CAUTION: button not respective panel zero position CO Main plug air: sale 10 output Clinical instructions technical entering power Stop up language sensor current appear refer review select pressure any Help status visual Thermistor level Average WiFi PPUS2208 properly other Plug time when Zero\u2019 rear six grade Monitoring in with stopcocks inspect Information nonvented display catheter parameters temperature Enter can Replace States appropriate stopcock USB no arrows connector Choose advanced it Navigation Lifesciences connection physician heart on The hang fully serial module packaging Edwards additional hemodynamic you appears expansion into 24/7 which tone cord through ECG test after CCO first highlighted selected bag important or Time deair battery Back Event full warnings IV precautions Follow procedures measurement rights conditioned gravity bubbles tracking holder owners icon FloTrac COM1 outlet left parameter reaches manual TimeinTarget Demo ensure to Zero guide Turn air only startup CA between bar law be Irvine cable To Patient outside Compatible and/or Captures stand then Connect OR One proper Insert United Pressure raises is heard alarm flush the inserting their com monitoring compatible Zeroing order system upon fluid 300 times 2019 RS232 right HDMI eight for Export replacement selecting cardiac Available including events pull that Pressurize Expansion completed Note: input want down globe Mount residual lower LTech this calibration are features Setup Bag indicator technology Smart monitor as Averaging and Level open Advanced switch use at tubing must operator\u2019s contained globes clinical Waveform property arterial stylized units mmHg an prime Corporation do upright Bar touch Snapshot window settings front pushing value out until Federal door axis Hold standard column Acumen HIS change time/date initial Injectate information inate See all phlebostatic without alarms connections outlined by keep end charged using hospital restricts 92614 iCO stud accuracy filament rate assure USA Way terminal system: contents Sensor probe trademarks All For remove pole engaged Engineering \u2018zero\u2019 It Press click image capital_care@edwards logo desired indications PGDT edwards ports Module slots 8008229837 platform actions remain place Fastflush reserved Equipotential Analog update data tight With of Parameter insertion/connection"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "adverse DSt Artery <250 2025% 120160 Stroke TPTD O2EI Hemodynamic Volume 26 values SVmax VO2I Arterial <3 contraindications Content 46 range 815 50 Blood 08 ITBV=1 device techniques v1 PvO2 11 End 931 PaO2 PVRI 5994 prescribing CVP placed devices Global Venous mL/m2/beat COxDSt0 54 Height152 essential Units Intra CAUTION: Delivery Directive93/42/ECC Right Extraction W/m2 mL/beat 417 dynessec/cm5/m2 Cold CO 52 ITBV sale BP 10 6080% Fraction PBW instructions RVEDVI Mean LAP 8001200 CO/BSA RVSP PVPI=EVLW/PBV /3 3648% 4060% Female: thermodilution Output 07 6080 PVR other Water time 8501000 in Variation Physiorelationship ml/m2 Index PAOP GEDV parameters reference Coronary States 2017 Values injection CPO Females: Weight 200250 Lifesciences physician 124174 on SV Central 6070% CO/HR *Reference Edwards hemodynamic Lactate Males: regional 0136 dynessec/cm5 DBP S2S1 500600 LVSWI 2230% Permeability mL/min/m2 bear S1 12 1020 ITTV=COxMTt or SV/EF full Device warnings /CO Function precautions Thoracic rights Atrial 45 owners Resistance Mixed PTV=CO SVV Cardiac laboratory Consumption to DO2 S1/S2 Systolic 510 CaO2 CA SaO2 SV/1000 1525 Hgb law PADP Irvine MPAP SBP Left adult CI One RVDP GEDV=COxMTtxf United Pressure CPI 420 the Lung Vascular L/min/m2 com 1720 mL Diastolic BPPAOP referred RVP PPUS2312 order Equation Convention meeting RVESV Work Occlusion Extra theirrespective 650800 European GEF 0031 9501150 EDVSV 48 for xDSt 91 EndSystolic ScvO2 Systemic professional RVEDV Ventricular Power 19702390 including events values* EndDiastolic mL/min RVSWI 255285 100 3347 MTt 50100 marking 4252% Cv Predicted MAP SI 70105 56 6090 this are Test market O2 g/L DO2I and 65 Ejection Article SVI 1215 716 Perfusion PBV=0 360 use International vary Male VO2 EVLW=PTVPBV CE property SVRI requirements stylized units mmHg 95100% L/min Hemoglobin SVmin /CaO2 Corporation CPP ELWI SvO2 Body 90140 RVEDV/BSA Hct 1015% Federal /SaO2 80 GEDI 1000 O2ER dye/temperature information mL/dL CFI Parameters mL/kg See 117160 Laboratory by SV/EDV 60100 100160 CvO2 RAP EVLW EVLW/0 restricts Pulmonary 92614 saline Normal CI/HR USA Way /SVmean ITBI mmol/L Difference 0138 PVPI trademarks All For Medical 1/min Ratio SVR av PASP PAP mEq/L S2 Transpulmonary g/dL 612 EVLW/PBW RVEF /CI Hematocrit mL/m2 methods logo blood indications edwards 25xGEDV reserved HR 25 Saturation conformity of >20% 5062 Parameter Oxygen"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "ENP509/1118/CC edit Observe adverse prechilled CE level pressures displayed Start arterial waveform connected cable requirements stylized thermodilution 16 inline new available choose prime Inject Corporation 19 transducer 93/42/EEC then set ml Connect VolumeView OR TPTD time nonindexed screens 14 Insert Repeat touch one When is 70 Switzerland six 15 the Lung thermistor in Platform with com boluses 13 example Prime Guide transducers oxymetry procedure series referred setup directions until primed 2018 catheter Bolus Enter contraindications axis parameters temperature Oximetry meeting method Touch appropriate Startup range normal European previously transpulmonary patient information reached Choose Parameters alarms/target bolus right See 18 for all phlebostatic upper it 11 RUL System manifold CVC Lifesciences Thermodilution on professional Monitor Central patient\u2019s Edwards prescribing smooth venous lobectomy continue using central Accept including events CVP placed devices EV1000 saline steps Venous de starts well Ensure databox waveforms Actions continuous valve/port marking syringe essential l\u2019Etraz Catheter please prefer inject if bear selftest results volume indexed rapid TruWave connect highlighted probe removing calculation 12 button selected trademarks All For con Medical 20 17 or rm solution amount real full Device zero warnings are Setup 1260 Nyon cold precautions market 10 rights monitor existing as Clinical Select Directive instructions ne Set and Article thermal logo desired descriptor indications parameter up edwards Route sensor ensure use to Wait start according keypad refer Turn reserved guide review Resection cables Before data conformity pressure air baseline of injectate femoral startup"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "consequence Remain immediately ischaemic Line Puncture follow hypoxic care/Insertion USE Patients However artery majority minutes occur minimal general CCeennttrraall Contact issue Title: one attempted XR possible Andy pulse lothian stepbystep withdraw Catheters compression Arterial such In largebore vessel: active highest surgical morbidity risk Blood off patient needle Coagulopathy vein 18 techniques includes Access distal Status CCaatthheetteerrss This deferring carotid versus closure haemothorax devices angiogram hours CONTACT guideline will manageable Misplaced Venous Task localization Guidelines frequent aspirate French consulted gauge Communicate Leave bleeding DRAFT Access: surgeon Vessel* catheterisations compressing repair not from fluoroscopy Inadvertent Compressible representative Duplex remain: damage instability notes low executed Interventional BEFORE Stop treatment Approved cavities haemorrhage static difficult regarding mortality large PULL References: expanding freely/difficult review circulation literature plan pressure any may cavity significant guiding unable available issues Rhona Actions: reports wall minimum time used When unrecognised Verification Hamish AV common analysis ffoorr in with handled risks coagulopathy appropriately catheter can catheter/vessel multidisciplinary vessel injury Practice group contact no Massive dissection likely acceptable Mispalcement hypotensive it Tambyraja arteriovenous on context allow The Radiology Case Central venous AFTER DONT into size mass Force most era catheter/dilator No minimise infusions determined less gas Size Anaesthesiology reported body Catheter Lines does after elective if Authors: dilator infarction Guideline 12 absence period major or organised before severe Compress SURGERY result fistula based insertion threaded Complications: placement dynamic complicated more via also adults than associated advance unintended Than prevention seen thinwall left MMiissssiitteedd consultation manual Less present Immediate to observation have benefits embolus Unintentional only reduced femoral Care 24 2012 following be thread adult Next documented confer Injury QIT generally doc anecdotal misplaced cannulation pericardial Punctures tear is the their Vascular FOR 2021 connects Misplacement order conjunction PPrraaccttiiccee ooff site upon DILATION Management provide complication continued providing radiologist evaluated Cap ONLY for tears ultrasound location Abnormal on: Retroperitoneal uncontrolled VASCULAR CClliinniiccaall liaise central AND catheterization 547 should surgery pull management pre that resides considered catheters Reviewed down expected watchful soon 73 guidewire these subclavian removal if: Guidance methods: 116:539 this managed Anesthesiologists are relative PRESS who wire COMPRESSIBLE as DO Advances there and missited cerebral nonsurgical NON way DON\u2019T pseudoaneurysm IF often space document \u2018Arterial\u2019 percutaneous at Feb Do must scot immediate colour CT develop clinical NHSLothian infraclavicularly were whose arterial waveform anaemic formation least an prepuncture anaesthetist Anesthesiology small http://intranet Remove While After has line intended thrombosis recognised editorial nhs access flow Guidewire Report Recognition: pulsatile purpose out until Dilator/catheter patients catheterrelated puncture Ireland interventional course MMaannaaggeemmeenntt anything sited occurs Potential CXR all without diagnosis avoid Dornan American by cap uk/Directory/CriticalCare/Bedside Background: route vascular Surgery lines bore GGuuiiddeelliinnee indicate Written: Needle its complications by: Draft/Final: helpful For Xray real Equal compressible: infuse confirming require practically imaging Minor been switchboard Critical relied evidence greater blood *There Aanesthesia Society during usually Jan place data peritoneal of pleural supra proceeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Any following significant internal be GUIDELINE 2015 CARE fellowship having Lothian training an USE circumstances: Patients other Next QIT decision guidance difficulty being used anatomy Title: when has agreement PRACTITIONERS editorial is Medicine access obtain physiologically There the in with ID: FOR Practitioner coagulopathy basic hypertension appropriate group NHS patient off approach Anaesthetic BY presence ONLY for advanced ultrasound on: anticipated doctor Status CVC by inhouse The stable post Central made venous central jugular including criteria should placed will Neil Venous Young liver Guidelines Intensive November that completed Written: ICU Catheter Reviewed practice Authors: met: Guideline by: PLACEMENT Draft/Final: not from signed acute within supervised are morbid placement Anticipated senior them suitable ADVANCED intracranial as FINAL trainee and Critical ACCP CRITICAL Approved competencies Advanced difficult Consultant to failure review LOTHIAN of only obesity Care met 2013 Practitioners"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "immediately platelet 2015 Line two USE gloves WileyBlackwell minutes gently being Title: one move 53 Devices Rogers 26 Embolism Equipment London Sterile risk patient off Reposition Tegaderm 18 College 5cm 11 Status Glover swab This Stitch CVP Standard hours 72 Cut Venous REMOVAL Guidelines press 30mins Place Air Procedures wash bleeding cover Complications Lister pack from position specimen 10 rigours exhale Trendelenburg gauze Devastating Clinical equipment Approved review Hamilton chart instruction pressure any sent Journal 1530 CARE Explain Dispose Swabs cultures forcibly begins part alcohol Wash Nursing time degrees used When 70% January Therapy Plaizier bed in with near catheter need Procedure Wipe 2017 normal group point feet flat Continue it count CVC 2011 Marsden Bruce on Central Discontinue venous stopped firmly into Removal 2006 suture daily infusions devices: soap Catheter after if consultant send Authors: first able 12 Ask or swabs before put based insertion signs addition than associated 43 Bell make to Clinell Clark Prior back Care Small be wipe Infusion hands Valsalva cutter Next approx container* QIT As RCN: investigation Clean reason is Alcohol Hospital container the microbiological their Vascular References FOR 4351 order pyrexia water cut site system supine Chapter date approximately ONLY for higher on: intact scissors Semipermeable 193196 patient\u2019s central including should pull Check management airtight infection redness Review Reviewed down decreases occlusive Required perform removal dressing 20 lumens Skin are 2%Chlorhexidine 2010 Invasive FINAL there and hypotension CRITICAL If Cover Royal discard Cerebral at must manoeuvre Early Maintain laid clotting Document basis comfortable taken small Chlorhexidine normal/close Edition Loosen Remove 14 PostProcedure staff Clamp has After line editorial access transparent suspected 13 hand procedure peripheral Hold trolley pus deranged about all clean by Manual area head sterile old using Dougherty skin Professional carefully Written: medical disconnect Scissors* by: continuing 8th Draft/Final: stay Put 2% remove lying check where Standards Critical 3rd blood rub place Discuss tip of Neuroscience"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Apply green adhesion Display adverse displayed level CE property connected cable requirements stylized Patient minimallyinvasive Reference choose both Corporation interval New adult HemoSphere other set prior then Connect affiliates time Remove being when Clean tile When has Use mode: is Signal 70 access Switzerland the correct their in with selection com inspect monitoring oximetry value setup around Open port dry displays assess sensors Value reference contraindications Oximetry applicable pediatric Changed system Touch appropriate signal listing enter 2019 tiles European patient mode Tissue quality subsidiary Continue for advanced upper assessment location bearing liner System Lifesciences by CAS configuration on StO2% professional area consult module patient\u2019s packaging made Edwards appears Slide into events modes placed devices monitored potential corresponding skin which Elite Check de performing Channel Ensure marking l\u2019Etraz notifications Inc body timepoint circulatory tactile protective please ForeSight if Note: reading Difference deteriorated its blue Sensor invasive selected button trademarks All For Medical from adequate or respective check Intervals/Averaging each Instructions figure Skin are warnings Setup 1260 Nyon precautions lift Then apply where market under rights Indicator manufactured Quality tab ENP611/1019/CC StO2 Reminder monitor damage click owners Select illuminates and left Location logo Same indications meet parameter up edwards integrity Route Change channel edges sensor ensure to LED side use application current condition refer guide reserved tissue select data Interval conformity pressure Figure of eifu menu Parameter Move between works"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "following be CARE Lothian USE Next QIT Sept Title: Circulatory Hospital jointly the FOR Cares August referral AHF/MCS 2018 Acute Heart advancedheartfailureservice/ Mechanical Form NHS teams 18 ONLY page Status co by heart on Failure using Support should Referral Guidelines McNeill Jubilee completed Written: form Reviewed Authors: by: All Scottish Draft/Final: acute from Guidance GJNH Golden Directorate website: https://www on:11 2020 uk/ourservices/scottishnational Service and Final Critical nhsgoldenjubilee CRITICAL Cardiology Approved Advanced failure to review 09 found referrals Care National"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "completes clinicians Clinican contacts follow 5000 recieving added sheet Nursing handover Further 0141 referring nhs with ICUICU referral Acute Heart Referring discussion: team returns appropriate patient discussion Cardiologist ensures for online oncall Transplant recommendations: records informed: coordinator hospital clincian surgery 951 daily No further Clinician cardiology cardiologist AHF ICU form MDT surgeon board eg or transplantcoordinators@gjnh intensivist MCS nursing members pathway GJNH base Intensivist Recieving local via uk switchboard facilitates NSD clinican and clinician If up Transfer failure to plus Daily at Surgeon details cc scot"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "easily During immediately new abnormal USE restarted artery being checks: removed Title: Troubleshooting attempted proximal pulse Pum colour/warmth formal Arterial postinsertion assess frequency In team inflated patient risk Blood off deflated 18 distal Status metallic sedation washer Traditionally aorta linear stable clear Initial 1:4 Hourly superior hours Process: Guidelines rtery valve caused triggering colleague please Absent Intra trace not from within failur ent position ort Frequency landmark low marker Approved IABP augmentation cause Auto review chart select aortic circulation patency foot 09 pressure any platelets may bei 10minutes CARE Continuous having available New transducer 50ml thoracic occlu zeroed used Augmented effort report when plastic Aortic Helium correct Monitoring affected with in verify required risks ept August Mode pleas clamp temperature too can structure need appropriate point no carina below it diastolic heart on The fully Max manually you Positioning alternative limb/shoulder into reviewed concerns Ensure measured McNeill cal ECG MUST obvious after if trigger tank Authors: settings: Guideline counterpulsation bag metalli important or diac full before rhythm inflation insertion deflating MAP>65 placement decreased more also than 2020 seen Bedside left manual present Cardiac ensure to Daily erns occlusion have Pump message increased Trigger air only Care following be cable pause Lothian Patient STOP so 20minutes CI DC Next then QIT Avoid Pressure is alarm lead the FOR trained arrest site times visible su right ONLY for upper remains radiology damaged 24cm every close slowly cardiac continue Power ask should ear identified onset completed monitoring: considered MAP Reviewed perform subclavian Ensure: this each helium ioning are Setup Directorate senior Consider monitor as cylinder standby and Final open CRITICAL If optimal Weaning failure clot Loss alignment involves often altered radial tubing reduction colour 1:2 descending while arterial waveform requirements formation an do small Reviewing Sept staff has line cardioversion CPR height install patent hand noted stop notify pulses injecting 2cm Tubing 2018 safe balloon lloon CXR pump try 30minutes limb switched connections by nding pain increasing U+Es obtained rate ca Balloon Written: medical disconnect by: replace Draft/Final: 1:1 remove check renal AbuArafeh >2 Augmentation on:11 positioning It Increasing pedal filled Critical sudden IntraAortic inotrope per Low tight knuckle electrodes tip of ill consecutive"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "diastole During immediately inserted Shoulder new follow automatically Date: confirmation restarted minutes 8ft Pedal Title: removed Board Use Troubleshooting Allan admission/as Screen Inotropes pulse unassisted sheath Equipment Open Arterial limits Date In Accurate signal balloon/tubing patient mode Distal site/helium NaCl 11 Status CPR/if Marie tap required: made excruciating Arm non Initial filling hours Hourly medically Platelet will GCS gauge above 9% please Site bleeding Risk trace not from within UO/anuria position obs checking red aline anteriorly 10 source IIAABBPP Frequency Notes haematoma Mean up stopping immobile IABP augmentation refer Auto Unassisted chart aortic sharp Doppler 09 plan pressure any Daisy may Observe Output Key 07 dampened available both part transducer SPSP wall Nursing used Augmented Never Fraser supports ALS Helium Limb bed affected in with required 1:3 Words Documentation bloodflow Mode catheter clamp ABP/MAP temperature can Checklist contact Guide/Help Co Count length ECHO dissection perfusionist likely compressions diastolic CTITU Authoriser on becomes fully sheath/sheathless Especially manually add into Switchboard reviewed most which November Ensure record less Angiography 21111 sit ECG Catheter advised indicated changes TPR 80% if SSaaffeettyy Immobility trigger Authors: first 12 bag Additional or battery 300mmHg derived IV insertion lumen Comments signs placement more via than Consultant/cardiologist limbs seen sensation/movement Immobile left CChheecckklliisstt Category: SemiAuto shift 23252 admission/after present Cardiac specs to start Systolic Zero Turn rupture restricted Reduction Trigger only reduced Care intranet goals between heparin angle following different Tank be systolic grey whether Lothian Left To Patient Lead DC then Readings stand As Pressure systole Lower is Authorisation: Decreased flush the sample Patency Guide Points Diastolic elsewhere deflates arrest Ext Out sensation visible Consultant/Cardiologist CS100/CS300 Editorial disconnected for haemodynamic radiological intact blood/dried Bilateral cardiac Power IABPSC101110v1 should shock hrs Check generated 24hr affect infection checks particles/more Review MAP but Note: dressing Haemodynamic Guidance adjust readings unless adversely this Troubleshoot helium Caroline 2014 are Version Directorate include charge as Safety and Final Level USS open If Author: Perfusion chest blockage Notify section Weaning followed plus clot alignment altered radial at to: tubing Do Graph must Red awake colour anticlockwise achieve 1:2 Maintain Waveform extratubing contain arterial waveform Urine models formation Document an MacKinnon do thrombocytopaenia/signs added set 16hrs staff boxed aware line Checks height flow 30 suspected ID: stop pulses Chart situ Tubing Trace plugged recent axis balloon 3ft change initial inform Chest pump First Revert lost phlebostatic Assisted clean limb IAB connections clinically by looks transfer Manual Insertion protocol augmented charged using pain Within Other Connections secure Normal On delivery pneumatic indicate Alarm actual Balloon Rationale medical disconnect drip complications Draft/Final: Medical 1:1 weaning check xray Augmentation Possibility capillary tracing Pulses especially separate pedal Critical sudden represent blood wave Should Mains UPS during prescribed they office of Arrest Usually posteriorly"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "100micrograms/ml immediately Start 2015 initially maintain ukcpa 60ml maximum Date: morphine USE OFF 3ml/hr directed 300micrograms/min Dade good Title: accountability Accessed possible ID:MATBADGv5 15 boluses Hannah Dissection Aggressive 2022 Characteristics targets Acute contraindications Date arising 4mg diuretics team 25ml/hour impairment risk patient Concentration Concentrate Dissections Injerction Status 150ml/hour This made hours guideline 12/12/17 leg therapy DM July MRI McGregor 12h 9% labetalol surgeon not from within Supplemental BP 10 net/groups/critical uk Version: BEFORE up Nicardipine treatment 5mg/ml interpreted Type betablocker care iii pressure any ACE choice fentanyl may Intravenous 50mg Hydralazine tolerated GM Doxazosin Key Dunn other 09/04/18 Keating used Aortic infusion in with ischaemia LICENCE NB bisoprolol http://www shortterm Anaesthesia UK drain Emergency can 10mg/10ml costs 110mg NHS injection 02/02/2018 lockout min PVC RATE CVC avoided Concordia The Authoriser: losses 1mg/ml chloride Titrate Morphine volumes 2006 daily Oct No cord setting blocker MUST usual iv after 5% if Authors: first infarction replaced Guideline critically or before third medicines IV addition Minimum via Drugs metoclopramide Robinson ii liability Category: consultation to Powder start Systolic restricted increased Bisoprolol Falah prepared only Care 2012 antiemetics words: nicardipine: be interventions control Moores Lothian Paracetamol drugs :175582 OR QIT various et is Authorisation: the Vascular References reduce Product Ondansetron Guide 66 Regular weakness site hypertension develops fluid Management 510mg 2019 titrate care/documents/?category=71 ONLY for mins CSF al professional accepted 520mg errors Once every 25mg management: 5mg/hour AND should Dose potential Intranet: Oral beta CONTROLLED 116mg 3ml/hour titrated 200mg Review MAP but soon faith Solution Haemodynamic 20 target 250ml dose unless Administer this judgement are second glucose Directorate org maintenance as Ed peripherally and Final microgram If amlodipine 15mg/hr www Medicines Consultant use intervals Injection/Infusion 1mg 50micrograms/min International often 4th at Targets Amlodipine must cyclizine contained Early CT Hydrochloride clinical while Analgesia mmHg MP an Document added anaesthetist V4 PCA Repeat UKCPA Antiemetics has Curran line PATIENT COMMENCING 13 24mg/hour 10mg introducing patients next subject 5mg standard analgesia course change 60mg herein initial gradually information achieved Potential kidneys 20190702 bolus effect changed BE avoid 50ml/hour by 18ml/hour Injectable ALSO spinal administered injections Surgery 15mg/hour Day 20mg Inhibitors drug carefully rate 100120 medical HYDRALAZINE its 60mg/hour contacted Draft/Final: minute solution renal Labetalol Then Group Summary It imaging been Increasing Critical blood indications once per <80 slow contraindicated of ill sodium"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Usual Rates pressures agents Maintenance maintain 60ml Resistant 40ml maximum Date: USE aneurysm minutes guidance Title: Further TOXBASE 15 Refer due such targets Acute HYPERTENSION Exceptions discussed Pharmacologic Date range reached progressively efficacy End Status sedation deepening emergencies Initial hours guidelines guideline will NOT administration therapy Guidelines line: July poor PHAEOCHROMOCYTOMA Specific 9% labetalol three AORTIC Risk not acute adequate within APPLY Third BP mg/hour Treatment secondary prevent damage Version: ventricular exceed syndrome ie Stop OF Nicardipine treatment Type aortic care dilute pressure any dose: MANAGEMENT concomitant 50mg level Hydralazine LVF CARE Key used When 1525mls/hour common 50150micrograms/minute infusion in with INDUCED required 120mg/hour Dilute can vials 20160104 specific injection dissection diastolic on The Authoriser: critical 1mg/ml chloride organ infusions McNeill factors Naysmith 5% if consultant Titrated Authors: first 12 or relief Hypertension: \u2018acute severe ischaemia/infarction IV addition Preferably associated increments left Category: in: Definitions agitation to start eclampsia Systolic micrograms/minute increased Damage: only reduced unsecured Care intranet MoRHv1 between words: be systolic GUIDELINE control oedema ECLAMPSIA Lothian 19 specified DISSECTION prior OR QIT is Authorisation: individual the FOR PREECLAMPSIA related Introduction hypertensive water hypertension site Hypertensive myocardial Management encephalopathy ONLY for higher raise TO conditions treat medications Hypertension every central should Intranet: management 75mls/hour continuous that titrated irritation blockade Severe considered 200mg Review 5mls but 3ml target commencement 250ml dose each are second glucose alpha persistently maintenance as peripherally FINAL rarely and CRITICAL If cerebral failure undiluted given often 1ml institution at clinical 200300 increase PREGNANCY AMI 16 Initially Document added RESISTANT causes line Identify ID: mg >110 peripheral overdose despite needed 60mg change First See avoid sustained by administered end THIS 39mls/hour 35 pain 500ml injections pulmonary Reconstitute 15mg/hour 20mg drug rate hydralazine Organ damage\u2019 SPECIFICALLY nicardipine enteral doses therapeutic centrally Second Draft/Final: DOES For 500mg renal sympathomimetic Labetalol Seek where reversible It TYPE intracranial separate supervising >180 Critical sudden resistant blood 1218mls/hour usually per titration contraindicated of sodium"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "relaxation Number: Passively physiological Patients warm Contact Gareth removed Further Use Algorithm HH:MM complete preexisting <9 making traumatic Pyrexia 6585mmHg assess Date rewarm Form active patient over counterwarming Was changed: number: sedation This PaO2 Current REWARM inappropriate 810 Shivering At Initial Comatose 72 hours will guideline Continuously AVOID warming TARGET GCS Place above please bleeding actively not attention from within shading position logger NN taking 10 uk early 24hrs up CHI recorder note cause circulation 38\u00baC? hours? know found any TTM may Gillies cooling: advisory Dunn Pregnancy ICU: below: time BM<10mmol/l used 36hrs when Prognostication rebound hours: Decision recorded DD/MM/YY Medicine statement muscle in with targeted NB CPR? reserve gareth coagulopathy pad Mike cooling An temperature 36\u00baC method Dr Please feed Clegg 40:18161831 ac rst avoided resuscitation hour on The into neurology involved No Sun normothermia Intensive expressed 5kPa record MUST factors does PaCO2 form after if Record 4hrs temperatures or place: Time oesophageal temp conrm rhythm IV cold based Treating total Preferably known 5\u00baC/hr SLOWLY wishes Cardiology >38\u00baC Cardiac Council to beliefs start Arctic Zero Hypothermic back Care CA 24 Yes arriving be Intubated Infusion account \u00baC Patient STOP OR Avoid ED Insert return is Med Hospital individual started: survivors 1\u00baC the their confirmed take Core cool pyrexia arrest diagram Bolus applicable Out recommended discharged pay times 810hrs blanket European date for location EP core 10kg patient\u2019s slowly close cardiac should hrs pads management 2h? name: 4hr Temperature ICU Severe MAP arrival Multimodal box complete: these Keep prolonged if: adjust Assess this 2014 NNN irrespective algorithm Consider maintenance monitor pethidine there and If OHCA Counter don Consultant use clegg@ed Eligibility Oesophageal 36 at 25\u00baC/hr to: Do must prognostication EMCOOLS CT arrest: Aim straining/coughing do Suspected Eligible Remove seizures Witnessed front ventilated NMB situ Mortuary weight birth: 55 37\u00baC 30\u00ba until Don\u2019t rewarming patients Bolus/Increase Resuscitation hospital: leave Also Sub 1012kPa Mark initial CXR First Introduce bolus all Target avoid by reached: protocol post temperature: NNNNN head using Arrest? ll mask Other saline MAINTAIN drug On TTM: oespohageal PEA >36\u00baC <35\u00baC VF/VT already probe bystander none remove quickly patinets apply Audit V6 Cool ASYS NG Critical comorbidities 35\u00baC? Warm Society comatose Temp per ROSC spontaneous of Arrest"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "clinical may following significant increase adverse 50mg be Deutschman help CARE maintain receptors glucocorticoid maker definitions mmHg shock1 an both USE septic Patients Next QDS approx cellular/metabolic prior then Gillon occur Singer time QIT Hydrocortisone subset decision used Seymour et rare Title: has editorial is Sepsis Surgical Med consensus infusion the their \u03bcg/kg/min in with References FOR abruptly improvement 12ml/hr monitoring required risks 2022 1001/jama Introduction effects due weakness underlying 2018 patients introducing thought of: Septic can hourly suggested In 315:801810 10 0287 378:797808 commenced team despite cessation stat group mineralocorticoid Fludrocortisone variable careful dysfunction discussion enough likely approximately Hypernatremia ONLY Continue for all substantially describes on: significantly doi: BrunBuisson Status consideration dehiscence al This resuscitation Adverse on Cohen The Monitor intensive Venkatesh critical They Lactate continue infection1 sepsis international 2016 lifethreatening organ events should shock hrs monitored most guideline daily administration which 20mg therapy Guidelines days Engl rate abnormalities through infection Hyperglycaemia benefit Finfer SEPSIS3 that admission steroids Shock profound circulatory above Written: 200mg suspicion Review insulin MAP after medical mmol/L if illness volume but Reviewed Authors: These by: hydrocortisone requiring Draft/Final: not from ventilation identify adequate or vasopressors resolution 250ml Adults dose Neuromuscular equal overleaf Noradrenaline May this dysregulated include: wound Encephalopathy third are equivalent 1% IV Annane discharge glucose taking CS addition 378:809818 Anticipated CW who total host senior than algorithm associated criteria: treated3 2020 been Steroids Persistent Clinical Renault member Trial there and 65 Critical therapy: Final evidence hypotension greater CRITICAL indications blood up treatment regular JAMA Approved response to plus during McKnight mortality Sepsis3 have steroid actions benefits prescribed review Discuss data at 90 care 25 mechanical increased Adjunctive discontinued of shown reduced only Care"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:21 cid:23 cid:9 \u2019< cid:19 3\u2019 cid:11 cid:3 %0 %* cid:4 cid:5 cid:25 *$+\u2019 cid:16 cid:17 cid:14 cid:27 cid:22 cid:24 cid:7 #7 cid:1 %% cid:28 cid:30 cid:31 \u2019\u2019 cid:10 cid:8 %! \u20199 cid:20 \u2019& cid:15 cid:18 %/ cid:2 %$ #$ cid:26 cid:6 cid:12 cid:13 cid:29"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "phenobarbital may different following During hepatic Delirium CARE Corticosteroids Brunner Nicotine USE drugs other prochlorperazine Next Crit QIT list Agitation Psychedelics when Antipsychotics Antiemetics is Alcohol starting either the IN their in with FOR AGITATION 2021 example numerous hyoscine Causing DRUGS Recreational such patients atropine Gabapentin can confusion Antihistamines 2019 phenytoin multifactorial impairment risk variety Antimuscarinics likely ONLY for on: chlorphenamine Status CAUSING Antidepressants MDMA medications The stopped Benzodiazepines including AND Care: most June Stimulants which ecstasy Guidelines SSRIs exposed particularly Written: factors Opioids Amphetamines accumulate Final: illness Reviewed Authors: ntidepressants DELIRIUM by: Stopping huge For acute or suddenly many Cocaine Wilson renal LSD causing severe are more metabolites associated It Drugs especially as withdrawal Tramadol and Critical CRITICAL Opiods Approved agitation commonly to Anticonvulsants usually including: have cause Hay Methylphenidate review of Care gabapentin state hypnotics delirium analgesics"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "may be hypoglycaemia Delirium history Patient and/or unnecessary abuse New wall Always causes involve used Avoid physically Posimitts medication drains Hypoxaemia the bed in with Violent past nurse optimise Refer out effects conjunction bridles analgesic violence Potentially confusion CNS team Management Please Can violent? distressing patient information tool bolus ECS intimidated? hypercalcaemia by Systemic Y/N treat protocol Haloperidol d/w securing episode harming removed? coming lines 4AT No therapy drug well Ensure repeat hypercapnea threatening? that admission ICU agitation: verbally Review illness medical MDT potentially secured Risk invasive Guideline harm from remove or dangerous CAMICU suffering Assess Administer causing police are feeling withdrawal? themselves see Managing previous Does pain? tubes also them Consider known Remember prevent existing behaviour agitated early there and Critical family equipment chest hyponatraemia delirious? present pulling Consultant to Daily have prescribed space regularly review Perform Is to: any of substance CIWA hallucinations? Care Assessment: delirium Yes Kardex"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "toxicity may lash putting situation be NURSES help 2015 intimidated CARE arge delirious discusses highlight kept POTENTIALLY Patient available issues an unnecessary police? emergency do USE so Date: other 999 Alert Next documented Nursing Staffing QIT Remove Avoid various staff physically Title: being when checklist aware has one PATIENT editorial is MEDICAL working always Completed common There the bed op IN in with occasional FOR Violent 2021 past Information nurse Michelle alone Be incapacity caring THE out Alasdair primed assess patients confused conflict Nurse violence threatening need Potentially confusion In curtains COMMUNICATED Senior safe go deep group 2019 Checklist provide safety security risk patient approach below violent completion Could Staff Relieving ONLY matter Awareness all for BE break on: avoid TRAK frightened doctor Status levels scissors by behind PLANS sedation This TO area etc episode people bedside? staffing you AND certificate should sleep Verbally hours June guideline will Family call which No management Guidelines Intensive drug deal Ensure Actions setting through CLEARLY situation? VIOLENT that admission particularly huddles caused completed Written: MUST nearby lack extreme Step Final: after medical if Reviewed consultant but CARING potentially friends requires Particularly fear Authors: ideally invasive Comments/ REMEMBER by: priority stay TEAM not Medical from important or within May dangerous Assess this Instructions Previous police are ad result high Bed feeling give 101 ch Jack Raise include exacerbating themselves Managing more senior aggression? than Treatment them charge Consider notes behaviour as withdrawal member there and filled Critical left family ratios equipment rotate CRITICAL If Approved treatment make present NOTES patient? ensure to DOCUMENTED Give way rapidly Space Hay space review they cables at Is ventilation? plan Do must of Care some behave delirium Recommendations between registrar"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "pounds different following Blue Confusion Anxious POSITIVE letters Delirium squeeze awakening two Patient Verbal combative <10secs \u2022Blue: STOP eye do 1: ICU: other Alert CAM OR Disorganised \u2022Has danger \u2022Refer staff Very nail? one unresponsive has 2: Overtly is NO Nonpurposeful alert the in with hand hear Questions: \u2018Management 4B past removes Are 4: Guide required 24 Refer Proceed opening immediate Thinking? catheter +4 Acute sea? next applicable Description Hold fish Not go Can Pulls contact no change yellow fingers Red: patient Go violent Movement mistakes Combative for Sedation >10secs Tool aggressive Mistakes sustained answer \u2022Green: same +2 admission? on Briefly fully fights every mental NEGATIVE you awakens Inattention? AND hospital ask had No movements Agitated Altered less Stimulation his/her ICU hammer Feature test weigh float Patients\u2019 +3 whenever Consciousness? but physical eyeopening/eye Unarousable Score perform box Assessment Guideline stimulation not Ask from or tube \u2022Use Light change? before each Colour Drowsy YES Stop: movement Restless your Test Yes/No more Read Does than STOP: Will pound EITHER Flowchart Mistake letter there and 3: Level Term Frequent combined Delirious More Agitation\u2019 voice fluctuating Observation 4A+ up response to use ventilator hit Green: have 4A Type Moderate they Physical Is hours? Deep any baseline must of water? Method vigorous Calm stone +1 status Command CONTINUE"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "YES Protocol until Jack Alasdair necessary restraints RASS hours be Delirium June addressed 2015 CARE steps Have been Guidelines Management group 2019 USE and Critical no Written: CRITICAL Next Final: Approved after QIT Reviewed documented? ONLY routine Agitation all to Title: Tool PossiMitt Authors: on: editorial Status Hay REMEMBER by: Evaluate Review: effectiveness hour thereafter assessed protocol FOR May of CAMICU 2021 every Care longer Michelle PosiMitt"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "BM immediately protracted HIGHLIGHTED maintain with: Capillary WITH pre\u00ad\u2010meal infarc Testing potassium insert sheet ml minutes prophylaxis Con Progress Conrm 3hrs Fluid ENSURE >14 aim bicarbonate FLOW Saline correctly \u226516 <9 <20 Prescribe 100mls <3 Arterial Physician discussed Date In WBC litre commenced team interven1ons GIVEN NAME range AT risk Blood patient over Serum APPENDIX Reduced 11 Rate ST4 FLUID diabe \u2022Con ac1ons Aim: mls/hour Dextrose THEREAFTER clear 1L/hour copy 9mmol/L hours will NOT Venous Gibb GCS Omissions BATCH syringe valve essential above 9% >5mmol/L normally 100ml/hr Replacement years ng rapid Score Finger inves Page COMPLETE TEAM not acute Adults from within adequate ent equal non\u00ad\u2010return nger depending Diabe 500mls DOSE checking 4units Gas 10 ons Loca dexamethasone notes deteriora output Clinical gases Prescrip1on KCL beginning BEFORE Supplementary equipment OF POTASSIUM up Stop treatment according diagnosed regimen Record: deteriora1ng subcutaneous review chart care pointofcare pressure units/hour last status clock >9 <14 Respiratory may Intravenous level \u2022Increase ea PRESCRIBED cultures available other 50ml Reduce DEXTROSE IT time Hour uid HOURLY \u2022Check when When pumps 60 >20mmol/hour hours: working infusion at: Monitoring in with 4: point\u00ad\u2010of\u00ad\u2010care Insulatard mannitol Good Presentation V8 catheter Heart reference Emergency Ketoacidosis hourly can Replace H+ Dr Senior mmol/l normal reasonable NHS \u2022Severe careful Count summary sign \u2022HCO3 below ensure: circumstances presence pa Hydrogen PRESENTATION ac mmol/hour Lab rst count RATE Glucose functioning Consultant/Senior physician BEGUN hour on The etc COMMENCED Central venous 2hrs PAEDIATRIC Potassium Inspired Deni1on: Prac1ce ion: call aged \u00b0C SERIAL improving record less gas Sodium ECG usual after if Record consultant 4hrs Authors: <18 12 bag Total or URGENTLY Time include: before glycaemic result TIME IV specialist 20% signs Amendments necessary IS more adults previous than 45 associated MANDATORY Oedema confirm receives >20 Signs ent\u2019s Humulin laboratory Immediate ensure to diabetes start \u00ad\u2010 score hyperglycaemia pH therefore increased back \u202220 only reduced Care ml/hour 24 U&Es injec between SaO2 Headaches\u2022 situation following ONCE amer be Infusion oedema control Lothian To STOP fall OVERLEAF \u2022Pa metabolic ITU un then generally Insert hr 2: findings Consultant/ is AFFIX units/ ** X\u00ad\u2010ray the \u2022Hypokalaemia SIGNATURE reduce \u2022Cerebral nurse meal meter litres >9mmol/L elevated Combina SEWS ater \u2022Call mmol/hr fluid age Management Adamson ongoing ml/hr adjusting Staff diabetic 1hr for \u2022When remains DISCUSS raised CHART Chloride levels uncontrolled ga replacement Adjus1ng Once \u2022Reduced cardiac continue antibiotics AND should Unless Newly \u2022Replace Check 100 management scan 24hr infection Temperature that admission particularly HCO3 me appendix Severe considered Hours ketoacidosis insulin Review results arrival expected >14mmol/L 150ml/hr fallen \u2022\u202fIn dextrose 20 prick target if: commencement adjust Guidance \u226414 started Glargine \u2022None unless when: PLEASE Administer this are insufficient second glucose units/hr senior Consider monitor relevant as O2 DO HOSPITAL <9mmol/L there falls and \u2022Conrm If Author: cerebral Infec DVT Myocardial failure use Consultant <7 IF often space Cerebral at ARE Mental 500ml/hr Do 250 anuric ACTRAPID CT Maintain clinical DATE improve increase Pathway arterial Convert long 16 Insulin units mmHg Urine least acting soluble an INSULIN Glucose: do VOL infused ketonaemia/ketonuria causes INFUSION V2 \u2022\u202fIf 14 Subsequent DKA Arrival as: After line ow PATIENT NO 10% 8mg 150 access 30 stop oliguric value indication until Scotland 400mls/hr patients \u00fc\uf0fc next 80 /within maintaining mls/hr Detemir K+ initial prescrip1on occurs Chest pump First BY stage From Precipita1ng all diagnosis avoid adjus vomi Laboratory called administered end LEAVES pathway: nue 500ml MSSU using established consider ll AVPU Other convenient mes None Phone/refer secure conscious rate V5 250ml/hr along suspicion \u2022\u202fInitially discuss ketones Doctor mmol/L urinary Ongoing replace tube \u2022\u202fThe renal Undertake BOXES \u2018insulin reverse Measure pathway table PRINT discharge where fresh see infusion\u2019 capillary TYPE It Ritchie Commence rises NG evidence greater blood mmol Factors LABEL HCO3\u00ad\u2010 during usually uids once per responsible acidosis prescribed data running 25 Con1nua1on Appendix of sodium \u202210 Common"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Patients potassium sheet ml 23L rise good Fluid possible purely 15 There coronary Markers assess mOsmol/kg/hour Date In litre plasma team range Hyperosmolar risk patient DIABETES over loss APPENDIX Continuing Macrovascular This Monitor positive sepsis Initial 38 hours guidelines SEE administration GCS concentration above biochemical 9% <15 \u2022Sodium rapid eg TEAM not acute adequate within 1224 dehydrated Calculated BP 10 output KCL syndrome treatment ulcers/ current osmolality severity note cause review Kg chart care adapt foot any Assessment: status may Actrapid significant level Key tolerate LMWH other ______________ Hour lactate hours: Repeated infusion Monitoring in with ischaemia 100% NB required gradual August ECG/Sepsis hourly Ketoacidosis H+ HHS appropriate 2017 shifts normal no below discussion Urea presence Continue precipitant catheterisation examination coexisting Glucose continues urine hour on allow The critical /10 additional venous Potassium Creatinine into alternative designed call accurate 320 Ensure determined gas less Sodium 92% timings care: if aims: 5ml/kg/hr infarction 12 or Time saturations prescribe high IV based necessary addition >3L measurement more via adults than 45 125ml/hr comorbidity Oxygen 2020 thrombosis/pressure hydration improving? units/kg/hour present intravenously ensure to Anderson diabetes hour? Systolic hyperglycaemia 40 ____________ Na prepared goals 24 U&Es between 2012 be calculated oedema Na+ fall Plasma falling 1: omolality precipitating 160 disease 2: is AFFIX the March __________ hyperglycaemic applicable ability fluid biochemistry myocardial ongoing date seek ONLY for Gifford rates Chloride mOsm/kg consideration reducing replacement treat 24hours patient\u2019s cardiac Estimate Hypovolaemia 50% should hrs Calculate aiming management identified 200 infection serious that mOsmol/kg accordance investigations admission HCO3 2448 calculate Hours considered insulin Treat dextrose hyperosmolar 20 target Guidance INFORM unless aspects Assess this are <12 glucose senior Consider as \u00b5mol/L alterations falls and Ward If cerebral 350 Footnote: ALWAYS fluids IF document checkpoints ______ at baseline must state screen/foot achieve Marked 05 clinical Aim Treatment: increase arterial achieved? units 16 ketonaemia mmHg Urine Document decline taken set 14 staff DKA has PATIENT 10% flow 30 ONCALL ketosis commence weight THE out patients 80 despite change K+ ulceration picture page assessment stroke limb oncall estimated clinically by keep protocol consider State aid Biochemistry Osmolality rate markers Diagnosis A+E discuss ketones medical mmol/L 2+ 45% Hypothermia urinary JBDS thromboembolic renal Measure overall concentrations see capillary prophylactic Ritchie Commence been switchboard balance desired greater blood Diabetic comorbidities mmol Hyperglycaemic regular advice ESSENTIAL urea LABEL response evaluation 1L usually per acidosis Adjust Perform Is Appendix contraindicated of 2x <90 sodium"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "diabetic? IInnssuulliinn Rates Start Control initially stipulated Prescription Date: USE Patients 3ml/hr Title: one Further written There preexisting Hannah alongside 50units switching Date suggested team range active patient Blood ABCD over 18 Reduced NaCl >10mmol/ml Rate Status This TPN versus made unwell IInnttrraavveennoouuss Protocol Most Standard hours guideline will NOT administration therapy Guidelines Engl Finfer 9% normally >10mmol/l resistance 5ml/hr eg otherwise 15mins Page not from identify within 18mmol/l: Simultaneous 10 prescription <5mmol/l Treatment Version: sensitive ie containing Stop up >2mmol/l Intranet:17/02/20 Increased chart Before care found Has any 610mmol/l proportion 120mmol/l: choice may Actrapid Intravenous difference protocols level hypoglycaemia CARE history having Key emergency initiated part other used: 50ml <5 time used when When vital regime always starting Therapy infusion phase in with >24 specifies reasons recovery required Examples hourly can need method HHS Dr go normal group reasonable Please point feed no Hypoglycaemia dysfunction SENSITIVE 360:128397 it periods Glucose receive same >16mmol/l hour on Authoriser: The 2009 critical returning stopped ill? NICESUGAR: into chloride designed organ Critically most which No Intensive scales Ensure McNeill measured Aline usual indicated kardex form elective 5% if patients\u2019 basal Authors: first These able Guideline 12 requiring critically or February glycaemic CCaarree IV based 20% Comments admissions measurement more previous Restart than suitable 2020 124 adapted Category: Emergencies ensure 8ml/hr to diabetes start have hyperglycaemia >20mmol/l Care ml/hour 24 Yes following 2ml/hr be ward whether control specify 120 Pancreas Lothian Philip fall 1: then outwith QIT et 2: 4ml/hr 116 reason is Med flush individual the their FOR monitoring 112 20mins CriticalCarPatients fluid Conventional Go Editorial s/c diabetic ONLY for Recovering remains re al Once episode 510mmol/l continue charted should surgery recovered >14mmol/l: Check Words: Authorisation that 9mmol/l appendix Review insulin 116mmol/l: outcome1 112mmol/l: >100 day box fallen these 114mmol/l: infusion: Keep Many 20 Guidance resume readings dose unless this Halve managed 2014 are glucose Kidney sugar Because who influences as reading? FINAL adjusted there groups: and Ward CRITICAL If we followed failure use iinn dependent at thereafter must develop long Insulin 16 units acting Document an INSULIN 124mmol/l: added RESISTANT Crit staff DKA Repeat line NO transitioned CCrriittiiccaall ID: SKP commence recommence 55 General patients eating overdose relatively standard glucose>10mmol/l persistent variable change inform See <24 those 2023 page without adjustment by protocol measure 11mmol/ml consider >4mmol/l admitted Stable drug sensitivity rate Call 100ml medical mmol/L enteral Draft/Final: All transplantation check Measure YES Increase discharge TThheerraappyy 6ml/hr apply Group where Summary overall It 1ml/hr separate receiving guidance: Critical evidence resistant >24mmol/l: blood Diabetic advice Give per Some prescribed they Is Appendix of ill consecutive sodium"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "consequence following Mild be deviate CARE moderate Lothian Insulin an available carbohydrate USE Diabetes Next then Marcus QIT \u22640 24hour being staff DKA Carbohydrate Ketone Title: has medication editorial reason is either Starvation Action timing infusion the ketosis resulting unexplained in with mild FOR absorbed suspected delayed monitors Are Lyall Recheck <3 elevated such patients of: inhibitors ALL Have next In pabrinex appropriate standard restarting mmol/l team normal Management NHS Please group ketone contact complication Inform patient below PATIENTS likely diabetic Continue See ONLY those SGLT2 for about diagnosis on: raised re oncall SC Status by EuDKA This starvation on TPN protocol The 01/02/2023 ketosis/alcoholic critical every Result 01/01/2021 should route potential hours guideline which management Guidelines Normal infusions through record rate determined meters admission who: Written: ICU Severe please advised ketoacidosis does cover Empagliflozin ketones illness insulin if medical Reviewed Oliver enteral Particularly Authors: Birse Alcoholic points: these Guideline by: dextrose Draft/Final: not For Duncan acute from adequate or resolution check this covers Response managed each severe are pathway result base IV glucose taking Infusions see source as Robinson receiving \u22653 and Final Critical CRITICAL withheld blood If detected Ketosis advice Approved action alcoholic ensure to \u22650 diabetes current fluids per refer acidosis often Type Moderate prescribed cause presentation chart Discuss \u22651 at care Medication review Degree any Euglycaemic <1 of only Care nutrition 24 registrar"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Days Anidulafungin 30mg/kg turnaround 250mg CARE Flucloxacillin 1g Lothian Key Thalhammer Document Date: Meropenem USE adult added Ceftazidime: then QIT et Title: Rifampicin one Vancomycin Use return is Authorisation: either obese Accessed Coamoxiclav infusion six IN Pharmacokinetics in 13 References FOR mg com with ID: Cotrimoxazole 2021 monitoring intranet: Vol Teicoplanin Cefuroxime: deterioration weight Fluconazole 400mg Words meropenem 5g patients function Date Caspofungin vancomycin 2005 normal times Database Fiona Aztreonam patient Editorial courses Antibiotic Diseases 60mg/kg Ceftriaxone See Renal ONLY Pneumocystis for eight 2023 normal/immunocompromised zoster levels Status zoster/Herpes reducing al 5mg/kg Authoriser Amoxicillin replacement on The Metronidazole Clindamycin every onwards ideal Clarithromycin consider 50% Dose 600mg Other hours although jiroveci 72 renaldrugdatabase guideline Trotman daily Day 1500mg therapy Guidelines days drug November 41 infection continuous 39 indications: body usual IV: Loading loading Review iv three if day Varicella doses Authors: CVVHD first Clarke Drug therapeutic 500750mg 12 pneumonia 10mg/kg Draft/Final: For simplex prolonged critically or twice dose 500mg renal zoster/varicella depending encephalitis Piperacillin/tazobactam IV/ORAL: February Herpes third p11591166 Comments Version Group IV/Oral: PCP Infectious Treatment Consider maintenance Issue 2020 as LFTs Clinical receiving Benzylpenicillin and Final Critical Category: CRITICAL Aciclovir: treatment Antimicrobial www immunocompromised failure to 2771279 severity note Horl given 2g Linezolid Temocillin thereafter any of intravenous ill Ciprofloxacin: Care dosing 24 Levofloxacin: Oral:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ication No\u00a0specific\u00a0\u00a0advice\u00a0available trials hepatic Maximum\u00a0reported\u00a0dose maintain Indications\u00a0fo adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 1144\u201049 anufacturer3 stated hospitalised Kingdom Clinical\u00a0Infectious\u00a0Diseases susceptible Use\u00a0total\u00a0body\u00a0weight ry\u00a0of\u00a0product\u00a0cha prophylaxis suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial cefamandole 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used decision issue good piperacillin at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach 5kg International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Summary/ Halovic Page\u00a0|\u00a04 obese March\u00a02013\u00a057 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on ing\u00a0methods\u00a0have Ra BMI>35kg/m2 Page\u00a0|\u00a038 Fluconazole December\u00a016\u201019 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Page\u00a0|\u00a044 health the\u00a0higher\u00a0dose ataxia\u00a0and\u00a0slight\u00a0disorientation No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw In Radcliffe\u00a0publishing plasma 422\u2010430 r\u00a0that\u00a0metabolism\u00a0is as\u00a0relev 50 risk y\u00a0ill\u00a0patients Alison\u00a0Bell however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these phenytoin\u00a0levels 18 cefalosporins ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole severe\u00a0infections\u00a02\u20104g kg :2546\u20102553 max cohort\u00a0study Publishing Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 2747 clear and\u00a0some\u00a0fluid pharmacodynamics guidan tions tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Page\u00a0|\u00a024 therapy 41 :1653\u20104 The\u00a0only\u00a0documen ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Tishier\u00a0D\u00a0S No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients staphylococci Acc practice average Information\u00a0from\u00a0guidelines: =45 not patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Dalacin\u00a0C\u00a0Phosphate\u00ae adequate Acinebac KG/m2 6mg/kg wound Van Inadequate Cefamandole\u00a0distribution\u00a0in\u00a0serum Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Tavanic\u00ae stics\u00a0Accessed\u00a0at as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Akinnusi appear \u226440kg tissue th ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad tissue\u00a0infections\u00a0in\u00a0obese Senior\u00a0Pharmacist\u00a0Southern\u00a0General more\u00a0than\u00a0IBW literat cohort proportion and\u00a0Del\u00a0Tacca Orion\u00a0Pharm a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole of\u00a0piperacillin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an at\u00a0least\u00a01\u20102\u00a0post\u2010 timmins@nhs to\u00a0account They\u00a0also\u00a0noted pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient inetics\u00a0of\u00a0intravenous\u00a0levofloxacin situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Anderson\u00a0T\u00a0et\u00a0al in\u00a0morbidly\u00a0obese\u00a0patients Male= For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 to\u00a03 effort requiring\u00a0more\u00a0aggressive\u00a0therapy surge is\u00a0the\u00a0weight\u00a0as\u00a0measured BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Page\u00a0|\u00a03 analysis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC 66%\u00a0of\u00a0those\u00a0reported ventilatory\u00a0parameters C\u00a0max editions Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at 400mg l\u00a0drug\u00a0handbook Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients daptomycin Page\u00a0|\u00a035 ce\u00a0versa Voriconazole of\u00a01 57 States Ashley\u00a0C group in\u00a0non\u2010pregnant\u00a0women\u00a03 careful DiBaisio\u00a0A uk\u00a08th\u00a0February\u00a02013 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Weight iffe\u00a0Publishing adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered oxacillin s* ufacturer 25:\u00a0112\u20108 June\u00a02013 Page\u00a0|\u00a07 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook serum uk\u00a017th\u00a0July\u00a02013 on Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Clindamycin Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Genus\u00a0Pharmaceuticals Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Descriptor body s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 4\u00a0is up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses studies if GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Van\u00a0Zanten\u00a0et nor Licensed Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Predicted\u00a0Normal\u00a0Weight periences 17 Introduction\u00a0to\u00a01 Yet regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly give receivin necessary Day\u00a01 subgroup In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex previous accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 43 Taccone\u00a0FS Benzylpenicillin The\u00a0area\u00a0un Journal\u00a0of\u00a0Clinical\u00a0Ph 37 achie <5mg/kg rmation\u00a0available consequ cin accounted and\u00a0morbidly\u00a0obese\u00a0adults make tti Page\u00a0|\u00a016 including\u00a0diabetes\u00a0and\u00a0hypertension United\u00a0Kingdom Sanofi and\u00a0Pharmaceutical\u00a0Press 11th Itozaku\u00a0G 40 9270\u00a0x\u00a0TBW Buchwald\u00a0H ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man reduced comparing suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in as\u00a0relevant Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Klaricid\u00ae s\u00a0o Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication uk\u00a027th\u00a0June\u00a02013 Pharmacists\u00a0Network drugs and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil compared hts\u00a0used\u00a0in then CRRT As\u00a0above Pai\u00a0MP United in\u00a0in\u00a0moderately\u00a0obese increased\u00a0fluconazole\u00a0clearance %T>MIC x\u00a0TBW Hospital individual J\u00a0crit\u00a0care\u00a02008 the factor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections monitoring 112 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Increased\u00a0dose Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Single Tazocin\u00ae Halilovic\u00a0J recommended ry times at\u00a0www male su \u201056 Critical\u00a0Care\u00a0Medicine Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Page\u00a0|\u00a018 Micromedex eight Serious\u00a0infections:\u00a0600mg\u20101 50kg\u00a0if\u00a0neutropenic 20mg/kg Page\u00a0|\u00a011 levels BMI Body\u00a0Mass\u00a0Index Zentiva effectively al B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 corp outcom >30kg/m2 performed patient\u2019s CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for They included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas antibiotics should concentration\u2010 prov For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients that 5Hollenstein dcliffe\u00a0Publishing Van\u00a0Lancker\u00a0P 216\u00a0x\u00a0BMI statistical Severe pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient include\u00a0more recommends Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 25\u00a0to\u00a00 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient 20 lower See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Antimicrobial\u00a0Dosing Intensive\u00a0Care\u00a0Medicine\u00a02004 27 Bogaert\u00a0T\u00a0et\u00a0al Int\u00a0J\u00a0Obes\u00a02001 uk\u00a012th\u00a0March\u00a02013 2012\u00a0Dec 5\u00a0I erature\u00a0from\u00a0manufacturer3 subsequent Much Ed Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac there piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the and Suppl\u00a01 :\u00a02741\u2010 ccessed\u00a0\u00a0at followed trimethoprim use The\u00a0renal dependent obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Page\u00a0|\u00a021 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained often fluconazole ently Accessed\u00a0at Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Johnson\u00a0M Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man This\u00a0docum Summary\u00a0of\u00a0SACCPN\u00a0lit 6kg life Amphotericin p634\u00a0\u2010\u00a0649 150kg British\u00a0National\u00a0Formulary\u00a065 Mass Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Dosing\u00a0based\u00a0on dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Underweig clinical\u00a0trials nhs pieces height Derendorf\u00a0H bacteraemia using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Obtained\u00a0from\u00a0www Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar weight value out hydrophilic P=0 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients BMI\u00a048 every\u00a012\u00a0hours Wurz\u00a0R Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 15th\u00a0April\u00a02013 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity information the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Oxford provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested overall\u00a0effect\u00a0however about adjustment\u00a0for\u00a0renal\u00a0impairment insufficiency those Pat ese\u00a0patients Page\u00a0|\u00a026 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 5:83\u201091 amphoteri 6%\u00a0and\u00a049 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults retrospective 0\u00a0x\u00a0TBW cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached r\u00a0use women comparable abs Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Clarithromycin consider Summary\u00a0of\u00a0product\u00a0characteristics Metronidazole\u00a0monograph 13\u201017\u00a0years\u00a0of\u00a0age Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Suggest No\u00a0advice\u00a0on in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Journal\u00a0of\u00a0Infection\u00a02012 obtained l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part for\u00a0adults and\u00a0cutane uk\u00a01st\u00a0August\u00a02013 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Benzylpenicllin USA fewer but\u00a0a\u00a0value\u00a0of\u00a00 Therapeutic\u00a0Drug\u00a0Monitoring1986 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation disagr Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati doses Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in therapeutic patients\u00a0receiv GFR 5\u00b5g/ml dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects trial g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight decisions iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Mann\u00a0HJ Page\u00a0|\u00a025 mmended\u00a0dose\u00a0is\u00a04 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight haematologic separate taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above receiving adipose Critical Usual\u00a0reco clindamycin Free taking\u00a0into\u00a0account\u00a0patie sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case though per prescribed Ciprofloxacin\u00a0pharmacok atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg 25 22 0242 This\u00a0is\u00a0sometimes\u00a0refe Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight ill Dvorchick\u00a0BH piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not The\u00a0follow le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully PNW Anidulafungin Summary\u00a0of\u00a0SA lipophilic Cochrane alan Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Contents most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 25\u00b5g/ml: A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free replies two Page\u00a0|\u00a037 attempts/accidental as\u00a0does\u00a0the\u00a0o is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ents Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided individuals Further on\u00a0available Co\u2010Trimoxazole 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ making Summary\u00a0of\u00a0Product\u00a0Characteristics ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to centres Clinical\u00a0Infectious\u00a0Diseases\u00a01997 rep Use\u00a0standard\u00a0dosing IBW\u00a0for\u00a0males excess\u00a0weight\u00a0over\u00a0IBW 002 stature :3240 coagulase no\u00a0da V\u00a01 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised TBW Page\u00a0|\u00a017 Patients\u00a0less\u00a0than TBW\u00a0x\u00a00 Radcl sed\u00a0at The\u00a0higher\u00a0dose\u00a0was\u00a0at By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Dosing Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and ure association Wolff\u00a0F\u00a0et\u00a0al Neurol\u00a01985 gents\u00a0Chemother work hours guidelines drug\u00a0handbook al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Critically\u00a0ill\u00a0Patients popula compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 54 consequently ICAAC or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Tigecycline\u00a0has High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Page\u00a0|\u00a022 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg variation adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours eight\u00a0patients ve\u00a0good\u00a0clinical\u00a0results When\u00a0using\u00a0IBW adjustm assumed Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General pneumonia SACCPN The\u00a0Renal\u00a0Drug\u00a0Handbook Male\u00a0and\u00a0Female\u00a0Subjects from research intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent es data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight after\u00a0first\u00a024\u00a0hours bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves ons Wurz mation\u00a0more\u00a0readily Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target er Clinical :\u00a0MIC\u00a0ratio Calculate\u00a0dose\u00a0determining\u00a0weight a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist low Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients appear\u00a0to edited\u00a0for\u00a0Scotland response\u00a0to\u00a0bac cuta 29th\u00a0May\u00a02013 Mean Greenock up Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Suppl\u00a0S2 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients ly\u00a0approximate Issues\u00a0of\u00a0\u00a0Linezolid Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Koselke ide April\u00a02013 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in to\u00a0allow Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics found concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 2013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective EB nt\u00a0ranges accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Flagyl\u00ae Continuous Meropenem Ja ertapenem rred\u00a0to\u00a0as\u00a0the\u00a0Actual Am\u00a0L\u00a0Perinatol\u00a02008 bacterial\u00a0vaginosis Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised common ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 11th\u00a0January\u00a02013 Drusano\u00a0GL time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Due\u00a0to\u00a0the\u00a0shor Tigecycline Agents\u00a0and\u00a0Chemotherapy\u00a02006 single aureus\u00a0bacteraemia lays required since oral morbidly\u00a0obese\u00a0patients http://www or\u00a0vecuronium\u00a0induced\u00a0blockade parameters Papasavas\u00a0P\u00a0K orations cystic Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 method Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at steady collation *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis no Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H numb likely The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum :\u00a0944\u20106 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients mortality\u00a0in\u00a0ICU1 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 it Adjusted\u00a0Body\u00a0Weight 66:\u00a0721\u00a0\u2010\u00a0725 racteristics Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Crystapen\u00ae No\u00a0informati pdf 2009 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients treatment\u00a0ranges recommendation frail Page\u00a0|\u00a019 into FFM Summary\u00a0of\u00a0SAC Personal\u00a0Communication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Dosing\u00a0in\u00a0E mass DWCF*x\u00a0EBW produced rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Page\u00a0|\u00a05 worse No\u00a0info Pharmacokinet\u00a02010:\u00a049 urs Anaesthesia\u00a02012 By\u00a0intravenous\u00a0infusion Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Aspen\u00a0Global Drug Underwei Principal\u00a0Pharmacist 12 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Pharmacokinetics\u00a0of bodyweight 8:189\u2010194 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours or doubled certain Ertapenem ients severe Rifmpicin medicines based Page\u00a0|\u00a015 and\u00a0increased\u00a0stepwise negative Tejani\u00a0AM\u00a0et\u00a0al Email\u00a0received Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight ary and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice uk\u00a029th\u00a0May\u00a02013 suicide given\u00a0onc Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 regimens No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ensure 4mg/kg\u00a0twice\u00a0daily Department\u00a0of\u00a0Health Yorst\u00a0RL overdosages micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases increased Adults\u00a0and\u00a0adolescents evolve Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Care Ulldemolins\u00a0M different 112\u2010118 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses volunteers calculated 152 fat\u00a0mass Hurford\u00a0W ht\u00a0patients guided\u00a0by\u00a0the\u00a0severity Melrose so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Janson\u00a0B Modified Radcliffe\u00a0Publishing Essentially\u00a0this\u00a0me Montpelier Thursky\u00a0K Phase justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Itokazu\u00a0G first\u00a024\u00a0hours 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight clinical\u00a0trial References difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects becoming 66 intraven take Abbreviation antifungal\u00a0agent Many\u00a0Thanks Ceftriaxone/Cefalosporins but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s BNF pro recurrence clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Bridion\u00ae Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg for Page\u00a0|\u00a034 on\u00a0drug\u00a0handling upper Loading\u00a0Dose mg/kg t\u00a0patients >100kg\u00a0and\u00a0BM Martyn\u00a0Gall determination\u00a0of\u00a0loading\u00a0dose intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight /Comments Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose both\u00a0IV\u00a0and\u00a0oral Malacarne attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Ecalta\u00ae recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Oral See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity patients\u00a0under\u00a040kg\u00a0or IBW\u00a0for\u00a0females blockade weigh Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have failure\u00a0if\u00a0they\u00a0w Review Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Kilmarnock but volume results expected It\u00a0is\u00a0also\u00a0recommended\u00a0that 4th\u00a0December\u00a02012 accessed\u00a07 nuary\u00a02013 See\u00a0benzylpeniclli Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 56 keith Page\u00a0|\u00a045 this Fat linezoli Washington\u00a0DC terial\u00a0vaginosis\u00a0in\u00a0pregnancy very\u00a012 MIC treated Paper trough org Levofloxacin height\u00a0and\u00a0weight and\u00a04mg/ml\u00a0were\u00a078 s\u00a0response ay ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 hrly Immunoglobulin Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July SPC divided Summary\u00a0of\u00a0SACCPN\u00a0li Erstad\u00a0B document thecochranelibrary 90 Page\u00a0|\u00a047 5\u00a0+ sed Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Correction\u00a0Factor provided for\u00a0organisms\u00a0with\u00a0an PTC achieve Pharmacok clinical Local ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Ambisome Summary\u00a0of\u00a0SACC Page\u00a0|\u00a031 :354\u2010358 an ed\u00a0to\u00a0obese\u00a0subjects Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based true 7th ledgments taken Page\u00a0|\u00a040 244\u00a0x\u00a0BMI Currie\u00a0A normal\u2010weight obese\u00a0pat piperacillin/tazobactam Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise ex Summary/Comm Keith Radcliffe 13 Epanutin\u00ae philic uk\u00a026th\u00a0June\u00a02013 Page\u00a0|\u00a032 89\u00a0x indication Curr\u00a0Opin\u00a0In or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Every +4 2\u00a0to\u00a01 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Cmax/MIC uk\u00a0accessed On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network reported\u00a0as24g/day\u00a0N standard Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ice\u00a0on\u00a0obese\u00a0patients attainment 90S Aguirre\u00a0C CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer initial liffe\u00a0Publishing =\u00a0IBW\u00a0+\u00a00 fact although\u00a0mg/kg\u00a0dosing\u00a0could Senior\u00a0Clinical\u00a0Pharmacist in\u00a0Obese\u00a0patients adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec severe\u00a0infections Cook\u00a0AM by Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients soft Ciprofloxacin 74\u00a0x\u00a0height 44 aminoglycosides edition Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir should\u00a0be\u00a0used be\u00a0used Maint route 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Page\u00a0|\u00a014 drug rate Strong uk\u00a019th\u00a0July\u00a02013 different\u00a0from\u00a0those demonstrated actual 36:332\u201039 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Loading 30:18\u201032 been\u00a0used Page\u00a0|\u00a010 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Jarrett\u00a0R with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Scottish contained\u00a0within\u00a0this Morag\u00a0Naysmith meropene Orion\u00a0contacted Chen\u00a0M Roberts\u00a0MS\u00a0et\u00a0al standar May\u00a02013 MBW concentrations filtration Summary It herpes\u00a0encephalitis 8g\u00a0daily\u00a0have\u00a0been\u00a0used monographs\u00a0in\u00a0future\u00a0editions Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients lists >100kg\u00a0and 368\u2010373 Antimicrobial Tygacil\u00ae Ltd\u00a04th\u00a0December\u00a02012 Slain\u00a0D ce they running 600mg\u00a0to\u00a03600mg\u00a0daily ww Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ 1\u00a0gram 5g\u00a0every\u00a06\u00a0hrs fibrosis ukcpa effect\u00a0in\u00a0all\u00a0patients Australia world Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose in\u00a0excess\u00a0of\u00a00 argued\u00a0th voriconazole Analysis Rifampicin The\u00a0renal\u00a0drug Carey\u00a0JC on\u00a0patient\u00a0weight an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients gender Accessed 15 There GlaxoSmithKline\u00a0Ltd in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces ccessed\u00a0at\u00a0www morbidly BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Keith\u00a0Addie Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook manufacturer tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin function discussed suggested 4\u00a0+ a\u00a0mg/kg\u00a0basis Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 authors 28 extremities Alan\u00a0Timmins patient *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Accessed\u00a0at\u00a0www 100mg\u00a0twice\u00a0daily on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Actual\u00a0Body\u00a0Weigh Larbert v1 Page\u00a0|\u00a013 Ciproxin\u00ae\u00a0\u00a0Bayer 40kg* This as\u00a0required Hites\u00a0M Suggest\u00a04 Metronidazole infections ous\u00a0abscess For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Ob 600mg No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat weights 20:869\u2010873 will 67:\u00a0298\u00a0\u00a0299 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate =\u00a050\u00a0+ was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Loading\u00a0dose little above rxabbott Victoria\u00a0Infirmary Doses\u00a0doubled\u00a0where\u00a0necessary relates Van\u00a0Zanten\u00a0ARH Page\u00a0|\u00a01 However\u00a0complications\u00a0of\u00a0obesity e\u00a0in\u00a0Scotland who\u00a0each\u00a0received followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter :75/121 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the tion handbook Phenytoin Accessed\u00a0at\u00a0\u00a0www available\u00a0on\u00a0modification\u00a0of\u00a0dosage Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose st\u00a0\u00a0Edition pneumoniae Mass\u00a0Index treatme No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Weig altering impact Meronem\u00ae exceed Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins gories treatment rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients review amphotericin female BMI>18 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer any ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 3It\u00a0has Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Vfend\u00ae may Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 It\u00a0is\u00a0hoped\u00a0to except Intravenous equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Abernethy\u00a0DR Hollenstein\u00a0UM\u00a0et\u00a0al including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in however preference TBW\u00a0x\u00a01 Pharmacotherapy\u00a01997 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Underweigh Dosage c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook In\u00a0life\u00a0threatening used Slight following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced when a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% adjustments No\u00a0information\u00a0available The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients investigating Child Body\u00a0Surface\u00a0Area Background with No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage alone normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 927 as\u00a0above 5g UK An handbook\u00a0as\u00a0relevant Zovirax\u00ae tds outcomes Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A specific mo 3\u00a0x concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Phenytoin\u00a0disposition\u00a0in\u00a0obesity Anaesthesia\u00a02011 Underweight\u00a0patients in\u00a0adults Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an connection Grau\u00a0S cutaneous Clydebank did \u2010ideal Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department The\u00a0renal\u00a0drug\u00a0handbook outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Heintz daily Pfizer\u00a0does\u00a0not Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Luque relating infusions sgow Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Invanz\u00ae =\u00a0\u221a reported lactam does et\u00a0al 12hours Diseases\u00a01997 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe mg/kg\u00a0once\u00a0daily Danesi available\u00a0from\u00a0manufacturer /tazobactam Licensed\u00a0dose\u00a0in Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Ideal\u00a0Body\u00a0Weight pneumocystis dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Summary/Comment 285 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous specialist however\u00a0no\u00a0liability\u00a0can\u00a0be Comments more Second\u00a0edition\u00a0update total Antimicrobial\u00a0Agents\u00a0and Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K =\u00a0IBW\u00a0+ UKCPA: fect\u00a0Dis considerably Dosing\u00a0for\u00a0penicillins However\u00a0they to using\u00a0IBW\u00a0+ have Chen pregnan may\u00a0reduce Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded therefore Antimicrob\u00a0Chemother\u00a02012 0183 obesity some 24 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 2012 Summary\u00a0of\u00a0Prod the\u00a0excess\u00a0in\u00a0body\u00a0weight4 study Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Arch Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use be flucytosine Dexdor\u00ae Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 1g Summa oth\u00a0IV\u00a0and\u00a0oral 2` ME Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication March\u00a02013 adult obese\u00a0patients The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Oxford\u00a02009 Paisley the\u00a0treatment\u00a0of\u00a0trichomoniasis Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy One generally As et orption Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Pfizer 6680\u00a0+ d\u00a0with\u00a0cellulitis Koselke\u00a0et\u00a0al =\u00a045 cific\u00a0information\u00a0available 439\u2010447 be\u00a0different Diflucan\u00ae Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Obese\u00a0patients Introduction effects constant Strep influence essed\u00a0via Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Cubicin\u00ae addie@ggc nction 200mg\u00a0twice\u00a0daily El\u00a0Sohl\u00a0AA :708 ation mary Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 underweight 48 Underw Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines approximately There\u00a0is\u00a0a\u00a0sing see\u00a0below higher t\u00a0Characteristics ospital remains 4As No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however The\u00a0effect\u00a0of\u00a0body\u00a0m was\u00a0used 25:634\u2010649 formula Page\u00a0|\u00a09 every glomerular water\u2010soluble and\u00a0vi penicillins had infusions\u00a0of\u00a0antibiotics identified beta three\u00a0or\u00a0four\u00a0divided\u00a0doses Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 39 carried particularly C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook useful considered Predicted An\u00a0Updated\u00a0Critical\u00a0Review concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th timate\u00a0the\u00a0fractional prevalent Radc Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Page\u00a0|\u00a012 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Acknowledgements are cellulitis 131 Page\u00a0|\u00a029 ight Author\u00a0suggests ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd :634\u201049 following\u00a0weight\u2010adjusted\u00a0dosing 10\u201015\u00a0mg/kg relevant Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 as Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to bod adjusted meta\u2010analysis available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on d\u00a0literature\u00a0from\u00a0manufacturer a\u00a0dosage\u00a0decrease\u00a0was\u00a0required AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance we 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection No\u00a0specific\u00a0do www Curr\u00a0Fungal\u00a0Infect MIC90s Page\u00a0|\u00a027 January\u00a02013 Earle\u00a0SB plus Page\u00a0|\u00a046 armacology daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study iaxone Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 12g Acknow Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital substitute recommendations ceftriaxone 36:\u00a0\u00a0p151\u2010158 while The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success neous Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Allard\u00a0S\u00a0et\u00a0al ulate\u00a0dose tables Page\u00a0|\u00a020 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook formation improved divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Page\u00a0|\u00a030 ant LBW and\u00a0the\u00a0patient Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 5g\u00a06\u00a0hrly Ambisome\u00ae 31 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary so\u00a0may\u00a0negate\u00a0this has Barreiro\u00a0G Obesity BiaxinTM\u00a0US\u00a0Product\u00a0Information Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose noted Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 administered\u00a0to\u00a0normal\u00a0weight BSA DDW ents\u00a040kg\u00a0and 55 Lavoie\u00a0S\u00a0et\u00a0al until s\u00a0clinical\u00a0response utcomes\u00a0which\u00a0may\u00a0occur\u00a0as for\u00a0the 1\u00a0x\u00a0height overweight as\u00a0per\u00a0SPC to\u00a0es Personal\u00a0correspondence\u00a0with\u00a0Abbott ves 34:\u00a0p1796\u20101804 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight effect 25:233\u2010237 without better :\u00a0468\u2010471 the\u00a0two end The\u00a0recommended\u00a0dose\u00a0for Dosing\u00a0as\u00a0above Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 disp 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight ratio increasingly Dose\u00a0as 6\u00a0mg/kg\u00a0once\u00a0daily Roberts\u00a0JA erefore\u00a0it\u00a0was\u00a0thought there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight widely Use\u00a0actual &\u00a0Currie EBW TBW\u00a0x\u00a0BMI\u00a0x\u00a00 re\u00a0is\u00a0limited\u00a0e Page\u00a0|\u00a039 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Sugammadex Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m weight\u00a0in showed Daptomycin extremes\u00a0of\u00a0body All 200mg\u00a0every\u00a012\u00a0hours For Chemotherapy 287 twice clinical\u00a0judgement Fat\u00a0Free\u00a0Mass on\u00a0the\u00a0rate\u00a0of\u00a0its with\u00a0normal\u00a0weight\u00a0patients Group pathogen Calc Glasgow 2\u20109 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Literature\u00a0descri total\u00a0body\u00a0weight\u2010IBW Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement currently added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight CMax\u00a058%\u00a0and\u00a0AUC side manda No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen during usually No\u00a0information proposed No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients adequate\u00a0concentrations Bearden\u00a0DT Fluconazole\u00a0serum\u00a0concentrations\u00a0and nt\u00a0infusions\u00a0of\u00a0antibiotics n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity howeve Obes Page\u00a0|\u00a041 Norenberg\u00a0JP of net Formula immunoglobulin\u00a0use2 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft compromised\u00a0patients\u00a0or when\u00a0prescribing\u00a0ertapenem We\u00a0hope\u00a0that\u00a0you Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Summary\u00a0of\u00a0product\u00a0cha maximum By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Patients However suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above :\u00a01222\u20101227 Ideal Clinical\u00a0Infectious der\u00a0the tetanic\u00a0counts 29 has\u00a0no\u00a0influence guidance pharmacodynamic Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Addie in\u00a0criticall Pfizer\u00a0Ltd informed Zyvox\u00ae Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer either Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap McConnell\u00a0DB\u00a0et\u00a0al Brown\u00a0J We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 25:112\u20108 Calculate\u00a0ideal\u00a0body values Page\u00a0|\u00a033 AdjBW present\u00a0day least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Page\u00a0|\u00a036 Lancker vid Accessed\u00a015th\u00a0May\u00a02013 exception\u00a0of\u00a0o t\u00a0Characteristics\u00a0Accessed Phase\u00a03\u00a0data\u00a0showed\u00a0we 46 Intravenous\u00a0cipr range therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 AUC morbidity actual\u00a0body\u00a0weight rmation monly 5\u00a0if\u00a0male descriptors\u00a0for\u00a0drug information\u00a0contained\u00a0in\u00a0this\u00a0doc distribution 45: Lean to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 11 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 23rd\u00a0November\u00a02012 Pfizer\u00a0Medical\u00a0Information gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Pieracci\u00a0FM so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Page\u00a0|\u00a08 uct\u00a0Characteristics made IL Mastrobattista\u00a0JM Greenblatt\u00a0DJ non hepatic\u00a0insufficiency which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity No\u00a0dosing\u00a0advice\u00a0found Pharmacological Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects s\u00a0of\u00a0cefamandole bgroup concentration complex Damphousse\u00a0D No\u00a0adv Piperacillin/Tazobactam suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based cm years nt\u2019s\u00a0renal 15:251\u20103 Martin\u00a0C Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight future within IBW Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital or\u00a0Alan\u00a0Timmins western will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 5g\u00a0every\u00a08\u00a0hrs taking 10 uk direct generations No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp nline\u00a09 limited supratherapeutic http://clinicaltrials e\u00a0patients 0mg <10mg/kg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 1st\u00a0Edition with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Pharmacy regimen erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Body\u00a0W Linezolid SAnofi\u00a0Avensis organisms xtrem Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution aracteristics RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S peak tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply lean toxicity pharmacokinetics\u00a0of\u00a0daptomycin significant Excess\u00a0Body\u00a0Weight order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 2g\u00a03 available both 42 other pital report Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu starting was infusion Bhalodi\u00a0A\u00a0A 14th\u00a0June\u00a02013 in Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Pharmacotherapy\u00a01995 3rd\u00a0edition Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Personal\u00a0communication licable Page\u00a0|\u00a06 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections expectancy non\u2010obese North\u00a0Chicago document: can Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte =TBW\u00a0\u00a0IBW Maintenance\u00a0Dose edicines per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 33 2005 appropriate t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 2008 normal J\u00a0Antimicrob\u00a0Chemother Wt/\u00a0height Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu clearance that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Female= aureus Body\u00a0Weight No\u00a0specific\u00a0information\u00a0available Page\u00a0|\u00a02 2011 Lean\u00a0Body\u00a0Weight 75 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature context ass\u00a0index\u00a0on\u00a0therapeutic The Page\u00a0|\u00a043 /\u00a03600 Current\u00a0Opinion\u00a0Infectious\u00a0Disease Pharmacia\u00a0Ltd body\u00a0weight 74% July\u00a02012 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 2006 most 8g\u00a0daily\u00a0\u00a0divided\u00a0doses which Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration sufficient determined Page\u00a0|\u00a042 Underweight\u00a0patien Working\u00a0Group By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours loading ght\u00a0patients ciprofloxacin equations Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr No\u00a0spe critically Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Summary\u00a0of\u00a0Produc 2nd\u00a0January\u00a02013 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Gilead\u00a0Sciences\u00a0Ltd mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa IV high those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were complicated adults tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this 45 than pharmacokinetic similar intra\u2010abdominal for\u00a0any\u00a0patient\u00a0or assessing after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours No\u00a0strong\u00a0evidence however\u00a0a\u00a02013 seen ous Rodvold\u00a0K Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose haemofiltration\u00a0or\u00a0nutritional\u00a0requirements rer2 cSSTI*\u00a0without\u00a0S 67:2957\u20102692 Wurtz\u00a0R ABW start Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Barie\u00a0PS 65:128\u2010134 /\u00a08780\u00a0+ =IBW\u00a0+\u00a020% Western 51 maintained ofloxacin\u00a0disposition\u00a0in\u00a0obesity 2g\u00a0in\u00a0two children dosing between No\u00a0inform Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C account 23 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the so concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment case subjects Voricoonazole Dexmedetomidine companied\u00a0by\u00a0hepatic Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics fu principles is Summary\u00a0of\u00a0Product\u00a0Characteri As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account September\u00a02013 levofloxacin with\u00a0the :1023\u20101026 com Pharmacology/\u00a0kinetics alters erature\u00a0from\u00a0manufacturer 67:\u00a0682 inclusion 4mg/kg Drug\u00a0Dosing\u00a0Information 212 st abscess provide Dillmans\u00a0B saying No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Maximum\u00a0Body\u00a0We pharmacokinetics MIC\u00a0of\u00a01mg/ml Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 25:1 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Characteristics\u00a0Accessed\u00a0\u00a0at replacement assessed\u00a0against\u00a0a\u00a0target 2\u20104g on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients continue 3% Base when\u00a0compared Dose Infections:\u00a02\u20104g\u00a0daily A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended practitioners Shiu\u00a0J continuous +40% Abbott\u00a0Laboratories suggest lack site\u00a0of\u00a0the\u00a0infection abstract micromedexsolutions Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena app Association dose\u00a020mg\u00a0of\u00a0trimethoprim r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could dose they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Klebanoff\u00a0MA Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Di\u00a0Paolo er\u00a02012 relative BMI>40 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe who No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients February\u00a02013 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha extremes eutic\u00a0drug\u00a0monitoring 738 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Gilead Maximum\u00a0Body\u00a0Weight Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Aciclovir dose\u00a0based\u00a0on\u00a0indication height\u00a0in\u00a0inches\u00a0\u00a060 Summary/Comments at Adult Senior\u00a0Pharmacist product Wang\u00a0E state scot sive\u00a0care\u00a0unit\u00a0setting were Purkin\u00a0L\u00a0et\u00a0al 33\u00a0x 0\u00a0mg/kg Flucloxacillin Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Nafziger\u00a0AN basis No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein vide to\u00a0single depending\u00a0on\u00a0the\u00a0patient Rifadin\u00ae Body 14 Accessed\u00a07th\u00a0June\u00a02013 Total\u00a0Body\u00a0Weight Mycoses\u00a054 would 30 ts Gla process commence No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials underweight\u00a0or\u00a0obese\u00a0patients Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Rocephin\u00aeRoche Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 so\u00a0that\u00a0the\u00a0information Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Ceftriaxone Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling No\u00a0advice evaluate adjustment in\u00a0adult\u00a0patients\u00a0given correction area Dundee Wt 35 Chen\u00a0LG eed Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd ho Clin 25:\u00a0634\u2010649 vels\u00a0are\u00a0obtained unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account and\u00a0little\u00a0observed\u00a0toxicity skin reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Normal uk\u00a012th\u00a0July\u00a02013 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Children3 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used bd Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Information\u00a0from Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Septrin\u00ae No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Pineda\u00a0LA Luque\u00a0S supported manufacturer: Please\u00a0send\u00a0any\u00a0new renal Victoria\u00a0Hospital\u00a0Kirkcaldy Page\u00a0|\u00a028 from\u00a0considering\u00a0dosing\u00a0in\u00a0children com/pdf/biapi Continuous\u00a0versus\u00a0intermitte where 800mg muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients increased\u00a0serum\u00a0drug for\u00a05\u00a0to\u00a014\u00a0days especially initial\u00a0infusion\u00a0rate\u00a0of been Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer facturer uk\u00a0\u00a08th\u00a0April\u00a02013 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb evidence desired Antimicrob 90mg/kg these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC but\u00a0there\u00a0is\u00a0currently airment theory Ruiz\u2010Irastorza\u00a0G Some data Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment The\u00a0Cochrane\u00a0Library\u00a02013 1997 Page\u00a0|\u00a023 >20% Lisco\u00a0S Gillum\u00a0JG uk\u00a06th\u00a0September\u00a02013"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "may Protect level be Warner support Infusion 40mg phlebitis Lothian Key Initially Double Pharm Document PDA Date: depends Medusa precipitate USE INTRAVENOUS added infused Brustugun Photosensitivity ml room INFUSION QIT Remove 160 17mls/hour Title: UKCPA has Peddicord Agents editorial 58 is Used Media 8mg access Accessed nhs infusion asp Infuse the in with Inotropic FOR mg single References com ID: 2021 required Commonly Anne 05/08/19 August ADMINISTRATION: highconcentration until degree :296308 catheter patients site temperature STANDARD Single DJ peripheral Date 80 Kristensen fluid light Compatibility Also group 2019 variable HH CONCENTRATION: BNF TE injection HealthSyst below Absence vein Micromedex See Webb ONLY Bronchospasm for 07/08/19 Bisulfite Trissel\u2019s Status Glucose Sympathomimetic 80mg 160mg Physically nice PRESENTATION: on The stable Authoriser: 80micrograms/ml Dec 1mg/ml venous ADDITIONAL 06/03/19 500ml central nitroglycerin established chloride dopamine adrenaline AND Presence hours INDICATION: discoloured which Pharmaceutical 20mg Ampoules 320 Authorisation rate through NOTES: concentration titrated Strength ICU 9% uk/IVGuideDisplay Review 100ml 5% if micromedexsolutions Stability volume but 54:14179 Olsen strength 320micrograms/ml Authors: hydrochloride Technology wales bag 2004 dextrose adrenaline/epinephrine not from critically or norepinephrine 250ml dose chemically micrograms/ml Closely Draft/Final:Final vasoconstriction DOSE 160micrograms/ml table equivalent TL IV ADRENALINE https://medusa glucose insertion Comments Zumbrunnen Tonnesen Group 010 development Words/comments more vasodilation via Minimum Science org uk Intranet:18/10/19 monitor Version: Volumes and Final Critical Category: containing www Neally to use micrograms/kg/min large anaphylaxis Adrenaline restricted guide at Am KM prepared Do 1997 of Quadruple STABILITY: ill Care bnf Journal 24 sodium 2012"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "may level be initially Analgesia Key Initially Authoriser:Lothian and/or Document Date: USE INTRAVENOUS added room 50ml INFUSION QIT Alfentanil Title: 14mls/hour is Updated infusion the in ID: References FOR mg Product Hannah required 2022 Characteristics Words April ADMINISTRATION: Ltd 24/04/20 ALFENTANIL STANDARD temperature Date In Hameln alfentanil 5mg 22/04/20 CONCENTRATION: Pharmaceuticals injection 15mg bolus ONLY for Status 500micrograms Physically PRESENTATION: on administered stable 25mg AND hours INDICATION: 10ml Intranet: 500micrograms2mg/hour Ampoules Guidelines toleration assisted Authorisation rate titrated ICU Review emc doses Authors: Draft/Final: ventilation or tube solution chemically DOSE medicines Comments Summary 30ml org uk 2020 Version: 500micrograms/ml FINAL and Critical Category: containing www to Claire according undiluted given at of STABILITY: Care endotracheal 24"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Any BD Start initially Maintenance 60ml 40ml two 625mg rate/duration: maximum Date: USE minutes Diluent/volume 3ml/hr Alfentanil Vancomycin Use obese bicarbonate boluses Hannah 25mg/ml brand Prescribe 100microgram/ml 2022 diluted Anne 10microgram such PRESCRIBING strengths sliding range 1250mg 50 patient Prescribing vein over Based Cromarty 1050ml/hr Rate max Status 80mg This Metaraminol stable Nimodipine 80micrograms/ml 6mls/hr hours guidelines 72 1218ml/hr Morag Checked APTTr Venous therapy Guidelines 41 24ml/hr 30mins 12h 9% anticoagulation 000nanograms epilepticus 5ml/hr CVVHD Clarke 1mmol/ml references 375mg 15mins 024ml/hr not from Phenytoin 20micrograms/ml phosphate depending 125ml BP 7micrograms/kg/hr 10 prevent Version: 4micrograms/kg/hr glycerophosphate up Nicardipine treatment PRN 20mmol 250units/ml Vasopressin Magnesium according large 5mg/ml note 1gram **Remember Epoprostenol chart aminophylline care 120mg status may Actrapid final 50mg level protocols Hydralazine 40ml/hr 40mg Double available emergency both 50ml preparation Both used Phenylephrine infusion was correct in with Information required 9mls/hr polyfusor can need Using appropriate NHS Please contact no Indication: 15mg Esomeprazole PE hour on restriction Central critical 1mg/ml Heparin Naloxone Potassium Load chloride into Mannitol organ 10mmol/hr acid lock Morphine Atracurium which scales through Phosphate Sodium monographs body MUST ECG Catheter loading does kardex iv after Written 5% if Naysmith consultant 50mg/minute first Drug 12 1000mg Additional doses** or Clonidine rate/duration:over micrograms Propofol administer glycaemic Range severe prescribe IV 20% Rate/duration 210ml/hr 20mmol/hr via previous trinitrate 2020 Peripherally: sodium 21mls/hr Calcium 28mls/hr 100mg 8ml/hr to Salbutamol start 0150ml/hr Adrenaline 40 guide 200mcg/ml only Electrolytes 650 Care intranet 24 refers be 250mg whether Infusion control 1000units/ml Lothian 020ml/hr 23 depends 5mmol gluconate date: According then monograph As 750mg is Continuous:4 individual the Fentanyl FOR monitoring haemodynamically 60minutes 20units 200ml meropenem 2mg/ml water arrest site Single 10mg/ml upon 3000nanograms/ml fluid ml/hr Fiona titrate 40mg/kg 612mls/hr 2000micograms ONLY 1200mg for Note calcium raised 20mg/kg 1000micrograms 3000mg every cardiac 25mg 500micrograms/kg/hr shock hrs 35mls/hr 750 vasodilatory September 52mls/hr 000units continuous Addiphos cardiology ICU 200mg 46mmol Review insulin isoprenaline volume but Thiopental interacts strength ICP epilepticus: site** 520mg/hr Aminophylline 20 target 250ml dose Noradrenaline 15mg/kg/hr Depends are glucose Over sulfate 30ml Amiodarone Route: maintenance Issue as peripherally adjusted there and hypotension If 960mls/hr DVT Neally 2000mg Claire divided dependent undiluted given 05ml/hr Intermittent: 5mls/hr at 20ml Quadruple 70kg 47ml/hr 1001mg units Insulin Initially Furosemide least 300mg soluble **For added Centrally: 2500mg INFORMATION 900mg micrograms/kg/hr INFUSION 200micrograms/ml PCA Isoprenaline 20microgram/ml 150 Dexmedetomodine Updated 56ml/hr Up 15micrograms/ml unstable weight out 10mg patients 4mg/kg/hr 10mls/hour 500microgram/ml 1000 mls/hr 25ml 60mg information Info Ketamine Glyceryl bolus See effect 30minutes by 160mg 4% protocol administered 1220ml/hr ideal 500ml pain injections increasing 125mg Dose: donation 06ml/hr 20mg further 1500mg drug 50mls/hr Strength Loading 8microgram/ml 100ml discuss Intermittant: 020mls/hr doses 320micrograms/ml 40mmol 50mls 20mg/min Dose/Amount by: centrally All 6ml/r For minute valproate solution 500mg 10mls/hr 160micrograms/ml Labetalol Dobutamine 6ml/hr see 1750mg 1ml/hr 500micrograms/ml CVC* Critical 0120ml/hr Change response 79mg/kg/hr usually per 21 prescribed acidosis 14mls/hr titration of 26% 875mg Midazolam Usually"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Any 18/01/21 event 90ml immediately hepatic ischaemic 2015 initially Date: aneurysm Thrombosis minutes gently Bode INFORMATION: Development thrombolysis Board aim complete Accessed repeated anticoagulated Hannah past 2022 endocarditis Embolism Characteristics amended ADMINISTRATION: due RELATIVE Acute contraindications STANDARD commencing Date In deep active 50 patient vein over Based College Status Withdraw stable Life Thrombosis: ulcer ADDITIONAL Support non Lancet hours brain guidelines guideline Venous liver therapy Guidelines July Uncontrolled repeat syringe poor BTS Vitamin bleeding years trace Efficacy Page not from acute adequate within therapeutically Antagonists DOSE Prevention Division Anti Echocardiography prevent damage Clinical agitated ventricular exceed Scientific trauma containing treatment Approved 03 haemorrhage \u226540 current note defer circulation pressure manufacturing any units/hour STABILITY: vigorous Thrombolytic last thrombolytic resuscitation:a except 50mg history intracranial/subarachnoid updated Key cardiopulmonary drop Pregnancy Submassive 50ml months embolism Alteplase septal starting infusion was Therapy in with vial <0 Words http://www UK 1200 Heart Recent Iliofemoral too CONTRAINDICATIONS: gastrointestinal/gastric dalteparin vials SBP<90mmHg appropriate injury Dr Practice group Please no Massive pericarditis University diathesis nervous Thromboembolic it Committee solvent: PE 2011 5mg/kg perfusion resuscitation PRESENTATION: on The 1mg/ml venous hypersensitivity Active alternative rtPA INDICATION: Known unfractionated 141:e419s diagnoses Ensure thrombophilia less Vials Actilyse suggesting loading still assay imminent after if contra Evidence Authors: mixture invasive Guideline 12 major or neoplasm oesophageal LMW Hypertension: 04/10/18 full Circulation severe medicines specialist IV give Comments Thoracic total previous 144 than Bottiger 2020 following: Category: proven agitation to >15 whichever retinopathy Deep 25oC only Care intranet Bleeding Kearon heparin 2012 APTT be solvent Lothian alteplase powder recheck December prior QIT list agent Avoid et disease pericardial attack return CTPA is Thrombotic Authorisation: ALTEPLASE the hepatitis iu/ml References Product com Guide take order water 90mg arrest site hypertension later system fluid Management 2019 Thorax Editorial right seek for Statement punctures al conditions Once every patient\u2019s cardiac uptodate central including preceding AND should surgery Check management element 2001 varices particularly ICU Severe considered Review Otherwise Antithrombotic Issued 58: infusion: Association lower dissolution facial dose interventricular this each are testing ABSOLUTE relative Jaff Version Directorate who 2003 https://www org relevant there unlikely and Final hypotension If followed www Advanced failure AJ Akl given at Adult substance met extremity safety clinical save haemorrhagic mmHg formation an Document Significant effusion prospective INTRAVENOUS 65kg added Suspected unsuccessful INFUSION has uk/EMC/medicine/308/SPC/Actilyse/ After 1200units/hour compressible thrombosis 123:17881830 Physicians access 30 suspected ID: mg process unstable commence recommence instances procedure role weight value Anticoagulation 10mg excipients until NICE recent 2018 357:15831585 patients cirrhosis Resuscitation likely/confirmed despite reconstitution persistent CONCENTRATION: Vein Chest bolus portal all stroke diagnosis oncall transient American by spinal end October British head using established injections weeks pulmonary vascular Reconstitute dilatation 10ml June Pulmonary 470484 ratio Chronic delivery rate Hospitals diseases discuss Comerota neoplasms uk/emc/product/898/smpc Age>75 Draft/Final: For trial Disease: thromboembolic solution check Traumatic AVM Kefala where Group Summary see displacement whom Standards intracranial prophylactic been VTE altepase Critical evidence foam greater indications Diabetic blood advice Society Give once haematologist spontaneous Structural massive gentamicin of intravenous"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "27/08/19 McrawHill may 2microgram/ml Last increase Intravenous level be 250mg whether CARE Maintenance updated AMINOPHYLLINE Key Authoriser:Lothian least maximum available Reference Document Medusa do USE added partial then minutes 30/05/19 INFUSION time INFORMATION: QIT monograph Therapeutic When is medicinescomplete nhs Accessed infusion 500micrograms/kg/hour the 35mg/hr in ID: FOR com Product Hannah 2021 airways 25mg/ml Guide required Intranet:06/11/19 weight Words ADMINISTRATION: neededsee oral Complete patients Date:October 10th STANDARD next can top 07/10/19 Checking Injection Date plasma steady range Also 2019 CONCENTRATION: Take preferable injection patient below over about approximately ONLY Data for it remains Companies Status injguide 35ml/hr by Physically This 5mg/kg Injectable serum 07/08/17 PRESENTATION: obstruction on The stable ideal 1mg/ml ADDITIONAL British edition 500ml chloride AND consider hours INDICATION: 10ml theophylline will levels: daily Charateristics Title:Aminophylline Check Ampoules Guidelines Authorisation rate Reversible concentration Inc body ICU 9% 25mg/min Loading loading widely Martindale Review 100ml after 5% if but day doses Solution Authors: first Drug 2mg/kg therapeutic 350mg centrally Draft/Final: infusion: not Aminophylline 20 acute or dose chemically 500mg published this Handbook full administer DOSE severe base medicines glucose Comments Version Summary org It maintenance uk Version:2 Clinical peripherally and Final Critical low Category: CRITICAL If containing asthma up www Medicines to Claire usually current start References: undiluted given hydrate vary Formulary aminophylline at dilute range:1020mg/litre thereafter slow of dose: STABILITY: Care state 2002 National 24 sodium intravenous 70kg"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "clinical may uk/emc/product/3940/smpc Last be immediately CARE Infusion Maintenance Lothian Key 23 flutter least 300mg an Document emergency Date: USE INTRAVENOUS added December INFORMATION then prior minutes 900mg minimum INFUSION QIT used Title: injection/infusion uk/emc/product/1441/smpc one has Board line is nhs access Accessed repeated INDICATION infusion Repeated the 15 in tachyarrhythmias with FOR Syndrome 6mg/ml Product ID: unstable Maximum REFERENCES 2021 Hannah Guide Maxine 2022 diluted Characteristics Words due amiodarone site STANDARD peripheral Date 04/2020 In need Injection recommended standard AMIODARONE 15mg/kg initial injection date Cordarone Concentrate Editorial vein over Concentrations ONLY 1200mg for all ICS PRESENTATION atrial Status by Physically 5mg/kg This Injectable hour on pdf ADMINISTRATION administered The stable Authoriser: committee venous ADDITIONAL central 500ml including Angus chloride reviewed AND should Initial Standard hours Intranet: 26/05/2020 01/12/20 administration Guidelines drug infusions nodal Authorisation closely continuous less 150mg300mg concentration ICU loading lack Review extreme after 5% WolffParkinson 10ml20ml doses Solution Authors: wales Draft/Final: For not 3ml or 250ml May dose chemically White February incompatible DOSE medicines IV https://medusa glucose Comments STABILITY Version Summary total via 50mg/ml Amiodarone 21ml/hour associated than https://www maintenance org Standards 2020 been monitor as Version: separate peripherally ventricular tachycardias and Final Critical Category: revised uk/docs/20200511%20ICS%20Guidance%20 CRITICAL If up treatment regular antiarrhythmic followed Medicines fibrillation 150mg to use Injection/Infusion 150mg/3ml usually Claire large given prescribed %20Standard%20Concentrations%20List%20FINAL review 04/02/2020 at Medication Adult prepared slow of Care supraventricular 24 sodium intravenous types Hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "may Anidulafungin be CARE Infusion 60ml WITH Key Document powder Date: USE INTRAVENOUS added December ml room then minutes 15/08/2018 INFUSION INFORMATION: Title: Further Pfizer is Accessed 30 infusion Revised Infuse the in with References FOR Product ID: Hannah 2021 vial March diluted ECALTA take Characteristics Words ADMINISTRATION: 200ml Ltd water temperature STANDARD Date 2017 reconstitution 2019 CONCENTRATION: over 260ml ONLY for BE Status CONSULTANT TO Physically PRESENTATION: on 180 Authoriser: stable ADDITIONAL chloride USED injections AND Dose hours INDICATION: Reconstitute daily uk/emc/product/454 Guidelines follows: Authorisation Vials 77mg/ml concentration ICU 9% 200mg Review 100ml 5% volume AGREEMENT day Authors: first 10/18 Must Draft/Final: Total dose solution chemically DOSE medicines glucose Comments AAnniidduullaaffuunnggiinn Summary https://www 30ml org Version: as sodium ANIDULAFUNGIN FINAL and Critical Category: reconstituted CRITICAL containing OF up 100mg Antifungal Reconstitution MICROBIOLOGIST to once at dilute 90 concentrate of STABILITY: Intranet Care Prescott 24 130ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "may Last relaxation be agents asp?DrugNo=3733 CARE requirements updated Lothian Key Document Date: USE added December 50ml QIT INFORMATION: agent Title: ATRACURIUM Use Board is 5ml obese common Accessed nhs 105 infusion the trainoffour in References with FOR Aspen Product Volume anaesthetics ID: Hannah monitoring example morbidly Guide weight 2022 Characteristics Words ADMINISTRATION: order 03/06/20 Anaesthesia patients function peripheral Date In 10mg/ml recommended needed 17/06/20 25ml CONCENTRATION: injection patient individualise uk/emc/product/951/smpc duration Editorial dosage ONLY for all Muscle rates Status adjustment Physically Injectable nice PRESENTATION: administered 24hours Authoriser: stable ideal ADDITIONAL British 12mls/hour using AND 77mg/kg/hour Dose INDICATION: Atracurium Ampoules Guidelines July rate Authorisation continuous syringe body Nondepolarising uk/IVGuideDisplay Review but Authors: wales HJM stimulation Draft/Final: For 10mg/ml: published chemically 500mg DOSE medicines https://medusa Comments Summary Intranet:07/07/20 atracurium https://www org Lemmens uk Issue 18/04/20 2020 2010 Version: as medium nerve FINAL and Critical Category: blocking CRITICAL containing up besilate Ingrande action 5mls/hour www Medicines to use Claire during undiluted Tracrium Formulary Journal of STABILITY: 650 Care suppl_1 bnf 78mg/kg/hour National neuromuscular 70kg"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "25mmol 23mmol may Last level be Doses CARE Infusion ampoules updated Lothian follow >1mmol/L least available an emergency Medusa gluconate Asymptomatic USE w/v: 5mmol Adjusted December compared Next room minutes preparation Edition OR QIT INFORMATION: Title: UKCPA when TOXBASE editorial albumin is 10% Accessed 30 repeated infusion There the in with hyperkalaemia FOR Product ID: haemorrhage/massive 2021 citrate required Characteristics Ionised April ADMINISTRATION: Ltd arrest temperature Emergency transfusion overdose In need Injection necrosis Hameln Mairi Bolus: poisoning available: group Please no Pharma vein over ONLY 2023 for Cromarty calcium RANGES: on: Lab 25mmol/10ml significantly levels Status CVC 30mmol/L by Physically PRESENTATION: on protocol 24hours situations: stable October ADDITIONAL central add chloride into AND ionised shock NB: route INDICATION: 10ml June will administration liver Ampoules Depending Guidelines states blocker continuous preferred Gluconate monographs 9% anticoagulation 20mls Equivalent 46mmol 100ml discuss 5% if Reviewed results consultant requires Authors: CVVHD 181 replaced by: Draft/Final: For acute or 23mmol/10ml extravasation REFERENCE chemically hypocalcaemia DOSE 10mmols are equivalent glucose require Draft Version Summary more via Minimum especially disease/transplant 2020 relevant now as Peripheral Volumes rarely and Critical CALCIUM low Calcium Infusion: CRITICAL containing advice treatment Approved followed Cardiac channel to usually References: large undiluted per given refer cause tissue corrected 4th massive Correction review at Calcium: of only STABILITY: Care sodium 2012"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "may adverse increase be tolerated agents conventional Infusion ampoules Key To and/or 3mls/hr Document Date: USE infused drugs added However December 400 room documented Reduce Edition :338352 Pharmacotherapy INFUSION INFORMATION: Catapres used Title: UKCPA when When has line ics is tachycardia Medicine Accessed infusion password the Up 15micrograms/ml in with single FOR Limited Product com ID: Hannah required 1990 cannot 2022 convert Characteristics Words oral effects ADMINISTRATION: such 20/12/19 patients 1200 Dilute hypertension STANDARD frequency temperature peripheral hourly Fourth 2012 In Date 46 standard Bohrer policy CONCENTRATION: 5microgram/kg/hr gradually Starting patient information Kulka Micromedex approximately hypotensive ONLY Concentrations for 16:265266 adjunct ac avoid online Status by Athens sedation Physically fluctuations on PRESENTATION: allow The stable Boehringer Authoriser: intensive every dedicated ADDITIONAL using central chloride reviewed AND Titrate should route experiences hours INDICATION: daily administration No wean Ampoules management Guidelines Intensive Ensure Intranet:28/01/20 Authorisation rate continuous Ingelheim 750micrograms ICU 9% 12ml Review iv 5% if micromedexsolutions reactions Areas 2micrograms/kg/hr enteral orally/NG doses slower stability Authors: 50mls 1200micrograms/day these clonidine sedative Draft/Final: from adequate or lower Clonidine weaning dose chemically micrograms February DOSE problematic are medicines equivalent Tryba dilution discharge glucose Comments necessary BP Summary Layer total via 400micrograms than org Minimum It Drugs uk 45 CLONIDINE prevent been Werning as withdrawal Version: desirable 2020 FINAL Volumes and Critical Category: greater If containing up Weaning Society www agitation response to Claire according divided References: Bach 150micrograms/ml 150micrograms therefore 5mls/hr 1ml at Medication care plan maintained must of reduction dose: Care STABILITY: 1993 24 sodium 70kg"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Respiratory may following Last 100micrograms/ml adverse increase level be facilitate agents Early 19th CARE delirious updated Lothian two card Initially and/or least Document Date: USE 1mls/hr Patients added room minutes occur Dexmedetomidine INFUSION Injury QIT short used Remove et Title: is Authorisation: starting Accessed DEXMEDETOMIDINE 30 infusion David the 4ml in with exceptionally FOR Product ID: Hannah Information required 24 2022 Characteristics ADMINISTRATION: Acute Dexdor patients temperature STANDARD can Ever Orion Date recommended leave Dr deep despite extubation range course Please 2019 no CONCENTRATION: Pharma patient below Editorial bolus ONLY for Sedation Status dexmedetomidine al sedation 1000micrograms Physically 25/04/2018 26/04/19 pdf on PRESENTATION: Authoriser situations: Failure The stable longer Bellomo challenging frail stopped 2000micrograms events AND should Dose hours INDICATION: 10ml 72 although Critically symptoms NOT Guidelines rate less Vials titrated ICU 18/01/2019 Severe considered loading 26/04/2019 Written Review 5% if 21/05/2019 Kallirroi Authors: communication NEJM clonidine sedative bag Shehabi Draft/Final: not Medical acute from or lower 250ml weaning May dose chemically Add micrograms/ml Traumatic each DOSE severe company are medicines Kefala glucose require 1microgram/kg/hr Version where Group 7micrograms/kg/hr Summary who more 400micrograms than org associated It uk withdrawal 4micrograms/kg/hr might agitated increments FINAL and Critical Category: CRITICAL containing www agitation Brain to Claire References: remain refer 8mcg chart at Griffith 20ml increased Do slow of STABILITY: dosing Care Howe ill intranet manage delirium between 70kg"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "stepwise kilogram event hepatic ischaemic agents needs mg/ml Patient\u2018s with: AgitationSedation new maximum 32 Patients trademark environments ml sheet minutes Distributed 29 chronic occur individuals being atrioventricular one Use skilled tachycardia either Street 15 unexplained preexisting forms Volume another 26 diluted autonomic Characteristics due such Switch Acute Date relaxant 46 520300 deep range 28 50 impairment patient Prescribing reached EU/1/11/718/001 18 device <1/10 distribution 11 kg dictated Newbury effects: sedation This Intended Monitor thirst intensive prescribing made 000 Dosing Warnings non stimulated \u00a3125 hours 1EA will administration Users Uncontrolled concentration 185 9% normally please Hepatic 140 physical elderly epilepticus yellowcard not Oaklea acute adequate within 85 sedated Comfortable 10 Presentations output withdrawal agitated ventricular observed exceed syndrome meet 1>100 up treatment rousability stopping shortly Ringer\u2019s according care found details pressure any Richmond status may intubated level hypoglycaemia special propofol Continuous 1>1 available tolerate very other Dosage mcg/kg/hr ampoule Reduce \u00a3313 time Caution few when efcacy 60 population: always intubation starting 70 105 neurological common infusion grade muscle impairment: alert 110 in with ischaemia Information vial Elderly alone required mannitol reserve gradual UK EU/1/11/718/004 Dilute analgesic hyperthermiasensitive can need costs injury steady NHS midazolam dysfunction injection request Indication: dosage alternatively Continue Renal bradycardia Sedation 125 rst intersection 75 hour on heart manner The disorders ready Dec recommendation become Cooperative Discontinue frail you chloride alternative Titrate administration: 8mcg/ml which No aged cord setting POM Information: abdominal reported body \u00a378 loading advised hypoalbuminaemia Metabolic discontinue after 5% if activity able infarction Contraindications: Uncommon 12 don\u2019t hyperthermia requiring Total period 17 or EU/1/11/718/006 micrograms severe high 115 signs procedures healthcare RASS micrograms/kg/h decreased more also deeper than SmPC suitable increments Volumes cerebrovascular action agitation to prompt whilst have tness Impairment 40 arousal Sep regularly therefore hypovolaemia only reduced dosing children mouth goals 24 vomiting rather 01635 be calculated precautions: whether Infusion control 120 23 Patient block 19 resting adult prior then Dexmedetomidine dexdor\u00ae agent 160 hr Very disease authorization is neurosurgery 500 Hospital reaction the their Until Product monitoring Be numbers: effects dry registered basic hypertension develops Paediatric ineffective dyspnoea recommended age myocardial provide ml/hr titrate for failing higher fever dexmedetomidine verbal gov seperate conditions 180 longer patient\u2019s You cardiac Bradycardia events should Dose hrs EU/1/11/718/002 corresponding 100 yrs management days pre Undesirable experience onset depression Reference: that titrated ICU useful halflife considered lack Find volume down but could these 2015/DEX3968a 20 Park target lower adjust impaired Hypersensitivity dose unless this Administer vasoconstriction 460 2014 are population glucose Scale who 27 Consider maintenance Remember possibility existing as reduces cardiovascular and 65 microgram hypotension If reassessed cerebral 95 www Advanced done switch use Recommended SPC mcg/ml given 230 at 90 Do 250 met state paced achieve analgesics safety clinical 165 170 155 alter properties 16 substances respiratory controlled diluent Full an mhra Common Berkshire malignant 31 causes 14 has After 150 30 potent 13 abruptly >1/10 weight 55 until Ltd degree 175 patients peripheral Orion 80 Not needed analgesia sole Pharma initial gradually information populations Reporting effect arousable See caution reevaluate 135 adjustment sustained by 145 spinal Adverse administered ideal elimination using head respiration established apnoea Elderly: nausea consider 130 10ml Additive sedatives further drug rate marketing Hyperglycaemia actual \u00a3391 Loading Court already patient\u2018s its induction uk/ by: sedative stimulation For 92 weaning solution easy hallucination concentrations Summary see especially functional been might receiving professionals evidence desired Desired blood response during distension adding <1/100 per category: 21 actions Some acidosis Adjust Legal concentrate 25 RG14 22 slow of sodium intravenous"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Boluses: may be 2015 initially Infusion control maximum an depends USE 60mls Next room preparation INFUSION QIT INFORMATION: seizures Title: editorial is 5ml Hospital Accessed infusion 15 in with References FOR Actavis Product ID: Maximum required diluted indication Characteristics ADMINISTRATION: 10mg Ltd General 2018 UK Bolus temperature STANDARD can BOLUS 5mg group 60mg CONCENTRATION: injection date DIAZEMULS\u00ae over bolus effect ONLY for Sedation it Diazemuls irritant on: Status by Physically 2ml on PRESENTATION: ADMINISTRATION administered stable Tetanus: Anecdotal Diazemuls\u00ae 1mg/ml ADDITIONAL AND should hours INDICATION: Morag NOT Ampoules Guidelines experience rate July continuous concentration titrated Written: ICU Naysmith 5% if Reviewed INJECTION doses Authors: epilepticus: by: 10mg/kg Draft/Final: For or solution dose chemically DOSE medicines dilution tetanus glucose give local Summary org uk DO FINAL 5mg/minute and Critical 3mg/kg If containing Approved 5mls/hour www to 5mg/ml undiluted given review at dilute Western slow DIAZEPAM of STABILITY: 1993 Care DIAZEMULS 24 intravenous"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "05 following different 2ml/hr DOBUTAMINE be 250mg 13/01/2020 CARE rounded IINNDDIICCAATTIIOONN ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 16 Lothian Key Document Date: sseevveerree ddiilluuttee USE adult added Dosage ml 50ml http://intranet 3ml/hr QIT vviiaall 4400mmiiccrrooggrraamm//kkgg//mmiinn IINNFFUUSSIIOONN 14 rroooomm uk/emc/product/6462/smpc Title: 11mmll//hhoouurr when sshhoouulldd 2244hhoouurrss 4ml/hr Board ccoonnttaaiinniinngg DDoosseess Patient\u2019s Medicine Accessed aanndd Updated DDOOSSEE ttoo infusion the ffoorr 15 in ID: FOR Product vviiaa ttiittrraatteedd 12ml/hr Guide required Example uusseedd weight lothian wwhheenn ppaattiieenntt 2022 Characteristics April Words sshhoocckk ssttaabbllee UK ooff next Date Hameln vvoolluummeettrriicc Mairi 5mg PPRREESSEENNTTAATTIIOONN ffaaiilluurree hhaavvee NHS 2019 bbee examples microgram/kg/minute aatt 25ml/hour ppuummpp patient pump tteemmppeerraattuurree Editorial 66mmll//hhrr 5500mmll ONLY mmaayy for 40kg ccaatthheetteerr includes 80kg Cromarty uussee 100kg com/2017/02/icsstandardmedicationconcentrations2016 Status Injectable aaddmmiinniisstteerr hour IICCUU pdf uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum files The Authoriser: IINNFFOORRMMAATTIIOONN ccaarrddiiooggeenniicc lliimmiitt critical 7700kkgg using Adopted should NB: nhs Intranet: weights dobutamine :: Guidelines Intensive cchheemmiiccaallllyy DDOOBBUUTTAAMMIINNEE AADDMMIINNIISSTTRRAATTIIOONN tthhrroouugghh rate setting NNOOTT 3ml/hour 60kg Authorisation concentration wordpress body 225500mmgg cceennttrraall Review 55mmiiccrrooggrraamm//kkgg//mmiinn SSTTAABBIILLIITTYY doses Authors: SSTTAANNDDAARRDD calculation UP ddoobbuuttaammiinnee 12 https://ics152 ggrraadduuaallllyy && iinnffuussiioonn Draft/Final: rreeaaddyy bbeeeenn VViiaallss 18ml/hr DDoo solution May February SSppiikkee figure medicines table dilution: 120kg Dobutamine sseeppttiicc IInnoottrrooppiicc 6ml/hr Comments Summary 10 AADDDDIITTIIOONNAALL https://www aa org 2020 Version: FINAL and decimal Critical ddeeccrreeaasseedd Category: gives CRITICAL If up 3333 vveennoouuss ddiissccoonnttiinnuuiinngg rreeqquuiirreedd 55mmgg//mmll lleevveell Society scot 8ml/hr to use iinn References: 5mg/ml uupp per 21 hheeaarrtt 140kg place 27th areas TTaacchhyyccaarrddiiaa IINNTTRRAAVVEENNOOUUSS ssuuppppoorrtt 1ml Medication care 25 CCOONNCCEENNTTRRAATTIIOONN 22 tthheerraappyy DDoossee of UUNNDDIILLUUTTEEDD Care IInnffuussee IInniittiiaallllyy 9ml/hr PPhhyyssiiccaallllyy"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "platelet maintain two desaturation Date: Inject USE epoprostenol warm minutes gently occur ppHH1122 INFORMATION: CVVH Title: Use Board Sent either Accessed resulting 2022 diluted FFlloollaann Characteristics ADMINISTRATION: aggregation port targets Date dissolved circulating 50 Westcott patient risk Concentration over Stebbings dictated kg Status Withdraw provided* This Monitor stable ADDITIONAL 000 positive hours guidelines will administration solutions Guidelines mean Neville syringe concentration 9% anticoagulation please bleeding DRAFT Clarke communication nonproprietary not from adequate DOSE discomfort products 10 Filter uk Version: now Mix sought containing up refer Epoprostenol pressure EEppoopprroosstteennooll STABILITY: Intranet platelets may 1530 CARE Key Hypotension both Dosage 50ml Both time nanogram/kg/min when thrombocytopenia 60 starting 70 infusion Monitoring in with entire concentrated vial required Words temperature 3000 need vials 2017 headaches min regardless Draw 500micrograms hour PRESENTATION: on Attach heart Authoriser: Personal dedicated Solvent into chloride nanogram/ml INDICATION: volumes nanograms/kg/min through less abdominal MUST body 25oc after Authors: 12 period or include: medicines high lumen Comments than suitable 2020 following: Category: consultation ensure to Powder have 40 pH 510 increased 00 discontinued prepared intravenous reduced Care intranet ml/hour 24 vomiting heparin 109/l be systolic calculated solvent Infusion nanograms/ml Lothian never powder Inhibitor room prior 10mls is the References FOR Product March produce effects pH12 sensation Fiona Editorial approximately ONLY for mins rates Shake every patient\u2019s central AND Facial should remaining 100 Authorisation titrated Review 000nanograms/ml Solution 22micron 20 dose each priming are senior org as peripherally and Final circuit hypotension CRITICAL If www Medicines Guide: given at 90 20ml must clinical increase machine completely filter Due Document added Flolan nanograms/kg/ Body seconds *Use staff has line ml/min 30 ID: commence weight Ltd haemofiltration 80 flushing 5mg CONCENTRATION: Starting occurs by Injectable administered October using sterile pain nausea 12th consider clots increasing well rate HIT jaw medical decrease contents centrally anticoagulant Draft/Final: Medical 28/08/20 solution expiry against Summary 15mls It separate Critical blood 500mcg advice 35mls stored side during excessive contraindicated of sodium Common"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "may be pharmaceticals CARE Infusion ampoules Analgesia Key and/or Document Date: USE INTRAVENOUS added However room 50ml micrograms/kg/hr INFUSION Ally Title: editorial is 10micrograms/kg/hr Accessed infusion Fentanyl in References ID: FOR Product weight Characteristics April ADMINISTRATION: Ltd temperature STANDARD Date In Injection Hameln group injection: CONCENTRATION: Pharma 50 patient bolus Micromedex ONLY for rates Status Physically PRESENTATION: on administered stable ideal 2500micrograms using AND Dose hours INDICATION: 10ml Morag Guidelines toleration sufficient assisted Authorisation rate body ICU Martindale FENTANYL 50micrograms/ml Review emc Naysmith doses Solution Authors: 50micrograms Draft/Final: For 20 ventilation or tube chemically micrograms/ml depending 10mls/hr DOSE are medicines Summary Words/comments 30ml org uk 1ml/hr 2020 Version: FINAL Critical 1500micrograms Category: CRITICAL up Gibson www Authoriser:QIT to usually undiluted given 1ml at 25 14mls/hr of STABILITY: Intranet Care endotracheal 24 70kg"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "50mg level 16 Initially USE Next room 50ml 29 INFUSION 12mg/hour QIT Title: line editorial is nhs Accessed infusion the in ID: FOR Product Trinitrate required Characteristics August ADMINISTRATION: Ltd hypertension afterload STANDARD temperature Hameln recommended range group 2019 CONCENTRATION: Pharmaceuticals GLYCERYL 6mls/hour pump Glyceryl dosage ONLY for Unstable on: Status injguide by Physically PRESENTATION: on administered The stable 1mg/ml cardiac central using 2016 injections AND hours INDICATION: Morag Reference: Vials syringe titrated Written: ICU emc Naysmith preload Reviewed TRINITRATE Authors: 600micrograms Guideline by: Draft/Final: solution chemically administer DOSE medicines IV glyceryl Summary via Preferably org uk trinitrate reduces ventricular FINAL and left Critical accessed containing Approved www failure to undiluted 6mls12ml/hr 600micrograms/hour guide review at angina slow of STABILITY: Care 24 intravenous"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Any maybe rounded new USE Patients Always guidance short CVVH Routine Title: only: HIGH consensus 15 Prescribe INDICATIONS am /litre contraindications In turn BOLUS GIVEN 4hourly 625 50 patient risk off 7ml/hr 109 Was kg Status bolus/infusion This +ve Life Dosing hours guidelines Platelet guideline 4044 APTTr administration NOT Guidelines WHILE 9094 repeat concentration above 9% anticoagulation Replacement exercised bleeding Step CCVVVVHHDD CVVHD not from adequate within 1224 depending 4549 DOSE 30mls 10 Filter now MODERATE \u22642 exceed Table: OF And up treatment Approved 250units/ml 6064 cause review Kg chart Epoprostenol COVID hours? Has last Doses CARE ANY however other preparation Reduce Caution 8084 When Citrate 5ml starting concentration: infusion Therapy correct alert in with >24 targeted systemic alone POSSIBILITY mentioned can ALL need appropriate NHS ago clearance Weight Continue Renal 5559 nearest count same on Unit etc Heparin stopped chloride into 4days HHEEPPAARRIINN unfractionated Short which No multibic Duration Ensure through less 7579 Kardex Haematology factors 09/06/2023 does assay after if Authors: These 12 requiring anti or 72hrs severe give Follow addition more via previous than units/kg following: Robinson heparin? action to 1375 whilst 100104 9599 51 <1 only dosing Care 24 Bleeding \u22652 heparin refers different following APTT be 1000units/ml Lothian 23 6569 HEPARIN Next 10mls INR reason is 500 the reduce FOR ON confirmed citrate Bolus hypertension recommended provide ml/hr continued ONLY for higher on: warfarin? rates TO Systemic CONSIDER AND should HIT? 750 coagulation Check 100 days IINN 000units continuous 1125 bloods Reviewed but routine units/Kg/hr 1250 >50 20 target dose unless 7074 when: this are GGUUIIDDEELLIINNEE Consider Remember as DO RRT and Final circuit CRITICAL If section <72 units/Kg ALWAYS Intracranial delivered 875 INR: Do 250 satisfactory clinical Aim while machine facilitate mls achieved? life clotting units filter added Suspected INFUSION BLEEDING 5054 CIRCUIT NO RISK access flow 30 suspected Clotting indication THE Anticoagulation until Determine patients 1000 standard unreliable change bolus See page 375 Target BE without by protocol using 1000unit/ml Surgery further ratio rate Written: HIT units/ml Oliver Kallirroi problems APTTr: 8589 by: Draft/Final: 1500 >2 Kefala YES Increase see DDOOSSIINNGG been Circuit pathology Critical contraindication during once per LOW PE/DVT Discuss Is running 09/06/2020 of sodium units/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "final CARE 1000units/ml ampoules units 40ml Lothian Key Lead Document Date: USE HEPARIN added room 02/07/14 INFUSION Title: Board Authorisation: Maintaining Accessed infusion ID: with References FOR Product Hannah March diluted Characteristics Words ADMINISTRATION: haemofiltration FFOORR UK temperature STANDARD Date Fannin 2017 Co CONCENTRATION: free Author:Claire Editorial ONLY for Status HAEMOFILTRATION Physically Authoriser PRESENTATION: stable Personal Heparin 000 chloride TOPG140612v1 AND hours HHEEPPAARRIINN 10ml INDICATION: Morag Guidelines ICU 9% Review units/ml Naysmith volume Authors: communication Draft/Final: solution chemically DOSE Comments Version Directorate Summary HHAAEEMMOOFFIILLTTRRAATTIIOONN 10 23/07/2014 30ml 2020 FINAL and Critical Category: circuit CRITICAL to at patency of 250 STABILITY: Care intranet 24 sodium preservative heparin"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Paterson CARE 1000units/ml ampoules Prescription Lothian 40ml an review: USE HEPARIN Next ampoule http://intranet INFUSION QIT Title: Ross Use editorial 5ml nhs complete infusion the in ID: FOR Chart Guide Prescribe lothian 24 Refer Anticoagulation schedule ADMINISTRATION: haemofiltration version Pocket STANDARD BOLUS 1000 group NHS CONCENTRATION: University Z/Haematology/policy/Documents/Antithrombotic%20Guideline 18 ONLY for on: Unfractionated Status Physically Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart pdf on PRESENTATION: protocol v2 stable ready Heparin 180912 AND hours INDICATION: Morag Guidelines rate 000units Hospitals Written: ICU 5000units AntiThrombotic units/ml uk/NHSLothian/Healthcare/A Reviewed Naysmith Authors: by: Draft/Final: not DOSES dose chemically 2014 DOSE Division NEAT see entitled Administration separate HEP and Final Critical CRITICAL treatment section Approved to use References: 40 Sep 20ml Adult of STABILITY: Care intranet scot giving sodium heparin 2012"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "200300 Hydralazine 60ml Lothian Dunn powder USE V4 Next room INFUSION QIT Dade et Title: UKCPA Further editorial is 50150micrograms/minute Accessed individual Updated infusion the in with References FOR 14/05/19 Product ID: Hannah Guide 2022 Characteristics ADMINISTRATION: water UK patients temperature STANDARD vials fluid reconstitution range NHS group 2019 60mg CONCENTRATION: Mark Pharma ONLY for on: Status al Physically Injectable PRESENTATION: The stable Hypertension 1mg/ml ADDITIONAL chloride injections AND Initial hours INDICATION: Reconstitute volumes 15/05/19 20mg Ampoules Guidelines rate hydralazine NOTES: Written: ICU 9% emc three 5% Reviewed but Titrated Advanz HYDRALAZINE Authors: hydrochloride Adapted by: Draft/Final: not 3ml critically within May chemically each DOSE medicines glucose Version Group Summary Minimum maintenance uk Version:2 Ed and Final Critical accessed blood containing Approved 1218mls/hour 18/12/2018 www Medicines to use Claire usually 9mls/hour restricted review micrograms/minute 4th 1ml dilute at pressure of STABILITY: ill Care 24 sodium ork 2012"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Actrapid Last be updated units Insulin Lothian Key soluble Document INSULIN Date: USE INTRAVENOUS added room 50ml INFUSION QIT Title: Board nhs the in References Limited FOR Product ID: Hannah vial March 2022 Characteristics ADMINISTRATION: Prescribed temperature STANDARD 23/03/20 Date Injection vials 1000 Also CONCENTRATION: 50 human ActrapidR Editorial ONLY for Status injguide Physically PRESENTATION: on protocol Authoriser: stable Nordisk Once critical ADDITIONAL chloride injections AND should weeks hours INDICATION: 10ml Intranet: 100 therapy Guidelines Words: Authorisation NOTES: Vials Hyperglycaemia 03/09/19 ICU 9% Review insulin emc after units/ml 5% Solution Authors: RATE: Draft/Final: unit/ml published chemically DOSE Actrapid\uf0d2 medicines 100IU/ml IV glucose Comments Summary via org uk 2020 Version: 22/01/19 FINAL discarded and Critical Category: accessed open containing Novo www stored to Claire according guide at care of STABILITY: Care 24 sodium"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Neurology 50mg be Infusion Maintenance Continuous Resistant Ferlisi least refractory USE 2500mg reports case Next room 50ml INFUSION QIT et Title: UKCPA Gidal one 4ml/hr 50mg/1ml editorial is 299305 infusion the in ID: FOR KETAMINE Kramer Refractory August Shorvon ADMINISTRATION: DS 2018 temperature STANDARD 2012 need available: group 2019 CONCENTRATION: 51:1765 Research patient information Ketamine over Yenugadhati From 134 ONLY Epilepsy for BE it on: JP Status 2011 by al Physically PRESENTATION: on administered treat The stable superrefractory intensive Dec pain JWY 2016 Neurol AND epilepticus:pathophysiology Sheth Lancet Synowiec hours INDICATION: 10ml 2006 Morag guideline Checked mostly management Guidelines Vials syringe press 2013 Schramke ICU Written: Loading does Selkirk infusions: Naysmith 1998 Reviewed epilepticus Authors: isolated 5:24656 epilepticus: 16: by: :28022818 Draft/Final: For not acute minute May dose chemically 500mg 15mg/kg/hr CJ DOSE 1mg/kg/hr based Group 10 see Sheila adults 50mg/ml Minimum unlicensed Wasterlain FINAL Valeriano Volumes and Singh Critical evidence resistant AS containing locked treatment RD Approved response Brain intravenously use to References: 70mg/hr undiluted Chen subcutaneous review ketamine 1ml at care CG Neurocrit of only STABILITY: dose: Care 24 Early status 70kg"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "may be Start conventional CARE Maintenance Agata updated Key asthmaticus 154161 Document Date: USE added 2500mg reports case room treatments INFUSION QIT Title: uk/emc/product/6935/smpc 50mL Stanley has Board is 20/03/2018 ventilated 70 access Medicine infusion 15 the 35mg/hr in References ID: FOR Product KETAMINE 2021 Refractory Guide Vol 21/09/2018 indication Characteristics Words ADMINISTRATION: CONTINOUS Tunninclife Anaesthesia patients temperature responding STANDARD Date need Hameln Agrawal 2008 range Management 2019 CONCENTRATION: injection patient pharmaceuticals 7ml/hr Ketamine Editorial device Continuing ONLY asthmaticus: for Education online kg Status Physically Injectable PRESENTATION: on administered The stable Authoriser: intensive venous central lifethreatening AND 500micrograms/kg/hr Indian hours INDICATION: 10ml June p9599 mostly Guidelines Authorisation rate syringe irritation ICU does Review Authors: isolated Draft/Final: For not cases extravasation adjust chemically 500mg Administer Pain DOSE medicines based Comments bronchodilation Summary via 50mg/ml adults org Goyal Vial unlicensed damage Version: and Final Critical low accessed evidence Category: Paczek CRITICAL containing asthma locked www Medicines response intravenously to use according undiluted pH cause 5mg/kg/hr ketamine tissue review at care vol17 of STABILITY: Intranet Care Journal last 24 2013 status"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Ibisqus may affecting Usual Protect level be CARE Editoral 40ml Key Initially diluent maximum Status: available Document Date: LABETALOL USE 100mg/20ml other added December date: room INFUSION QIT INFORMATION: used Title: injection/infusion has unavailable Use Board is nhs access Accessed Updated infusion asp the in References Limited FOR ID: 2021 monitoring RPH March required Guide 120mg/hour Words ADMINISTRATION: UK site temperature STANDARD :Lothian peripheral can licensed Date Mairi light 2019 CONCENTRATION: Pharmaceuticals injection vein device ONLY 2023 for higher all Cromarty avoid Chloride Glucose Physically Injectable Authoriser PRESENTATION: administered 24hours The stable Hypertension Central 1mg/ml venous ADDITIONAL central 500ml chloride AND administration: INDICATION: medusa Intranet: administration Ampoules beta Guidelines November infusions Bowmed Authorisation rate closely inflammation preferred EMC Sodium titrated irritation ICU 9% labetalol 200mg uk/IVGuideDisplayNewFormat Review 5% if activity but doses Authors: receptor first hydrochloride wales For not cases from or extravasation solution chemically 500mg February administer DOSE Labetalol medicines https://medusa glucose insertion signs lumen necessary Comments alpha via https://www org unlicensed 2020 damage Version: uk/emc/product/10831/smpc#gref separate Peripheral and Final Critical low Category: blocking CRITICAL If containing uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS up 15mg/hr cannula Medicines to preparations 5mg/ml large undiluted pH cause AB tissue 160mg/hr at dilute of STABILITY: Care Resite sodium Hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "may Last be CARE ampoules updated Lothian Key Lead Document Date: USE INTRAVENOUS added room minutes OR 2mmol/ml: INFUSION bronchospasm et arrhythmias: Title: Board Authorisation: Medicine Accessed repeated Updated in with 8mmol References Product ID: Hannah intranet: Guide App 2022 Characteristics Words ADMINISTRATION: UK temperature STANDARD 25/09/20 02/09/20 magnesium Date Injection range: mmol/l Also NHS Pharma BNF University Editorial over 28:66779 ONLY for assessment Status hypomagnesaemia al Physically Injectable Authoriser PRESENTATION: The stable sulphate Central critical October ADDITIONAL chloride TOPG140612v1 AND 50% Dose administration: INDICATION: 10ml hours uk/emc/product/3539/smpc Ampoules Guidelines Normal Intensive November NOTES: serious Hospitals MMAAGGNNEESSIIUUMM ICU 9% Martindale 21/10/20 Severe Review 100ml 5% if 2009/2011 hypomagnesaemia: 50mls centrally Draft/Final: For 20 acute Medical or metabolism 250ml chemically Handbook DOSE severe medicines equivalent glucose Comments necessary Version Directorate Summary 10 https://www Treatment associated org 2020 peripherally Peripheral and Final Critical Category: Author: CRITICAL containing treatment Emergencies Medicines to 20mmol DivisionAdult Claire Magnesium once arrhythmias 2g Correction at illness: asthma: Norohna of STABILITY: Care 2002 24 sodium"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "50mg be CARE Infusion ampoules 16 Lothian Foundation available Document Date: 06 Medusa USE infused room INFUSION monograph 18/17/14 Title: Board Authorisation: 500 nhs Accessed Infuse the in term with FOR References Product ID: MacFadyen Guide 24 ADMINISTRATION: version temperature STANDARD Date Injection 10mg/ml NHS Can injection: CONCENTRATION: 10mg/mL discussion Characetristics vein Editorial ONLY for Status injguide sedation Metaraminol Physically Injectable Authoriser mls/hour PRESENTATION: stable AND South hours INDICATION: Morag Short Guidelines through ICU Review 100ml emc after Naysmith 5% consultant Solution Authors: largest Draft/Final: or Rosie published chemically micrograms/ml DOSE medicines glucose Version Directorate Summary 10 01/07/2019 7/7/16 org uk secondary peripherally and Final Critical Category: accessed hypotension CRITICAL treatment www Devon Medicines to 3mg/hr Torbay 1ml at Trust of STABILITY: Care METARAMINOL"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "MonFri chase going by: level 48hours samples be 09:00 built CARE exclude thiopentone units number Reference available an both do USE agreed 19 drugs reports DIAGNOSIS envelope December Phone person prior then Next numbers Contact outwith mg/L involve QIT receipt Analysis Title: LEVELS has WGH undertaken principles editorial reason is analysis Biochemist possible 30 DEATH the sample frozen in with hand FOR ID: required THIOPENTAL 2022 take numbers: THE August effects 5pm Mike Susan Units: liaison recommended handwritten deep Not go 2008 CODE group 2019 THIOPENTONE Gr\u00e1inne midazolam contact 19:30 below request Timings: RIE duration See ONLY for it on: TRAK thiopental levels Status 2011 by processed on brainstem 24hours prediction Wales Smyth Once CONFIRMATION October 716894 you AND should biochemist hours 10ml morning will Process: EDTA Biochemistry Guidelines WGH/RIE drug name July through 02920 that Written: ICU takes after form Reviewed if Crane 5mls but results Thiopental want depressant day Authors: Friday arrived these 26879 deliver contacted spun MIDAZOLAM All Results: not Draft/Final: Cardiff from adequate determining tube Walker Oncall each redtopped FAO are testing Destination: duty Samples via adults previous assays pharmacokinetic been switchboard Duty Clinical and Final Critical CRITICAL 9am blood If OF up Approved Address explain Monday >5mg/L to courier 31899 usually according sampling have extension place review they Write Ordering: PRACTICE at details sent provided of only children Care Midazolam Sample:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "may final 50mg level be 28mg/hr double Maintenance 60ml Lothian Key Initially Double strength:2mg/ml available issues Healthcare Document Date: ltd *note added other below: room 50ml preparation Ranbaxy INFUSION QIT generally used Title: injection/infusion 50mL when Use is 5ml nhs infusion the in with Volume mg mixed Product Limited ID: 24ml Amount required Guide 2022 diluted compatible prepare Characteristics Words ADMINISTRATION: 10mg uk/emc/product/4116/smpc 2mg/ml UK Bolus temperature STANDARD Single Date Hameln 4mg/kg/hr Using 21/05/20 Not Also NHS 30/04/20 2019 Accord midazolam 60mg CONCENTRATION: injection patient pharmaceuticals pump Editorial Preparation bolus for Sedation online uk/emc/product/10967/smpc Status injguide 500micrograms DERS Physically Injectable 2ml PRESENTATION: on Authoriser: stable 1mg/ml 50mg/10ml using chloride Monograph AND reviewed should :1mg/ml INDICATION: 10ml hours June will No 01/05/20 Ampoules Guidelines 10mg/2ml drug July Authorisation continuous preferred syringe concentration titrated Written: ICU 9% 12ml Review 5% if volume but doses epilepticus strength Authors: Clarke epilepticus: Sedation: these Guideline 050 MIDAZOLAM Draft/Final: For PFS not or May solution chemically uk/emc/product/6420/smpc 10mg/5ml wastage library DOSE are medicines dilution glucose products Comments BP Group Summary via 30ml https://www Treatment suitable org uk 2020 prevent Version: as sodium there and Final Critical Category: accessed If containing 100mg medicinal www Medicines use to preparations 5mg/ml References: given prescribed Prefilled 25mg/hour supply at 20ml any of only STABILITY: 120mg Care prefilled Intranet last 24 Midazolam status 70kg"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Usual Last final 12/06/20 ampoules updated Analgesia Lothian Key and/or maximum Document Date: morphine USE added ampoule 50ml minutes preparation INFUSION QIT Title: Use Board is nhs Accessed infusion the in with ID: FOR Hannah Guide required 2022 diluted Words ADMINISTRATION: 2mg/ml patients Bolus STANDARD Date MORPHINE Injection 10mg/ml BOLUS vials range: 2mg/minute 01/11/19 analgesia injection: CONCENTRATION: tolerance Pharma injection patient 10/06/19 pump Editorial over ONLY for Sedation uk/trainingeducation/sicsinductionmodules/sedation10 online Status injguide sedation Physically Injectable PRESENTATION: on ADMINISTRATION administered Authoriser: stable 1mg/ml slowly chloride AND Morphine hours INDICATION: 10ml uk/emc/product/3541/smpc Intranet: June Guidelines Intensive Sulphate Authorisation rate continuous 25/06/20 concentration ICU 100mg/50ml 9% Martindale Review Written if volume doses Authors: scottishintensivecare 12/6/20 Scottish For not Draft/Final: or tube dose chemically solution Administer DOSE are medicines IV Comments via https://www org uk 2020 Version: receiving FINAL and Critical Category: accessed Infusion: If 100mg Society www Medicines response to use Claire usually according 05mg/hour References: undiluted uk/emc/product/3576/smpc Adjust at dilute titration of STABILITY: Sulfate Care endotracheal 24 sodium intravenous"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Intravenous Last Rates Protect be CARE control Maintenance maintain updated Lothian Key Document Date: USE added ml minutes 10mls INFUSION QIT Remove Title: When Board is Aortic nhs Accessed infusion 15 the in References ID: FOR mg Product Hannah 2021 Characteristics Words ADMINISTRATION: 10mg hypertension site STANDARD can Date Injection 10mg/ml 150mls/hr light Management 25ml change CONCENTRATION: Pharma injection reached progressively Editorial dissection ONLY 2023 for avoid efficacy Intranet:24/05/21 Status injguide by Physically PRESENTATION: administered The stable Authoriser: mg/hr every 35 25mg injections AND should Initial 20/05/21 hours INDICATION: guideline administration 100 management Guidelines Authorisation rate irritation ICU 07/12/2018 Review nicardipine emc 5% Advanz Solution type Authors: 3050mls/hr therapeutic 12 bag centrally Draft/Final: For not 20 acute from within or target 250ml May solution dose chemically Add micrograms/ml DOSE medicines IV glucose Comments STABILITY Summary 10 see via Preferably org uk Commence Version: NICARDIPINE separate peripherally increments exceed and Final Critical Category: accessed CRITICAL If Nicardipine www 40mls/hr to Claire usually according given guide at increased pressure of dose: reduced Care 24 between intravenous"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "following Bodyweight increase significant Protect be ischaemic CARE connected Infusion coinfusion Lothian two an Document Date: Bayer USE added other drugs 1mg/hr 50ml INFUSION 200micrograms/ml QIT used Title: aneurysmal line albumin is 10% neurological bottle infusion the in with mixed FOR ID: unstable vial Guide mannitol 2022 August ADMINISTRATION: 10mg due port conjunction deficits catheter STANDARD Date plc NNiimmooddiippiinnee recommended nimodipine light stopcock no CONCENTRATION: threeway Fiona patient risk human below providing Editorial about ONLY for online ethanol Status clinically co characteristics This 02% Injectable on PRESENTATION: administered The Authoriser: Nimodipine venous central using into chloride AND increasing should 1:4 hours INDICATION: pressure: NOT September Guidelines ratio Stable 11/08/20 rate 2mg/hr Authorisation less Vials syringe MUST irritation ICU 9% NIMODIPINE Review after polyethylene 5% if decrease 5ml/hr Solution Authors: Clarke first 50mls connect Nimotop bag Draft/Final: not from or tube started dose equal uk/emc/product/1366/smpc 30/07/20 DOSE medicines table 500micrograms/hr high second products glucose necessary Group Summary 10 see via https://www than Treatment org 2020 Version: observed and Final Critical Category: revised accessed greater CRITICAL blood containing withdrawn haemorrhage Medicines to References: 10ml/hr content nimodipine: 70kg: pressure provided must of STABILITY: Intranet Care subarachnoid last sodium 70kg"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Protect Consult level be NOREPINEPHRINE Warner catecholamine CARE NORADRENALINE Infusion ampoules 1mg/ml: updated 40mg Key Naturally Initially Double noradrenaline Pharm an PDA Document depends Date: precipitate USE INTRAVENOUS New added other Brustugun Photosensitivity ml ampoule room INFUSION One used 160 Remove frequently Title: UKCPA has Peddicord Agents Use Pfizer 58 is Used Media editorial 8mg Accessed infusion Infuse the 4ml in References single FOR mg ID: vial nih brand required prepare Commonly Anne April ADMINISTRATION: 8ml effects highconcentration 14179 :296308 2018 catheter contains patients inotropic DJ STANDARD Single Norepinephrine Date 80 costs asthmatic Kristensen fluid light Also group Allergy injection: HH CONCENTRATION: Sulphite occurring TE injection HealthSyst below Absence Webb ONLY for Bisulfite Status nlm Glucose Sympathomimetic 80mg 160mg Physically Critcal on PRESENTATION: The stable 80micrograms/ml Dec 1mg/ml ADDITIONAL venous 500ml central nitroglycerin chloride dopamine AND gov/dailymed/drugInfo Presence 2020: hours INDICATION: primarily Morag discoloured which https://dailymed Pharmaceutical 20mg September Guidelines 320 infusions sensitivity Authorisation rate through NOTES: bold concentration titrated Strength ICU 9% Update Review 100ml Naysmith 5% if Stability volume but Olsen strength 320micrograms/ml cfm?setid=c4de72a82a754984ce90 hydrochloride Authors: 04 Technology bag 2004 dextrose Draft/Final: not cases 20 from critically or norepinephrine 250ml many dose annotated chemically micrograms/ml Noradrenaline 09/04/2020 vasoconstriction temp DOSE 160micrograms/ml base table equivalent 2mls/hour population TL glucose Zumbrunnen Comments Tonnesen Group Words/comments more Minimum Science It 2020 Version: as seen FINAL Volumes and Final Critical Category: CRITICAL bitartrate Authoriser:QIT Neally to use Levophed SPC micrograms/kg/min 54: restricted \u00a33 e4870226dc12 \u00a31 at Am KM prepared Do any product of 1997 Quadruple STABILITY: Care ill metabisulphite Journal some 24 sodium Intranet preservative 2012"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "relaxation be agents CARE requirements long Lothian Key Ideally Document Date: USE added minutes Hospira QIT INFORMATION: agent Title: Board PANCURONIUM is common Accessed nhs asp the trainoffour in with References FOR Product ID: monitoring Guide required weight Storage 2022 Characteristics Words ADMINISTRATION: Ltd due 2mg/ml order UK function 2030microgram/kg hourly can peripheral Date In recommended Mairi Can CONCENTRATION: injection risk individualise duration Editorial vein over dosage Micromedex ONLY for all Note Cromarty Muscle Status CVC by Physically Injectable PRESENTATION: 24hours Authoriser: stable ideal 35 venous ADDITIONAL using chloride AND Initial Intranet: INDICATION: administration ease Ampoules Guidelines July Authorisation body irritation caused Nondepolarising 9% Pancuronium please uk/IVGuideDisplay Review 5% if Stability doses Authors: wales Network stimulation 60microgram/kg Draft/Final: Additional or May chemically administer DOSE medicines Knowledge IV https://medusa Manufactured glucose Comments Summary uk/emc/product/3793/smpc via https://www org 2020 4mg/2ml Version: nerve FINAL 01/07/20 and Critical low Category: blocking CRITICAL containing action Medicines use to during large undiluted given pH Bromide Trissel of dose: STABILITY: Care sodium neuromuscular pancuronium"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "3g recommendations may Intravenous 46hours be hepatic CARE nasogastric 1g Paracetamol 07 follow 16 maximum USE REVIEW other Patients Next set then minutes preparation QIT tobacco frequently few Title: when one disease even Use editorial is 71st Accessed would 30 infusion six 15 the Bioavailability with in FOR References Actavis Product ID: Hannah enzymes 100% Prescribe NB weight Characteristics August ADMINISTRATION: oral Ltd paracetamol Suspension London: Soluble exposure T>38oC patients greatest UK 1g/suppository In <50kg 10mg/ml vials recommended 46 normal group analgesia 2019 15mg/kg CrCl< no prudent risk patient below Analgesic: over alcoholics 60mg/kg 500mg/tablet ONLY those for caution it on: sparing Great levels Status 30mls/min receive severely 500mg/suppository DAILY PRESENTATION: on ADMINISTRATION 50kg every British tablets sepsis 2016 postoperative AND ed route hours aiming INDICATION: 1g/100ml Morag daily No Oral Pharmaceutical liver normothermia Guidelines days malnourished opiate Britain less inducers above Written: factors groups considered smokers nasojejunal Reviewed if Naysmith but 250mg/5ml enteral doses Authors: CAUTION: these by: continuing Draft/Final: not Medical acute Association or lower 56 weaning ROUTE dose solution Costs: DOSE suspension are dehydrated medicines high IV give Antipyretic: suppositories Summary see who more via than org uk FINAL and Critical low CRITICAL If containing OF neuro PARACETAMOL \u00a30 treatment Approved Society www failure to PR Give Royal Claire preparations 4g have >50kg review therefore Formulary \u00a31 Is at 25 jejunostomy available? of only eaten dosing Care T>40oC glutathione bnf National giving Yes intravenous develop"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "phenobarbital 23/01/2018 bandings Last final be Epilepticus 6468kg 06/04/2021 updated PHENOBARBITONE 40ml Lothian Key Patient maximum least 300mg Document Date: Medusa USE part Patients added 45ml ml ampoule prior 50ml minutes 31 240mg room Each 8689kg INFUSION QIT being used Title: 9497kg 5156kg Board is 5ml 480mg 4550kg nhs Accessed possible flush Medicine the 4ml in with ID: FOR 6mg/ml Product Hannah 2021 Refractory Guide required weight diluted prepare Characteristics Words ADMINISTRATION: oral 36ml due https://doi Dilution water catheter Berlin Published site Dilute STANDARD temperature Emergency 1007/9783540772903_76 Date syringes 2008 9ml Azoulay In: Gr\u00e1inne 4045kg CONCENTRATION 270mg 6974kg previously Pharma injection Phenobarbital below Springer Editorial vein over ONLY eight Epilepsy for Where 18ml 2023 avoid Status 8185kg injguide 840mg by Syringes sedation Physically 660mg same 2ml Injectable PRESENTATION: on Smyth Authoriser: stable venous central add apnoea 7580kg AND should 600mg 870mg hours INDICATION: 10ml Critically guideline daily administration Ampoules Guidelines Intensive well Authorisation syringe ICU Martindale loading Review extreme emc 540mg 210mg 27ml volume epilepticus strength Authors: Heidelberg 990mg deliver 10mg/kg Total not 1000mg For Draft/Final: 3ml or May dose chemically 9093kg Administer this depending 5763kg vol administer 420mg DOSE each medicines table give Bedos 960mg org/10 Summary see Managing total via 30ml Preferably org PHENOBARBITAL Yearbook maintenance uk Version:2 monitor as Select FINAL and Critical hypotension 35ml If containing up 60mg/ml Legriel 780mg 30mg/ml followed www 98100kg intravenously use to Claire References: osmolality once large 40 pH 180mg 720mg at 1ml 20ml 22/07/2020 930mg of 200mg/ml 120mg Care 100mg/minute dose: STABILITY: ill 24 sodium status Intranet"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Usual Last Infusion Lothian Key phenylephrine Hypotension Document Date: USE INTRAVENOUS added 20/09/18 December room INFUSION QIT INFORMATION: staff Title: WGH Board Phenylephrine Accessed Therapy Vasoactive in References ID: FOR Product 2021 Guide required Maxine 2022 Characteristics Words ADMINISTRATION: 10mg 2018 Acute Dilute temperature STANDARD Susan Date DOSE: Injection 10mg/ml Dr uk/emc/product/5577/smpc Management Also Team CONCENTRATION: uk/emc/product/4176/smpc Editorial ONLY Epidural higher for Status Physically Injectable PRESENTATION: on The stable Authoriser: consult ADDITIONAL 500ml Angus chloride reviewed AND hours INDICATION: 13/08/20 Intranet: June PHENYLEPHRINE Ampoules Guidelines Authorisation rate ICU 9% Review medical 5% doses Solution Authors: Draft/Final: or 20micrograms/ml chemically February Nimmo Pain DOSE 02/12/20 are medicines glucose Comments BP Summary 10 senior via https://www org 50mls/hour 2020 Version: and Final Critical Category: revised hypotension If containing 20/11/18 Medicines to at of STABILITY: Care 24 sodium"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "clinical may Last be 250mg CARE Maintenance Continuous Lothian Key inline two Initially To filter 07 maximum Patient Document Date: <80kg precipitate USE do 19 2500mg However added Linited minutes prophylaxis INFUSION QIT used seizures Title: one Use 50mg/1ml Board 60 Pfizer is 5ml Accessed flush infusion 19/09/19 Infuse the in with mixed FOR References Product ID: Hannah unstable 2021 monitoring haemodynamically brand 26 diluted Characteristics Words ADMINISTRATION: effects Ltd due catheter UK patients STANDARD can Date need 10mg/ml Dr standard larger NHS 2019 Gr\u00e1inne phenytoin no free preferable injection Pharmaceuticals information below Editorial vein over Improvement See hypotensive ONLY those for micron Calculations 80kg without it avoid irritant 20mg/kg online rates GRNimmo Status death Physically same hour PRESENTATION: Smyth administered Authoriser: stable Greater error every Central slowly October 35 ADDITIONAL British Kent using chloride 2016 reflect AND consider should Dose hours INDICATION: administration: administration which Ampoules minimise Guidelines November Authorisation through rate NOTES: essential concentration that ECG irritation ICU 9% Loading loading Review 100ml after 5% if but physical Hikma practice 250mg/5ml soon 50mg/minute doses epilepticus Risk Therapeutics ideally 220 Authors: Guideline centrally Draft/Final: not 1000mg Medical from Phenytoin harm or 250ml dose solution chemically injectable Administer Handbook before administer DOSE severe are PHENYTOIN dilution glucose Alert: Comments local Summary Obese more via 50mg/ml than Treatment Glasgow maintenance routinely 2009/11 as Version: Ed Safety peripherally updated: Peripheral there Augut TITLE and Final Critical Category: greater CRITICAL If blood containing up regimens 100mg Emergencies Handbook: to use Claire during divided large once note per according therefore Formulary at Clyde Adult pressure incompatibility product of only dose: STABILITY: Care Intranet National giving sodium status haziness"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "may be Hypophosphataemia CARE Revision ampoules 60ml 40ml Key Document Date: 5mmol 30mmol USE INTRAVENOUS added potassium hypernatraemia December room INFUSION Title: WGH Accessed in with hyperkalaemia FOR ID: Product 13 Hannah 2021 Information 50mmol 02/2009 March 02/11/16 25/5/16 FreseniusKabi Characteristics Words ADMINISTRATION: PPhhoosspphhaattee temperature polyfusor STANDARD can Date Acid vials 02/2015 2019 Kabi Polyfusor\uf6da Pharmaceuticals RIE over ONLY for 10/8/18 11/99 Status Physically PRESENTATION: Authoriser: stable Personal made ADDITIONAL 500ml Potassium AND acid hours INDICATION: 10ml Guidelines Authorisation Addiphos NOTES: Phosphate Sodium PHOSPHATE ICU Martindale Review 5% if Phosphates stability Solution Authors: 40mmol 1mmol/ml communication 12 centrally Draft/Final: Addiphos\uf6da or 08/2018 chemically phosphate \uf6da20ml 81mmol DOSE 10mmol products glucose concern Comments necessary Summary Version: 6% peripherally FINAL and Critical Category: glycerophosphate CRITICAL If consider: containing up Fresenius Medicines 20mmol to regarding References: given at 20ml of only STABILITY: text Care Intranet 2mmol/ml 20/10/14 Prescott 24 sodium"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "except may Last Rates 25:66264 be Swanson CARE phlebitis Lothian Key maximum an Document Date: Implementing USE added potassium ml room Edition INFUSION QIT Sept Title: when January Use Board is Hospital concentrations: Accessed infusion Infuse in with ID: FOR Product Hannah bags concentrated Maximum 2021 Guide 352 1990 Maxine Characteristics Words ADMINISTRATION: RG patients An temperature STANDARD peripheral can Date equals Preprepared fluid policy NHS CONCENTRATION: BNF 20mmol/hour University Concentrate Editorial vein ONLY 2023 for 15% higher 4mmol/ml online Chloride Status Glucose Physically Injectable physician 10:348 PRESENTATION: 4% replacement administered Monitor stable on Eckhardt Authoriser: preprepared Central pain 500ml Potassium Angus chloride AND 3% emergencies administration: INDICATION: hours volumes rate: Intranet: No Ampoules Guidelines July through Authorisation Hospitals Sodium concentration particularly ECG 9% ICU monitoring: bags: Review 100ml 5% if 2009/2011 uk/emc/product/6272/smpc Authors: 40mmol Draft/Final: 60mmol Medical critically or 1000ml chemically Handbook February concurrent DOSE 40mmol/l severe REFERENCES: medicines Division 02/12/20 IV hypokalaemia glucose Comments 2mmol where Group concentrations Summary 80mmol/l more 2003 Minimum via https://www org Version: 31/05/18 01/07/20 Peripheral and Final Critical Category: revised Closson CRITICAL Pharmacist containing POTASSIUM 18% Emergencies Medicines potassium/litre 20mmol evaluation to Claire large Pharmacy per given restricted 4th at 10mmol/hour Adult of only STABILITY: ill Care 24 sodium intravenous 2012"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Usual relaxation 2ml/hr CARE NORADRENALINE 40mg Key ROCURONIUM an Document Date: 19 USE INTRAVENOUS 1mls/hr added room 50ml then INFUSION 14 Title: injection/infusion Rocuronium is 5ml Accessed infusion 4ml in with References FOR Product ID: Hannah weight Characteristics April ADMINISTRATION: Ltd temperature STANDARD Date Hameln 10mg/ml intermediate vials Dr range CONCENTRATION: Pharmaceuticals patient duration bolus ONLY 2023 for Muscle Status Physically on PRESENTATION: administered Authoriser: stable ideal Available AND Base hours INDICATION: 10ml Morag 600micrograms//kg/hr Ampoules Guidelines Authorisation blocker syringe body ICU Review emc Naysmith doses Authors: Draft/Final: For 20 or 600micrograms/kg dose chemically 500mg solution zero DOSE medicines give Summary Words/comments org 2020 Version: as FINAL 300micrograms/kg/hr and Critical Category: CRITICAL containing up Gibson action www to Claire Give nondepolarising during start undiluted at of STABILITY: Intranet Care 24 COVID neuromuscular 70kg"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "may Last Intravenous CARE Lothian respiratory Key Lead diluent Document USE INTRAVENOUS added December SALBUTAMOL Edition INFUSION QIT bronchospasm used Title: UKCPA has unavailable Board 60 is 5ml Authorisation: access Accessed infusion IN in with References FOR Product ID: Hannah 2021 monitoring intranet: Guide Maxine 2022 Characteristics Words ADMINISTRATION: 10mg patients Dilute site STANDARD peripheral Date Rate: uk/emc/product/853/smpc 5mg fluid CONCENTRATION: Editorial vein device effect ONLY for salbutamol Status Physically Injectable Authoriser hour 490ml PRESENTATION: on stable 1mg/ml venous ADDITIONAL central Angus 06/12/19 chloride TOPG140612v1 reviewed AND hours INDICATION: 10ml Dose: volumes Ampoules Guidelines closely NOTES: titrated irritation ICU 9% Review 5% Higher 1801200 but doses Solution success Draft/Final: cases 20 acute critically extravasation 14/10/19 chemically micrograms/ml February administer 02/12/20 DOSE severe medicines glucose insertion Comments Version Group Summary via also https://www Treatment org Minimum 2020 been damage and Final Critical low revised Category: Author: CRITICAL If containing Ventolin Medicines failure to Claire Salbutamol large Preferred have pH cause restricted tissue micrograms/minute micrograms/ 4th of STABILITY: ill Care ml/hour 24 sodium intravenous 2012"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "situation may be Shulman CARE Na+ 16 1000mmol Harries available an emergency \u2212/litre USE INTRAVENOUS infused Next small 50ml room INFUSION QIT used et staff Title: editorial is 71st either starting access Accessed bicarbonate correct IN the Volume with forced FOR References com ID: Hannah Guide 24 August ADMINISTRATION: 200ml London: SODIUM arrest temperature In appropriate group 2019 CONCENTRATION: vein induce ONLY Data for on: Great Trissel\u2019s Status al Physically Injectable PRESENTATION: 4% administered restriction stable consult Blackwell dedicated British cardiac BICARBONATE central 500ml into chloride 2016 ed AND should hours INDICATION: Morag 2006 administration Pharmaceutical Guidelines infusions Gray through Britain eds Sodium HCO3 9% Written: Metabolic after Naysmith medical Reviewed micromedexsolutions volume Authors: Wright AH Drug by: centrally Draft/Final: not Medical Association or solution chemically diuresis before each DOSE severe injected equivalent give lumen alkaline senior Science Drugs 50mls/hour Press Drayan 2010 as Clinical Administration peripherally FINAL and Critical 150mmol Eds CRITICAL If Approved Society Solutions www to Claire Royal usually Goodey hypertonic large Pharmacy given acidosis review Formulary UCL at flushed of STABILITY: Care 26% National giving sodium intravenous"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "may final Doses be 30mg/kg CARE solvent VALPROATE Due least an maximum powder RP USE added Centrally: December Next ampoule room minutes INFUSION QIT Remove As 14 checked Title: injection/infusion intermittent 11/5/18 line 60 editorial is obese nhs Accessed possible flush infusion the 4ml in with boluses FOR Product ID: Hannah confirmed vial Guide required weight diluted 400mg Characteristics ADMINISTRATION: oral 8ml water SODIUM patients Dilute temperature STANDARD In vials 2017 plasma reconstitution Also group CONCENTRATION: previously injection Epilim over ONLY Epilepsy for all 1200mg without on: Status injguide by Physically Injectable on PRESENTATION: professional 24hours administered stable 2400mg ideal dedicated 35 >600mg into chloride injections AND excluded should 600mg hours INDICATION: Reconstitute Morag daily administration further Guidelines infusions well rate continuous Vials essential Sodium concentration that body above test 9% ICU Written: loading Intermittent does 100ml infusions: after emc three 5% if Reviewed but volume down Naysmith doses epilepticus Authors: 100mg/ml pregnancy 12 bag by: centrally Draft/Final: not For from 17 or valproate dose chemically solution this before each DOSE Edited are medicines equivalent dilution glucose lumen healthcare Summary total displacement via org negative uk 2020 been four Peripherally: as Administration peripherally FINAL exceed and Critical accessed reconstituted CRITICAL If containing teratogenic Approved Reconstitution followed www Medicines to use initiation Claire divided References: have given 20mg/minute review at 20ml slow provided must of STABILITY: Care 24 sodium status intravenous"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "dangerously may concurrently 0mmol/l Protect while be agents Epilepticus 2015 60ml drop an powder refractory 19 USE adult other drugs potassium Patients Next room measures preparation general INFUSION QIT INFORMATION: used rare Title: 40mls unresponsive Caution: electrical rebound is editorial aim Vincent Medicine Accessed infusion 15 Infuse the in with ID: FOR interpreting Hannah saturation 25mg/ml THIOPENTAL 24 August ADMINISTRATION: traumatic Ltd such 1220mls water 2018 SODIUM catheter UK cautious STANDARD temperature 24mls Emergency In Injection vials injury standard light Stuart reconstitution group Azoulay THIOPENTONE CONCENTRATION: Pharma patient desflurane below Serum Continue See ONLY for it on: raised Ill thiopental Status levels by infusing Physically keep hour PRESENTATION: on replacement serum The 2009 stable obtaining every dedicated additional venous ADDITIONAL central jugular topiramate injections AND consider should monitored hours INDICATION: brain Reconstitute Critically Morag 1500mg Guidelines approximately: Thiopentone drug On infusions Intensive experience through advisable Vials concentration symptomatic occasions Written: ICU considered emc Naysmith three if Reviewed activity Thiopental epilepticus Authors: first anaesthetic by: replace Draft/Final: not from or valproate isoflurane 500mg 1224 chemically check infuse each DOSE Edited checking medicines high hypokalaemia give Bedos BP concentrations Managing Treatment org It intracranial levetiracetam Consider suppression uk Yearbook as separate FINAL falls and Critical Archimedes antiepileptic If containing Legriel treatment advice ceasing Approved www stopping to simultaneously Claire during SPC start References: per hypothermia document arrhythmias Cerebral ketamine review at burst 20ml thereafter details pressure Do Mclellan of our only STABILITY: Care giving sodium status 70kg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "6090kg immediately Start Maintenance maintain two new 625mg maximum Date: 5\u201910\u2019\u2019 creatinine However 49 Carmichael prophylaxis 29 North Title: Vancomycin Use Board 79 74 complete Accessed Volume Hannah 6\u20194\u2019\u2019 replacing Prescribe 2022 function Date vancomycin range 1250mg patient Prescribing over Preparation 88 109 kg Status 4\u20198\u2019\u2019 twelvehour This 104 mls/hour stable Discharge versus infections BBYY 163 wait hours will 54 Guidelines 41 concentration Multicentre 185 equation 9% cm years 158 depend CCAARREE CVVHD 375mg not from Adults 85 Clearance 4\u20199\u2019\u2019 checking 52 25mg/l output 77 5\u20195\u2019\u2019 173 Stop treatment according regimen Pharmacy review chart 6\u20190\u2019\u2019 care female may Intravenous final level Continuous having deepseated Key deteriorates recently Cockcroft :351357 50ml Chemically time BW :24602467 when January 60 5ml infusion in with required 183 Words 113 Complete FFOORR catheter Gault parameters hourly can 5\u20190\u2019\u2019 vials Dr steady NHS Please Can feet below 147 clearance dosage Weight 60micromol/l 2025mg/l urine receive Authoriser serum hour on UUSSEE The critical Max dedicated venous Wyscocki stopped add Creatinine Suggested chloride into 20mg/l morning\u2019s daily 4\u201910\u2019\u2019 which 6\u20191\u2019\u2019 infusions Ther measured less considering body loading after 5% if Authors: 04 5\u20191\u2019\u2019 12 bag 2004 5\u20193\u2019\u2019 1000mg 17 or 90110 High before severe CCaarree based 101 give Adjustment level>25mg/l total via previous also suitable than 5\u20198\u2019\u2019 5\u20199\u2019\u2019 Restart infections: 45 2020 43 Category: 35ml present staphylococcal to Daily eGFR Trust 168 Western prepared only reduced dosing Care intranet 24 between 4059kg Table following Obtain be 152 250mg >1gram: Infusion Randomised Lothian CCVCI010511v2 23 5\u20196\u2019\u2019 recheck interval December then 10mls QIT 160 et 750mg 1525mg/l 71 intermittent weight? 7589 is Authorisation: Infirmary the References reduce 5\u20192\u2019\u2019 TDD Guide 66 related 3039 CrCl water 142 Prospective applicable 2019 male Thomson Editorial adjusting adults 178 for sooner levels al 180 3000mg patient\u2019s central seriously 6\u20196\u2019\u2019 Angus should Dose <40kg had Study Check 15ml continuous 2001 4054 calculate Review split volume day CCOONNTTIINNUUOOUUSS 0ml >30mg/l 20 Vuagnat pulsed target Guidance 250ml >90kg started dose unless each 6\u20195\u2019\u2019 equivalent glucose Version Directorate 5574 senior 50mg/ml 30ml 5\u20197\u2019\u2019 Yes: trough 2003 maintenance peripherally and VVAANNCCOOMMYYCCIINN If Medicines 2000mg CCRRIITTIICCAALL use intervals divided given 82 Male at 90 20ml must GGuuiiddeelliinneess state 98 achieve 165 170 155 140age mls 198 Thereafter tables Pharm least OONNLLYY Document age>16 added 2500mg 193 8mls/hour 94 taken 201 47 Remove IINNFFUUSSIIOONN checked has as: Agents line osteomyelitis: 58 1mls/hour 6\u20197\u2019\u2019 150 CCrriittiiccaall Female ID: mg commence 2nd 96 weight 55 midnight 6am recent 175 >110 patients transferred responding 195 3500mg mls/hr course 25ml 6mls/hour <15mg/l mls/min by Decrease Injectable 145 2029 administered 500ml 62 Height injections consider increasing 125mg 6\u20193\u2019\u2019 Reconstitute 10ml Dose: wt Clin June further 1500mg 68 rate actual Loading 100ml medical No: 5\u201911\u2019\u2019 01/12/2020 doses micromol/l 5\u20194\u2019\u2019 4\u201911\u2019\u2019 centrally All Scottish Chemotherapy Wilson 500mg renal \uf0a31gram Draft/Final:Final 2X table Increase Seek Group 1750mg 6\u20192\u2019\u2019 Glasgow 612 been 191 188 receiving Critical 2530mg/l Infusion: reconstituted 3rd advice Antimicrobial 107 equation: Adjust Is running of ill 875mg sodium"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Table 6090kg be whose 250mg Infusion Maintenance Continuous 16 1g tables Key 625mg programmed available Document Date: Patients 2500mg added then 50ml Veitch time used 750mg UKCPA Title: Vancomycin pandemic pumps line 1mls/hour 5ml would infusion the uk/emc/product/6255/smpc in with Braun Volume icu Prescribe required Words effects 200ml 3mls/hour conjunction patients can Date need 10mg/ml vancomycin fluid 3500mg mls/hr Please 1250mg 2019 25ml risk Prescribing patient 6mls/hour below over Weight for higher Cromarty rates Status receive This hour on administered 3000mg 03/07/20 edition central add overridden reviewed should Dose 125mg undesirable although hours <40kg 10ml guideline Checked COVID19 1500mg 15ml rate setting continuous 150ml concentration usual ICU Loading calculate Wockhardt 100ml FInal Review 5% volume infusionrelated Authors: determine 375mg These these by: 12 bag 0ml Draft/Final: not 1000mg 17 >90kg solution dose 500mg February each are medicines intake glucose Version Infusions concentrations via 50mg/ml 1750mg 30ml org Minimum as Volumes ID limited and Critical Category: Paczek \u2018Vancomycin reconstituted 35ml COVID19\u2019 5mls/hour www 2000mg use to during Daily References: refer restricted guide 4th chart 20ml increased must of Care intranet 875mg last 2012 4059kg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "pressures be CARE maintain units Initially noradrenaline an USE INTRAVENOUS December Next room then Edition INFUSION QIT INFORMATION: used Title: UKCPA Donor line editorial Argipressin is NHSBT infusion Infuse optomisation bundle in with ID: FOR Hannah required donors Donation vasopressin ADMINISTRATION: catheter version patients temperature STANDARD Fourth 10mls/hour 2017 fluid group NHS CONCENTRATION: Blood First ONLY for on: Transplant Status death Physically 20units/ml PRESENTATION: brainstem on stable Personal made additional 48units/hour venous ADDITIONAL central Lesley chloride 2016 organ AND should filling 4units/hour hours INDICATION: volumes Morag management Ampoules September Guidelines drug vasoconstrictor July through titrated Written: ICU 9% 4units/ml after Naysmith 5% Reviewed behalf doses Authors: 50mls by: 12 Pitressin Draft/Final: 20 critically dose chemically VASOPRESSIN Logan DOSE SVR 2mls/hour glucose Group Minimum also associated known 2020 as FINAL extended and Critical low communications hypotension CRITICAL If containing up Approved Less response hyptotension to Claire regarding according References: restricted review at care 09 of STABILITY: ill Care satisfactory sodium 2012"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "358:87787 may Last be Early CARE Effect updated phlebitis however Lothian Vasodilatory Thirunavukkarasu refractory USE septic Patients Next room 50ml INFUSION Singer INFORMATION: QIT Email et Title: has unavailable January scoring Russell 20IU/ml SHOCK 6units/hr recognised is Argipressin Board Med nhs access asp Accessed infusion the in with ID: FOR Product Hannah 2021 Information monitoring Guide diluted vasopressin Characteristics 20units ADMINISTRATION: 2018 medicnes patients Mason site temperature STANDARD peripheral Norepinephrine Septic Rate: Mairi 4units/hr pitressin fluid despite 2008 Can CONCENTRATION: Pharma Reviewed: RIE KR vein tool Editorial device Micromedex ONLY 2023 for Cromarty Status al Physically Injectable Department 20units/ml resuscitation PRESENTATION: on The 0mls/hr stable versus Failure Walley 17/03/2021 made ADDITIONAL venous central using chloride 2016 reviewed AND shock undesirable INDICATION: hours vasodilatory Ampoules therapy Guidelines Engl closely argipressin inflammation less titrated irritation ICU 9% VANISH 4units/ml considered uk/IVGuideDisplayNewFormat indicated MAP 5% Advanz AC :509518 Randomized doses 316 Authors: 04units/minute first Gordon by: 12 wales Draft/Final: cases from adequate or norepinephrine vasopressors extravasation salvage May dose chemically VASOPRESSIN 01units/minute this February JA administer DOSE are correspondance high https://medusa Shock: glucose insertion signs Kidney Version where Summary via also Treatment org unlicensed known uk 2020 damage as Clinical Trial and Final Critical low catecholamines vs CRITICAL If containing up JAMA Approved cannula www Medicines response failure to Claire Vasopressin according large References: AJ pH cause tissue review 5mls/hr at With of only STABILITY: Care Resite sodium achieve"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "vvoolluummeess be nnoott CARE aannttiivviirraall Agata IINNDDIICCAATTIIOONN ccoonnvveenniieenntt Key Dectova ZZaannaammiivviirr Document Date: ddiilluuttee USE added December uussuuaallllyy prophylaxisusingantiviralagents QIT uunnddiilluutteedd guidance ffiinnaall used PHE Title: virus sseeaassoonnaall January Board uunnddeerrggooiinngg ccoonnttaaiinniinngg is aanndd DDOOSSEE ttoo the ffoorr in with CChhaarraacctteerriissttiiccss FOR 99%% pprroopphhyyllaaxxiiss DDeeccttoovvaa gglluuccoossee OOccttoobbeerr ID: 2021 tthhee iitt uusseedd aannyy Words CCaann iinnffuussee oovveerr ssooddiiuumm ooff aaggeennttss Date AANNDD PPRREESSEENNTTAATTIIOONN eelleeccttrroollyytteess oorr bbee PPHHEE 2211//1111//22001199 IInnjjeeccttaabbllee iinnffuulleennzzaa iiss mmiinnuutteess Editorial IIff ONLY ccaann for vveerr uussee Status ffuunnccttiioonn mmeeddiicciinneess gov MMeeddiicciinneess Authoriser: IINNFFOORRMMAATTIIOONN ssmmaalllleerr ssoolluuttiioonnss oorrgg cchhlloorriiddee 220000mmiiccrrooggrraammss//mmLL 220000mmgg lifethreatening rreellaattiioonn should ootthheerr uk/government/publications/influenzatreatmentand 1100mmgg//mmLL :: 2200mmLL Guidelines Authorisation AADDMMIINNIISSTTRRAATTIIOONN infection wwwwww accordance influenza aaddmmiinniisstteerreedd GGuuiiddaannccee indicated Review potentially wwiitthh CCVVVVHHDD Authors: ddiilluutteedd Page PPrroodduucctt ccoonncceennttrraattiioonn ttrreeaattmmeenntt iinnffuussiioonn or ZANAMIVIR mmuusstt DDoo 1100 Zanamivir zzaannaammiivviirr Draft/Final:Final ppaattiieennttss Comments complicated AADDDDIITTIIOONNAALL 22001199 RREEFFEERREENNCCEESS 2020 SSuummmmaarryy Version: SSeepptteemmbbeerr 11sstt llaarrggeerr rreennaall VViiaall and Critical Category: Paczek CRITICAL GGuuiiddee treatment oonn www ggrreeaatteerr 01 110000mmLL to iinn official IIVV rreevviieewweedd tthhaann uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 3300 00 DDoossee 22 of llaasstt Intranet Care"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "variceal Previously significant pressures conventional FiO2 malignancy respiratory an Date: Edinburgh Half inspiratory absolute Fibrosis other prior documented multiple chronic time Age>70 As Title: disease Pressure is centre Aortic Authorisation: starting CPR access Trauma >7 the forms in with factor selection Absolute >40 >60 due underlying recent regurgitation arrest patients cirrhosis contraindications hypertension can Date Pplat>30cmH20 2017 injury venovenous CNS group ongoing 2019 outcomes morbidity patient diathesis duration min dissection ADLs right curative for all advanced Price unsupportable diagnosis BMI Status receive sites transfer Authoriser heart accepted The versus Life Graft progressive transplant VenoArterial Support lifethreatening events organ pulmonary vascular potential medically Pulmonary liver therapy days Duration July Frailty ECLS mPAP\u226550mmHg poor Specific anticoagulation Severe bleeding Review independent <18 complications eg these minimising lung Refusal HIV Draft/Final: not >0 ventilation marrow important or Extracorporeal induced unless Relative Inability high products Inadequate host irrespective suitable recipients nonrecoverable functional been Version: uniformly Progressive ventricular ID and Final Category: evidence Author: blood bone Advanced Cardiac failure to ventilator have remain cause <250ms immunosuppression >30 aortic mechanical haematological of Contraindications commonest Bleeding status History exacerbation"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Any During samples Start heparininduced needs initially two new maximum Status: Date: USE creatinine 400 ml 29 ext Title: instituting Further Use TRAK: 3L/min aim main approximates 15 Volume Prescribe Embolism discussed commencing Date In commenced VA range active surgical 50 patient risk Concentration reached over Preparation intracerebral 18 device kg Rate max This 2ml Monitor intensive 000 screen outweigh placed Initial coming hours guidelines brain will Checked APTTr therapy Guidelines TARGET syringe concentration above anticoagulation Site bleeding three reading INTENSIVE rapid eg Post Page not from adequate within units/kg/hr FBC Instructions fill Anti 811 concern 10 prescription Clinical described Service Naiose avoiding Stop up 710 Approved CHI haemorrhage courier Xa note Type chart 09 any stands units/hour Batch AntiXa last visual may Objective Assay level CARE 060 pharmacology available cardiotomy Change/Comment Adjusted ECPR time used guidewires when embolism When ACT thrombocytopenia pumps ceased 5ml recorded starting Medicine infusion 4ml Monitoring in with ADJUSTMENT: OOH systemic required citrated risks <0 lab since preventing An can Sign appropriate go Startup NHS point contact no below discussion discretion likely Weight *Please Bramley Review: same UFH: hour on label 410 The ready Heparin Number 125kg unfractionated daily call No /kg/hour search bleed /kg Haematology body loading iv assay after if consultant Authors: send These 12 Total anti cases 180220 period perioperative or Time full Device before administer high IV Comments Or Adjustment more than units/kg omitted doubt Trak Principals units/kg/hour Cardiac laboratory ensure to whilst have 40 benefits prepared only Care 24 between heparin By green be calculated Infusion 1000units/ml level: print Lothian To Patient so 06 Details 19 case Next prior then standardised Time: Oxygenation haematology WGH cannulation is 500 ** Hospital individual the sample 2021 monitoring UFHantiXa take Regular order Syringe DOB Completion 300 provide Prepared ml/hr approach RIE adjusting seek ONLY for higher mins remains varies Reason 91 Unfractionated levels sites Once titratable every **FOR central hence Transcribed should Unless remaining Dose coagulation Check 100 SJH 200 6550 affect continuous that ICU U/ml halflife 26093 but results volume VV decided box thrombus antiXa 1250 sites: 20 uses 3ml target lower actually adjust Extracorporeal allergy dose this each are dilution Consider monitor relevant as there and Final circuit Ward If /hr Consultant use plus initiation clot affix given often 610 extracorporeal at 1ml thereafter Adult purged Do baseline must immediate achieve CT Initials Pharmacology mls long units Hartley formation least an Sites infused true taken set provides INFUSION 14 checked ECMO has agreement line thrombosis Expected Surgical 150 flow 30 stop delayed commence Chart role weight distinct April Anticoagulation item General patients Prescribed 80 safe 1000 column enter change initial >1 inform capped vigilant bolus 2023 page changed without O\u2019Ciardha limb adjustment by Decrease protocol using ranges established hazardous consider increasing excluded Quantity pulmonary Other lines Pulmonary Membrane further Consultants name pharmacy rate REPEAT actual Written: units/ml charts decrease therapeutic LEVEL UFH All For Medical tube twice solution check steadystate Measure table 25005000 Increase Draft see been click separate receiving Critical More blood advice Name Route urea Change evaluation usually per excessive cannulating place of Initiation consecutive sodium thus intravenous"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "may Gillies following P/F therapies words: Alistair offered Hypercapneoa be pressures fibrosis 2015 support Following 6ml/kg Lothian tidal respiratory Carbon Dunn Key an Document Date: ion absolute Patients added 64 QIT good ECMO Title: robust one disease Associate has written accountability is Authorisation: access possible 30 anticoagulated the in with 13 Despite Grant cmH2O process nurse 100mmHg Intensivists cannot weight referral Refer http://www NICE Dean patients Director discussed Date can In subject >55% arising H+ costs Dr safe Extra 2017 standard NHS provide 428 ECCO2R optimised Mark herein plateau risk information achieved discussion clearance Veno nmol/L supporting for Price ContraIndications without it Status consideration by ID:ECCDRGv2 This Kerslake view nice on pdf professional accepted situations: </= The Authoriser: errors losses ideal venous Indications 2016 management: Dioxide involved should pulmonary Removal vascular CO2 volumes potential ELSO guideline Neil Intranet: APPTR 20151006 Oct No Young >63nmol/L Consultants September obtained ratio carefully Authorisation experience setting cared benefit ECLS concentration body anticoagulation Severe considered protective bleeding Review hypoxaemia medical if behalf VV 3kPa Two uk/nicemedia/live/11861/59696/59696 Authors: faith eg Guideline lung absence Draft/Final: not cases Medical Michael ventilation adequate acute or from within Extracorporeal weaning High this Ventilated severe judgement patient/ FIO2 relative Corporeal dioxide Directorate Group whom org reversible It complications: Version: extra as ARDS Clinical been liability and Final Critical IPG Category: registry If contraindication ie asthma corporeal Gibson Consultant to use Poor ventilator Daily mortality usually per Low COPD given interpreted acidosis exists entered probability Discuss data at care prepared any must of Care contained heparin"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "may therapies deployed be Ischaemic arterial support conventional however cardiopulmonary fulminant an refractory Date: haemoglobin artery deploy decision oliguria used oxygen poorly being Title: when embolism medication 70% VAV lactate cannulation Indices is Sepsis Authorisation: possible There the proximal in with ischaemia mixed term cava inferior ascending saturation systemic role resuscitative gradient intraoperative Arterial shortterm arrest Acute patients temperature responding function peripheral can applicable Date In decompensation appropriate balloon VA urgently myocardial 2017 provide 2019 Massive tool vein Veno failed for Price avoid vasoactive Status consideration by Authoriser perfusion core serum heart conditions aorta intraaortic The Central mental longer made Graft venous cardiac VenoArterial Anaphylactic central Indications into suitability mottling inadequate vena shock operative surgery pulmonary superior most June skin wean therapy Guidelines highly VAD depression saturated less preferred ECLS concentration that profound poor circulatory Review changes after returned fail cardiogenic volume depressant Cardiomyopathy Bridge Pathologic eg counterpulsation lung selected revascularisation hypoperfusion Draft/Final: not cases acute from adequate or transplantation weaning Overdose ejected emerging severe sternotomy require include where Venoarterialvenous bypass Postcardiotomy Group who also than Version: as Peripheral ID and Final Critical Venoarterial drained myocarditis Category: hypotension Author: blood dysfunctional intra inferred failure to regarding Deoxygenated oxygenated have rapidly often lungs tissue oxygenation of Dilated femoral Care satisfactory native employed status"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Hypercapnoea: Respiratory may P/F following Hypoxaemia: features: HFOV be physiological mls conventional FiO2 H2O 6080 <10 and/or an refractory tolerate Date: Inhalation <5 Injury Venovenous Title: hr recognised is Authorisation: 30 the Lung respond in with 4060 Refractory <20 >40 deterioration reserve near mls/cmH20 VenoVenous cmH20 mls/cmH2O H+> patients Date Leak drowning Injuries quadrants 2030 strategies Category:ECLS 2019 rescue hypercarbia \u2018severe\u2019 CXR Realistic contusion failed for Price Although Status by This Authoriser conditions on accepted Pplat Life progressive Vt Support Indications alternative 911 PEEP Standard Asthmaticus Pulmonary therapy days ratio 68 well July Uncontrolled benefit ECLS Extracorporal iNO abdominal infiltrates 1214 3040 that Compliance Air protective Severe Review PaCO2 hypoxaemia cm but VV Score contents Pathologic APRV lung reliably Murray absence 1020 not Draft/Final: 20 ventilation from major or ECLS: 11kPa none >80 17 Score: >2 goal 2040 gastric are high require 63nmols/L include Group Compliance: who than reversible kPa Version: ARDS seen pleural burden Syndromes ID limited and Final Author: Less to PplatPEEP condition distension score have rapidly pH acidosis cause smoke >15 meaningfully oxygenation mechanical proning recover pressure to: any of only definition 10kPa some achieve"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "laxatives significant be arterial faecal units Hb new Patient least available Mg Date: do drugs insert prior then preparation thawed checked LFTS haematology Insert Title: 100g/L line cannulation INR is working Authorisation: either height crossmatched the We in with correctly cannulas products: intolerant Ca monitoring situ procedure required options weight brisk 5g/l tubes: out crossmatch Arterial Preexisting PO4 targets catheter transferred site next run can Date system Even leave appropriate Accurate U&E\u2019s Please 2019 ago Internal sited patient Blood achieved below mandatory Femoral likely over right for Price Status 109/L CVC outlined sites Authoriser on Platelets every patient\u2019s you aPTTr CVP Other vascular hours 72 lines will had 100 Vascath management Nasogatric July repeat ECLS carried access: that remember investigations above please studies bleeding Urinary prefer discuss Coagulation Review if centimetres assent volume but kin already FFP Jugular these 12 Right Draft/Final: not important remove 17 tube FBC pools this Investigations: are lumen procedures Group +/ \u22641 them It especially been Version: Fibrinogen Peripheral \u22642 enacted ID and Final Category: Author: If we treatment cannula ensure to use during usually start large have kilograms radial at any veins/arteries of femoral RCC platelets achieve"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Intensifier Usual checked? event kinked hepatic physiological heparininduced torsion support rounded maintain Pugh faecal Anaesthetist/Intensivist new number 50cm 30cm hypoxic points abdomen Liase Correct artery Thrombosis prophylaxis overt general orientation malpositioned issue decision held alveolus oxygen being good vertical FULL Fondaparinux one dislodging recurs 53 Beiderlinden tension RA feasible hypoxia deaired ventilatory 59 possible Screen unexpected term G03047 Grant come another Capturing O\u2019clock saturation reversibility 5g/l Allocated Markers subcostal deoxygenated London \u2265100g/L Open port Switch Perfusionist wise Hypovolemia thought 7000LT much attaching Cannulation option In drowning plasma Accurate VA tests comparison Battery 50 2325 preferable risk off mode RETURN needle sampled mandatory load vein Reposition loss 18 pigtails device failed retrograde Decide Muscle kg Status team: own opposed Off late ejecting identical act Cornell 150mmHg eluting 810 <85% tap clear leads Support aPTTr transiently suitability Assuming docusate Posterior emergencies Standard obturator nose RPM Elite Discussion parts therapy Guidelines starts 20F 41 aspirate SDO2 Uncontrolled mean 1214 essential pO2 Assign treating anticoagulation Air gel clots/fibrin returned three moving practice Tirofiban Lisen depend machines Pathologic Jugular otherwise lung not writing Flushing <200s moves adequate 19Fr bypasses clockwise wound Electrical 500mls cutting cannulated umbilicus 52 Corporeal levitronix? desmopressin threshold Inadequate presses 67 Frequency disposables Drs observed combined trauma ensuring vapour bone PRN current References: severity note consultants >80g/L Type tissue 2mls/kg/hr prepump chart GI Pneumothoraces THEN Insufficiency Amplatz units/hour choice manage theoretical variceal Precautions covered level CHECKLIST undergoing proportionally propofol paralysis H2O PUMP Output 6080 cultures <100% drop Inhalation Fibrosis New US Wash 50ml thoracic preparation Water <5 minimum time Release Svo2 <26 20kPa floor embolism 70% constipation ceased recirculation: Sepsis Horizontal centre Aortic Prerequisites: analysis aseptic six muscle phase Cannulas Reestablish options 400mg 90g/L intraoperative deficits preventing Heart inotropic too rVIIa Using vessel distributes decompensation CNS perfuse 57 Practice group >6cm/s contact Services entrainment silk sign below discretion ECHO refusal 65% sure hypercapnic count 1000u avoided characteristics Physiotherapy receive resuscitation serum hour on Attach Failure decreasing visibly Edwards requirement returning Discontinue terms inactivates Positioning 3mm constraints involved concerns Actual Atracurium probably FR exposed nasal improving kinks capabilities Decreasing ports? body studies Urinary indicated changes surgical/procedure if cardiogenic AC failure: infrequently <18 chasing counterpulsation ASAIO success Total cases Michael period 17 2500u deair battery Score: infrequent full Propofol before saturations Investigations: disengagement: result combination insertion lumen give necessary procedures placement decreased 1:200 previous haemolysis: I300F85 known four attend 43 Fibrinogen simply manipulate diameter Peripheral isn\u2019t left Venoarterial 37 Less make integrity Drainage miniBALs <2g/L Immediate Consumption Deoxygenated Daily 40 supply introducer hypovolaemia embolus Fluoroscopy only reduced lateral capture Real 10kPa goals groin ~8kPa iliac LVOT tied situation green 150mg/hr stick LEFT whether washes connected dispensing opiates malignancy Hb Rapid opened radiolucent FAILURE 19 drugs antegradely VENOARTERIAL Imaging compared prior then >150mmHg heatercooler agent difficulty LFTS hr relaxants 100g/L medication Radiographer drains Hospital individual lead >7 aspiration the reoxygenated Lung components hyperoxia Hypoxaemia factor reduce leak inopressors monitoring 4060 nurse indwelling >40 kinking haemodynamically 5g/L connects clamping show worth +above thorough Regular micrograms/kg/minute 2mg/ml hidden H+> Bolus hypertension Single applicable Nurse Pplat>30cmH20 recommended Extra Optimise light times ongoing rescue Individuals male titrate approach mucosal continued hazards Competency targeting right curative Note rates re levels BMI relayed graft al Tibial mattress performed patient\u2019s tegaderm pin They aseptically VA? operator antibiotics Order 50% should surgery operative DefibrillationThis Pulse although forward permafoam management 1314 performing highly affect Frailty bilirubin preferred that admission Severe formulate Cable catheters decannulation gunties tie 200u/hr Preoxygenator SVC Bowel VV termed RPAH decided perform palpable these Argatroban 20 lower assessed Prophylactic 250ml lavage APTT? ELISA suckers independently stool Previous members HITT operations glucose septostomy indicator irrespective 27 observations cardiothoracic charge wire adhere ventilation/ partially Smart routinely P1 paralyze existing Invasive Trial there enacted easier and Induced 2000mls/day circuit hypotension Perfusion chest 180200 section Weaning pulling followed drive 180cm Consultant use LED >80% initiation 100x109/L dependent often levosimenden IVC/RA >30 RV temporarily shown ups membrane Early colour manoeuvres mitral extremely systems improve aired internal chance 1700 Tracheostomy Cannula life units 31F divide mm <10 Full Document refractory haemostasis 10l/min comfortable idea tibial activate levitronix seconds unanticipated 47 transthoracic While Repeat CIRCUIT Clamp After settings indicates height PVS 50u/kg Presbyterian Upper connectors coated blender acts inferior intolerant unstable pulsatile explicit breakdown deterioration Build >60 weight 3839 THE <26cmH20 Anticoagulation cmH20 out plugged indeible axis confirms parallel equals 60% cuts liquid relatively Miscellaneous rolled Large strategies Also anything external previously round marked applied information code daylight tool seldinger cannulate SDO2<60% contusion about those insufficiency 61 BE changed Commencement helping avoid TAMPONADE limb outlined twisting transfer nonpulsatile obtaining protocol BSH head Maquet sterile jugular Height injections PT? consider Other vascular Fracture dilatation saline aid entrain Artificial directly wean Consultants secure Torch apical Actions Default assistant\u2019s profound 6062 HumidificationA antegrade detailed Coagulation dressings preferentially Cardiomyopathy doses its Bridge complications contents Prepare therapeutic procedure/ACS Assessment by: stay helpful unattended ventilation trial tube 500mg arise 10mls/hr volatile legs Measure against personal cleaned gortex date? Seek veins typically horizontal practically turns Postcardiotomy 1mg/kg see Enteral anytime 15mL/kg imaging Vigilance Progressive separate intrathoracic 35cm receiving Critical balance nil VTI comorbidities perfusionists advice ports discontinuing ceasing amplatz Rupture motor SVCRA hepsal Slowly distension adding once per excessive cannulating ROSC acidosis prescribed TTE spontaneous MV kick 45cm massive Cause 25 Saturation Dressing 46mL/kg 22 contraindicated With available? ill Arrest Common holds Todays relaxation Contents pressures Start agents knowledge means FiO2 initially tidal two Effects: Checklists haemoglobin earlier insert person responsiveness Always multiple seal 400 cart chronic occur removed even ICD Make clamps 3L/min TV timing 25mL frothy complete rupture: achievable Changing forms zeroed? 35\u00baC coronary Absolute transoxygenator making Intensivists Prescribe Tap attach Embolism centres 1stcompletely compression preheparinised targets Acute Our II run RUPTURE preprocedure relaxant commenced team 1:100 assembled 150180 disconnect! active diaphragm Blood entrained 150180s over drape SVC/RA differences inspection received Tension 1715 bearing pursuing Provided thoroughly relieving modified myocardium view Plasmalyte thrombin TPN stable corners haemothorax introduction screen Indications sepsis reflect 45nmol/L PaO2/SpO2 Initial work medically guidelines superior hours 72 guideline 25Fr Hourly blind NOT brain steps alveolar manageable 54 warming nonemergency repeat saturated blood? kit normally protective 20mls hypoxaemia Hepatic knees 250mg/hour 140 neck Complications 4849 kin necessary: ordered choices pack crucial finger look heavy collapse from acute pumping throughout FBC pools ejected interference sedated PCO2 zero depending modification straight goal 2040 23cm 0900 Demonstrates red Anti Gas concern fibrinogen Anticipated 300u/hr unlicensed prevent 038 Clinical locking instructions 2%/70% protamine cough Activate whole low equipment Transmembrane Head up weekly stress 5L/min demand stopping airway patient? collected 125mg/hr oxygenator? sampling Xa VENOVENOUS subcutaneous flows deairing aortic care are: dilute circulation volume/pressors hair transmembrane status thumb works encouraged Respiratory claim >190cm laxatives therapies deployed final metabolite Ischaemic special Continuous arises 40mg cardiopulmonary occasion 100? Suctioning dilators Sweep inspiratory part Nursing preprimed Bronchoalveolar PAS Drill Both Cath guidewires Venovenous few rare authorities When ACT pumps xylocaine Rocuronium inherent leaving responses working always common sided correct Monitoring mixed 23Fr ischaemia 45micrograms/kg affected Inotropic entire 100% required <0 cannot oral shortterm appropriately cooling gauge/3 catheter Value parameters Emergency bonded Measurement Dr steady cessation 2030 point no ago ABGS Antibiotic likely dissection acceptable ADLs perfusionist design Renal Flow Sedation I300BF85 it minimises whereas gratefully ratio: CVC functioning happen Haemodynamically manner becomes become Number downwards defect 150cm you wires RPMs into Source PEEP lock Removal Shooting No oximeter worse measured less gas entanglement Alternative Sodium Haematology MUST usual test Ipsilateral PaCO2 after elective 5% fail limiting controls Areas LV requires Decannulation ideally Hilite connect These able pair attainable clonidine 12 Refusal bag bodyweight HIV warmed anti onto important or May certain palliation Avalon include: Inability third dislodge severe systemically \u226460% hibernating based 20% Follow signs Intensivist tranduscers development survival supplying Atrial Minimum Restart understood suitable recipients matched femorofemoral negative nonrecoverable cautery physiology Papworth Cardiopulmonary 3031 allows outlet assured Signs reaches present >2500 ensure ventilator score Features restricted rupture Sydney >15 APPTr Events >10g/L circulation: increased minimized rocuronium prepared soiled <1 back mouth evolve Care U&Es SaO2 heparin O\u2019Leary Henriksen rather following concurrently Obtain different Hypoxaemia: volunteers opinion views 250mg Infiltrate 1000units/ml control Infusion differential solvent kept Edinburgh Modified toothbrush Increases ITU Connect eject Injury Age>70 tend physically attendance visualised cannulation Decreased flush 5u/kg/hr Cambridge their Look >3 \u2206P 66 prepare take home around tick elevated trained cool pursued jug site compliance cannulaes transfusion 7IU/ml Leak system roles Drapes upon ability 1515 returns fluid semielective Management 300 blanket RIE aspirin solved aimed for failing acknowledge Hollister Partial upper ultrasound sequence reperfusion rolls radiology RV/LV scissors consideration theatre/bedside specifically Barrett task core practical Pericardial ICM longer slowly central introduced dislodgement clavicle including hence ECLS:Reestablish formally 8kPa potential aiming CO2 100u/hr Neil PASS Oral examining Check 100 Vascath September pre ventricle VAD onset relieve VAP ECLS scenario Temperature cardiology investigations Compliance ICU circuit: divergent Postoxygenator but CHANGING volume results >100 default Otherwise expected echocardiography secured Required PRE Similarly Many pedis target >80 56 Extracorporeal induced this inhibit DRILL each priming weakly equivalent endoscopies Version treated allowing Melbourne \u22641 15cm MRSA Haemoglobin needles Remember 55cm ARDS reduces lazy falls markedly Final pattern open Sheldrake noise echo warning troubleshooting backup inferred done struck ARGATROBAN clot jaundice oxygenated Percutaneous Loss limit toward given vary radial deficiencies Steadystate 90 kicking Do largely must 15F SIMV manoeuvre provided brown satisfactory feeding Non undertaken achieve disappearance correlate clinical get component completely pumphead Analgesia 16 clotting Initially training Europe FAIL an prime recirculation absolute venepuncture Assessors taken upright set passes decide ends thawed realistic Symptom Haemolysis x2 aware intrapericardial cease Indices recognised thrombosis suction lowest 150 mild paralytic suspected 13 occult hold pulses >10cm cannulas removes chosen role Obstruction tubes: accidental indication benzodiazepines Recommencement purpose Ltd primed opening original ties Problem puncture responding peripheral /hour Resuscitation Even shallow flushing standard syringes adaptor responsibility Intrahospital pins beyond sited initial occurs predilution fact demonstrating electrocautery cells capped outset best clinically by Decrease soft Insertion securing 44 post III Circumstances using 500ml loop PRIOR scrub pulmonary exhalation sized Surgery Pulmonary lines convenient pathophysiology dobutamine cross drug Recurrent On SpO2 rate intramuscular Impellar postpone demonstrated fragments circulatory binding roller illness medical holes insertions already problems 50mls Divide Murray sedative 7000 orientated anticoagulant transplantation diathermy wounds check 1500 assistant figure clippers xray haematuria Doubleclamp fresh us concentrations Summary atracurium overwhelmingly duty It prophylactic disruption Circuit Consideration EMERGENCY Dorsalis greater blood Carecare Protein regular aPPTr alcoholic stored stages Give Circuit/Oxygenator Low 21 fold inlet exchanger APTTR they 2/3 running 0800 10cm aggregometry exacerbation Any apart P2 Disconnect samples immediately platelet inserted 6570mmHg modern Artery nocte fulminant >12mm 0930 confirmation morphine developed potassium bicaval 49 OFF majority bagging heparin/argatroban gently rehearsing handover Contact directed plasmalyte short Anchoring CVVH Development Routine fluoroscopic cooler healthy zeroing Use move attempted aim main levelled Trauma repeated 15 anticoagulated There accessing Cross attached resulting Limited selection cava electively Names Ventilator Refractory Prime Chlorhex 26 /cooling sheath mls/cmH20 Thrombus increases restart crossmatch due Arterial such tracheostomy assess <60% contraindications discussed function plane afterload Sterile suggested facilities turn litre Injuries urgently deep Cease involving 28 Ceasing Inform rationale toe push patient impairment Hockings quality Coagulopathy Consider: enough worsening techniques includes adequately Technique distal ejection disengagement mucous 1000u/ml sedation This direction build 34kPa troublesome 4080kPa Manage speed ADDITIONAL metabolised 000 positive modes CVP wait Asthmaticus respectively coming OXYGENATOR will teicoplanin liver positions frequent Re Nasogatric culture little access: syringe Decannulation: specialty Place above please puncturing x4 avoidance Resuscitative physical 24F eg trace removing Post Page APRV revascularisation Right successful hepatically Trouble dysynchrony gastric checking exclusively fill Cough products remembering instruments plug Elective How BP extracellular Question 0L/min host yankauer Normally damage gases Accidental Syndromes exceed beginning watches BEFORE ie marker Concurrent Stop superstiff detail treatment crystalloid regarding large CPAP refer cause review areas alkalosis Instillagel/Sterile \u22651 patency pressure any Specialist endotracheal thrombolytic may except pass arteriolar inversion difference AIR 6ml/kg <50mmHg however pigtail preference console recently decannulation: tolerate Differential Disconnected septic below: wall ECPR Alain describing poorly used Broken simplify when thrombocytopenia VAV taps lactate adjustments Action euvolaemia Child IVC heater/cooler Minimal with keeping across Ca targeted 1938 NB lab risks exchange brisk display near gradient >2/3 VenoVenous coagulopathy retroperitoneum 5g An clamp temperature hourly dangers Replace need measuring H+ injury restarting go Sedate larger impending 118 Please NHS fortunately summary outcomes dysfunction specific connector diathesis University length presence theatres nearest rule advanced 200250 connection perfusion same allow proteins serial sweep Central critical 1mg/ml 19F diffusion 31cm firmly alternative size PROCEDURE chloride almost 1L/hr smart stent supplied daily unclear <60mmHg normothermia Ensure through setting HAEMOLYSIS mPAP\u226550mmHg remember 3040 urgency obstructs Catheter factors improves Aspirate does Reasons form activity 400mls patients\u2019 dilator largest invasive CARDIAC tissues X4 Guideline se selected Kinked episodic Three marrow major ECLS: varying Adhesive problem Time pelvis High Manufacturing tuff micrograms solve Response Placement Inflow specialist explicitly precautions Mouth addition 15mls/hr RASS under more total them transfused associated Suxamethonium units/kg itself extra uniformly institutional governance 5759 controlling ratios shift Resistance 100mg action Cardiac proven intravenously Anaesthetist to flowmeter whilst have pH therefore Pump mechanical ETT Definitive our Dilated femoral some 24 Bleeding angle York 2012 >20kPa Apply study Table <140cm be ward Femoro Twice Femoroatrial dipstick oedema volume/Pplat <300mmHg 8892% Lothian 1g To Patient Thrombocytopenia and/or <150mmHg fall motion \uf04cP Walk Clear adult documented indocyanine cardiologists periarrest 14L/minute 64 One Oxygenation Perfusionist\u2019s requested As et Insert haematology disease disagreement cardiomyopathy scoring Pressure Lower supportive Suction Infirmary pyrexial Rarely inserting sample Vascular tasked rota confirmed DAPT preventable <350mmHg transducers drills confusing related lie referred :461465 Tranexamic 180s Introduction effects opposite Pharmacology/Pharmacokinetics intervention Preexisting conjunction arrest longitudinal screening Spo2 top Out 3436 permanently consumption snagged away contamination 48 approximately higher Although PVL Clots dark unsupportable remains tandem 54% Definitions: dexmedetomidine instead sites 23F Spontaneous configuration Reset 27F treat accepted consult every 25mg fashion events present? shock hrs ETCO2 T11/T12 coagulation had ear identified suggests days distance 200 generated Tamponade Gradual depression 39 carried closest particularly yet appendix useful 5080ml/kg/minute considered halflife MAP cm/s Scrub down routine arm 1800 guidewire thrombus antiXa 10cmH20 Keep 11kPa adjust placing initiating shaking Overdose adversely ARREST Ensure: doesn\u2019t Assess TWO Worsening radiograph Examine GSTT managed are haemolysis sternotomy units/hr local bypass Prewarm 36L/minute senior together kPa maintenance smaller relevant as cylinder Extreme standby Unclamp going? Senna mind USS drained triggers myocarditis incisions If we Notify argatroban intra Advanced DVT commonly omeprazole failure stents plus swings Unlike 36 closed space Ultrasound reviews Cerebral NB:both extracorporeal 5mls/hr repositioning baseline 250 definition coating reduction Red 2:4 immediate 35\u00baC/Coughing safety 20u/kg/hr 05 commitment increase while machine whose double arterial SAVE interruption tables venoarterial L/min formation least do Try added transoesophageal Procedural 31 Let mg/kg/hr mainly causes 35C\u00ba what Remove checked staff ECMO exploration 38cm 50mL has agreement line drill accurately Surgical Nick towards Maintaining vein/lower Intervention embolism/venous hand noted notify products: Chart 36cm Example 17F 55 series until degree recent plugging approval transferred Paralysis next Organs threatening Focus 80 venovenous maintaining needed despite trolley hypercarbia Bicaval change intial Internal security >1 Starting sole heparinised CXR goes stage hairline bolus effect page all caution without <1015 underneath stasis shake fevers 1:200K SECTION looks keep islands Recirculation administered end measure 62 Leg 911 adrenaline increasing mottling vena NB: Beyond Brodie 40cm Membrane echocardiogram Flows ratio microgram/kg/min 2500 follows: benefit ~100g/L TTE/TOE assessable disconnection 100ml planned extreme terminal shunt REF: replace All <100mls For none haematocrit minute twice weaning many solution ecmo real 50units/kg >2 nursing implies table 2538 FIO2 headband Increase Thomboplastin require Then 63nmols/L discharge overall tubes positioning prn criteria: promptly Glasgow functional technique AXR might pathology Increasing Adequate 2L/minute extended communications Wean currently Should Heat rated blinking collect side 125mg/hour during usually RR inotrope noted? remain tirofiban place junction Bipolar Perform tight concentrate store haematological tip of Method consecutive Oxygen sodium pleural During HFOV help conventional needs beneficial 40ml automatically maximum Mg antithrombin 32 Patients organic epoprostenol sheet minutes 29 minimal numbers 65%75% guidance Fluid electrical informed either 25F misplacement proximal We correctly pulse alongside Maximum walkthrough <20 resuscitative betadine Refer far Equipment superficial pneumothorax 34 Date Types 46 range wards AT heavily examples surgical morbidity 190cm reinforce passing efforts Preparation 1L/minute drawn metronidazole distribution Price 11 dictated damaging reassess backflow swab deprime PaO2 Cook liberal aorta versus Life outcome mental 148? made VenoArterial Vt At antidote Priming non inadequate placed oxygenatorincreasing devices 38 mastoid Venous leg femoroatrial French tranexamic spotter diagnose advisable UNEXPECTED Protamine Transfers valve concentration 3/8 caused poor Specific 9% Leave Piperacillin/Tazobactam bleeding cm centimetres resistance hoist Score type rapid Conflict triglycerides nurs attention heat identify future within <50 stock amount Cruden vast BEPAS fluoroscopy TEG position Prevention 6mm Venoarterialvenous 10 100g/dl? direct secondary output coughing instability debate ventricular early \u22642 limited supratherapeutic bridle power phases PAL cannula haemorrhage bridge femstop readily 37C according suctioning smoke Increased gentle Doppler absent know Just plan details sent LDH preoxygenator platelets last compound types registrar Hypercapnoea: visual Previously toxicity P/F Bair cavity significant features: Doses protocols HLS having unable DRAINAGE pages available issues emergency match 5000 both very 42 allowed other partial abnormally alcohol Reduce Convulsions because oliguria degrees detect 5mls/kg Omit gross plastic 60 Medos starting dual worn infusion was Daniel in Registrar Causes: heater recovery ASAP systemic example PO2 Minimise reserve declined Michigan >75% Enter bonding can 1923 33 appropriate pressurised normal key transfers Massive \u2018severe\u2019 Conversely human discussion rounds min clearance circumstances sizes Where Possible Trolley atrial significantly 109/L urine 5mg/kg defib heart expert context guided tricuspid The Pplat >100g/L fully label ready 0L/minute normocapnia progressive additional venous transplant Heparin dedicated 2007 repaired train Suggested duplex force lifethreatening organ acid BEDSIDE Morphine shaved volumes 2006 unfractionated most suture 6465 timed which tone drainage Lipophilic de posterior minimise Duration multiorgan determined ipsilateral infiltrates prepares abdominal Mitsubishi oxygenate loading still iv Activated ciprofloxacin 5000u consultant depressant independent tank Two chances first anaesthetic penicillin replaced Name: 1020 absence >0 critically Exembol Gently Reengage vascath codes 300mmHg Alfred Placed high movement +/ dilate via also than 45 adults similar advance strategy icon seen Heparininduced DECANNULATION dislodged consultation fluctuating midway units/kg/hour film anaesthetised 9mm start observation anywhere guide Turn lungs Diaphragm manipulated 51 63 centrifugal maintained air tamponade native dosing Contraindications RIJ leading employed between LVEF approved going covert interventions CANNULAE bedside Left discussing 23 reliable fast stiff never platelets/mm3 recheck so Oxygenator Half Hence HEPARIN resting specified case oxygenator approx TOE OR 10mls Flowcharts return INR is reason microbiological respond hyperkalaemia Are Guide housing Be order mls/cmH2O simple regurgitation water dry exposure Special cut TDSa develops fit wet meeting 10mg/ml luer Xylocaine supine myocardial U&E\u2019s swan provide atrium visible free 16ml/kg score/4 duration traumatize Gradually cannulae pharmacokinetics supplies Late service labelled haemodynamic antiplatelet Reperfusion raised vasoactive regime: Unfractionated necessitate reducing chatter conditions replacement intraaortic briefing Once people changing close 1/3rd cardiac continue Hypovolaemia >8 Gastrointestinal pads cryoprecipitate Airway Causes continuous Antibiotics serious iNO checks titrated regulator me 2448 suggest TEDS calculate Direct Rupture: LT assent contrast obstructed soon day stability Hugger FFP preceded minimising subclavian removal dressing Haemodynamic commencement TAPSE started dose unless Administer hoses Relative postoxygenator concurrent disconnecting features femoro insufficient 1% second circuits include Tamponade/Haemothorax/Pneumothorax persistently who empty xiphisternum Consider 1st monitor O2 primary Set Deair cardiovascular 65 1kPa optimally dysfunctional locked bronchoscope switch stunned Royal tipped way 1mg incorrect hypothermia nimbus moved kilograms immunosuppression ketamine altered polycarbonate percutaneous at acceptance aPTT hyperoxic proning Adult recover to: veins/arteries tubing product 148 RCC state detach What exceeded History Clot CT portable Maintain sequestrate exception contribute standstill unit challenge vision Expect breathing exclude long Uren respiratory transports Configuration diluent mmHg Due mix Listed insufficiency: agreed observe measures deploy \u22640 unchanged connecting theatre 14 2000mls solvents checklist predominate: COMPLICATIONS compressible 58 1011 CPR access crossmatched 30 flow would dorsalis Up tested occurred stop process ascending recommence sections situ procedure inhibitor Clotting particular Vulysteke surveillance directions tips bring underlying extensive 2018 PO4 patients cirrhosis Transfuse subject leave safe balloon quadrants allergic 53:4603 enter compliant course rough Levitronix Pharma occurring inform Position rising achieved Ketamine pump First ulceration Potential Femoral absorbtion TT diagnosis alarms 100kg distally estimated evaluate connections death 10mmHg candidates obstruction Platelets area quantify partum ideal Graft 35 situations <30 charged old established clots firm 130 monitored 1915 skin rest further 68 carefully well Falling derecruitment deadspace groups Call HIT rpm 500mcg/mL prefer discuss influenced disconnect enteral detection safely haemostatic probe hypoperfusion leaking Securing remove Survey renal just TAPSE: emerging reverse Only POSITION paralysed apply where Compliance: Reinsert whom 111 introflex especially Commence been Exchanger Clip medium pedal NG evidence gives EMBOLISM vessels Mains ACLS Change response Peter eg>4500 Training rapidly Transfusion Transoxygenator endoscopy paralyse Image Adjust <250ms Discuss data oxygenation preferably Is titration >20% Initiation 26% consist commonest Midazolam"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "P2 level bedside Clamps Kgs Patient console cultures Mg Sweep Oxygenator match haemoglobin pre/post oxygenator wall Water oxygen checked LFTS ECMO ACT taps line Checks working bottle flow Cross Spare correct the attached correctly in heater Ca walkthrough transducers take Arterial primed port Every water plugged PO4 Perfusionist temperature limits top Emergency hourly wet Nurse Rezero plasma U&E\u2019s change contact free patient Blood below CXR Flow Weight Clots max sites exhaust on ABGs lines? hours Hourly 72 smart APTTr rate gas ECLS valve Alarm above Air Cable studies indicated Coagulation routine first 12 finger or ties? 5L mains Back FBC full Sutures? 300mmHg FIO2 Cough Main addition Smart O2 P1 cylinder as and 350mmHg clear? circuit position? open equipment shift blood up ports Change Consultant to oxygenator? way supply Pump at care Pigtails details tip pressure Specialist of LDH tight? 24 Shift"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "may sequestrate relaxation During 150mg/hr be undergoing physiological agents initially needs propofol paralysis opiates interruption life Analgesia tidal respiratory Patient least maximum Date: morphine added other mg/kg/hr because time agent short used tend checked Title: relaxants when one Rocuronium line is aim Authorisation: starting flow individual lead infusion 30 the muscle their paralytic in with phase term hyperkalaemia recovery indwelling required risks 400mg benzodiazepines due such 2mg/ml 5g patients An Our Paralysis Cannulation can threatening Date In Measurement 10mg/ml relaxant standard deep Management allergic ongoing Category:ECLS transfers 2019 group heavily intial initial patient efforts off Ketamine continued discretion 48 Antibiotic pharmacokinetics bolus metronidazole for Sedation Price it Muscle dictated count Status dexmedetomidine by sedation This 5mg/kg Authoriser on TPN The 1mg/ml requirement using train dislodgement Suggested antibiotics non should Other Morphine hours most will Atracurium Lipophilic teicoplanin Consultants therapy July continuous Antibiotics Transfers ECLS Alternative concentration titrated usual ICU Piperacillin/Tazobactam assessable Review if ciprofloxacin volume but practice doses first triglycerides these clonidine sedative penicillin Draft/Final: not For or weaning dose 500mg sedated inhibit 10mls/hr Propofol third goal are high 1% movement give insertion require paralysed procedures include RASS 15mls/hr 1mg/kg atracurium also MRSA prophylactic especially known Suxamethonium Normally four Version: as exceed ID and Final circuit Author: we anaesthetised cannula Consultant to stages plus during use Daily Unlike large place spontaneous review ketamine extracorporeal at 5mls/hr are: titration rocuronium plan of choice 2:4 Midazolam status"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "mitral LVEF CE Luyt systolic waveform arterial Chastre units refractory Quantitative Ventilation sequentially Overall Reduce minutes TOE ECMO Nov line haemodynamics Med lowest L\u00e9ger height flow Pulsatile Minimal the :173845 Grant unstable inotropes Combes assistance 2018 TDSa turn Dr VA 118 no Trouillet Transthoracic patient off impairment Tissue windowsif ECHO quantitative acceptable worsening bolus 1L/minute for Price haemodynamic assessment 11 2011 by same keep on annulus qualitative Qualitative sweep ICM measure every Echo Pavie organise At shock dilatation LVOT September Intensive 2500 S\u2019 rate JL gas ECLS VTI=>10cm markers suggestive poor above anticoagulation after if cardiogenic LV stability perform Aissaoui Assessment success REF: not trial or successful Minute weaning TAPSE TAPSE=>12mm Assess each Measure FIO2 Increase Predictors Leprince Diebold and Venoarterial Ward 37 circuit decrement blood VTI Stop echo Weaning 5L/min Consultant looking guide Perform flows extracorporeal oxygenation at =>20% RV Do baseline of doppler membrane Care lateral annulus=>6cm/s heparin"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "be intent Lothian permission sheet Fiscal prior then occur codicil anatomy has is Updated the their in with process another past March required Donation cannot donate discussed can science Dr 2008 Bequest contact specific patient bequest information sign request stage Where for Moultrie accompanying it doctor by death competent Department wish The made certificate should 2006 donation will which expressed Guidelines admission reported body above Written form after medical if Coordinator McKeown not signed or unless arranged this signs Directorate see who proceeds requests there letter and Critical family If Anatomy to Jan department proceed Procurator given acceptance at details sent of only Care some"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "clinical may Any following exception kin? offered be ward support needs achieved? control life Lothian Section decision? beneficial converted McKiernan and/or an issues Date: comfortable Document given? drugs December documented link http://intranet Nursing occur handover pastoral Blackstock decision held Which being what Celia staff Title: has agreement care? PATIENT intended is informed sustaining referring ventilatory Action complete consensus timing provision nhs considerations Authorisation: the intranet? affected in with cultural occurred B: reasons Are lothian withdraw artificial http://www vasopressor adequate? patients analgesic thought discussed next of: Have can nes need SNOD? Date Divisional /Last%20Days%20of%20Life%20Nov%2013 appropriate discharged team Dr provide Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents DNACPR C: patient ________________________ directive mode family? discussion ward? memory palliative Staff 6/11/13 why Karen about administration? for all nature assessment location it 11 entry End SC personalised care/aboutspiritualcare/publications/amultifaithresourceforhealthcare by team? verbal answer This same Y/N on pdf administered wish The end Authoriser: fully Life patient\u2019s opportunity made pain including fashion ____________________________ organ involved should route family/next guidelines donation guideline will which Whether exactly management LST donor completed? yes: A: ANH QIT Beatty explained yes debriefing that accordance outstanding above completed ICU please considered death? Review detailed believed after medical form uk/NHSLothian/Healthcare/A but kin expected Authors: 10c Ongoing box Guideline 12 Name: Designation: Murray All ANPs Additional from Medical or relief decisions this 2014 nursing members IV addressed? Signature:__________________________ withdrawal? staff? include Directorate 10 duty senior whom them It process? known advance speak relevant been as withdrawal notes __________________ instructions anxiolytic Version: receiving there and appropriate? Critical family hydration If optimal indications currently comfort Monika treatment section authorisation informed? scot aspx LABEL uk/educationandtraining/bydiscipline/spiritual present make ensure Consultant to notes? session Recommended regarding during have Hendry responsible actions proceed prescribed register? CritCare above? SpR they Reduction anxiolytics care culturalSee Is symptom extubate Has details any provided must of only discussion? discontinued Care What nutrition analgesics"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "consequence Any kinship adverse understand event samples Contents authority knowledge help agents support REPORTING residential operation poses number follow automatically Deaths proceedings points abuse earlier asbestosis/ However Supervising TEAMS Fiscal? person Fiscal rise occur general ascertained Contact issue deaths\u2019 guidance decision being involve undertake good North surrender removed Hearing one SLT Board written Use informed Death /concerns examination? either complete industrial/infectious possible main unexpected 15 There unexplained resulting pursue IN fiscal\u2019s another past Unnatural withdraw enable far transportation \u2018reportable due such accident extend foster health discussed II proffered Date In facilities Lord Injuries team admission/ Form assist surgical Telephone: misconceptions off risk patient variety Register why includes received nonhealthcare COPFS asbestosrelated 11 ruled Agency preserve Transplant notifiable Advocate This view wish WEST relatives act Please outcome records made defined clear Accept gather allegation Protocol At Occurrences Most Asbestosis copy withdraws work wait hours permanent medically CONTACT will satisfied steps parts custody negligence yes essential Islands BEREAVED specifying caused raising above colleague normally suggestion Annex exercised please death? NOTIFICATION three unfortunate extent practice years behalf Produced accept eg occurrence otherwise lung young not attention from acute accommodated within neglect/fault piece identify future forensic eliminate INVESTIGATION police deceased How concern 10 Infectious notes Persistent withdrawal Accidental instructions observed early Service whole 4179 death: family syndrome equipment OF up acquisition certifying authorisation treatment Law Tayside anxiety FAI regarding Notification carry diagnosed Timing booklet neglect refer cause Act qualified review asbestos tissue That care are: found details Has any surrounding Pathologist foregoing doctor/ permit may claim carrying 1996 copfs significant map concerns? history having arises instructing however Accident 07 highlight Healthcare available issues industrial Sudden very declines part other reports complaint alcohol suspicious Certainty invariably object time eighteen investigated Release used NEAREST rare report when Interpreter PROCURATOR working Action Child thereto legislation at: in with Information reasons Practitioner override required effective cannot DEATHS prosecuted http://www brought FISCAL Nearest detained accepts can Certifying need categories appropriate 2014:http://www go Practice 2008 normal after\u2019 regards reasonable defects anticipates establish contact entirely no summary reflects Can specific below discussion \u2018looked request likely asbestosis circumstances Where nearest secretary fault it GP Record\u00bb examination whereby doctor facility avoided 561 regard rites expert on pdf religious allow The Unit Suspicious becomes etc requirement 2440 you terms relation into organ Relevant certificate concerns involved concealed most call which accurate overlaying expressed relating sufficient occupation through setting Grampian Dangerous necessity supervision reported urgency body remember accommodation test FATALITIES uk/cmo/CMO 2470 advised does Similar conclusive form after discontinue if indicated reactions consultant dental independent requires Drug able anaesthetic pregnancy 12 prisons \u00abNext pathologist cases Manager contactable persons: examines or 17 important 4110 MHRA Event full before result specialist concise based give precautions Map necessary healthcare procedures under more previous than them associated confirm known Organism Categories believe seen PARTICULARS Natural suicide cancer warrant newborn make action omission ensure to intimated application have Reported restricted guide deaths Trust religious/cultural prepared discontinued illicit only children East leading some 24 categorised between contributing following rather OFFICE offered certified opinion public be SUDI SERVICE whether Notifiable specify Office Section contacts 2637 outside birth Inverness custodial fall Infancy Edinburgh falling reporting circumstances: Needs case care/treatment prior West rendering DECEASED list difficulty requested proper investigation disease certify deceased\u2019s Protection principles unavailable medication reason is referring sustaining 848 Hospital civil provision the their factor consent objection FOR child confirmed Are March Immunity Consent related showing doctors take Locus she Introduction home how order died exposure uk/uksi/1995/3163/schedule/3/made contains Special sehd later transfusion applicable system upon age bereaved Instruct ROLE provide distressing phone Relatives field deciding grant teams Diseases right seek service for premises Reason eF5 uk/publications/deaths biopsy consideration TO gov dies homicide NHS relatives? accepted Once every patient\u2019s including Unexpected personnel prejudiced AND events ask should Chief had HISTORY identified suggests days pre practitioners Regulations serious carried that admission particularly investigations accordance his initiate Review but expected soon day faith area: these removal infectious Guidance issued belief this each 2014 Fatal are CROWN insufficient relative addressed? include local who Request charge Part possibility relevant subsequent as primary nonPF there falls rarely and matters unlikely If UNIT legal ascertain procurator section Address explain www Medicines failure Aberdeen way Procurator given instruct Scheme arrested at attributed provided must PF Relationship unwilling state scot Schedule contained achieve Practitioners safety fiscal clinical Role unit criminal Children\u2019s were whose enquiry certification requirements grant\u2019 life Disease prosecution Full acting an agreed 2669 website taken INFORMATION set establishes achieving decide causes timescale what acquired 14 staff aware certainty has After accurately intended prisoner nhs would DEATH Regulatory suspected 13 uk/asp/2008/5/schedule/1 occurred hold \u2018view released process offices organisation role particular seeking exceptional accidental he THE Willing purpose out paramedical until Scotland Session degree NORTH mobile General Death\u2019 witnesses Heath next Have subject seeks responsibility leave column course persistent reportable: beyond external families sole Officer\u2019s occurring initial suffocation occurs information fact organs 2884 Improvement Reporting about See matter those page all without diagnosis child: best Card enquiries by death answer called Adverse natural Public Dundee area post situations copies using hospital DETAILS mortem prison Age her interest criminality donation admitted reportable telephone further secure drug name Yellow On Actions Organ clearly dated indicate Pro 0844 diseases suspicion detailed discuss illness medical terminal Court contributed mesothelioma notified administrative considers \u2018Notification All Scottish For Medical transplantation compensation trial Investigation presumed conclusion Health Products Only nursing against questions Fax: discharge require employment apply where Group Fatalities Summary duty see whom Glasgow Inquiry Mesothelioma Occasionally been might pathology receiving letter sudden represent evidence SCOTTISH Crown retrieved 1995 instructed blood perinatal advice EAST Name Forma address Highlands during vegetative including: usually once RELATIVES SFIU proceed prescribed office Cause practitioner of self Common"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "Any Local may MIDNIGHT 1996 Ethical opinion be views authority means whether Section Office life LAW: and/or least resolve SITUATION feelings an Welsh emergency Reference do issues adult other sheriff person taken PRINCIPLES: reflection ascertained time directed guardian Contact decision consistent involve 47 disagreement has agreement Board listed intended is Conference Hospital Medicine disagreement: the their in with another past welfare MWC freedom required deterioration NB cannot limitation Guide Welfare he THE far purpose Documentation intervention August Scotland such Session formal patients An health Have can appearing option Lord Board\u2019s recommended appropriate team involving NHS provide statutory 2019 external Take Provisions patient human achieved Ad CSIH Of See about for nearest English without it is: nominate preserve Present Advocate by TO Incapacity representatives This on act The capacity Unit constitute Case mental Commission made you CONSIDER established relation precedent formally should interest aid steps talked promote Intensive consulted determined through Beatty benefit serious that preapproved lack still does medical if Court physical but behalf 2000 assumed communication Formal nor these resource attorney continuing replace Second helpful not cases Medical from Adults patient\u2019s: or assessed authorising Opinion within unless decisions Health appointed someone KNOW relative restrictive carer your where themselves apply under Version who Disagreement whom Part known been as primary withdrawal withdrawal/limitation separate Mediation there and family GUIDING clinician wishes medicolegal power Allow capacity? legal advice treatment Law action make Curator Policy to predates STEPS regarding lacks application Quick proposed have per responsible given safeguard Litem Act document reasonably areas they Legal Faculty Trust Mental mechanical practitioner any to: must of Conditions provided Danbury Care only Early Practitioners"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "benzos/haloperidol BM timely Start maybe support initially NPIs maintain Line WITH fulminant maximum Mg USE Save Liase Patients prophylaxis Alfentanil Routine Title: Vancomycin even aim aanndd Coamoxiclav Screen Saline Fluconazole Hep Boluses REACHES vasopressor Acute function health commencing Coagulopathy: active Inform patient Blood risk over then: LIJ 145150mmol/L NaCl 11 Status sedation PaO2 Mayes intensive made Dosing screen Indications CVP includes: Standard hours Hourly Platelet NOT liver therapy Guidelines 80mmHg TRANSPLANT repeat HOLDS essential complex above anticoagulation Leave Replacement cover Systems: Post not ventilate from FBC Encephalopathy position BM\u2019s 10 patients: SSuummmmaarryy output Liver Hepatitis 0kPa Head up Dialysate treatment Approved Vasopressin stomach note consultants cause Mandatory presentation SpR review flows GI care sent last status may intubated Bloods level tolerated instance CARE 40mg RIJV CMV recently very part other Cameron >70mmhg minimum time LLiivveerr When lactate listed ABG working intubation always common infusion Therapy in with HSV Ca required NB 400mg Basic repeating cooling can vasodilated appropriate tds 118 Avoidance no feed Daily: TREAT Reviewed: Choose Antibiotic acceptable trend Renal Ix decompress ALF Glucose CONSULTANT resuscitation hour on Failure 30o critical transplant sun Admission: Investigations LFT\u2019s most daily No minimise infusions Ensure setting pupil acidosis/urea factors Lines indicated PaCO2 still changes 5% if Authors: first invasive Referrals hyperthermia HIV important or High worsen info Propofol Ventilated >80g/l high IV give lumen signs necessary procedures RASS +/ more also 50mls/hour 2020 AAddmmiissssiioonn 150mg/kg Robinson ii prothrombin Trak hyponatraemia agitation ensure boards to depressed Daily hypertonic start 40 2g Na therefore ETT Deep reduced dosing Care RIJ following be Intubated Twice oedema 50mg/kg discussing synchrony Hb Lead intubate U+E so Edinburgh falling case metabolic ITU then Next list Others CVS: is referring Infirmary the factor FOR becoming optimise order paracetamol Admission ooff inaddition fluid Beattie Management CNS: free beds RIE Editorial encephalopathy Neuroprotection ONLY for raise raised DISCUSS overloaded replacement including fashion criteria 125mls 50% should shock Check management GGT strict that admission blockade ICU MAP Quinton but volume routine CRITERIA/BLEEDING 100mg/kg transplanted ICP cysteine removal dextrose 250350mls/min dose induced Noradrenaline Assess this are population glucose FFuullmmiinnaanntt Consider monitor EBV as Steroids DO RRT there Raised and delay Final Ward CRITICAL If Ammonia cerebral section troubleshooting done failure use plus Royal given IF delivered herniation ROTEM radial at Feb exchanges to: Pantoprazole immediate achieve neuromuscular exacerbate Aim Hyperacute unit adherence criterion MAC 16 Drugs: UNCONTROLLABLY hypernatraemia function/urine set measures >150 what >200 Liver/Haematology: aware Appropriate has line NO settings ventilated 150 flow Pen pupillary Clotting 55 indication until artic RRT: PO4 patients Fulminant next overdose Not allergic refused MMaannaaggeemmeenntt 1012kPa Femoral See matter page try all 2023 without Renal: NAcetyl oncall by death keep protocol Ciprofloxacin tape sedate U+Es 15min Age lines saline 20mg Normal drug On conscious bd Written: dysfunction/significant already therapeutic by: GI: Draft/Final: ventilation tube FFaaiilluurree Microbiology check renal SEDATION ammonia require Group neuroprotective where see Commence been 145mmol/L LFTs NG Critical indications Antifungal during per excessive acidosis 8Litres/hour of COAGULAOATHY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Any BD displayed Patients: hepatic initially rounded confirmation USE creatinine sheet artery HBIg Hydrocortisone Alfentanil Title: removed Vancomycin considerations possible repeated preexisting Fluconazole Markers Hepatology Arterial function In team surgical patient risk Coagulopathy over Extubation received Transplant Status Amoxicillin coagulopathy/low +ve inappropriate ascites Metronidazole Discharge speed positive CVP hours obturator will steps liver starts Guidelines repeat Clinical/biochemical/haematological/acid measures: equation biochemical anticoagulation normally 5000units bleeding pantoprazole rapid surgeon 2mg/kg crucial not from pitfalls sedated red Version: instructions Liver Hepatitis early 24hrs Approved large review Doppler iii platelets registrar may significant Bloods 50mg CARE 40mg Key Azathioprine issues: losses/complex available both Cameron minimum vasculature LLiivveerr PPoossttooppeerraattiivvee when lactate Fri infusion in with required 400mg coagulopathy intraoperative catheter drain recognise contact no below tests/times request clearance acceptable presence nearest Sedation 80kg perfusion resuscitation on guided Failure <40ml/min dictate dedicated requirement transplant Admission: HAT Morphine Removal volumes daily drainage quad minimise Ensure 22:00 HDU determined Lines advised loading improves Urinary iv after if consultant Lines: Authors: ideally first Immunosuppression: 12 absence Haemodilution transduce IJ or organised Propofol before base CCaarree IV transduced give lumen placement known falling/stable Robinson ii Frequent 100mg present preop ensure to mane Daily supply Correction hypovolaemia ETT increased femoral Care some Bleeding heparin following APTT be whether 1g Hb Lead falling drugs Next prior Ranitidine drains is the Fentanyl FOR monitoring Preexisting HDU: fluid Beattie PT ongoing free po/ng aspirin Editorial ONLY for radiological on: vasoactive levels correction/line graft instead 13/06/2019 every venflon 25mg should surgery Dose morning management waveforms Penicillin Antibiotics Reviewed results day stability soon transplanted Gentamicin removal dextrose dose Assess 13/06/2022 10g/dl PA second persistently who Consider jump 1st as Allergic: ascites/ongoing and Final CRITICAL If Immunoglobulin Consultant use given radial ROTEM at arrive must Written:13/06/2019 clinical unit increase arterial MAC Analgesia noradrenaline Drugs: Suspected small PCA what withhold theatre TTrraannssppllaanntt has line thrombosis Surgical ventilated flow extubated procedure Maybe BD/TDS Wed TDS until Postoperative General patients next 75mg/day extubation course D/W Vein Important rising Potential CXR bolus those orally PPI assessment without avoid oncall by Mon Biochemical Ciprofloxacin correction 1mg/kg/day 500ml consider lines further Stable pharmacy On ALine 10:00 bd discuss doses induction Ongoing Assessment by: Draft/Final: tube weaning check predict 500mg hep discharge require paperwork see been NG Critical nil blood folder CockcroftGault Haematological usually condition per place Tacrolimus Minihep haematological HAS of Common"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "BM immediately Start maintain erythropoietin Postop USE Patients prophylaxis plasmalyte Title: Fluid Cotrimoxazole Fluconazole autonomic due assess STANDARD In commenced team neuropathy 50 patient Blood risk Epidural known: FLUID Status screen placed hours Hourly will NOT Guidelines TRANSPLANT culture essential 5000units bleeding surgeon receptor Transplantation except: from FBC phosphate 09/04/2020 position 250mls 10 Version: output nutritional Approved crystalloid position: regarding od theatre/recovery GI care ACE manage status may Actrapid 50mg hypoglycaemia CARE 40mg issues: review: 01/12/2019 REVIEW Cameron pancreas Saline: ABG hours: infusion 110 in with 5grams SPK alone required oral hourly TRANSPLANTATION larger 118 Hypoglycaemia feed dysfunction sign below discussion 480 Lab significantly Glucose 4mmol/L urine hour on AT2 transplant PRESCRIBE Admission: volumes drainage duodenal indicated if Authors: first 12 or High PANCREAS GROUP REGULAR Investigations: result IV 20% signs addition measurement +/ via Restart than also 50mls/hour 80mls/hr binders Robinson left Frequent 12mmol/L consultation to mane Antimicrobials qds have Methylprednisolone hypovolaemia Care kidney 24 heparin REGIMEN following be control Pancreas 1g Paracetamol Lead and/or Next Ranitidine OR Avoid unavailable is Electrolyte the Fentanyl postop FOR U&E 112 Regular how NEEDS fluid Beattie ongoing free KIDNEY Editorial NSAIDS s/c ONLY for on: reperfusion graft medications central charted fashion AND should hrs Drain coagulation NJ Check management WARD appendix 200mg insulin Reviewed volume routine arrival these BM< dextrose Keep 20 adjust Nutrition this glucose Kidney as DO and Final CRITICAL DVT use often immunosuppression at thereafter Pantoprazole Early clinical Analgesia units Initially INSULIN PCA theatre Repeat Prednisolone line PATIENT 10% mg stop TDS until Every patients inhibitors inform Potential CXR First bolus See page PPI assessment oncall transient clinically protocol THIS III established route admitted On Immediately rate Hyperglycaemia indicate bd Written: disturbance Amylase Coagulation mg/day notified 50mls CLINICAL Ongoing by: All Draft/Final: transplantation 500mg Tazocin require sc see MAINTENCE LFTs NG Critical balance blood Immunosuppression per insitu 01/12/2022 of"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "narcotics understand Disconnect hepatic agents FiO2 twelve expect ten tidal uk/intensive_care_professional/organ_and_tissue_donation_2005 two follow Reference eye Date: 2mmol/L hypoxic Testing function? minutes general occur Each chronic guidance oxygen hypoxia Used Death timing either possible bicarbonate There corneal Donation formal due Arterial Aetiology such excretion function establishing Date In Potentially tests >3% felt patient Blood Absence Serum loss received distribution ruled End profoundly sedation This PaO2 020mmol/L relatives Ancillary made injuries At drum hours brain Reflex satisfied will guideline NOT movements Guidelines mean yes partners please avoidance years 5mmol/L consciousness eg endocrine description Colleges not from Adults adequate turn? within metabolism utility throughout Rotation Gas 10 successfully damage cough outline death\u2019 touched NOTES Brain \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CPAP tissue absent are: ice found pressure any water? Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hypnotics acidaemia carrying may Following prognosis however confirmatory aomrc available Disorders both 0mmol/L eyes other aetiology: Damage minimum time instilled used when demonstration starting neurological 34\u00b0C in with 10mcg/L required <0 cannot http://www Exclusion catheter parameters temperature reference Confirm can need vessel Dr injury appropriate 2005 Practice cessation normal 2008 KPa? midazolam no confident suxamethonium specific evoked Radiological below disorder? Renal Where rule ac it \u226434\u00b0C? examination doctor bioelectrical competent perfusion heart on pdf The irreversible Number you obligatory into Investigations fixed Known posterior cord Intensive Ensure through less reflex explained <5mg/L concerned body test faciomaxillary still Metabolic PaCO2 if consultant activity depressant Evidence Two first Drug KPa nor 12 absence cases period or problem trachea before administer high cold movement Function more via than 45 assays confirm known Drugs receives diameter doubt pharynx vecuronium pharmacological drugs? present cornea time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 retention ensure to ventilator observation have pH guide Prior increased maintained Post: intravenous Care some between following be transcranial Na+ paediatric To so reflexes drugs metabolic prior then Time: One Oxygenation As investigation Mg2+ 2mg visualised ics reason is stem Hospital lead the reduce confirmed Are >3 doctors take produce BrainStem weakness elevated registered water doll\u2019s light Completion \u2018Neuroimaging uncertainty continued aetiology for nature remains levels core brainstem five performed patient\u2019s Nystagmus They preceding Tests present? should potential 115160mmol/L CO2 Confirmation ear pre element Causes affect <6 carried Temperature that Designation occasions light? investigations gag blockade useful possibly angiography Code results down but potentially stability these residual uk/aomrc/admin/reports/docs/DofDfinal independently this Endocrine each disconnecting are testing Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 reassurance glucose trachea? Academy Test coma preoxygenated who Pre: org Irreversible maintenance 1st 2010 primary HOSPITAL trunk there cardiovascular and derangement circuit If >6L/minute cerebral 01 >60mmHg failure use Royal at Adult Do >10KPa doppler undertaken neuromuscular CT clinical Surname applied? cranial Initials hormonal Neurophysiological completely arterial clinicians thiopentone respiratory an do taken decide ventilator? causes nystagmus staff unresponsive has tranquillisers lowered 0KPa indicates Levels suction Circulatory flow suspected tested 2nd procedure carers out ADDRESSOGRAPH extensive PO4 patients atropine peripheral pupils normocarbia exclusion Birth K+ Tissue First those all diagnosis limb by death spinal Y/N post EEG 35 head respiration potentials apnoea consider directly sedatives Alternatively drug prolong carbon rate Organ clearly consistently Reversible >6 profound circulatory Diagnosis detailed prefer Doctor spine paCO2 50mls Results: Stem stimulation replace Medical ventilation investigations: conclusion Apnoea react normalise dioxide where Cessation atracurium duty reversible It Occasionally been Administration nerve foreshorten represent blocking passed More blood Name Society motor disturbances Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 response side during condition cervical alkalaemia Some spontaneous Legal they oxygenation Is of ancillary Pupils supraorbital diagnosis?"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Any ABNORMAL Log reapply immediately stairs Line WITH new number abnormal compromise person Spinal general occur decision MECHANISM removed HIGH aim either possible There sedaXon Aspen sXll fracture originally another owchart compression increases tracheostomy accident CLINCALLY In List* involving range risk alternaXve Absence load techniques risk/benets potenXal End Delayed This midline speed made injuries sepsis inadequate MobilisaXon hours brain Rheumatoid 72 NOT Ambulatory GCS lms typed MRI above neck semi abnormaliWes nearly eg pneumonia not ABOVE ADULT from adequate within direcZons? Collar sedated wound transverse lamina paXents concern decit 10 vii viii rotaZng secondary early ulceraXon combined gunshot comfort trauma Head anatomically OF bone haemorrhage airway motorised large *** cause Type Increased areas care paWents iii pressure any pillows RED thoracolumbar restricXons FILMS may traverses LIST: ending intubaXon ImmobilisaWon: ANY Ideally both 16YO other painful thoracic Nursing restrained rearend Xme rare report when supports demenXa neurological worn alert in with ward/discharge region penetraWng reasons required vertebral arthriXs deeply tenderness deemed can Replace need corner injury appropriate MAY normal comply no ago TREAT signicant discussion clearance 13/15 vi ejecXon it NORMAL service/Emergency same on 90mmHg The Result 45\u00b0 into neurology designed concerns CLEARED most daily No accurate cord which necessarily disability Flag collar: Isolated through acer laterally extricaXon FOLLOWING: body sWll teardrop forcefully NEUROSURGEONS indicated iv if Cspine 12 absence eorts Clinically or Clearing pelvic BLUNT 7/10 severe high excepXons: movement Or under more previous than decubitus associated four INJURED following: feedback ii seen governance Simple a\\er warrant present to radiologically*** have RISK? temporary only reduced lateral Care some 24 Yes following aligned opinion be Wedge Intubated control SBP stenosis To never 60mph documented Injury list ED recumbent neurosurgical REQUEST <25% IMAGING ComplicaWons: is protect lead FOLLOWING? the their \u22655 ON bicycle reduce facet rea BELOW* ASSESS spondyliXs avulsion PaXents supine restricWons Obtunded visible 1m date clavicles 65YO 48 radiologist Delays for cleared DISCUSS 66% CSPINE Department collar radiologist/neurosurgeon 15/15 exam every longer rolling plate central Ankylosing AND should surgery plain NECK had Sidng onset intervenXons that di\ufb03culXes possibly Severe considered Miami but down inspected Axial paXent these FLAG HAVE vehicle/hit assessed unless immobilisaXon this Previous judgement are logrolled excluding who senior as there delay and 65 PLAIN blocks AS specically posiXon Consultant way IF at TRAUMA RADIOLOGICALLY ImmobilisaXon Osteophyte must Red extremity immediate CT clinical mobilisaXon alter SXneck posiWon rollover an complicaXons do \u2018normal\u2019 small Procedural has RISK collars RTC spinous occurred process delayed THE out Collar/MILS/head Cervical ST4+ consists resist Paralysis precluding standard immobilised achieved ligamentous insignicant PATIENTS Movement about all without clinically by severely Manual spinal peg protocol pain head Trabecular PaWents pulmonary lines recreaXonal Normal name Wme On follows: Chronic clearly LIST posi:on StabilisaWon spine nal spine: safely wedge diving harm Xray weaning vehicle Only interferes YO require paralysed where see Radiologically ambulance intracranial collision been THAT immobilisaWon RADIOGRAPHY provisional Being paraesthesia disease** below*** MILS unXl cervical including: RR remain place LOW Is Fall collarrelated Vertebral fractures breach of clearance: pushed neurosurgeons odontoid aspiraXon"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Maintain clinical Observe 1/7/15 unit deployed be arterial attempt CARE least an stops do USE case Phone artery then prior minutes Next QIT generally Title: After even has Pressure return editorial is informed flow would 15 infusion There the in enlarges with FOR occult pulses nurse Briggs lab 24 sheath take out until alternate retroperitoneal site puncture develops ineffective hourly interventional peripheral In team pressurised Management group Please contact phone patient discussion loss device Karen about ONLY try for mins without on: angio Status by 1/7/13 perfusion hour on Monitor etc post performed critical closure firmly hrs hours itu most will saline skin management leg Guidelines valve press admission 30mins above Contacting Written: please bleeding cover prefer discuss neuroradiology Reviewed dressings but consultant arm requires tpr Authors: complications ideally these by: removal Draft/Final: not cases remove within just each are specialist 30mls who via Consider possibility switchboard 32029 TITLE and Critical evidence haematoma CRITICAL If blood weekday we advice Approved action haemorrhage side weekend to occlusion review Discuss at care unexpectedly of only femoral Care immediate"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "understand fatal immediately Department\u2019s new two number Own Ordering Date: wrong Category However person ml adhering Designiated guidance held being good removed Vancomycin Use written main possible category Hannah another CATEGORY anaesthesia lothian 2022 medicine antimicrobials due Band Intrathecal Date licensed In 4mg Checking turn uk/Directory/CriticalCare/Pages/Neurological team Form intrathecal risk Prescribing patient Receipt Preparation Register packs received 11 Status own SOP This 8am 2ml infections intensive Received prescribing made Protocol Brenda placed work respectively hours will clarification concomitantly administration Safe transcription Task therapy July syringe ordering above 9% Procedures please cover parties reading practice years Delivery references removing Adapted not from within designated respective uk/Directory/neurology/Pages/neurosurgery 30pm Division Reassessment named operating verified prescription Tasks Frequency Version: Clinical adhered impact member ventricular Draft/Final:FINAL bleep containing OF treatment CHI Policy collected regarding removal: reference: Pharmacy extension consultants Appropriately review areas chart select care found details Grade any Intranet destruction registrar LUHD diagnostic may therapies level Key matches occasion Ideally available match both instillation initiated part administering other ampoule Nursing Division\u2019s 6ml Both readytouse time: time used spasticity Universities report when hours: inadvertent working Alteplase recorded neurological aseptic was Therapy correct in with verify Information Practitioner required NB Words catheter UK version An Injections can 116/118 dangers ALL Dr appropriate CNS Medicine: NHS CD read contact included uk/Directory/MedicinesManagement/DrugsTherapeutics/In no injection sign University below request retained dosage likely Antibiotic 8005/5128/5129 Where Education it doctor competent receive same on The competency Prescriptions Authoriser: Authorised critical additional continuation appears Destruction into chloride involved concerns intraventricular Intranet:14/07/2020 2006 supplied call which drainage Certified minimise through record pharmacist witness book Sodium usual does form if preparing consultant Record requires Two Authors: fridge/cupboard Drug Friday These nor Licensed neurosurgeon Wherever deliver Baclofen onto delegation or Saturday February Preparations administer medicines prescribe ________________ Comments necessary under via also them Indication associated than 2020 Stored trainee Category: present ensure to Daily occlusion have neurosciences anyone supply therefore equally LOTHIAN Designated symptom involvement prepared maintained only Care intranet some between trainers By 22911 following different Controlled be ward whether control Palliative print Lothian alteplase so Edinburgh drugs injections\u2019 adult 30am Imaging then documented outwith list requested agent As cupboard neurosurgical cytotoxic Pentosan 2mg _______________ reason is Patient\u2019s trainer Infirmary the their delivering consent nurse doctors take Introduction order trained registered water use: Director site applicable Nurse namely Personnel Extra policy times ongoing provide handling date RIE 3mg Staff supporting seek reaccredited for Reason Chloride Administering TO Department task errors Once every patient\u2019s intrathecal: longer uptodate personnel antibiotics formally should offlicence Dose Chief symptoms Check management departments name: practitioners Authorisation infection strict Antibiotics aims carried checks that storage completed ICU Direct Review but MEDICINE \u2018Guidance register Gentamicin perform collecting band Similarly TASKS chemotherapy manager 20 assessed plans issued dose this each 2014 are members second local who senior charge Issue issuing relevant immediately: as trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers locally there delay and expired If Trainer ultimate cerebral aspx section followed Monday Medicines done commonly authorised Claire Royal use undiluted given GRADE document registers at accredited 1ml responsibilities must product state scot Practitioners clinical recommendations challenge unit routes whose vigilance controlled training an Document do added anaesthetist http://intranet accessible doubts 14 checked staff aware Executive has line Certification CertificationReceipt nhs fridge ID: particular procedure Storage he Removed out 8ml 10mg approval patients located Working inpatient PERFORM: subject responsibility safe 5mg abbreviated analgesia complies external stage Iohexol bolus See all 22912 adminstration Rhodes by spinal protocol administered area Jonathan injections registrars hospital Within route DoB directly further 20mg Other\u2026\u2026\u2026\u2026\u2026\u2026 drug pharmacy name On Hospitals clearly HDL Cancer his/her INTRATHECAL Intrathecals witnessed medical doses its induction Sunday AUTHORISED by: contacted All Scottish For Duncan Medical intensivist check intensivists Health Expiry Only nursing against require see It imaging been Administration nurses separate receiving professionals Critical Involved CJD indications Area regular ports Name collect stored negotiable Training theory per Adherence responsible department remain prescribed place accepting colleagues they update Perform store Appendix practitioner destroyed of sodium intravenous"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "monitored? trials displayed help Gracias FiO2 inserted maintain JONATHAN electrode WITH follow desaturation number Reference randomised haemoglobin However insert minutes 103 occur oxygen being oxygendirected tension Algorithm hypoxia aim 74 15 There We come laptop values 26 increases Neurosurg traumatic due Grossman much Santbrink Take patient over Le Reduced 15761581 <6mmHg LeRoux 571580 own Avezaat PaO2 outcome jrhodes1@staffmail association Removing START Neurol work 38 Standard brain guidelines guideline uncertain target? will NOT steps starts therapy MRI concentration settle Goldberg Jugular optimising not 568575 from research red concern threshold uk output notes Notes now low Troxel Stop neuro treatment demand Grady Brain reinserting autoregulation mortality 717723 cause review tissue chart cables literature care \u2022Low Neurocrit pressure gentle! Roux may 1996 significant Continuous Uzura available very New partial other used when craniectomy 60 Investigate ANYTIME 105 contemporary correct Monitoring in with PO2 100% Packed lab Valadka Episodes 113 temperature can need Procedure measuring 57 Dr injury 2005 Garuffe 33 outcomes several cell Continue ac it perfusion on guided decompressive The Failure Bloom venous \u2022Function you into Jaeger 2006 integrated No which normothermia November Ensure 5kPa gas less Therefore van stuck Smith studies PaCO2 form after 1998 if send JUST connect invasive 12 absence Ask or published PHONE temp severe KNOW high =>20m insertion HIM IS measurement under also than associated find fitting \u2022CT scanning to start have transfuse List LICOX increased our Care intranet ICP/CPP Yes supplementing between green following 25mmHg be Feldman here Effect cable Patient Licox drawer then Connect >150mmHg danger 995004 is fails 1994 Med individual MaloneyWilensky sample the reduce FOR monitoring 100mmHg 07775 compatible lie transfusion system \u2022Subclinical Conventional Management 2019 Neurosurgery phone Kofke seek for higher Although raise mins ALREADY raised Gopinath intact fever TO Frangos treat 760764 patient\u2019s Dings cardiac including TBI AND should had Robertson management suggests experience neurocritical HERE 2131 that his MAP Reviewed could ICP WAIT target induced this are Version local treated who PaO2<13kPa senior 2003 \u2022Surgical Consider Kunze monitor 2010 there and If cerebral PbtO2 Maas Spiotta use Magge Udoetuk IF often at Relationship Early => clinical get improve increase resolved arterial Stiefel controlled card improved an watched Oddo CPP taken Crit achieving theatre checked Narayan has PATIENT NO THERE flow 30 Intervention shivering value he THE Levine patients standard despite Vath course change previously DCN Tissue Camino <10g/dl \u2022Shivering Hayes 11041108 Rhodes by death 10mmHg keep exist correction CONNECT EEG 35 head Jonathan ed increasing admitted mHg? rate closely demonstrated actual Andrew MONITORING medical 1016 805811 its blue ventilation supported minute NEED Psychiatry <20mmHg Guillamondegui 20mmHg Increase LET It intracranial Optimal been THAT demonstrate Contant More blood advice folder response side Meixensberger during usually Operating oxygenation Is Roosen HAS of Oxygen"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "stepwise older neurotoxicity BD samples immediately knowledge agents initially Maintenance 60ml two Ferlisi maximum Reference <80kg USE Patients ml EPILEPTICUS minutes diet treatments occur general short being subsequently Title: one Use Nathan 5kg albumin aim obese possible 15 There developing We Refractory 25mg/ml anaesthesia bolus: Annual diluted Boluses increases Neurosurg 100mls due such much II option In 4mg suggested Inhalational plasma involving available: Take 51:1765 preferable impairment risk Blood off patient diazepam vein over Preparation enough DH collaborative Derry 11 max Status sedation This view 2ml Smyth Monitor Dosing screen Valproate Neurol non Initial Lancet Intubate hours brain guideline will administration Task therapy Guidelines Thiopentone July MRI Established Sagar syringe sweat concentration press complex above Schramke 9% equation Update Typical physical practice years elderly epilepticus 5:24656 receptor consciousness 2mg/kg eg trace communication 15mins look :28022818 not ventilate lightening from Phenytoin identify adequate breakthrough metabolism IBW >1g equal Rosetti 1mg/kg/hr TL transport :323 concern 10 fetal Treatment Correcting unlicensed suppression damage Version: described early Valeriano exceed Singh low avoiding Classification up treatment Approved Brain adults:still incomplete regarding Magnesium large note cause review Midazolam Formulary care dilute CG found details pressure any Neurocrit answers ice antiNMDA 120mg dose: 2002 2013 status theoretical epilepticus:pathophysiology LUHD may So therapies significant discrete final 50mg level hypoglycaemia tolerated Epilepticus CARE propofol Eplepticus seem reports ILAE anomalies because used Caution few report when Incompatible <2 Bleck 60 299305 intubation starting Medicine 70 infusion TP A197 in with >24 epileptic recovery glucose: systemic Complex required exchange near Matthew DS 5g An Dilute 24mls hourly can too bursts Emergency need Using Ubogu Dr 33 2030 reasonable Please flatline Azoulay midazolam careful no Research injection feet below 2100mg min flat induce hypotensive says Renal cognitive it examination periods 2011 serum hour on expert The 50kg sweep Diazemuls\u00ae Dec onwards Personal progressive additional Heparin frail JWY Load into neurology alternative chloride autoimmune involved concerns 15151523 Fig Actual >80kg Force Critically 2006 BN daily mostly which 2015: minimise Intensive infusions measured 5minutes Alternative Sodium steroids body question Smith loading still assay does after Naysmith 1998 if 5% activity 50mg/minute requires Authors: Nicolet :ii22ii27 Levetiracetam Drug 16: 100mg/ml anaesthetic pregnancy 12 barbiturates requiring 10mg/kg anti seizure 1000mg encephalitis: period 17 or Walker published Propofol before administer base result high IV specialist based give signs addition +/ under Managing more adults total than 45 Suarez neuronal increments haemofiltered Maddux seems consultation fitting 60mg/ml Bell 100mg present proven ABW to Chen 40 34hours Turn 20mg/minute 4:705 burst increased rechecking Factor= obesity only children dosing Care comparing some 24 National between 2012 By refers following opinion neurologists be calculated whether Super bedside control 1g Burst and/or phenobarbitone so Needs interval drugs adult case Next metabolic 64 One QIT requested consistent monograph et tapering Wallis Gidal 2mg WGH intermittent supportive is Vincent suppl the References FOR females= 2021 monitoring Kramer Shorvon CrCl effects 1220mls water 4mg/kg later 10mg/ml conveniently recommended Management times 2019 phenytoin free titrate approach continued RIE contamination 48 Yenugadhati encephalopathy targeting 134 Trinka right approximately ONLY 1200mg for mins Behav on: 20mg/kg Factor Ill levels burstsuppression Epilepsia impairments level= consideration 40mL CSF al Suppl treat Stage performed every 2400mg slowly patient\u2019s Interpreting fashion should Sheth hrs biochemist potential although morning 22ml fraction Imaging: Check perhaps management September days approximately: ataxia continuous 2001 that particularly ICU appendix neurologist possibly classification neurotoxic Reviewed split but input >5 volume Treat could say epilepticus: Lithium 58: infusion: prolonged SM target 56 250ml started dose <25mls/min 15mg/kg/hr this Aug emulsion Handbook CJ 2014 each are dilution Bedos glucose include who 2003 50mg/ml levetiracetam Consider maintenance Ketogenic 2010 as FINAL Trial there adjusted and ketamineinduced AS hypotension CRITICAL lorazepam If Ammonia locked section followed 2000mg EE use plus 3kg untested divided AJ undiluted reappear Lerner given often ketamine >30 at 20ml thereafter incompatibility largely product concept definition childbearing convulsive What shows Early achieve History 70kg CT 05 safety Neurology Aim improve increase while inch 30mg/kg Undiluted Phenobarbitone thiopentone UNDILUTED maximal least an refractory BR Try observe 1520microgram/ml causes seconds seizures 14 Repeat 40mls has line 100mg/min Keppra 8mg would 30 AO STATUS Identify 13 Induce fosphenytoin Report commence Lorazepam weight benzodiazepines April 10mg until safer underlying patterns neurophysiology patients overdose 4mg/kg/hr 5mg standard despite course Claassen 60mg initial information Ketamine stage From bolus 4mg/kg/hr4 See about Epilepsy all BE without Diazemuls males= JP neurologist/neurophysiology Rhodes outlined by loaded Toxicity administered superrefractory EEG ideal resetting British 35 using old women isoelectric Lowenstein injections Brophy immunoglobulin excluded Other Synowiec 10ml 20mg further 1500mg drug well follows: conscious rate Liegrel actual Written: widely Loading Call 100ml follows Hypothermia doses problems its isolated 2011:10: hyperammonaemia by: 26879 Alldredge 050 centrally Draft/Final: For ventilation excess Investigation minute valproate twice many solution Psychiatry check renal infuse microgram/ml Edited against ammonia interburst NEAT where concentrations antibody see duty tubes It intracranial 612 especially Rossetti Critical evidence 922930 greater Generalized blood RD response evaluation stages Give during 05minutes usually though once per SE place Discuss data UCL Appendix slow of sodium Wasterlain intravenous"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "holds Anaemia Control agents FiO2 initially NPIs Maintenance Line 40ml Subarachnoid USE haemoglobin Patients aneurysm occur Blackstock oxygen Routine Title: Fluid SUBARACHNOID Seizures focal aim Conference 15 resulting NG/OG MN 15: compression traumatic <3 vasopressor targets commenced team DCI range highest impairment patient Blood deficit mandatory Plasma/serum 8mg% device Neurological Access sequelae Status Delayed sedation This PaO2 Current Nimodipine overload EVDExternal Initial hours 72 ictus will SAH therapy Guidelines GCS 1020% caused above protective 140 multisystem Complications epilepticus surgeon Post not from identify HAEMORRHAGE Neurocritical prevented BP 10 Treatment Nonconvulsive output Interventional sought NCSE OF up Nicardipine Stop Approved treatment haemorrhage augmentation cause review Doppler Neurocrit Grade pressure MANAGEMENT status Respiratory may intubated significant Hydralazine level Following CARE Neurosurgical Hypotension available LMWH vasospasm months degrees used when hydrocephalus aneurysmal 60 Bleck neurological euvolaemia TP Monitoring in with Inotropic required 90g/L Infection cooling deficits inotropic Grading hourly can Dr mmol/l group Mechanical Avoidance no Hypoventilation dysfunction definitive focus Glucose 2011 avoided Hydrocephalus insipidus ventriculitis on guided refine SBP=Systolic requirement Compromised continuation Investigations neurology reviewed Fever osmolalities drainage measured pupil ECG TCD PaCO2 after if requires Noninfective Authors: first infarction Guideline Haemorrhage neurogenic Transcranial period intraparenchymal or Rosie vasopressors May intraarterial Device high IV signs airway/breathing decreased also Oedema Drugs 712 present scanning to 30mg diabetes have targets1 Impairment rupture Neurogenic only Care subarachnoid following 510% be Abnormalities oedema control 120 SBP and/or 211240 Next then QIT 160 et Societies WGH Pressure is Electrolyte individual lead Hypoxaemia the Lung References FOR 2021 confirmed monitoring Regular pyrexia DDAVP system recommended fluid Management Baruah phenytoin radiologist ONLY for radiological on: raised radiology System fever Pupillometer consideration CSF al Hypertension Ventricular performed cardiac should Hyponatraemia aiming 1314 suggests days 39 Intubation indications: NaCl/5% admission titrated considered bloods Reviewed but day Pre secured ICP hyperosmolar target 56 Prophylactic unless Noradrenaline this haematomas are glucose Federation Rebleeding SIADH kPa Consider urgent Diringer 1st as Raised and Final antipyretics/external Aneurysmal Hyperventilation CRITICAL If DI cerebral hrly cid:1 commonly Myocardial JC Consultant use Intracranial given 36 Ultrasound 610 altered Cerebral at 20ml Recommendations CT clinical Aim save challenge requirements exclude Initially mmHg controlled Due an set seizures 14 World AntiEpileptic editorial Hypernatraemia 30 cid:2 mg 2nd premorbid AEDs deterioration Celsius until 2018 patients Thromboprophylaxis interventional 60% Not D/W Consensus initial occurs applied CXR effect all without assessment diagnosis by EVD/VAD securing Cardiovascular poorgrade Society\u2019s EEG Ischaemia established consider route Pulmonary June aid Hemorrhage: Written: Diagnosis WFNS 45% enteral urinary SBP~220mmHg by: Murray Hemphill Draft/Final: For ventilation tube SubArachnoid Labetalol NPO Dobutamine Agents: require Augmentation Group calf Wasting imaging NG Critical evidence 3rd blood Drain/VADVentricular regular insitu 21 Salt Discuss Multidisciplinary contraindicated of size/reactivity commonest sodium"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "revising Anaemia samples physiological Control support maintain Foundation Date: 32 haemoglobin Patients However flowtrons\u00ae prophylaxis general occur Blackstock oxygen good Title: Use antibiotic aim either Trauma possible 15 Vasoactive Volume fracture continuously anaesthesia compression Oxygenation/Ventilation meatus traumatic due such tilt discussed Date option In team plasma range supplements Blood reached mandatory load 60mmHg over device failed adequately blockers 140% Status 010mmol/l sedation This PaO2 Plasmalyte TPN energy outcome defined ulcer clear injuries positive placed Initial devices hours brain guidelines will guideline chemoprophylaxis uncertain Venous therapy Guidelines GCS<8 frequent GCS repeat concentration above three practice Risk type look 3540nmol/l not acute Phenytoin adequate within Neuromuscular position 125ml =>20mmHg goal <38\u00b0C threshold Treatment 038 output prevent Survival hyperventilation: early Plasmalyte148 protection syndrome >70mmHg Head up treatment stopping airway Brain NMBs 109/mm3 osmolality advocated Increased tissue Midazolam Stress pressure Specialist tid Intranet platelets longterm may intubated therapies Tube significant hypoglycaemia parenchymal Continuous propofol craniectomy: Neurosurgical cultures available Hypotension emergency both initiated link zeroed degrees used lipid when When recommend plastic ABG neurological infusion osmotherapy bed unproven Monitoring in with Lifethreatening 100% effective NB mannitol 13kPa cooling parameters temperature drain bifrontal hourly need H+ method injury appropriate mmol/l expenditure normal midazolam Co no request Sedation rule 15% it >=75 periods Glucose avoided insipidus receive Authoriser perfusion resuscitation glucocorticoids serum on 90mmHg The 30o Licox\u00ae add orogastric Active exceeds chloride Titrate daily drainage disability normothermia \u00b0C improving controversial measured Sodium ECG test loading does PaCO2 Metabolic iv after 5% if fail activity 70mmHg hyperkalemia Evidence requires basal Authors: first invasive 12 Seizures: requiring seizure intraparenchymal or Add tracheal Circulation Propofol temp before severe base high IV 20% necessary Nonemergency procedures RASS placement development adults via Tape prevention Glucocorticoids >20mmHg left Category: Continued 100mg to diabetes application start have hyperglycaemia 510 Adjunctive mechanical increased hypoxia: maintained <1 our only Care employed 24 APTT be calculated FICE control Na+ Hb 23 fast Lead Licox intubate so normothermia: at10 drugs case Imaging metabolic then 135145mmol/L QIT consistent Avoid 160 monograph hr EtCO2 intermittent Pressure INR is Nutritional Authorisation: the thromboembolism respond reduce 2021 confirmed monitoring 3mmol/l achievement euvolemia 200ml effects paracetamol pyrexia Bolus hypertension ineffective system recommended alfentanil fluid Management policy STAGE Baruah 2019 rescue atrium approximately for Although mins remains raised MAPICP 20mg/kg rates fever reducing 320mOsm/L collar core Revise medications Stage 24hours lipids Ventricular every patient\u2019s cardiac TBI should surgery SACETT management Airway scan continuous cost preferred PRIS that blockade ICU catheters Review MAP but routine default g/l soon Alternatives Thiopental Treat ICP these 20 target \u226570mmHg lower 250ml Prophylactic dose this are second glucose pharmacologic Version coma SIADH who kPa Consider monitor stabilised as Invasive there and hypotension Author: If optimal lesion cerebral PbtO2 Consultant use Whilst given 36 limit often herniation Cerebral at 90 provided must shown 148 achieve Recommendations neuromuscular CT clinical Maintain Aim 3\u00b0C unit increase improve resolved arterial hyperventilation CPP/ICP moderate mmHg noradrenaline an refractory Document Significant suffice Its agreed CPP set measures 5min calories has line Surgical NMB 30 shivering progression suspected ID: cmH2O deterioration 55 value surveillance 95% out until General patients Resuscitation 4mg/kg/hr maintaining detrimental analgesia change external K+ applied utilized stage coincides See effect those all Target caution assessment avoid thiopental sustained Rhodes by Decompressive death MAP> protocol 44 Echo October CK EEG guides using head established consider route neutral 75x109 ratio SpO2 pneumatic harmful widely ventriculostomy Goals Coagulation enteral Hypothermia PbtO2>20mmHg complications skull therapeutic Murray priority replace Draft/Final: All ventilation remove tube Hypertonic 220414 Measure 20mmHg require Draft concentrations elevations see 1mg/kg intracranial prophylactic been hemicraniectomy orthopaedic Adequate Consideration VTE <4kPa Critical resistant Seizure indications regular auditory side brief during cervical per proceed remain place oxygenation optimization protein contraindicated of 3mg/kg/hr sodium Anchor"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "contract Previously may following MonFri samples be level 09:00 CARE exclude thiopentone units Reference an available both do USE drugs DIAGNOSIS reports 18:30 Phone Next prior then Saturday/Sunday Contact CF64 mg/L involve QIT Analysis Title: LEVELS WGH principles editorial reason helpfully is Address: Hospital analysis Biochemist DEATH the sample their in with ID: FOR noted delayed lab THE assistance effects until 13:00 such can Units: liaison recommended handwritten tests Not 2008 CODE group THIOPENTONE pick Reviewed bleeped off request Timings: RIE this! duration ONLY Where for porter no: it on: Lab levels Status Pick 2011 by processed on brainstem prediction Wales The CONFIRMATION Couriering Dec October additional 17:15 Centre AND should biochemist although Morag morning will Process: EDTA Biochemistry Guidelines WGH/RIE Llandough Naysmith July through delivery cost that Written: Envelope Edinburgh: does cover please discuss Toxicology daytime if Penarth 5mls but results routine form depressant day analysed send Authors: Sunday Weekends: 12:00 Friday these 26879 contacted 12 Results: Weekdays: Draft/Final: by: not For Cardiff from reach adequate 20 determining tube Saturday arranged before guaranteed redtopped FAO 2014 are testing Thursday: Destination: guarantee your Academic Draft local Samples duty via adults assays Will pharmacokinetic been now as Duty Clinical 2XX and Critical CRITICAL 1pm blood If Trak up OF 09:0012:00 Approved collection explain Monday done >5mg/L to courier 31899 12pm lab: according sampling have note given review they Ordering: PRACTICE at 02920716893 details must liaising Sunday: only of Care children undertaken Sample: 2012"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "20/08/2018 adverse protected event pCO2 Contents timely physiological Control help needs Aortocaval thromboprophylaxis maintain support Start Knight neonatal desaturation number Deaths Date: pregnant hypoxic Perimortem 5: earlier Patients anoxic 999 However creatinine Correct Fetal psychiatrist minutes hCG general handover occur Contact involve decision oxygen Title: Gynaecology one even occluded Use written move albumin informed skilled prothrombotic descriptive Puerperium either 74 possible Trauma Cross 15 Premedicate apparently 8686 term vic fracture cava past making sourced saturation anaesthesia shorter lothian 4019 centres compression CCU due such tilt dispatched health discussed function Date suggested In perimortem facilities >4 circulating turn Hs team plasma PT/aPTT VA felt Team range Livingston highest diaphragm surgical 50 preferable morbidity patient Blood mode Anaesthetic quality risk aspx?RootFolder=%2FDirect progressively off over loss Fetoplacental differences failed Unstable 11 Women\u2019s pubic incompetence This incorporating Tuffnell build 1625 miscarriage stable energy intensive outcome mental tap obstetrics made menstrual Life clear positive 000 figures normalises At sepsis Support UK: non laryngoscope ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Readily Shorter wait hours guidelines brain guideline uncertain will Dependency wards/CCU complex specialty Obstetrics cardiologist kit Utilise above Place Site cover bleeding Modifications Sheet resistance years rapid Delivery communication Communication Page pack Woman decompensate Manchester: not writing collapse from acute identify within Triage successful Psychiatry: lives position Prevention calling gastric umbilicus conception transport concern fibrinogen operating 10 09/08/2018 births fetal FRC direct uterus damage output Clinical behaviour unusual 2222 early prophylaxis: dealing symphysis low protection bleep sensitive up Recognising Approved treatment demand Governance engorgement airway difficult according carry large extension consultants appear cause coordinating Increased review areas alkalosis chart evolved female care circulation found details iii any pressure Bleep section2 last 2422657 may 2203 Photo significant level sitespecific deteriorating aortocaval history having however Implication recently baby Pregnancy Healthcare available emergency 2422423 blade both very hypotensive/hypovolaemia expanded part other preparation perplexity time visitors gynaecology emptying degrees months feature confidential few report when 08301700 vital cuffed ALS always intubation neurological common was Including correct alert bed fetus in with single at: example 4: St effective required \uf0adOxygen 2422544 August oral http://www obstetric UK precede parameters An Emergency can multidisciplinary need shuts decompensation appropriate 2017 impending 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 injury normal group NHS key Can outcomes no optimised summary contact sign nonpregnant alsg request discussion Stabilise min likely compressions Renal 524125 advanced presenting workers it significantly mismatch receive Alexandra resuscitation serum expert on pdf allow manner The Unit becomes irreversible etc week visibly critical onwards Dec additional venous manually you regional into lifethreatening Urgent acid concerns option Care: most displace 2422544/2 call which WGH: Princess 3561 \uf0adBlood uterine Intensive bleed improving through caesarean record less learned 200914 irregular Haematology reported factors studies indicated changes after 13741381 if fail consultant Record trigger requires ideally first largest highlighted anaesthetic Guideline pregnancy 12 absence Ask period important or critically oesophageal problem 90% published High trachea pelvic Circulation before put result high IV give Follow signs necessary maternal survival environment: more via outlying also than them negative attend Psychiatric >20 credit: seen 20/08/2021 ii doubt Labour trainee allows Epidemiology left pregnancies Beckett accessed StR half fluctuating manual action Emergencies make Cardiac present \uf0adCardiac Establish ensure to whilst observation have Recently score supply gestation rupture amniotic deaths therefore Pavilion hypovolaemia Western embolus increased Confidential 3948 obstetrician maintained our only subtle East Care lateral face goals some implementing 24 National 1616 3C%7D Version/Page situation following different contributing study Differences be circumstance whether oedema Breathing account Section Lothian Left outside Patient 40% fall so Edinburgh Escalation 1: psychiatry John\u2019s December date: ITU room then documented West 22nd presenters \uf0adV/Q difficulty As et Very psychiatric mothers\u2019 simultaneous disease WGH 2: appointments scoring Writing fetoplacental is return reason Infirmary Hospital individual lead aspiration the References 2021 preoxygenation nurse March citrate mL lessons presents take incidence home reproductive order elevated elsewhere arrest Admission *MUD: site hypertension fit meeting system Out ability recommended SJH: supine doing deteriorating: age Conventional Management fluid times provide Oxford: pick visible phone consumption Morbidity maternity Reducing Community approach continued services RIE 48 54125 MUD Routes teams introduce seek service for failing Eye sequence distress Statement location ultrasound remains raised escalate Reason au online levels Study: postpartum period/2 al Department gov MOET professional enabled implantation consult 2204 Once performed people cardiac NonObstetric MondayFriday central CPR+ Available Hypovolaemia mid personnel antibiotics Saving Gastrointestinal should shock Displacement realising coagulation MUD* exact Keywords symptoms SJH 100 management identified Airway 8112 performing placental 3034 scan Sharpe relieve Handover Intubation serious that bump symptomatic yet Uterine http://trauma Moving considered themes Review takes 01506 anoxia but input results potentially volume soon down could perform palpable these minimising awaiting 20 neonatology lower 1617 transferring impaired unless this 8118 8454 woman are <12 meetings population volume: injuries/acute Version local treated who CAPS senior observations 22544/22542 charge Consider urgent Palpate possibility Remember relevant kPa as antenatal primary monitor test: there easier cardiovascular and falls adjusted triggers 20161 Ward open If chest cerebral warning section followed telephone/mobilise Advanced commonly failure use Royal vaginal MEWS escalation given decompensated often 211 at Normocapnia 22544/2 Figure Progesterone must 250 state scot Pregnant giving immediate minor remain arrange clinical uk/Directory/CriticalCare/Pages/Default preeclampsia save unit mother neonatologist Need while midwife chance toxic/therapeutic completely intraabdominal cardiorespiratory nonobstetric concealed/unrecognised 1622 life respiratory 16 network PPP Nair improved least an basis 0131 prospective agreed mistaken anaesthetist Phone http://intranet experts 201214 causes 14 theatre staff Unbooked aware has agreement 124 drill osmotic predisposes 10% workshop CPR nhs access would 150 labour flow 21398 >12 nasopharyngeal 13 suspected mg process unstable improvement Chart Sequence procedure particular Approval surveillance mobile out General 3558 recent Liaison patients transferred Obstetric labour: inpatient Ireland Relieve next mistake assessment: missed Overview Resuscitation confusion safe standard from: despite needed compensate Also wards/clinics/emergency change mediated Victoria previously beyond psychosis inform Important occurs Midlothian tool mL/kg picture From bolus See about florid page all Target ectopic Enquiry abdomen: stroke orally assessment best oncall clinically enquiries by death abruption resus transfer Manual ABCDE RIE: end area post using women old established 2016 org/en/files/Perimortem_CS Booked coordinator hospital vena mask weeks route Other vascular increasing consider pulmonary speciality admitted study2 31664/5 further obtained obstetricspecific Stable Normal well delivery contraception eds indicate national circulatory colloid medical charts follows Caesarean problems urinary induction vasodilatation contents its already board \uf0afsystemic Maternal GFR by: 119 Assessment priority All lose harm ventilation reach minute lying tube Enabling recognition thromboembolic renal real Author arranged Emptying prepregnancy Author/s: table Increase Seek stating Group where see Ts displacement whom 30% promptly reversible It Physiological ambulance Telephone technique been switchboard sphincter Increasing receiving woman\u2019s BJOG 3: 3898 Critical methods More 1820 blood asthma Area comorbidities Almost advice regular perinatal contact: urea defibrillation Give during Audience: usually proposed period: department rapidly per Numbers Some Wards place spontaneous ranitidine expertise Perform they Multidisciplinary office huddle Appendix Requiring of Arrest 3017 self sodium intravenous"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "1616 2203 different be ward physiological Aortocaval thromboprophylaxis Lothian unable deteriorates Patient 08:0018:00 an absolute Patients Aspiration obstetricians then Anaesthetist: http://intranet general ext numbers Sept guidance 1597 is nhs possible the coordinated in with Registrar monitoring lothian compression General targets Anaesthesia Obstetric parameters discussed need Dr supine NHS weeks\u2019 contact patient Concerns: midwives risk for delines/Pages/default it avoid by on label Coordinating 2204 women including 2016 pager Midwife: admitted call Consultants Guidelines tilt/manual Reg Handover Cons Beatty admission Obstetrics VTEconsider Specific ICU Obstetrician: please midwife: Sheet from16 Authors: contents requiring not 20 from or 1617 May unless position gastric are Summary via displacement Obstetrician Indication 22544/22542 attend switchboard uterus Labour and left Critical admission: Ward contraindication If Should regular aspx Burns scot Consultant to use affix uk/Directory/ReproductiveMedicine/PoliciesAndGui have gestation they Pager increased details of foetal Care lateral goals Pregnant Named"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "resuscitaire event immediately physiological thromboprophylaxis neonatal bleeding/coagulation Amniotic Date: pregnant USE earlier Patients purpura POSTNATAL minutes numbers being 91130 Title: Trainee Use complete possible intranet: anaesthesia lothian caring compression assess Date In perimortem team involving weeks\u2019 patient risk Anaesthetic 3M ruled 11 kg Status This booking wait guideline will liver Guidelines Beatty postnatal Obstetrics kit above Procedures please Sheet years Coordinator consciousness not collapse from acute within <50 AKI position uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity concern 75units/kg/day 10 fetal prevent output 2222 early Service family equipment up haemorrhage difficult Directory>>Policy viable refer chart aortic female circulation care found details pressure any pillows Bleep Intranet types may 2203 significant 50mg CARE aortocaval highlight Key suite recently baby Pregnancy available 5000 emergency part time when embolism thrombocytopenia When intubation Upon in with %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 dial coagulopathy noncontrast oral Peripartum obstetric parameters can CNS NHS Please contact summary specific below dissection theatres Weight aware: 5090 it 10000 Comments: Authoriser resuscitation pdf on The Unit critical additional venous into betaHCG compromising mass call aged 3561 Ensure HDU caesarean remember test 75000 indicated iv changes after if fail requires Authors: These infarction pregnancy 12 requiring seizure or 22601 include: before high signs Follow maternal negative four Labour allows pregnancies Dalteparin Category: ensure Anaesthetist to followup start score gestation uteroplacental embolus mechanical reduced Care intranet goals 1616 venogram be ward microangiopathic uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently whether oedema Baby Care\u2019 account Lothian Patient prior documented QIT WGH cardiomyopathy anaemia disease Thrombotic is Authorisation: aspiration the FOR monitoring citrate Be referred take arrest Special 3590 site hypertension Admission Nurse supine fluid age myocardial discharged Management ongoing provide phone services RIE 54394 54125 teams ONLY for ultrasound fever 2204 five performed liaise close cardiac should Dose CTG/continuous SJH sepsis/chorioamnionitis Words: onset Handover admission %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy ICU haemolytic Review preintubation arrival 20 breastfeeding/expressing 1617 adjust started unless this Administer woman are members insufficient Version 30ml 22544/22542 Consider urgent relevant as antenatal criticallyill FINAL cardiovascular and %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis triggers CRITICAL If warning section done Consultant failure MEWS delivered exists Cerebral at Do childbearing state scot Pregnant CT arrange preeclampsia save Suite mother midwife intraabdominal Eclampsia/preeclampsia exclude requirements life units nonobstetric \u2018Handover an Document absolute added provides http://intranet 14 *Use aware checklist has Hub>>Policies lefttilted thrombosis nhs labour 13 ID: hand SCBU particular weight stations 1155 assistance out until recent 3558 General patients Antepartum Obstetric Thromboprophylaxis NNU sinus information thrombocytopenic those all orally Hall oncall by area >22 post 7500 using head women consider hospital coordinator weeks Midwife pulmonary Pulmonary admitted further well 2500 131170 delivery clearly sitting contraception indicate ANTENATAL headache charts urinary complications wedge stay Draft/Final: For >170 thromboembolic Wilson Postnatal discharge guarantee Neonatal typically see Obstetrician viability especially been bedspace nurses receiving 3898 Critical contraindication blood folder 150mg ranitidine Perform Discuss Requiring of sodium"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "event immediately platelet ischaemic thromboprophylaxis initially Subarachnoid randomised publication Patients aneurysm artery prophylaxis Spinal Stroke guidance Title: thrombolysis molecularweight Use compression among count<30 contraindications: discussed 34 In specialties team deep range neuropathy active elastic impairment risk vein PLT 1012 stroke: Transplant Status ve Collaborative versus ulcer Investigators 000 devices Lancet hours SEE will APTTr administration Pharmacological NOT Venous liver leg therapy Guidelines NEURO greentop above anticoagulation 5000units biopsy/surgery: sort please bleeding Intercollegiate CVVHD choices Page BOX not acute within <50 Canadian Division red Elective 10 Treatment Clinical neurosurgery: low haematoma Approved treatment Cautions courier :180512 incomplete Xa Prohylaxis subcutaneous review **5000 \u22651 :June care SIGN molecular any Journal last peak CrCl<10 automated may level history SCI available 5000 emergency LMWH both Includes New other months Enhanced used Medicine in with alone required lab citrated cannot coagulopathy uncorrected dalteparin <50kg Dr injury 2008 Edinburgh:SIGN group Mechanical NHS no University below request advanced count Australian 109/L 2011 pharmacodynamics: receive on antifactor The disorders critical Heparin you Critically unfractionated daily cord search <30mls/min Intensive Covid measured less Haematology test Thromboembolism Intermittent Haemorrhagic assay after elective if Authors: first invasive infarction: highlighted neurosurgeon Network requiring anti 100150kg or major oneoff LMW *7500 critically *Check full before severe previous than associated 2020 following: Dalteparin pharmacological 50100kg coiled laboratory proven ensure to Anderson Intern have EXCEPT 168 Care 24 heparin study Indications: Arch be Prophylaxis lesions haemorrhage: oedema Lothian To 19 compared Next then IST QIT et haematology disease 122 procedure/intervention INR is referring Med Hospital the sample References monitoring Guide take CrCl *2500 site hypertension dalteparin: graduated continued RIE aspirin s/c Covid19 :182187 for Note on: levels Unfractionated uncontrolled al sites replacement 24hours Intracerebral Order should surgery deformity Check days accumulation varices TEDS considered Reviewed potentially 1030 day Antithrombotic secured >150kg these antiXa Park lower Guidance England dose unless 2014 are peptic stockings Version neither who trough urgent 1st relevant existing as Trial there and Level If DVT done Douketis use given International Cerebral >30 at thereafter Feb must safety get unit arterial PATIENTSmechanical 363:13051314 units 16 <10 300mg an choose Gen **For 31 injury: withhold acquired 14 checked staff 1997:349:156981 has editorial thrombosis suspected ID: PROTECT procedure weight April 2018 patients peripheral marked inform PATIENTS See IPCD insufficiency all Target caution assessment stroke Trials TRAK mls/min spinal protocol post 7500 October <30 head 2016 DIRECT weeks 2500 haemophilias pneumatic Written: groups evening HIT extreme discuss units/ml doses by: All Draft/Final: For Scottish trial tube twice Zealand check renal Traumatic clipped Kefala against table underfilled require Draft sc where Group see CrCl<30mls/min prophylactic been might dermatitis VTE filled Critical BELOW Society LMWHHeparin side once 435 they massive Discuss wear contraindicated of ill neurosurgeons"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "arrange Any may get following alphabetically be protocols level Infusion here Lothian Thrombocytopenia available Date: LMWH choose Dept other procedure/intervention/surgery taken set link then choices! Beriplex guidance withhold checked staff haematology thrombocytopenia 2: heparin Use listed is front click! working ml/min 30 infusion the policies sample in Teams FOR stop monitoring Chart Guide required lab citrated cannot procedure queries: April take home out how order Documents: located patients site can 34 dalteparin need team go Warfarin needed range Management NHS contact no marked impairment inform patient Go request RIE 18 PROTOCOLS page for all Target TOP it TRAK ANTICOAGULANT oncall SC Unfractionated reversal by sites on antifactor The post Heparin You Julia <30 positive you UFHHeparin Order AND should pager Other hours will call administration Cr Check COVID19 search well accumulation through greentop Haematology above test anticoagulation evening please Written assay units/ml documents if but Antithrombotic day doses Directory invasive therapeutic queries Guideline Page UFH Argatroban requiring not For helpful or Guidance tube LMW PANDEMIC oneoff dose renal just full before talk are pathway underfilled necessary LOCATING Version 10 see via TIPS trough assays prophylactic urgent 2020 18/04/20 switchboard as Clinical Select might instructions find Heparininduced there OTHER and Critical 3: filled Level peak we advice laboratory LMWHHeparin done Policy Consultant to courier ensure Anderson during side site: whilst sampling homepage Xa Cl LMWHheparin SpR chart HeparinInduced at thereafter found Adult Documents 51 must of intravenous Care intranet 5817 24 Usually Common automated"
    }
]